id	sid	tid	token	lemma	pos
admet-1622	1	1	challenges	challenge	NOUN
admet-1622	1	2	,	,	PUNCT
admet-1622	1	3	current	current	ADJ
admet-1622	1	4	status	status	NOUN
admet-1622	1	5	and	and	CCONJ
admet-1622	1	6	emerging	emerge	VERB
admet-1622	1	7	strategies	strategy	NOUN
admet-1622	1	8	in	in	ADP
admet-1622	1	9	the	the	DET
admet-1622	1	10	development	development	NOUN
admet-1622	1	11	of	of	ADP
admet-1622	1	12	rapidly	rapidly	ADV
admet-1622	1	13	dissolving	dissolve	VERB
admet-1622	1	14	fdm	fdm	NOUN
admet-1622	1	15	3d	3d	ADV
admet-1622	1	16	-	-	PUNCT
admet-1622	1	17	printed	print	VERB
admet-1622	1	18	tablets	tablet	NOUN
admet-1622	1	19	:	:	PUNCT
admet-1622	1	20	an	an	DET
admet-1622	1	21	overview	overview	NOUN
admet-1622	1	22	and	and	CCONJ
admet-1622	1	23	commentary	commentary	NOUN
admet-1622	1	24	doi	doi	PROPN
admet-1622	1	25	:	:	PUNCT
admet-1622	1	26	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	1	27	33	33	NUM
admet-1622	1	28	admet	admet	X
admet-1622	1	29	&	&	CCONJ
admet-1622	1	30	dmpk	dmpk	PROPN
admet-1622	1	31	11(1	11(1	NUM
admet-1622	1	32	)	)	PUNCT
admet-1622	1	33	(	(	PUNCT
admet-1622	1	34	2023	2023	NUM
admet-1622	1	35	)	)	PUNCT
admet-1622	1	36	33	33	NUM
admet-1622	1	37	-	-	SYM
admet-1622	1	38	55	55	NUM
admet-1622	1	39	;	;	PUNCT
admet-1622	1	40	doi	doi	NOUN
admet-1622	1	41	:	:	PUNCT
admet-1622	1	42	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	1	43	open	open	ADJ
admet-1622	1	44	access	access	NOUN
admet-1622	1	45	:	:	PUNCT
admet-1622	1	46	issn	issn	PROPN
admet-1622	1	47	:	:	PUNCT
admet-1622	1	48	1848	1848	NUM
admet-1622	1	49	-	-	SYM
admet-1622	1	50	7718	7718	NUM
admet-1622	1	51	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-1622	1	52	review	review	NOUN
admet-1622	1	53	challenges	challenge	NOUN
admet-1622	1	54	,	,	PUNCT
admet-1622	1	55	current	current	ADJ
admet-1622	1	56	status	status	NOUN
admet-1622	1	57	and	and	CCONJ
admet-1622	1	58	emerging	emerge	VERB
admet-1622	1	59	strategies	strategy	NOUN
admet-1622	1	60	in	in	ADP
admet-1622	1	61	the	the	DET
admet-1622	1	62	development	development	NOUN
admet-1622	1	63	of	of	ADP
admet-1622	1	64	rapidly	rapidly	ADV
admet-1622	1	65	dissolving	dissolve	VERB
admet-1622	1	66	fdm	fdm	NOUN
admet-1622	1	67	3d	3d	ADV
admet-1622	1	68	-	-	PUNCT
admet-1622	1	69	printed	print	VERB
admet-1622	1	70	tablets	tablet	NOUN
admet-1622	1	71	:	:	PUNCT
admet-1622	1	72	an	an	DET
admet-1622	1	73	overview	overview	NOUN
admet-1622	1	74	and	and	CCONJ
admet-1622	1	75	commentary	commentary	NOUN
admet-1622	1	76	abu	abu	PROPN
admet-1622	1	77	t.m	t.m	PROPN
admet-1622	1	78	.	.	PROPN
admet-1622	1	79	serajuddin	serajuddin	PROPN
admet-1622	1	80	department	department	PROPN
admet-1622	1	81	of	of	ADP
admet-1622	1	82	pharmaceutical	pharmaceutical	NOUN
admet-1622	1	83	sciences	science	NOUN
admet-1622	1	84	,	,	PUNCT
admet-1622	1	85	college	college	NOUN
admet-1622	1	86	of	of	ADP
admet-1622	1	87	pharmacy	pharmacy	NOUN
admet-1622	1	88	and	and	CCONJ
admet-1622	1	89	health	health	NOUN
admet-1622	1	90	sciences	sciences	PROPN
admet-1622	1	91	,	,	PUNCT
admet-1622	1	92	st	st	PROPN
admet-1622	1	93	.	.	PROPN
admet-1622	1	94	john	john	PROPN
admet-1622	1	95	’s	’s	PROPN
admet-1622	1	96	university	university	PROPN
admet-1622	1	97	,	,	PUNCT
admet-1622	1	98	8000	8000	NUM
admet-1622	1	99	utopia	utopia	NOUN
admet-1622	1	100	parkway	parkway	PROPN
admet-1622	1	101	,	,	PUNCT
admet-1622	1	102	queens	queen	NOUN
admet-1622	1	103	,	,	PUNCT
admet-1622	1	104	ny	ny	PROPN
admet-1622	1	105	11439	11439	NUM
admet-1622	1	106	,	,	PUNCT
admet-1622	1	107	usa	usa	PROPN
admet-1622	1	108	;	;	PUNCT
admet-1622	1	109	serajuda@stjohns.edu	serajuda@stjohns.edu	PROPN
admet-1622	1	110	received	receive	VERB
admet-1622	1	111	:	:	PUNCT
admet-1622	1	112	november	november	PROPN
admet-1622	1	113	27	27	NUM
admet-1622	1	114	,	,	PUNCT
admet-1622	1	115	2022	2022	NUM
admet-1622	1	116	;	;	PUNCT
admet-1622	1	117	revised	revise	VERB
admet-1622	1	118	:	:	PUNCT
admet-1622	1	119	december	december	PROPN
admet-1622	1	120	13	13	NUM
admet-1622	1	121	,	,	PUNCT
admet-1622	1	122	2022	2022	NUM
admet-1622	1	123	;	;	PUNCT
admet-1622	1	124	published	publish	VERB
admet-1622	1	125	:	:	PUNCT
admet-1622	1	126	january	january	PROPN
admet-1622	1	127	01	01	NUM
admet-1622	1	128	,	,	PUNCT
admet-1622	1	129	2023	2023	NUM
admet-1622	1	130	abstract	abstract	NOUN
admet-1622	1	131	since	since	SCONJ
admet-1622	1	132	the	the	DET
admet-1622	1	133	approval	approval	NOUN
admet-1622	1	134	of	of	ADP
admet-1622	1	135	a	a	DET
admet-1622	1	136	3d	3d	NOUN
admet-1622	1	137	-	-	PUNCT
admet-1622	1	138	printed	print	VERB
admet-1622	1	139	tablet	tablet	NOUN
admet-1622	1	140	by	by	ADP
admet-1622	1	141	the	the	DET
admet-1622	1	142	fda	fda	PROPN
admet-1622	1	143	in	in	ADP
admet-1622	1	144	2015	2015	NUM
admet-1622	1	145	for	for	ADP
admet-1622	1	146	marketing	marketing	NOUN
admet-1622	1	147	,	,	PUNCT
admet-1622	1	148	there	there	PRON
admet-1622	1	149	has	have	AUX
admet-1622	1	150	been	be	AUX
admet-1622	1	151	a	a	DET
admet-1622	1	152	great	great	ADJ
admet-1622	1	153	interest	interest	NOUN
admet-1622	1	154	in	in	ADP
admet-1622	1	155	3d	3d	NUM
admet-1622	1	156	printing	printing	NOUN
admet-1622	1	157	in	in	ADP
admet-1622	1	158	the	the	DET
admet-1622	1	159	pharmaceutical	pharmaceutical	ADJ
admet-1622	1	160	field	field	NOUN
admet-1622	1	161	for	for	ADP
admet-1622	1	162	the	the	DET
admet-1622	1	163	development	development	NOUN
admet-1622	1	164	of	of	ADP
admet-1622	1	165	personalized	personalized	ADJ
admet-1622	1	166	and	and	CCONJ
admet-1622	1	167	on	on	ADP
admet-1622	1	168	-	-	PUNCT
admet-1622	1	169	demand	demand	NOUN
admet-1622	1	170	medications	medication	NOUN
admet-1622	1	171	.	.	PUNCT
admet-1622	2	1	among	among	ADP
admet-1622	2	2	various	various	ADJ
admet-1622	2	3	3d	3d	NUM
admet-1622	2	4	printing	printing	NOUN
admet-1622	2	5	methods	method	NOUN
admet-1622	2	6	explored	explore	VERB
admet-1622	2	7	for	for	ADP
admet-1622	2	8	the	the	DET
admet-1622	2	9	development	development	NOUN
admet-1622	2	10	of	of	ADP
admet-1622	2	11	oral	oral	ADJ
admet-1622	2	12	solid	solid	ADJ
admet-1622	2	13	dosage	dosage	NOUN
admet-1622	2	14	form	form	NOUN
admet-1622	2	15	like	like	ADP
admet-1622	2	16	tablet	tablet	NOUN
admet-1622	2	17	,	,	PUNCT
admet-1622	2	18	the	the	DET
admet-1622	2	19	fused	fuse	VERB
admet-1622	2	20	deposition	deposition	NOUN
admet-1622	2	21	modeling	modeling	NOUN
admet-1622	2	22	(	(	PUNCT
admet-1622	2	23	fdm	fdm	NOUN
admet-1622	2	24	)	)	PUNCT
admet-1622	2	25	3d	3d	NOUN
admet-1622	2	26	-	-	PUNCT
admet-1622	2	27	printing	printing	NOUN
admet-1622	2	28	,	,	PUNCT
admet-1622	2	29	where	where	SCONJ
admet-1622	2	30	the	the	DET
admet-1622	2	31	drug	drug	NOUN
admet-1622	2	32	-	-	PUNCT
admet-1622	2	33	polymer	polymer	NOUN
admet-1622	2	34	mixtures	mixture	NOUN
admet-1622	2	35	are	be	AUX
admet-1622	2	36	first	first	ADV
admet-1622	2	37	converted	convert	VERB
admet-1622	2	38	into	into	ADP
admet-1622	2	39	filaments	filament	NOUN
admet-1622	2	40	by	by	ADP
admet-1622	2	41	hot	hot	ADJ
admet-1622	2	42	melt	melt	NOUN
admet-1622	2	43	extrusion	extrusion	NOUN
admet-1622	2	44	(	(	PUNCT
admet-1622	2	45	hme	hme	NOUN
admet-1622	2	46	)	)	PUNCT
admet-1622	2	47	and	and	CCONJ
admet-1622	2	48	then	then	ADV
admet-1622	2	49	the	the	DET
admet-1622	2	50	filaments	filament	NOUN
admet-1622	2	51	are	be	AUX
admet-1622	2	52	printed	print	VERB
admet-1622	2	53	into	into	ADP
admet-1622	2	54	tablets	tablet	NOUN
admet-1622	2	55	using	use	VERB
admet-1622	2	56	3d	3d	NUM
admet-1622	2	57	printers	printer	NOUN
admet-1622	2	58	by	by	ADP
admet-1622	2	59	applying	apply	VERB
admet-1622	2	60	computer	computer	NOUN
admet-1622	2	61	-	-	PUNCT
admet-1622	2	62	aided	aid	VERB
admet-1622	2	63	design	design	NOUN
admet-1622	2	64	principles	principle	NOUN
admet-1622	2	65	,	,	PUNCT
admet-1622	2	66	has	have	AUX
admet-1622	2	67	emerged	emerge	VERB
admet-1622	2	68	as	as	ADP
admet-1622	2	69	the	the	DET
admet-1622	2	70	most	most	ADV
admet-1622	2	71	attractive	attractive	ADJ
admet-1622	2	72	option	option	NOUN
admet-1622	2	73	.	.	PUNCT
admet-1622	3	1	however	however	ADV
admet-1622	3	2	,	,	PUNCT
admet-1622	3	3	no	no	DET
admet-1622	3	4	fdm	fdm	NOUN
admet-1622	3	5	3d	3d	ADV
admet-1622	3	6	-	-	PUNCT
admet-1622	3	7	printed	print	VERB
admet-1622	3	8	tablets	tablet	NOUN
admet-1622	3	9	have	have	AUX
admet-1622	3	10	yet	yet	ADV
admet-1622	3	11	been	be	AUX
admet-1622	3	12	marketed	market	VERB
admet-1622	3	13	as	as	SCONJ
admet-1622	3	14	the	the	DET
admet-1622	3	15	technology	technology	NOUN
admet-1622	3	16	faces	face	VERB
admet-1622	3	17	many	many	ADJ
admet-1622	3	18	challenges	challenge	NOUN
admet-1622	3	19	,	,	PUNCT
admet-1622	3	20	such	such	ADJ
admet-1622	3	21	as	as	ADP
admet-1622	3	22	limited	limited	ADJ
admet-1622	3	23	availability	availability	NOUN
admet-1622	3	24	of	of	ADP
admet-1622	3	25	pharmaceutical	pharmaceutical	NOUN
admet-1622	3	26	-	-	PUNCT
admet-1622	3	27	grade	grade	NOUN
admet-1622	3	28	polymers	polymer	NOUN
admet-1622	3	29	that	that	PRON
admet-1622	3	30	can	can	AUX
admet-1622	3	31	be	be	AUX
admet-1622	3	32	printed	print	VERB
admet-1622	3	33	into	into	ADP
admet-1622	3	34	tablets	tablet	NOUN
admet-1622	3	35	,	,	PUNCT
admet-1622	3	36	low	low	ADJ
admet-1622	3	37	drug	drug	NOUN
admet-1622	3	38	-	-	PUNCT
admet-1622	3	39	polymer	polymer	NOUN
admet-1622	3	40	miscibility	miscibility	NOUN
admet-1622	3	41	,	,	PUNCT
admet-1622	3	42	the	the	DET
admet-1622	3	43	need	need	NOUN
admet-1622	3	44	for	for	ADP
admet-1622	3	45	high	high	ADJ
admet-1622	3	46	temperature	temperature	NOUN
admet-1622	3	47	for	for	ADP
admet-1622	3	48	hme	hme	NOUN
admet-1622	3	49	and	and	CCONJ
admet-1622	3	50	3d	3d	NOUN
admet-1622	3	51	-	-	PUNCT
admet-1622	3	52	printing	printing	NOUN
admet-1622	3	53	,	,	PUNCT
admet-1622	3	54	and	and	CCONJ
admet-1622	3	55	slow	slow	ADJ
admet-1622	3	56	drug	drug	NOUN
admet-1622	3	57	release	release	NOUN
admet-1622	3	58	rates	rate	NOUN
admet-1622	3	59	from	from	ADP
admet-1622	3	60	tablets	tablet	NOUN
admet-1622	3	61	.	.	PUNCT
admet-1622	4	1	these	these	DET
admet-1622	4	2	challenges	challenge	NOUN
admet-1622	4	3	are	be	AUX
admet-1622	4	4	discussed	discuss	VERB
admet-1622	4	5	in	in	ADP
admet-1622	4	6	this	this	DET
admet-1622	4	7	article	article	NOUN
admet-1622	4	8	with	with	ADP
admet-1622	4	9	a	a	DET
admet-1622	4	10	special	special	ADJ
admet-1622	4	11	focus	focus	NOUN
admet-1622	4	12	on	on	ADP
admet-1622	4	13	drug	drug	NOUN
admet-1622	4	14	release	release	NOUN
admet-1622	4	15	rates	rate	NOUN
admet-1622	4	16	since	since	SCONJ
admet-1622	4	17	fdm	fdm	NOUN
admet-1622	4	18	3d	3d	NOUN
admet-1622	4	19	-	-	PUNCT
admet-1622	4	20	printing	printing	NOUN
admet-1622	4	21	usually	usually	ADV
admet-1622	4	22	leads	lead	VERB
admet-1622	4	23	to	to	ADP
admet-1622	4	24	the	the	DET
admet-1622	4	25	preparation	preparation	NOUN
admet-1622	4	26	of	of	ADP
admet-1622	4	27	slow	slow	ADJ
admet-1622	4	28	-	-	PUNCT
admet-1622	4	29	release	release	NOUN
admet-1622	4	30	tablets	tablet	NOUN
admet-1622	4	31	while	while	SCONJ
admet-1622	4	32	the	the	DET
admet-1622	4	33	rapid	rapid	ADJ
admet-1622	4	34	release	release	NOUN
admet-1622	4	35	from	from	ADP
admet-1622	4	36	dosage	dosage	NOUN
admet-1622	4	37	forms	form	NOUN
admet-1622	4	38	is	be	AUX
admet-1622	4	39	often	often	ADV
admet-1622	4	40	desired	desire	VERB
admet-1622	4	41	for	for	ADP
admet-1622	4	42	optimal	optimal	ADJ
admet-1622	4	43	therapeutic	therapeutic	ADJ
admet-1622	4	44	outcomes	outcome	NOUN
admet-1622	4	45	of	of	ADP
admet-1622	4	46	new	new	ADJ
admet-1622	4	47	drug	drug	NOUN
admet-1622	4	48	candidates	candidate	NOUN
admet-1622	4	49	.	.	PUNCT
admet-1622	5	1	pros	pro	NOUN
admet-1622	5	2	and	and	CCONJ
admet-1622	5	3	cons	con	NOUN
admet-1622	5	4	of	of	ADP
admet-1622	5	5	various	various	ADJ
admet-1622	5	6	strategies	strategy	NOUN
admet-1622	5	7	for	for	ADP
admet-1622	5	8	the	the	DET
admet-1622	5	9	development	development	NOUN
admet-1622	5	10	of	of	ADP
admet-1622	5	11	rapidly	rapidly	ADV
admet-1622	5	12	dissolving	dissolve	VERB
admet-1622	5	13	fdm	fdm	NOUN
admet-1622	5	14	3d	3d	ADV
admet-1622	5	15	-	-	PUNCT
admet-1622	5	16	printed	print	VERB
admet-1622	5	17	tablets	tablet	NOUN
admet-1622	5	18	reported	report	VERB
admet-1622	5	19	in	in	ADP
admet-1622	5	20	the	the	DET
admet-1622	5	21	literature	literature	NOUN
admet-1622	5	22	are	be	AUX
admet-1622	5	23	reviewed	review	VERB
admet-1622	5	24	.	.	PUNCT
admet-1622	6	1	finally	finally	ADV
admet-1622	6	2	,	,	PUNCT
admet-1622	6	3	two	two	NUM
admet-1622	6	4	case	case	NOUN
admet-1622	6	5	studies	study	NOUN
admet-1622	6	6	on	on	ADP
admet-1622	6	7	emerging	emerge	VERB
admet-1622	6	8	strategies	strategy	NOUN
admet-1622	6	9	for	for	ADP
admet-1622	6	10	the	the	DET
admet-1622	6	11	development	development	NOUN
admet-1622	6	12	of	of	ADP
admet-1622	6	13	rapidly	rapidly	ADV
admet-1622	6	14	dissolving	dissolve	VERB
admet-1622	6	15	fdm	fdm	NOUN
admet-1622	6	16	3d	3d	ADV
admet-1622	6	17	-	-	PUNCT
admet-1622	6	18	printed	print	VERB
admet-1622	6	19	tablets	tablet	NOUN
admet-1622	6	20	are	be	AUX
admet-1622	6	21	presented	present	VERB
admet-1622	6	22	,	,	PUNCT
admet-1622	6	23	where	where	SCONJ
admet-1622	6	24	one	one	PRON
admet-1622	6	25	outlines	outline	VERB
admet-1622	6	26	a	a	DET
admet-1622	6	27	systematic	systematic	ADJ
admet-1622	6	28	approach	approach	NOUN
admet-1622	6	29	for	for	ADP
admet-1622	6	30	formulating	formulate	VERB
admet-1622	6	31	rapidly	rapidly	ADV
admet-1622	6	32	dissolving	dissolve	VERB
admet-1622	6	33	tablets	tablet	NOUN
admet-1622	6	34	,	,	PUNCT
admet-1622	6	35	and	and	CCONJ
admet-1622	6	36	the	the	DET
admet-1622	6	37	other	other	ADJ
admet-1622	6	38	describes	describe	VERB
admet-1622	6	39	a	a	DET
admet-1622	6	40	novel	novel	ADJ
admet-1622	6	41	strategy	strategy	NOUN
admet-1622	6	42	to	to	PART
admet-1622	6	43	increase	increase	VERB
admet-1622	6	44	dissolution	dissolution	ADJ
admet-1622	6	45	rates	rate	NOUN
admet-1622	6	46	of	of	ADP
admet-1622	6	47	drugs	drug	NOUN
admet-1622	6	48	from	from	ADP
admet-1622	6	49	fdm	fdm	NOUN
admet-1622	6	50	3d	3d	ADV
admet-1622	6	51	-	-	PUNCT
admet-1622	6	52	printed	print	VERB
admet-1622	6	53	tablets	tablet	NOUN
admet-1622	6	54	,	,	PUNCT
admet-1622	6	55	which	which	PRON
admet-1622	6	56	at	at	ADP
admet-1622	6	57	the	the	DET
admet-1622	6	58	same	same	ADJ
admet-1622	6	59	time	time	NOUN
admet-1622	6	60	can	can	AUX
admet-1622	6	61	also	also	ADV
admet-1622	6	62	increase	increase	VERB
admet-1622	6	63	drug	drug	NOUN
admet-1622	6	64	-	-	PUNCT
admet-1622	6	65	polymer	polymer	NOUN
admet-1622	6	66	miscibility	miscibility	NOUN
admet-1622	6	67	and	and	CCONJ
admet-1622	6	68	printability	printability	NOUN
admet-1622	6	69	of	of	ADP
admet-1622	6	70	tablets	tablet	NOUN
admet-1622	6	71	and	and	CCONJ
admet-1622	6	72	lower	low	ADJ
admet-1622	6	73	processing	processing	NOUN
admet-1622	6	74	temperatures	temperature	NOUN
admet-1622	6	75	.	.	PUNCT
admet-1622	7	1	thus	thus	ADV
admet-1622	7	2	,	,	PUNCT
admet-1622	7	3	this	this	DET
admet-1622	7	4	overview	overview	NOUN
admet-1622	7	5	and	and	CCONJ
admet-1622	7	6	commentary	commentary	NOUN
admet-1622	7	7	discusses	discuss	VERB
admet-1622	7	8	various	various	ADJ
admet-1622	7	9	issues	issue	NOUN
admet-1622	7	10	involving	involve	VERB
admet-1622	7	11	the	the	DET
admet-1622	7	12	formulation	formulation	NOUN
admet-1622	7	13	of	of	ADP
admet-1622	7	14	rapidly	rapidly	ADV
admet-1622	7	15	dissolving	dissolve	VERB
admet-1622	7	16	fdm	fdm	NOUN
admet-1622	7	17	3d	3d	ADV
admet-1622	7	18	-	-	PUNCT
admet-1622	7	19	printed	print	VERB
admet-1622	7	20	tablets	tablet	NOUN
admet-1622	7	21	and	and	CCONJ
admet-1622	7	22	provides	provide	VERB
admet-1622	7	23	guidance	guidance	NOUN
admet-1622	7	24	for	for	ADP
admet-1622	7	25	the	the	DET
admet-1622	7	26	development	development	NOUN
admet-1622	7	27	of	of	ADP
admet-1622	7	28	commercially	commercially	ADV
admet-1622	7	29	viable	viable	ADJ
admet-1622	7	30	products	product	NOUN
admet-1622	7	31	.	.	PUNCT
admet-1622	8	1	©	©	PROPN
admet-1622	8	2	2023	2023	NUM
admet-1622	8	3	by	by	ADP
admet-1622	8	4	the	the	DET
admet-1622	8	5	authors	author	NOUN
admet-1622	8	6	.	.	PUNCT
admet-1622	9	1	this	this	DET
admet-1622	9	2	article	article	NOUN
admet-1622	9	3	is	be	AUX
admet-1622	9	4	an	an	DET
admet-1622	9	5	open	open	ADJ
admet-1622	9	6	-	-	PUNCT
admet-1622	9	7	access	access	NOUN
admet-1622	9	8	article	article	NOUN
admet-1622	9	9	distributed	distribute	VERB
admet-1622	9	10	under	under	ADP
admet-1622	9	11	the	the	DET
admet-1622	9	12	terms	term	NOUN
admet-1622	9	13	and	and	CCONJ
admet-1622	9	14	conditions	condition	NOUN
admet-1622	9	15	of	of	ADP
admet-1622	9	16	the	the	DET
admet-1622	9	17	creative	creative	ADJ
admet-1622	9	18	commons	common	NOUN
admet-1622	9	19	attribution	attribution	NOUN
admet-1622	9	20	license	license	NOUN
admet-1622	9	21	(	(	PUNCT
admet-1622	9	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-1622	9	23	)	)	PUNCT
admet-1622	9	24	.	.	PUNCT
admet-1622	10	1	keywords	keyword	VERB
admet-1622	10	2	3d	3d	NUM
admet-1622	10	3	printing	printing	NOUN
admet-1622	10	4	;	;	PUNCT
admet-1622	10	5	fused	fuse	VERB
admet-1622	10	6	deposition	deposition	NOUN
admet-1622	10	7	modeling	modeling	NOUN
admet-1622	10	8	;	;	PUNCT
admet-1622	10	9	hot	hot	ADJ
admet-1622	10	10	melt	melt	NOUN
admet-1622	10	11	extrusion	extrusion	NOUN
admet-1622	10	12	;	;	PUNCT
admet-1622	10	13	3d	3d	NUM
admet-1622	10	14	-	-	PUNCT
admet-1622	10	15	printed	print	VERB
admet-1622	10	16	tablet	tablet	NOUN
admet-1622	10	17	;	;	PUNCT
admet-1622	10	18	drug	drug	NOUN
admet-1622	10	19	release	release	NOUN
admet-1622	10	20	;	;	PUNCT
admet-1622	10	21	rapid	rapid	ADJ
admet-1622	10	22	dissolution	dissolution	NOUN
admet-1622	10	23	introduction	introduction	NOUN
admet-1622	10	24	three	three	NUM
admet-1622	10	25	-	-	PUNCT
admet-1622	10	26	dimensional	dimensional	ADJ
admet-1622	10	27	(	(	PUNCT
admet-1622	10	28	3d	3d	NOUN
admet-1622	10	29	)	)	PUNCT
admet-1622	10	30	printing	printing	NOUN
admet-1622	10	31	,	,	PUNCT
admet-1622	10	32	where	where	SCONJ
admet-1622	10	33	materials	material	NOUN
admet-1622	10	34	are	be	AUX
admet-1622	10	35	deposited	deposit	VERB
admet-1622	10	36	layer	layer	NOUN
admet-1622	10	37	by	by	ADP
admet-1622	10	38	layer	layer	NOUN
admet-1622	10	39	to	to	PART
admet-1622	10	40	form	form	VERB
admet-1622	10	41	solid	solid	ADJ
admet-1622	10	42	objects	object	NOUN
admet-1622	10	43	,	,	PUNCT
admet-1622	10	44	has	have	AUX
admet-1622	10	45	gained	gain	VERB
admet-1622	10	46	much	much	ADJ
admet-1622	10	47	interest	interest	NOUN
admet-1622	10	48	in	in	ADP
admet-1622	10	49	the	the	DET
admet-1622	10	50	pharmaceutical	pharmaceutical	ADJ
admet-1622	10	51	field	field	NOUN
admet-1622	10	52	as	as	SCONJ
admet-1622	10	53	it	it	PRON
admet-1622	10	54	can	can	AUX
admet-1622	10	55	deliver	deliver	VERB
admet-1622	10	56	personalized	personalized	ADJ
admet-1622	10	57	and	and	CCONJ
admet-1622	10	58	on	on	ADP
admet-1622	10	59	-	-	PUNCT
admet-1622	10	60	demand	demand	NOUN
admet-1622	10	61	medications	medication	NOUN
admet-1622	10	62	,	,	PUNCT
admet-1622	10	63	such	such	ADJ
admet-1622	10	64	as	as	ADP
admet-1622	10	65	tablets	tablet	NOUN
admet-1622	10	66	,	,	PUNCT
admet-1622	10	67	to	to	ADP
admet-1622	10	68	patients	patient	NOUN
admet-1622	10	69	for	for	ADP
admet-1622	10	70	better	well	ADJ
admet-1622	10	71	therapy	therapy	NOUN
admet-1622	11	1	[	[	X
admet-1622	11	2	1	1	NUM
admet-1622	11	3	]	]	PUNCT
admet-1622	11	4	.	.	PUNCT
admet-1622	12	1	3d	3d	NOUN
admet-1622	12	2	-	-	PUNCT
admet-1622	12	3	printing	printing	NOUN
admet-1622	12	4	is	be	AUX
admet-1622	12	5	essentially	essentially	ADV
admet-1622	12	6	a	a	DET
admet-1622	12	7	form	form	NOUN
admet-1622	12	8	of	of	ADP
admet-1622	12	9	additive	additive	ADJ
admet-1622	12	10	manufacturing	manufacturing	NOUN
admet-1622	12	11	(	(	PUNCT
admet-1622	12	12	am	be	AUX
admet-1622	12	13	)	)	PUNCT
admet-1622	12	14	that	that	PRON
admet-1622	12	15	is	be	AUX
admet-1622	12	16	extensively	extensively	ADV
admet-1622	12	17	used	use	VERB
admet-1622	12	18	in	in	ADP
admet-1622	12	19	many	many	ADJ
admet-1622	12	20	different	different	ADJ
admet-1622	12	21	industries	industry	NOUN
admet-1622	12	22	[	[	X
admet-1622	12	23	2	2	NUM
admet-1622	12	24	]	]	PUNCT
admet-1622	12	25	.	.	PUNCT
admet-1622	13	1	the	the	DET
admet-1622	13	2	interest	interest	NOUN
admet-1622	13	3	in	in	ADP
admet-1622	13	4	3d	3d	NUM
admet-1622	13	5	printing	printing	NOUN
admet-1622	13	6	in	in	ADP
admet-1622	13	7	the	the	DET
admet-1622	13	8	pharmaceutical	pharmaceutical	NOUN
admet-1622	13	9	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	X
admet-1622	13	10	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	ADJ
admet-1622	13	11	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-1622	13	12	mailto:serajuda@stjohns.edu	mailto:serajuda@stjohns.edu	VERB
admet-1622	13	13	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-1622	13	14	abu	abu	PROPN
admet-1622	13	15	t.m	t.m	PROPN
admet-1622	13	16	.	.	PUNCT
admet-1622	14	1	serajuddin	serajuddin	VERB
admet-1622	14	2	admet	admet	PROPN
admet-1622	14	3	&	&	CCONJ
admet-1622	14	4	dmpk	dmpk	PROPN
admet-1622	14	5	11(1	11(1	NUM
admet-1622	14	6	)	)	PUNCT
admet-1622	14	7	(	(	PUNCT
admet-1622	14	8	2023	2023	NUM
admet-1622	14	9	)	)	PUNCT
admet-1622	14	10	33	33	NUM
admet-1622	14	11	-	-	SYM
admet-1622	14	12	55	55	NUM
admet-1622	14	13	34	34	NUM
admet-1622	14	14	field	field	NOUN
admet-1622	14	15	has	have	AUX
admet-1622	14	16	been	be	AUX
admet-1622	14	17	most	most	ADV
admet-1622	14	18	intense	intense	ADJ
admet-1622	14	19	since	since	SCONJ
admet-1622	14	20	the	the	DET
admet-1622	14	21	approval	approval	NOUN
admet-1622	14	22	of	of	ADP
admet-1622	14	23	a	a	DET
admet-1622	14	24	3d	3d	NOUN
admet-1622	14	25	-	-	PUNCT
admet-1622	14	26	printed	print	VERB
admet-1622	14	27	tablet	tablet	NOUN
admet-1622	14	28	,	,	PUNCT
admet-1622	14	29	spiritam	spiritam	NOUN
admet-1622	14	30	®	®	PROPN
admet-1622	14	31	,	,	PUNCT
admet-1622	14	32	by	by	ADP
admet-1622	14	33	the	the	DET
admet-1622	14	34	us	us	PROPN
admet-1622	14	35	food	food	NOUN
admet-1622	14	36	and	and	CCONJ
admet-1622	14	37	drug	drug	PROPN
admet-1622	14	38	administration	administration	NOUN
admet-1622	14	39	in	in	ADP
admet-1622	14	40	2015	2015	NUM
admet-1622	14	41	[	[	X
admet-1622	14	42	3	3	NUM
admet-1622	14	43	]	]	PUNCT
admet-1622	14	44	,	,	PUNCT
admet-1622	14	45	which	which	PRON
admet-1622	14	46	is	be	AUX
admet-1622	14	47	evident	evident	ADJ
admet-1622	14	48	from	from	ADP
admet-1622	14	49	the	the	DET
admet-1622	14	50	exponential	exponential	ADJ
admet-1622	14	51	increase	increase	NOUN
admet-1622	14	52	in	in	ADP
admet-1622	14	53	the	the	DET
admet-1622	14	54	number	number	NOUN
admet-1622	14	55	of	of	ADP
admet-1622	14	56	publications	publication	NOUN
admet-1622	14	57	on	on	ADP
admet-1622	14	58	3d	3d	NUM
admet-1622	14	59	printing	printing	NOUN
admet-1622	14	60	of	of	ADP
admet-1622	14	61	pharmaceutical	pharmaceutical	ADJ
admet-1622	14	62	products	product	NOUN
admet-1622	14	63	in	in	ADP
admet-1622	14	64	recent	recent	ADJ
admet-1622	14	65	years	year	NOUN
admet-1622	15	1	[	[	X
admet-1622	15	2	4	4	NUM
admet-1622	15	3	,	,	PUNCT
admet-1622	15	4	5	5	NUM
admet-1622	15	5	]	]	PUNCT
admet-1622	15	6	.	.	PUNCT
admet-1622	16	1	various	various	ADJ
admet-1622	16	2	opportunities	opportunity	NOUN
admet-1622	16	3	provided	provide	VERB
admet-1622	16	4	by	by	ADP
admet-1622	16	5	3d	3d	NUM
admet-1622	16	6	printing	printing	NOUN
admet-1622	16	7	technology	technology	NOUN
admet-1622	16	8	in	in	ADP
admet-1622	16	9	the	the	DET
admet-1622	16	10	pharmaceutical	pharmaceutical	ADJ
admet-1622	16	11	field	field	NOUN
admet-1622	16	12	and	and	CCONJ
admet-1622	16	13	different	different	ADJ
admet-1622	16	14	challenges	challenge	NOUN
admet-1622	16	15	currently	currently	ADV
admet-1622	16	16	facing	face	VERB
admet-1622	16	17	its	its	PRON
admet-1622	16	18	application	application	NOUN
admet-1622	16	19	in	in	ADP
admet-1622	16	20	the	the	DET
admet-1622	16	21	development	development	NOUN
admet-1622	16	22	of	of	ADP
admet-1622	16	23	drug	drug	NOUN
admet-1622	16	24	products	product	NOUN
admet-1622	16	25	have	have	AUX
admet-1622	16	26	been	be	AUX
admet-1622	16	27	extensively	extensively	ADV
admet-1622	16	28	reviewed	review	VERB
admet-1622	16	29	in	in	ADP
admet-1622	16	30	the	the	DET
admet-1622	16	31	literature	literature	NOUN
admet-1622	16	32	[	[	X
admet-1622	16	33	6	6	NUM
admet-1622	16	34	-	-	SYM
admet-1622	16	35	12	12	NUM
admet-1622	16	36	]	]	PUNCT
admet-1622	16	37	.	.	PUNCT
admet-1622	17	1	several	several	ADJ
admet-1622	17	2	different	different	ADJ
admet-1622	17	3	3d	3d	NOUN
admet-1622	17	4	-	-	PUNCT
admet-1622	17	5	printing	print	VERB
admet-1622	17	6	techniques	technique	NOUN
admet-1622	17	7	,	,	PUNCT
admet-1622	17	8	such	such	ADJ
admet-1622	17	9	as	as	ADP
admet-1622	17	10	binder	binder	NOUN
admet-1622	17	11	jet	jet	NOUN
admet-1622	17	12	printing	printing	NOUN
admet-1622	17	13	,	,	PUNCT
admet-1622	17	14	fused	fuse	VERB
admet-1622	17	15	deposition	deposition	NOUN
admet-1622	17	16	modeling	modeling	NOUN
admet-1622	17	17	(	(	PUNCT
admet-1622	17	18	fdm	fdm	NOUN
admet-1622	17	19	)	)	PUNCT
admet-1622	17	20	,	,	PUNCT
admet-1622	17	21	semisolid	semisolid	NOUN
admet-1622	17	22	extrusion	extrusion	NOUN
admet-1622	17	23	(	(	PUNCT
admet-1622	17	24	sse	sse	NOUN
admet-1622	17	25	)	)	PUNCT
admet-1622	17	26	,	,	PUNCT
admet-1622	17	27	selective	selective	ADJ
admet-1622	17	28	laser	laser	NOUN
admet-1622	17	29	sintering	sinter	VERB
admet-1622	17	30	(	(	PUNCT
admet-1622	17	31	sls	sls	NOUN
admet-1622	17	32	)	)	PUNCT
admet-1622	17	33	,	,	PUNCT
admet-1622	17	34	and	and	CCONJ
admet-1622	17	35	stereolithography	stereolithography	NOUN
admet-1622	17	36	(	(	PUNCT
admet-1622	17	37	sla	sla	PROPN
admet-1622	17	38	)	)	PUNCT
admet-1622	17	39	,	,	PUNCT
admet-1622	17	40	have	have	AUX
admet-1622	17	41	been	be	AUX
admet-1622	17	42	employed	employ	VERB
admet-1622	17	43	for	for	ADP
admet-1622	17	44	the	the	DET
admet-1622	17	45	manufacture	manufacture	NOUN
admet-1622	17	46	of	of	ADP
admet-1622	17	47	tablets	tablet	NOUN
admet-1622	17	48	[	[	X
admet-1622	17	49	1,11	1,11	X
admet-1622	17	50	]	]	X
admet-1622	17	51	.	.	PUNCT
admet-1622	18	1	among	among	ADP
admet-1622	18	2	these	these	DET
admet-1622	18	3	techniques	technique	NOUN
admet-1622	18	4	,	,	PUNCT
admet-1622	18	5	fused	fuse	VERB
admet-1622	18	6	deposition	deposition	NOUN
admet-1622	18	7	modeling	modeling	NOUN
admet-1622	18	8	(	(	PUNCT
admet-1622	18	9	fdm	fdm	NOUN
admet-1622	18	10	)	)	PUNCT
admet-1622	18	11	3d	3d	NOUN
admet-1622	18	12	-	-	PUNCT
admet-1622	18	13	printing	printing	NOUN
admet-1622	18	14	is	be	AUX
admet-1622	18	15	the	the	DET
admet-1622	18	16	most	most	ADV
admet-1622	18	17	popular	popular	ADJ
admet-1622	18	18	and	and	CCONJ
admet-1622	18	19	widely	widely	ADV
admet-1622	18	20	used	use	VERB
admet-1622	18	21	for	for	ADP
admet-1622	18	22	the	the	DET
admet-1622	18	23	development	development	NOUN
admet-1622	18	24	of	of	ADP
admet-1622	18	25	solid	solid	ADJ
admet-1622	18	26	dosage	dosage	NOUN
admet-1622	18	27	forms	form	NOUN
admet-1622	18	28	like	like	ADP
admet-1622	18	29	tablets	tablet	NOUN
admet-1622	18	30	and	and	CCONJ
admet-1622	18	31	pellets	pellet	NOUN
admet-1622	18	32	.	.	PUNCT
admet-1622	19	1	in	in	ADP
admet-1622	19	2	this	this	DET
admet-1622	19	3	method	method	NOUN
admet-1622	19	4	,	,	PUNCT
admet-1622	19	5	drug	drug	NOUN
admet-1622	19	6	-	-	PUNCT
admet-1622	19	7	loaded	load	VERB
admet-1622	19	8	filaments	filament	NOUN
admet-1622	19	9	of	of	ADP
admet-1622	19	10	thermoplastic	thermoplastic	ADJ
admet-1622	19	11	polymers	polymer	NOUN
admet-1622	19	12	are	be	AUX
admet-1622	19	13	produced	produce	VERB
admet-1622	19	14	by	by	ADP
admet-1622	19	15	hot	hot	ADJ
admet-1622	19	16	melt	melt	NOUN
admet-1622	19	17	extrusion	extrusion	NOUN
admet-1622	19	18	(	(	PUNCT
admet-1622	19	19	hme	hme	NOUN
admet-1622	19	20	)	)	PUNCT
admet-1622	19	21	and	and	CCONJ
admet-1622	19	22	the	the	DET
admet-1622	19	23	filaments	filament	NOUN
admet-1622	19	24	are	be	AUX
admet-1622	19	25	then	then	ADV
admet-1622	19	26	printed	print	VERB
admet-1622	19	27	into	into	ADP
admet-1622	19	28	tablets	tablet	NOUN
admet-1622	19	29	using	use	VERB
admet-1622	19	30	3d	3d	NUM
admet-1622	19	31	printers	printer	NOUN
admet-1622	19	32	by	by	ADP
admet-1622	19	33	applying	apply	VERB
admet-1622	19	34	computer	computer	NOUN
admet-1622	19	35	-	-	PUNCT
admet-1622	19	36	aided	aid	VERB
admet-1622	19	37	design	design	NOUN
admet-1622	19	38	(	(	PUNCT
admet-1622	19	39	cad	cad	NOUN
admet-1622	19	40	)	)	PUNCT
admet-1622	19	41	principles	principle	NOUN
admet-1622	20	1	[	[	X
admet-1622	20	2	13,14	13,14	NUM
admet-1622	20	3	]	]	PUNCT
admet-1622	20	4	.	.	PUNCT
admet-1622	21	1	hot	hot	ADJ
admet-1622	21	2	melt	melt	NOUN
admet-1622	21	3	extruders	extruder	NOUN
admet-1622	21	4	used	use	VERB
admet-1622	21	5	for	for	ADP
admet-1622	21	6	the	the	DET
admet-1622	21	7	preparation	preparation	NOUN
admet-1622	21	8	of	of	ADP
admet-1622	21	9	filaments	filament	NOUN
admet-1622	21	10	are	be	AUX
admet-1622	21	11	now	now	ADV
admet-1622	21	12	commonly	commonly	ADV
admet-1622	21	13	available	available	ADJ
admet-1622	21	14	in	in	ADP
admet-1622	21	15	academia	academia	NOUN
admet-1622	21	16	and	and	CCONJ
admet-1622	21	17	the	the	DET
admet-1622	21	18	pharmaceutical	pharmaceutical	NOUN
admet-1622	21	19	industry	industry	NOUN
admet-1622	21	20	for	for	ADP
admet-1622	21	21	many	many	ADJ
admet-1622	21	22	different	different	ADJ
admet-1622	21	23	applications	application	NOUN
admet-1622	21	24	and	and	CCONJ
admet-1622	21	25	3d	3d	NUM
admet-1622	21	26	printers	printer	NOUN
admet-1622	21	27	are	be	AUX
admet-1622	21	28	relatively	relatively	ADV
admet-1622	21	29	cheaply	cheaply	ADV
admet-1622	21	30	available	available	ADJ
admet-1622	21	31	in	in	ADP
admet-1622	21	32	the	the	DET
admet-1622	21	33	market	market	NOUN
admet-1622	21	34	for	for	ADP
admet-1622	21	35	the	the	DET
admet-1622	21	36	printing	printing	NOUN
admet-1622	21	37	of	of	ADP
admet-1622	21	38	filaments	filament	NOUN
admet-1622	21	39	into	into	ADP
admet-1622	21	40	tablets	tablet	NOUN
admet-1622	21	41	,	,	PUNCT
admet-1622	21	42	both	both	PRON
admet-1622	21	43	of	of	ADP
admet-1622	21	44	which	which	PRON
admet-1622	21	45	contributed	contribute	VERB
admet-1622	21	46	to	to	ADP
admet-1622	21	47	the	the	DET
admet-1622	21	48	rapid	rapid	ADJ
admet-1622	21	49	growth	growth	NOUN
admet-1622	21	50	of	of	ADP
admet-1622	21	51	the	the	DET
admet-1622	21	52	fdm	fdm	NOUN
admet-1622	21	53	3d	3d	ADV
admet-1622	21	54	-	-	PUNCT
admet-1622	21	55	printing	print	VERB
admet-1622	21	56	technology	technology	NOUN
admet-1622	21	57	.	.	PUNCT
admet-1622	22	1	it	it	PRON
admet-1622	22	2	is	be	AUX
admet-1622	22	3	anticipated	anticipate	VERB
admet-1622	22	4	that	that	SCONJ
admet-1622	22	5	,	,	PUNCT
admet-1622	22	6	in	in	ADP
admet-1622	22	7	the	the	DET
admet-1622	22	8	future	future	NOUN
admet-1622	22	9	,	,	PUNCT
admet-1622	22	10	the	the	DET
admet-1622	22	11	filaments	filament	NOUN
admet-1622	22	12	can	can	AUX
admet-1622	22	13	be	be	AUX
admet-1622	22	14	mass	mass	ADV
admet-1622	22	15	-	-	PUNCT
admet-1622	22	16	produced	produce	VERB
admet-1622	22	17	in	in	ADP
admet-1622	22	18	the	the	DET
admet-1622	22	19	pharmaceutical	pharmaceutical	NOUN
admet-1622	22	20	industry	industry	NOUN
admet-1622	22	21	or	or	CCONJ
admet-1622	22	22	at	at	ADP
admet-1622	22	23	various	various	ADJ
admet-1622	22	24	pharmaceutical	pharmaceutical	ADJ
admet-1622	22	25	distribution	distribution	NOUN
admet-1622	22	26	sites	site	NOUN
admet-1622	22	27	and	and	CCONJ
admet-1622	22	28	then	then	ADV
admet-1622	22	29	sent	send	VERB
admet-1622	22	30	to	to	ADP
admet-1622	22	31	clinics	clinic	NOUN
admet-1622	22	32	,	,	PUNCT
admet-1622	22	33	retail	retail	ADJ
admet-1622	22	34	pharmacies	pharmacy	NOUN
admet-1622	22	35	,	,	PUNCT
admet-1622	22	36	hospitals	hospital	NOUN
admet-1622	22	37	,	,	PUNCT
admet-1622	22	38	nursing	nursing	NOUN
admet-1622	22	39	homes	home	NOUN
admet-1622	22	40	,	,	PUNCT
admet-1622	22	41	etc	etc	X
admet-1622	22	42	.	.	X
admet-1622	22	43	,	,	PUNCT
admet-1622	22	44	for	for	ADP
admet-1622	22	45	printing	print	VERB
admet-1622	22	46	into	into	ADP
admet-1622	22	47	individualized	individualized	ADJ
admet-1622	22	48	medications	medication	NOUN
admet-1622	22	49	as	as	ADP
admet-1622	22	50	per	per	ADP
admet-1622	22	51	the	the	DET
admet-1622	22	52	needs	need	NOUN
admet-1622	22	53	of	of	ADP
admet-1622	22	54	the	the	DET
admet-1622	22	55	patients	patient	NOUN
admet-1622	22	56	.	.	PUNCT
admet-1622	23	1	such	such	ADJ
admet-1622	23	2	personalized	personalized	ADJ
admet-1622	23	3	therapy	therapy	NOUN
admet-1622	23	4	can	can	AUX
admet-1622	23	5	mitigate	mitigate	VERB
admet-1622	23	6	some	some	PRON
admet-1622	23	7	of	of	ADP
admet-1622	23	8	the	the	DET
admet-1622	23	9	variability	variability	NOUN
admet-1622	23	10	in	in	ADP
admet-1622	23	11	patients	patient	NOUN
admet-1622	23	12	’	'	PUNCT
admet-1622	23	13	responses	response	NOUN
admet-1622	23	14	to	to	ADP
admet-1622	23	15	medications	medication	NOUN
admet-1622	23	16	observed	observe	VERB
admet-1622	23	17	due	due	ADP
admet-1622	23	18	to	to	ADP
admet-1622	23	19	differences	difference	NOUN
admet-1622	23	20	in	in	ADP
admet-1622	23	21	their	their	PRON
admet-1622	23	22	genetic	genetic	ADJ
admet-1622	23	23	compositions	composition	NOUN
admet-1622	23	24	,	,	PUNCT
admet-1622	23	25	gender	gender	NOUN
admet-1622	23	26	,	,	PUNCT
admet-1622	23	27	age	age	NOUN
admet-1622	23	28	,	,	PUNCT
admet-1622	23	29	body	body	NOUN
admet-1622	23	30	weight	weight	NOUN
admet-1622	23	31	,	,	PUNCT
admet-1622	23	32	disease	disease	NOUN
admet-1622	23	33	state	state	NOUN
admet-1622	23	34	,	,	PUNCT
admet-1622	23	35	and	and	CCONJ
admet-1622	23	36	so	so	ADV
admet-1622	23	37	forth	forth	ADV
admet-1622	23	38	.	.	PUNCT
admet-1622	24	1	the	the	DET
admet-1622	24	2	fdm	fdm	NOUN
admet-1622	24	3	3d	3d	NOUN
admet-1622	24	4	printing	printing	NOUN
admet-1622	24	5	will	will	AUX
admet-1622	24	6	be	be	AUX
admet-1622	24	7	especially	especially	ADV
admet-1622	24	8	suitable	suitable	ADJ
admet-1622	24	9	for	for	ADP
admet-1622	24	10	clinical	clinical	ADJ
admet-1622	24	11	testing	testing	NOUN
admet-1622	24	12	of	of	ADP
admet-1622	24	13	new	new	ADJ
admet-1622	24	14	drug	drug	NOUN
admet-1622	24	15	candidates	candidate	NOUN
admet-1622	24	16	where	where	SCONJ
admet-1622	24	17	the	the	DET
admet-1622	24	18	dose	dose	NOUN
admet-1622	24	19	is	be	AUX
admet-1622	24	20	often	often	ADV
admet-1622	24	21	unknown	unknown	ADJ
admet-1622	24	22	at	at	ADP
admet-1622	24	23	the	the	DET
admet-1622	24	24	outset	outset	NOUN
admet-1622	24	25	of	of	ADP
admet-1622	24	26	clinical	clinical	ADJ
admet-1622	24	27	studies	study	NOUN
admet-1622	24	28	and	and	CCONJ
admet-1622	24	29	may	may	AUX
admet-1622	24	30	need	need	VERB
admet-1622	24	31	to	to	PART
admet-1622	24	32	be	be	AUX
admet-1622	24	33	changed	change	VERB
admet-1622	24	34	or	or	CCONJ
admet-1622	24	35	modified	modify	VERB
admet-1622	24	36	depending	depend	VERB
admet-1622	24	37	on	on	ADP
admet-1622	24	38	clinical	clinical	ADJ
admet-1622	24	39	observations	observation	NOUN
admet-1622	24	40	on	on	ADP
admet-1622	24	41	patients	patient	NOUN
admet-1622	24	42	.	.	PUNCT
admet-1622	25	1	under	under	ADP
admet-1622	25	2	such	such	ADJ
admet-1622	25	3	circumstances	circumstance	NOUN
admet-1622	25	4	,	,	PUNCT
admet-1622	25	5	clinical	clinical	ADJ
admet-1622	25	6	studies	study	NOUN
admet-1622	25	7	may	may	AUX
admet-1622	25	8	be	be	AUX
admet-1622	25	9	accelerated	accelerate	VERB
admet-1622	25	10	as	as	SCONJ
admet-1622	25	11	new	new	ADJ
admet-1622	25	12	doses	dose	NOUN
admet-1622	25	13	may	may	AUX
admet-1622	25	14	be	be	AUX
admet-1622	25	15	printed	print	VERB
admet-1622	25	16	using	use	VERB
admet-1622	25	17	the	the	DET
admet-1622	25	18	same	same	ADJ
admet-1622	25	19	filaments	filament	NOUN
admet-1622	25	20	without	without	ADP
admet-1622	25	21	having	have	VERB
admet-1622	25	22	to	to	PART
admet-1622	25	23	wait	wait	VERB
admet-1622	25	24	for	for	ADP
admet-1622	25	25	the	the	DET
admet-1622	25	26	development	development	NOUN
admet-1622	25	27	of	of	ADP
admet-1622	25	28	new	new	ADJ
admet-1622	25	29	formulations	formulation	NOUN
admet-1622	25	30	.	.	PUNCT
admet-1622	26	1	additionally	additionally	ADV
admet-1622	26	2	,	,	PUNCT
admet-1622	26	3	fdm	fdm	NOUN
admet-1622	26	4	3d	3d	NOUN
admet-1622	26	5	printing	printing	NOUN
admet-1622	26	6	has	have	VERB
admet-1622	26	7	the	the	DET
admet-1622	26	8	potential	potential	NOUN
admet-1622	26	9	to	to	PART
admet-1622	26	10	provide	provide	VERB
admet-1622	26	11	multiple	multiple	ADJ
admet-1622	26	12	drugs	drug	NOUN
admet-1622	26	13	in	in	ADP
admet-1622	26	14	the	the	DET
admet-1622	26	15	same	same	ADJ
admet-1622	26	16	tablet	tablet	NOUN
admet-1622	26	17	by	by	ADP
admet-1622	26	18	printing	print	VERB
admet-1622	26	19	different	different	ADJ
admet-1622	26	20	drugs	drug	NOUN
admet-1622	26	21	layer	layer	NOUN
admet-1622	26	22	by	by	ADP
admet-1622	26	23	layer	layer	NOUN
admet-1622	26	24	,	,	PUNCT
admet-1622	26	25	side	side	NOUN
admet-1622	26	26	by	by	ADP
admet-1622	26	27	side	side	NOUN
admet-1622	26	28	or	or	CCONJ
admet-1622	26	29	in	in	ADP
admet-1622	26	30	different	different	ADJ
admet-1622	26	31	compartments	compartment	NOUN
admet-1622	27	1	[	[	X
admet-1622	27	2	15,16	15,16	NUM
admet-1622	27	3	]	]	PUNCT
admet-1622	27	4	.	.	PUNCT
admet-1622	28	1	the	the	DET
admet-1622	28	2	doses	dose	NOUN
admet-1622	28	3	may	may	AUX
admet-1622	28	4	also	also	ADV
admet-1622	28	5	be	be	AUX
admet-1622	28	6	individualized	individualize	VERB
admet-1622	28	7	in	in	ADP
admet-1622	28	8	such	such	ADJ
admet-1622	28	9	polypills	polypill	NOUN
admet-1622	28	10	.	.	PUNCT
admet-1622	29	1	objectives	objective	NOUN
admet-1622	29	2	of	of	ADP
admet-1622	29	3	this	this	DET
admet-1622	29	4	report	report	NOUN
admet-1622	29	5	despite	despite	SCONJ
admet-1622	29	6	its	its	PRON
admet-1622	29	7	early	early	ADJ
admet-1622	29	8	promises	promise	NOUN
admet-1622	29	9	and	and	CCONJ
admet-1622	29	10	relative	relative	ADJ
admet-1622	29	11	simplicity	simplicity	NOUN
admet-1622	29	12	,	,	PUNCT
admet-1622	29	13	no	no	DET
admet-1622	29	14	products	product	NOUN
admet-1622	29	15	based	base	VERB
admet-1622	29	16	on	on	ADP
admet-1622	29	17	the	the	DET
admet-1622	29	18	fdm	fdm	NOUN
admet-1622	29	19	3d	3d	ADV
admet-1622	29	20	-	-	PUNCT
admet-1622	29	21	printing	print	VERB
admet-1622	29	22	technology	technology	NOUN
admet-1622	29	23	have	have	AUX
admet-1622	29	24	yet	yet	ADV
admet-1622	29	25	been	be	AUX
admet-1622	29	26	approved	approve	VERB
admet-1622	29	27	by	by	ADP
admet-1622	29	28	regulatory	regulatory	ADJ
admet-1622	29	29	agencies	agency	NOUN
admet-1622	29	30	and	and	CCONJ
admet-1622	29	31	marketed	market	VERB
admet-1622	29	32	by	by	ADP
admet-1622	29	33	pharmaceutical	pharmaceutical	NOUN
admet-1622	29	34	companies	company	NOUN
admet-1622	29	35	.	.	PUNCT
admet-1622	30	1	this	this	PRON
admet-1622	30	2	is	be	AUX
admet-1622	30	3	because	because	SCONJ
admet-1622	30	4	fdm	fdm	NOUN
admet-1622	30	5	3d	3d	NOUN
admet-1622	30	6	-	-	PUNCT
admet-1622	30	7	printing	printing	NOUN
admet-1622	30	8	is	be	AUX
admet-1622	30	9	a	a	DET
admet-1622	30	10	relatively	relatively	ADV
admet-1622	30	11	new	new	ADJ
admet-1622	30	12	technology	technology	NOUN
admet-1622	30	13	that	that	PRON
admet-1622	30	14	faces	face	VERB
admet-1622	30	15	many	many	ADJ
admet-1622	30	16	developmental	developmental	ADJ
admet-1622	30	17	and	and	CCONJ
admet-1622	30	18	technical	technical	ADJ
admet-1622	30	19	challenges	challenge	NOUN
admet-1622	30	20	.	.	PUNCT
admet-1622	31	1	the	the	DET
admet-1622	31	2	objectives	objective	NOUN
admet-1622	31	3	of	of	ADP
admet-1622	31	4	the	the	DET
admet-1622	31	5	present	present	ADJ
admet-1622	31	6	overview	overview	NOUN
admet-1622	31	7	and	and	CCONJ
admet-1622	31	8	commentary	commentary	NOUN
admet-1622	31	9	are	be	AUX
admet-1622	31	10	to	to	PART
admet-1622	31	11	critically	critically	ADV
admet-1622	31	12	analyze	analyze	VERB
admet-1622	31	13	these	these	DET
admet-1622	31	14	challenges	challenge	NOUN
admet-1622	31	15	,	,	PUNCT
admet-1622	31	16	discuss	discuss	VERB
admet-1622	31	17	what	what	DET
admet-1622	31	18	progress	progress	NOUN
admet-1622	31	19	has	have	AUX
admet-1622	31	20	been	be	AUX
admet-1622	31	21	made	make	VERB
admet-1622	31	22	towards	towards	ADP
admet-1622	31	23	resolving	resolve	VERB
admet-1622	31	24	them	they	PRON
admet-1622	31	25	,	,	PUNCT
admet-1622	31	26	and	and	CCONJ
admet-1622	31	27	present	present	VERB
admet-1622	31	28	emerging	emerge	VERB
admet-1622	31	29	strategies	strategy	NOUN
admet-1622	31	30	that	that	PRON
admet-1622	31	31	may	may	AUX
admet-1622	31	32	lead	lead	VERB
admet-1622	31	33	to	to	ADP
admet-1622	31	34	the	the	DET
admet-1622	31	35	resolution	resolution	NOUN
admet-1622	31	36	of	of	ADP
admet-1622	31	37	most	most	ADJ
admet-1622	31	38	of	of	ADP
admet-1622	31	39	these	these	DET
admet-1622	31	40	problems	problem	NOUN
admet-1622	31	41	leading	lead	VERB
admet-1622	31	42	to	to	ADP
admet-1622	31	43	the	the	DET
admet-1622	31	44	development	development	NOUN
admet-1622	31	45	of	of	ADP
admet-1622	31	46	clinically	clinically	ADV
admet-1622	31	47	and	and	CCONJ
admet-1622	31	48	commercially	commercially	ADV
admet-1622	31	49	viable	viable	ADJ
admet-1622	31	50	fdm	fdm	NOUN
admet-1622	31	51	3d	3d	ADV
admet-1622	31	52	-	-	PUNCT
admet-1622	31	53	printed	print	VERB
admet-1622	31	54	tablets	tablet	NOUN
admet-1622	31	55	.	.	PUNCT
admet-1622	32	1	one	one	NUM
admet-1622	32	2	special	special	ADJ
admet-1622	32	3	focus	focus	NOUN
admet-1622	32	4	will	will	AUX
admet-1622	32	5	be	be	AUX
admet-1622	32	6	on	on	ADP
admet-1622	32	7	the	the	DET
admet-1622	32	8	development	development	NOUN
admet-1622	32	9	of	of	ADP
admet-1622	32	10	rapidly	rapidly	ADV
admet-1622	32	11	dissolving	dissolve	VERB
admet-1622	32	12	tablets	tablet	NOUN
admet-1622	32	13	since	since	SCONJ
admet-1622	32	14	fdm	fdm	NOUN
admet-1622	32	15	3dprinting	3dprinting	NUM
admet-1622	32	16	mostly	mostly	ADV
admet-1622	32	17	produces	produce	VERB
admet-1622	32	18	tablets	tablet	NOUN
admet-1622	32	19	with	with	ADP
admet-1622	32	20	slow	slow	ADJ
admet-1622	32	21	and	and	CCONJ
admet-1622	32	22	incomplete	incomplete	ADJ
admet-1622	32	23	drug	drug	NOUN
admet-1622	32	24	release	release	NOUN
admet-1622	32	25	,	,	PUNCT
admet-1622	32	26	while	while	SCONJ
admet-1622	32	27	tablets	tablet	NOUN
admet-1622	32	28	with	with	ADP
admet-1622	32	29	rapid	rapid	ADJ
admet-1622	32	30	drug	drug	NOUN
admet-1622	32	31	release	release	NOUN
admet-1622	32	32	rates	rate	NOUN
admet-1622	32	33	are	be	AUX
admet-1622	32	34	often	often	ADV
admet-1622	32	35	needed	need	VERB
admet-1622	32	36	for	for	ADP
admet-1622	32	37	optimal	optimal	ADJ
admet-1622	32	38	clinical	clinical	ADJ
admet-1622	32	39	efficacy	efficacy	NOUN
admet-1622	32	40	in	in	ADP
admet-1622	32	41	humans	human	NOUN
admet-1622	32	42	.	.	PUNCT
admet-1622	33	1	the	the	DET
admet-1622	33	2	importance	importance	NOUN
admet-1622	33	3	of	of	ADP
admet-1622	33	4	rapid	rapid	ADJ
admet-1622	33	5	drug	drug	NOUN
admet-1622	33	6	release	release	NOUN
admet-1622	33	7	for	for	ADP
admet-1622	33	8	the	the	DET
admet-1622	33	9	successful	successful	ADJ
admet-1622	33	10	therapeutic	therapeutic	ADJ
admet-1622	33	11	outcome	outcome	NOUN
admet-1622	33	12	of	of	ADP
admet-1622	33	13	new	new	ADJ
admet-1622	33	14	drug	drug	NOUN
admet-1622	33	15	candidates	candidate	NOUN
admet-1622	33	16	will	will	AUX
admet-1622	33	17	be	be	AUX
admet-1622	33	18	discussed	discuss	VERB
admet-1622	33	19	based	base	VERB
admet-1622	33	20	on	on	ADP
admet-1622	33	21	the	the	DET
admet-1622	33	22	biopharmaceutical	biopharmaceutical	ADJ
admet-1622	33	23	risk	risk	NOUN
admet-1622	33	24	assessment	assessment	NOUN
admet-1622	33	25	roadmap	roadmap	NOUN
admet-1622	33	26	(	(	PUNCT
admet-1622	33	27	bioram	bioram	PROPN
admet-1622	33	28	)	)	PUNCT
admet-1622	33	29	developed	develop	VERB
admet-1622	33	30	by	by	ADP
admet-1622	33	31	an	an	DET
admet-1622	33	32	international	international	ADJ
admet-1622	33	33	panel	panel	NOUN
admet-1622	33	34	of	of	ADP
admet-1622	33	35	experts	expert	NOUN
admet-1622	33	36	[	[	X
admet-1622	33	37	17,18	17,18	X
admet-1622	33	38	]	]	X
admet-1622	33	39	,	,	PUNCT
admet-1622	33	40	and	and	CCONJ
admet-1622	33	41	the	the	DET
admet-1622	33	42	pros	pro	NOUN
admet-1622	33	43	and	and	CCONJ
admet-1622	33	44	cons	con	NOUN
admet-1622	33	45	of	of	ADP
admet-1622	33	46	several	several	ADJ
admet-1622	33	47	strategies	strategy	NOUN
admet-1622	33	48	for	for	ADP
admet-1622	33	49	the	the	DET
admet-1622	33	50	development	development	NOUN
admet-1622	33	51	of	of	ADP
admet-1622	33	52	rapidly	rapidly	ADV
admet-1622	33	53	dissolving	dissolve	VERB
admet-1622	33	54	3d	3d	NOUN
admet-1622	33	55	-	-	PUNCT
admet-1622	33	56	printed	print	VERB
admet-1622	33	57	tablets	tablet	NOUN
admet-1622	33	58	reported	report	VERB
admet-1622	33	59	in	in	ADP
admet-1622	33	60	the	the	DET
admet-1622	33	61	literature	literature	NOUN
admet-1622	33	62	will	will	AUX
admet-1622	33	63	be	be	AUX
admet-1622	33	64	reviewed	review	VERB
admet-1622	33	65	.	.	PUNCT
admet-1622	34	1	finally	finally	ADV
admet-1622	34	2	,	,	PUNCT
admet-1622	34	3	two	two	NUM
admet-1622	34	4	case	case	NOUN
admet-1622	34	5	studies	study	NOUN
admet-1622	34	6	will	will	AUX
admet-1622	34	7	be	be	AUX
admet-1622	34	8	presented	present	VERB
admet-1622	34	9	where	where	SCONJ
admet-1622	34	10	one	one	NUM
admet-1622	34	11	of	of	ADP
admet-1622	34	12	them	they	PRON
admet-1622	34	13	will	will	AUX
admet-1622	34	14	provide	provide	VERB
admet-1622	34	15	a	a	DET
admet-1622	34	16	systematic	systematic	ADJ
admet-1622	34	17	approach	approach	NOUN
admet-1622	34	18	for	for	ADP
admet-1622	34	19	the	the	DET
admet-1622	34	20	development	development	NOUN
admet-1622	34	21	of	of	ADP
admet-1622	34	22	fdm	fdm	NOUN
admet-1622	34	23	3d	3d	ADV
admet-1622	34	24	-	-	PUNCT
admet-1622	34	25	printed	print	VERB
admet-1622	34	26	tablets	tablet	NOUN
admet-1622	34	27	for	for	ADP
admet-1622	34	28	rapid	rapid	ADJ
admet-1622	34	29	drug	drug	NOUN
admet-1622	34	30	release	release	NOUN
admet-1622	34	31	based	base	VERB
admet-1622	34	32	on	on	ADP
admet-1622	34	33	the	the	DET
admet-1622	34	34	work	work	NOUN
admet-1622	34	35	by	by	ADP
admet-1622	34	36	solanki	solanki	PROPN
admet-1622	34	37	et	et	PROPN
admet-1622	34	38	al	al	PROPN
admet-1622	34	39	.	.	PUNCT
admet-1622	35	1	[	[	X
admet-1622	35	2	19	19	NUM
admet-1622	35	3	]	]	PUNCT
admet-1622	35	4	,	,	PUNCT
admet-1622	35	5	and	and	CCONJ
admet-1622	35	6	the	the	DET
admet-1622	35	7	other	other	ADJ
admet-1622	35	8	will	will	AUX
admet-1622	35	9	provide	provide	VERB
admet-1622	35	10	,	,	PUNCT
admet-1622	35	11	based	base	VERB
admet-1622	35	12	on	on	ADP
admet-1622	35	13	two	two	NUM
admet-1622	35	14	recent	recent	ADJ
admet-1622	35	15	publications	publication	NOUN
admet-1622	35	16	by	by	ADP
admet-1622	35	17	patel	patel	NOUN
admet-1622	35	18	and	and	CCONJ
admet-1622	35	19	serajuddin	serajuddin	VERB
admet-1622	35	20	[	[	X
admet-1622	35	21	20,21	20,21	NUM
admet-1622	35	22	]	]	PUNCT
admet-1622	35	23	,	,	PUNCT
admet-1622	35	24	a	a	DET
admet-1622	35	25	multi	multi	ADJ
admet-1622	35	26	-	-	ADJ
admet-1622	35	27	pronged	pronged	ADJ
admet-1622	35	28	strategy	strategy	NOUN
admet-1622	35	29	to	to	PART
admet-1622	35	30	not	not	PART
admet-1622	35	31	only	only	ADV
admet-1622	35	32	increase	increase	VERB
admet-1622	35	33	drug	drug	NOUN
admet-1622	35	34	release	release	NOUN
admet-1622	35	35	rates	rate	NOUN
admet-1622	35	36	from	from	ADP
admet-1622	35	37	printed	print	VERB
admet-1622	35	38	tablets	tablet	NOUN
admet-1622	35	39	but	but	CCONJ
admet-1622	35	40	admet	admet	PROPN
admet-1622	35	41	&	&	CCONJ
admet-1622	35	42	dmpk	dmpk	PROPN
admet-1622	35	43	11(1	11(1	NUM
admet-1622	35	44	)	)	PUNCT
admet-1622	35	45	(	(	PUNCT
admet-1622	35	46	2023	2023	NUM
admet-1622	35	47	)	)	PUNCT
admet-1622	35	48	33	33	NUM
admet-1622	35	49	-	-	SYM
admet-1622	35	50	55	55	NUM
admet-1622	35	51	development	development	NOUN
admet-1622	35	52	of	of	ADP
admet-1622	35	53	rapidly	rapidly	ADV
admet-1622	35	54	dissolving	dissolve	VERB
admet-1622	35	55	fdm	fdm	NOUN
admet-1622	35	56	3d	3d	ADV
admet-1622	35	57	-	-	PUNCT
admet-1622	35	58	printed	print	VERB
admet-1622	35	59	tablets	tablet	NOUN
admet-1622	35	60	doi	doi	NOUN
admet-1622	35	61	:	:	PUNCT
admet-1622	35	62	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	35	63	35	35	NUM
admet-1622	35	64	at	at	ADP
admet-1622	35	65	the	the	DET
admet-1622	35	66	same	same	ADJ
admet-1622	35	67	time	time	NOUN
admet-1622	35	68	to	to	PART
admet-1622	35	69	also	also	ADV
admet-1622	35	70	enhance	enhance	VERB
admet-1622	35	71	drug	drug	NOUN
admet-1622	35	72	-	-	PUNCT
admet-1622	35	73	polymer	polymer	NOUN
admet-1622	35	74	miscibility	miscibility	NOUN
admet-1622	35	75	,	,	PUNCT
admet-1622	35	76	increase	increase	VERB
admet-1622	35	77	printability	printability	NOUN
admet-1622	35	78	of	of	ADP
admet-1622	35	79	polymers	polymer	NOUN
admet-1622	35	80	,	,	PUNCT
admet-1622	35	81	and	and	CCONJ
admet-1622	35	82	reduce	reduce	VERB
admet-1622	35	83	processing	processing	NOUN
admet-1622	35	84	temperatures	temperature	NOUN
admet-1622	35	85	of	of	ADP
admet-1622	35	86	filaments	filament	NOUN
admet-1622	35	87	and	and	CCONJ
admet-1622	35	88	tablets	tablet	NOUN
admet-1622	35	89	.	.	PUNCT
admet-1622	36	1	challenges	challenge	NOUN
admet-1622	36	2	in	in	ADP
admet-1622	36	3	the	the	DET
admet-1622	36	4	development	development	NOUN
admet-1622	36	5	of	of	ADP
admet-1622	36	6	fdm	fdm	NOUN
admet-1622	36	7	3d	3d	ADV
admet-1622	36	8	-	-	PUNCT
admet-1622	36	9	printed	print	VERB
admet-1622	36	10	tablets	tablet	NOUN
admet-1622	36	11	as	as	SCONJ
admet-1622	36	12	outlined	outline	VERB
admet-1622	36	13	by	by	ADP
admet-1622	36	14	solanki	solanki	PROPN
admet-1622	36	15	et	et	PROPN
admet-1622	36	16	al	al	PROPN
admet-1622	36	17	.	.	PUNCT
admet-1622	37	1	[	[	X
admet-1622	37	2	19	19	NUM
admet-1622	37	3	]	]	PUNCT
admet-1622	37	4	and	and	CCONJ
admet-1622	37	5	patel	patel	NOUN
admet-1622	37	6	and	and	CCONJ
admet-1622	37	7	serajuddin	serajuddin	VERB
admet-1622	38	1	[	[	X
admet-1622	38	2	20,21	20,21	NUM
admet-1622	38	3	]	]	PUNCT
admet-1622	38	4	,	,	PUNCT
admet-1622	38	5	the	the	DET
admet-1622	38	6	fdm	fdm	NOUN
admet-1622	38	7	3d	3d	ADV
admet-1622	38	8	-	-	PUNCT
admet-1622	38	9	printing	print	VERB
admet-1622	38	10	technology	technology	NOUN
admet-1622	38	11	faces	face	VERB
admet-1622	38	12	several	several	ADJ
admet-1622	38	13	major	major	ADJ
admet-1622	38	14	challenges	challenge	NOUN
admet-1622	38	15	that	that	PRON
admet-1622	38	16	must	must	AUX
admet-1622	38	17	be	be	AUX
admet-1622	38	18	addressed	address	VERB
admet-1622	38	19	before	before	SCONJ
admet-1622	38	20	it	it	PRON
admet-1622	38	21	can	can	AUX
admet-1622	38	22	progress	progress	VERB
admet-1622	38	23	from	from	ADP
admet-1622	38	24	the	the	DET
admet-1622	38	25	current	current	ADJ
admet-1622	38	26	scientific	scientific	ADJ
admet-1622	38	27	exploratory	exploratory	ADJ
admet-1622	38	28	phase	phase	NOUN
admet-1622	38	29	to	to	ADP
admet-1622	38	30	a	a	DET
admet-1622	38	31	mature	mature	ADJ
admet-1622	38	32	technology	technology	NOUN
admet-1622	38	33	for	for	ADP
admet-1622	38	34	the	the	DET
admet-1622	38	35	development	development	NOUN
admet-1622	38	36	and	and	CCONJ
admet-1622	38	37	manufacture	manufacture	NOUN
admet-1622	38	38	of	of	ADP
admet-1622	38	39	viable	viable	ADJ
admet-1622	38	40	and	and	CCONJ
admet-1622	38	41	commercially	commercially	ADV
admet-1622	38	42	successful	successful	ADJ
admet-1622	38	43	drug	drug	NOUN
admet-1622	38	44	products	product	NOUN
admet-1622	38	45	.	.	PUNCT
admet-1622	39	1	some	some	PRON
admet-1622	39	2	of	of	ADP
admet-1622	39	3	these	these	DET
admet-1622	39	4	challenges	challenge	NOUN
admet-1622	39	5	are	be	AUX
admet-1622	39	6	:	:	PUNCT
admet-1622	39	7	a	a	X
admet-1622	39	8	)	)	PUNCT
admet-1622	39	9	limited	limited	ADJ
admet-1622	39	10	availability	availability	NOUN
admet-1622	39	11	of	of	ADP
admet-1622	39	12	pharmaceutical	pharmaceutical	NOUN
admet-1622	39	13	-	-	PUNCT
admet-1622	39	14	grade	grade	NOUN
admet-1622	39	15	polymers	polymer	NOUN
admet-1622	39	16	that	that	PRON
admet-1622	39	17	are	be	AUX
admet-1622	39	18	suitable	suitable	ADJ
admet-1622	39	19	for	for	ADP
admet-1622	39	20	fdm	fdm	NOUN
admet-1622	39	21	3d	3d	NOUN
admet-1622	39	22	-	-	PUNCT
admet-1622	39	23	printing	print	VERB
admet-1622	39	24	,	,	PUNCT
admet-1622	39	25	b	b	NOUN
admet-1622	39	26	)	)	PUNCT
admet-1622	39	27	low	low	ADJ
admet-1622	39	28	drug	drug	NOUN
admet-1622	39	29	drug	drug	NOUN
admet-1622	39	30	-	-	PUNCT
admet-1622	39	31	polymer	polymer	NOUN
admet-1622	39	32	miscibility	miscibility	NOUN
admet-1622	39	33	,	,	PUNCT
admet-1622	39	34	c	c	X
admet-1622	39	35	)	)	PUNCT
admet-1622	39	36	the	the	DET
admet-1622	39	37	need	need	NOUN
admet-1622	39	38	for	for	ADP
admet-1622	39	39	high	high	ADJ
admet-1622	39	40	temperatures	temperature	NOUN
admet-1622	39	41	for	for	ADP
admet-1622	39	42	melt	melt	VERB
admet-1622	39	43	extrusion	extrusion	NOUN
admet-1622	39	44	and	and	CCONJ
admet-1622	39	45	fdm	fdm	NOUN
admet-1622	39	46	3d	3d	NOUN
admet-1622	39	47	-	-	PUNCT
admet-1622	39	48	printing	print	VERB
admet-1622	39	49	where	where	SCONJ
admet-1622	39	50	drug	drug	NOUN
admet-1622	39	51	,	,	PUNCT
admet-1622	39	52	polymer	polymer	NOUN
admet-1622	39	53	or	or	CCONJ
admet-1622	39	54	both	both	PRON
admet-1622	39	55	may	may	AUX
admet-1622	39	56	degrade	degrade	VERB
admet-1622	39	57	,	,	PUNCT
admet-1622	39	58	and	and	CCONJ
admet-1622	39	59	d	d	X
admet-1622	39	60	)	)	PUNCT
admet-1622	39	61	slow	slow	ADJ
admet-1622	39	62	and	and	CCONJ
admet-1622	39	63	incomplete	incomplete	ADJ
admet-1622	39	64	drug	drug	NOUN
admet-1622	39	65	release	release	NOUN
admet-1622	39	66	from	from	ADP
admet-1622	39	67	tablets	tablet	NOUN
admet-1622	39	68	.	.	PUNCT
admet-1622	40	1	the	the	DET
admet-1622	40	2	above	above	ADJ
admet-1622	40	3	challenges	challenge	NOUN
admet-1622	40	4	in	in	ADP
admet-1622	40	5	the	the	DET
admet-1622	40	6	development	development	NOUN
admet-1622	40	7	of	of	ADP
admet-1622	40	8	fdm	fdm	NOUN
admet-1622	40	9	3d	3d	ADV
admet-1622	40	10	-	-	PUNCT
admet-1622	40	11	printed	print	VERB
admet-1622	40	12	tablets	tablet	NOUN
admet-1622	40	13	are	be	AUX
admet-1622	40	14	discussed	discuss	VERB
admet-1622	40	15	below	below	ADP
admet-1622	40	16	using	use	VERB
admet-1622	40	17	fig	fig	NOUN
admet-1622	40	18	.	.	PUNCT
admet-1622	41	1	1	1	NUM
admet-1622	41	2	,	,	PUNCT
admet-1622	41	3	where	where	SCONJ
admet-1622	41	4	different	different	ADJ
admet-1622	41	5	steps	step	NOUN
admet-1622	41	6	involved	involve	VERB
admet-1622	41	7	in	in	ADP
admet-1622	41	8	the	the	DET
admet-1622	41	9	preparation	preparation	NOUN
admet-1622	41	10	of	of	ADP
admet-1622	41	11	fdm	fdm	NOUN
admet-1622	41	12	3d	3d	ADV
admet-1622	41	13	-	-	PUNCT
admet-1622	41	14	printed	print	VERB
admet-1622	41	15	tablets	tablet	NOUN
admet-1622	41	16	are	be	AUX
admet-1622	41	17	given	give	VERB
admet-1622	41	18	in	in	ADP
admet-1622	41	19	fig	fig	NOUN
admet-1622	41	20	.	.	PUNCT
admet-1622	42	1	1a	1a	NOUN
admet-1622	42	2	,	,	PUNCT
admet-1622	42	3	while	while	SCONJ
admet-1622	42	4	fig	fig	NOUN
admet-1622	42	5	.	.	PUNCT
admet-1622	42	6	1b	1b	PROPN
admet-1622	42	7	shows	show	VERB
admet-1622	42	8	the	the	DET
admet-1622	42	9	printing	printing	NOUN
admet-1622	42	10	process	process	NOUN
admet-1622	42	11	on	on	ADP
admet-1622	42	12	an	an	DET
admet-1622	42	13	expanded	expand	VERB
admet-1622	42	14	scale	scale	NOUN
admet-1622	42	15	:	:	PUNCT
admet-1622	42	16	figure	figure	NOUN
admet-1622	42	17	1	1	NUM
admet-1622	42	18	.	.	PUNCT
admet-1622	43	1	(	(	PUNCT
admet-1622	43	2	a	a	X
admet-1622	43	3	)	)	PUNCT
admet-1622	43	4	illustration	illustration	NOUN
admet-1622	43	5	of	of	ADP
admet-1622	43	6	melt	melt	NOUN
admet-1622	43	7	extrusion	extrusion	NOUN
admet-1622	43	8	of	of	ADP
admet-1622	43	9	filaments	filament	NOUN
admet-1622	43	10	and	and	CCONJ
admet-1622	43	11	3d	3d	NOUN
admet-1622	43	12	-	-	PUNCT
admet-1622	43	13	printing	printing	NOUN
admet-1622	43	14	of	of	ADP
admet-1622	43	15	tablets	tablet	NOUN
admet-1622	43	16	during	during	ADP
admet-1622	43	17	the	the	DET
admet-1622	43	18	fdm	fdm	NOUN
admet-1622	43	19	3d	3d	ADV
admet-1622	43	20	-	-	PUNCT
admet-1622	43	21	printing	print	VERB
admet-1622	43	22	process	process	NOUN
admet-1622	43	23	.	.	PUNCT
admet-1622	44	1	(	(	PUNCT
admet-1622	44	2	b	b	X
admet-1622	44	3	)	)	PUNCT
admet-1622	44	4	printing	printing	NOUN
admet-1622	44	5	gear	gear	NOUN
admet-1622	44	6	,	,	PUNCT
admet-1622	44	7	nozzle	nozzle	NOUN
admet-1622	44	8	,	,	PUNCT
admet-1622	44	9	and	and	CCONJ
admet-1622	44	10	printing	printing	NOUN
admet-1622	44	11	plate	plate	NOUN
admet-1622	44	12	are	be	AUX
admet-1622	44	13	shown	show	VERB
admet-1622	44	14	with	with	ADP
admet-1622	44	15	an	an	DET
admet-1622	44	16	expanded	expand	VERB
admet-1622	44	17	scale	scale	NOUN
admet-1622	44	18	.	.	PUNCT
admet-1622	45	1	adapted	adapt	VERB
admet-1622	45	2	from	from	ADP
admet-1622	45	3	ilyes	ilye	NOUN
admet-1622	45	4	et	et	NOUN
admet-1622	45	5	al	al	PROPN
admet-1622	45	6	.	.	PUNCT
admet-1622	46	1	[	[	X
admet-1622	46	2	22	22	NUM
admet-1622	46	3	]	]	PUNCT
admet-1622	46	4	with	with	ADP
admet-1622	46	5	permission	permission	NOUN
admet-1622	46	6	.	.	PUNCT
admet-1622	47	1	limited	limited	ADJ
admet-1622	47	2	availability	availability	NOUN
admet-1622	47	3	of	of	ADP
admet-1622	47	4	pharmaceutical	pharmaceutical	NOUN
admet-1622	47	5	-	-	PUNCT
admet-1622	47	6	grade	grade	NOUN
admet-1622	47	7	polymers	polymer	NOUN
admet-1622	47	8	as	as	SCONJ
admet-1622	47	9	shown	show	VERB
admet-1622	47	10	in	in	ADP
admet-1622	47	11	fig	fig	NOUN
admet-1622	47	12	.	.	PUNCT
admet-1622	48	1	1a	1a	NOUN
admet-1622	48	2	,	,	PUNCT
admet-1622	48	3	the	the	DET
admet-1622	48	4	extrusion	extrusion	NOUN
admet-1622	48	5	of	of	ADP
admet-1622	48	6	drug	drug	NOUN
admet-1622	48	7	-	-	PUNCT
admet-1622	48	8	polymer	polymer	NOUN
admet-1622	48	9	mixtures	mixture	NOUN
admet-1622	48	10	through	through	ADP
admet-1622	48	11	a	a	DET
admet-1622	48	12	hot	hot	ADJ
admet-1622	48	13	melt	melt	NOUN
admet-1622	48	14	extruder	extruder	NOUN
admet-1622	48	15	into	into	ADP
admet-1622	48	16	filaments	filament	NOUN
admet-1622	48	17	is	be	AUX
admet-1622	48	18	the	the	DET
admet-1622	48	19	first	first	ADJ
admet-1622	48	20	major	major	ADJ
admet-1622	48	21	step	step	NOUN
admet-1622	48	22	in	in	ADP
admet-1622	48	23	the	the	DET
admet-1622	48	24	fdm	fdm	NOUN
admet-1622	48	25	3d	3d	NOUN
admet-1622	48	26	printing	printing	NOUN
admet-1622	48	27	process	process	NOUN
admet-1622	48	28	.	.	PUNCT
admet-1622	49	1	for	for	ADP
admet-1622	49	2	this	this	DET
admet-1622	49	3	purpose	purpose	NOUN
admet-1622	49	4	,	,	PUNCT
admet-1622	49	5	it	it	PRON
admet-1622	49	6	is	be	AUX
admet-1622	49	7	essential	essential	ADJ
admet-1622	49	8	that	that	SCONJ
admet-1622	49	9	the	the	DET
admet-1622	49	10	polymers	polymer	NOUN
admet-1622	49	11	used	use	VERB
admet-1622	49	12	are	be	AUX
admet-1622	49	13	extrudable	extrudable	ADJ
admet-1622	49	14	.	.	PUNCT
admet-1622	50	1	however	however	ADV
admet-1622	50	2	,	,	PUNCT
admet-1622	50	3	melt	melt	VERB
admet-1622	50	4	extrusion	extrusion	NOUN
admet-1622	50	5	is	be	AUX
admet-1622	50	6	a	a	DET
admet-1622	50	7	relatively	relatively	ADV
admet-1622	50	8	new	new	ADJ
admet-1622	50	9	application	application	NOUN
admet-1622	50	10	of	of	ADP
admet-1622	50	11	polymers	polymer	NOUN
admet-1622	50	12	in	in	ADP
admet-1622	50	13	the	the	DET
admet-1622	50	14	pharmaceutical	pharmaceutical	NOUN
admet-1622	50	15	industry	industry	NOUN
admet-1622	50	16	,	,	PUNCT
admet-1622	50	17	and	and	CCONJ
admet-1622	50	18	most	most	ADJ
admet-1622	50	19	polymers	polymer	NOUN
admet-1622	50	20	currently	currently	ADV
admet-1622	50	21	used	use	VERB
admet-1622	50	22	for	for	ADP
admet-1622	50	23	the	the	DET
admet-1622	50	24	formulation	formulation	NOUN
admet-1622	50	25	of	of	ADP
admet-1622	50	26	conventional	conventional	ADJ
admet-1622	50	27	tablets	tablet	NOUN
admet-1622	50	28	were	be	AUX
admet-1622	50	29	originally	originally	ADV
admet-1622	50	30	developed	develop	VERB
admet-1622	50	31	and	and	CCONJ
admet-1622	50	32	introduced	introduce	VERB
admet-1622	50	33	by	by	ADP
admet-1622	50	34	their	their	PRON
admet-1622	50	35	manufacturers	manufacturer	NOUN
admet-1622	50	36	for	for	ADP
admet-1622	50	37	other	other	ADJ
admet-1622	50	38	pharmaceutical	pharmaceutical	ADJ
admet-1622	50	39	applications	application	NOUN
admet-1622	50	40	like	like	ADP
admet-1622	50	41	diluent	diluent	NOUN
admet-1622	50	42	,	,	PUNCT
admet-1622	50	43	binder	binder	NOUN
admet-1622	50	44	,	,	PUNCT
admet-1622	50	45	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	VERB
admet-1622	51	1	abu	abu	PROPN
admet-1622	51	2	t.m	t.m	PROPN
admet-1622	51	3	.	.	PUNCT
admet-1622	51	4	serajuddin	serajuddin	VERB
admet-1622	51	5	admet	admet	PROPN
admet-1622	51	6	&	&	CCONJ
admet-1622	51	7	dmpk	dmpk	PROPN
admet-1622	51	8	11(1	11(1	NUM
admet-1622	51	9	)	)	PUNCT
admet-1622	51	10	(	(	PUNCT
admet-1622	51	11	2023	2023	NUM
admet-1622	51	12	)	)	PUNCT
admet-1622	51	13	33	33	NUM
admet-1622	51	14	-	-	SYM
admet-1622	51	15	55	55	NUM
admet-1622	51	16	36	36	NUM
admet-1622	51	17	disintegrant	disintegrant	ADJ
admet-1622	51	18	,	,	PUNCT
admet-1622	51	19	drug	drug	NOUN
admet-1622	51	20	release	release	NOUN
admet-1622	51	21	modifier	modifier	NOUN
admet-1622	51	22	,	,	PUNCT
admet-1622	51	23	coating	coat	VERB
admet-1622	51	24	agent	agent	NOUN
admet-1622	51	25	,	,	PUNCT
admet-1622	51	26	etc	etc	X
admet-1622	52	1	.	.	X
admet-1622	53	1	as	as	ADP
admet-1622	53	2	such	such	ADJ
admet-1622	53	3	,	,	PUNCT
admet-1622	53	4	they	they	PRON
admet-1622	53	5	may	may	AUX
admet-1622	53	6	not	not	PART
admet-1622	53	7	have	have	VERB
admet-1622	53	8	suitable	suitable	ADJ
admet-1622	53	9	attributes	attribute	NOUN
admet-1622	53	10	,	,	PUNCT
admet-1622	53	11	such	such	ADJ
admet-1622	53	12	as	as	ADP
admet-1622	53	13	glass	glass	NOUN
admet-1622	53	14	transition	transition	NOUN
admet-1622	53	15	temperature	temperature	NOUN
admet-1622	53	16	(	(	PUNCT
admet-1622	53	17	tg	tg	PROPN
admet-1622	53	18	)	)	PUNCT
admet-1622	53	19	,	,	PUNCT
admet-1622	53	20	melt	melt	VERB
admet-1622	53	21	viscosity	viscosity	NOUN
admet-1622	53	22	,	,	PUNCT
admet-1622	53	23	thermal	thermal	ADJ
admet-1622	53	24	stability	stability	NOUN
admet-1622	53	25	,	,	PUNCT
admet-1622	53	26	etc	etc	X
admet-1622	53	27	.	.	X
admet-1622	53	28	,	,	PUNCT
admet-1622	53	29	for	for	ADP
admet-1622	53	30	hme	hme	PROPN
admet-1622	53	31	.	.	PUNCT
admet-1622	54	1	even	even	ADV
admet-1622	54	2	when	when	SCONJ
admet-1622	54	3	certain	certain	ADJ
admet-1622	54	4	polymers	polymer	NOUN
admet-1622	54	5	and	and	CCONJ
admet-1622	54	6	drug	drug	NOUN
admet-1622	54	7	-	-	PUNCT
admet-1622	54	8	polymer	polymer	NOUN
admet-1622	54	9	mixtures	mixture	NOUN
admet-1622	54	10	are	be	AUX
admet-1622	54	11	extrudable	extrudable	ADJ
admet-1622	54	12	,	,	PUNCT
admet-1622	54	13	the	the	DET
admet-1622	54	14	filaments	filament	NOUN
admet-1622	54	15	produced	produce	VERB
admet-1622	54	16	may	may	AUX
admet-1622	54	17	not	not	PART
admet-1622	54	18	be	be	AUX
admet-1622	54	19	printable	printable	ADJ
admet-1622	54	20	.	.	PUNCT
admet-1622	55	1	various	various	ADJ
admet-1622	55	2	issues	issue	NOUN
admet-1622	55	3	with	with	ADP
admet-1622	55	4	the	the	DET
admet-1622	55	5	feeding	feeding	NOUN
admet-1622	55	6	of	of	ADP
admet-1622	55	7	filaments	filament	NOUN
admet-1622	55	8	into	into	ADP
admet-1622	55	9	3d	3d	ADJ
admet-1622	55	10	printers	printer	NOUN
admet-1622	55	11	and	and	CCONJ
admet-1622	55	12	then	then	ADV
admet-1622	55	13	printing	print	VERB
admet-1622	55	14	as	as	SCONJ
admet-1622	55	15	tablets	tablet	NOUN
admet-1622	55	16	have	have	AUX
admet-1622	55	17	been	be	AUX
admet-1622	55	18	reported	report	VERB
admet-1622	55	19	in	in	ADP
admet-1622	55	20	the	the	DET
admet-1622	55	21	literature	literature	NOUN
admet-1622	55	22	[	[	X
admet-1622	55	23	23,24	23,24	X
admet-1622	55	24	]	]	PUNCT
admet-1622	55	25	.	.	PUNCT
admet-1622	56	1	as	as	SCONJ
admet-1622	56	2	shown	show	VERB
admet-1622	56	3	in	in	ADP
admet-1622	56	4	fig	fig	NOUN
admet-1622	56	5	.	.	PUNCT
admet-1622	57	1	1b	1b	NUM
admet-1622	57	2	,	,	PUNCT
admet-1622	57	3	the	the	DET
admet-1622	57	4	filaments	filament	NOUN
admet-1622	57	5	are	be	AUX
admet-1622	57	6	pushed	push	VERB
admet-1622	57	7	through	through	ADP
admet-1622	57	8	the	the	DET
admet-1622	57	9	printing	printing	NOUN
admet-1622	57	10	nozzles	nozzle	NOUN
admet-1622	57	11	by	by	ADP
admet-1622	57	12	using	use	VERB
admet-1622	57	13	gears	gear	NOUN
admet-1622	57	14	,	,	PUNCT
admet-1622	57	15	where	where	SCONJ
admet-1622	57	16	they	they	PRON
admet-1622	57	17	may	may	AUX
admet-1622	57	18	break	break	VERB
admet-1622	57	19	if	if	SCONJ
admet-1622	57	20	they	they	PRON
admet-1622	57	21	are	be	AUX
admet-1622	57	22	too	too	ADV
admet-1622	57	23	brittle	brittle	ADJ
admet-1622	57	24	or	or	CCONJ
admet-1622	57	25	may	may	AUX
admet-1622	57	26	not	not	PART
admet-1622	57	27	pass	pass	VERB
admet-1622	57	28	through	through	ADP
admet-1622	57	29	the	the	DET
admet-1622	57	30	nozzle	nozzle	NOUN
admet-1622	57	31	at	at	ADV
admet-1622	57	32	all	all	ADV
admet-1622	57	33	if	if	SCONJ
admet-1622	57	34	they	they	PRON
admet-1622	57	35	are	be	AUX
admet-1622	57	36	too	too	ADV
admet-1622	57	37	soft	soft	ADJ
admet-1622	57	38	.	.	PUNCT
admet-1622	58	1	therefore	therefore	ADV
admet-1622	58	2	,	,	PUNCT
admet-1622	58	3	the	the	DET
admet-1622	58	4	optimal	optimal	ADJ
admet-1622	58	5	flexibility	flexibility	NOUN
admet-1622	58	6	of	of	ADP
admet-1622	58	7	a	a	DET
admet-1622	58	8	filament	filament	NOUN
admet-1622	58	9	is	be	AUX
admet-1622	58	10	essential	essential	ADJ
admet-1622	58	11	for	for	ADP
admet-1622	58	12	its	its	PRON
admet-1622	58	13	printing	printing	NOUN
admet-1622	58	14	into	into	ADP
admet-1622	58	15	a	a	DET
admet-1622	58	16	tablet	tablet	NOUN
admet-1622	58	17	.	.	PUNCT
admet-1622	59	1	additionally	additionally	ADV
admet-1622	59	2	,	,	PUNCT
admet-1622	59	3	once	once	SCONJ
admet-1622	59	4	the	the	DET
admet-1622	59	5	filaments	filament	NOUN
admet-1622	59	6	are	be	AUX
admet-1622	59	7	fed	feed	VERB
admet-1622	59	8	into	into	ADP
admet-1622	59	9	the	the	DET
admet-1622	59	10	printer	printer	NOUN
admet-1622	59	11	using	use	VERB
admet-1622	59	12	the	the	DET
admet-1622	59	13	gear	gear	NOUN
admet-1622	59	14	,	,	PUNCT
admet-1622	59	15	they	they	PRON
admet-1622	59	16	are	be	AUX
admet-1622	59	17	further	far	ADV
admet-1622	59	18	heated	heated	ADJ
admet-1622	59	19	to	to	PART
admet-1622	59	20	attain	attain	VERB
admet-1622	59	21	certain	certain	ADJ
admet-1622	59	22	optimum	optimum	ADJ
admet-1622	59	23	melt	melt	NOUN
admet-1622	59	24	viscosities	viscosity	NOUN
admet-1622	59	25	such	such	ADJ
admet-1622	59	26	that	that	SCONJ
admet-1622	59	27	the	the	DET
admet-1622	59	28	molten	molten	ADJ
admet-1622	59	29	materials	material	NOUN
admet-1622	59	30	are	be	AUX
admet-1622	59	31	streamed	stream	VERB
admet-1622	59	32	through	through	ADP
admet-1622	59	33	the	the	DET
admet-1622	59	34	printer	printer	NOUN
admet-1622	59	35	head	head	NOUN
admet-1622	59	36	and	and	CCONJ
admet-1622	59	37	deposited	deposit	VERB
admet-1622	59	38	on	on	ADP
admet-1622	59	39	the	the	DET
admet-1622	59	40	building	building	NOUN
admet-1622	59	41	plate	plate	NOUN
admet-1622	59	42	layer	layer	NOUN
admet-1622	59	43	by	by	ADP
admet-1622	59	44	layer	layer	NOUN
admet-1622	59	45	to	to	PART
admet-1622	59	46	form	form	VERB
admet-1622	59	47	tablets	tablet	NOUN
admet-1622	59	48	[	[	X
admet-1622	59	49	25	25	NUM
admet-1622	59	50	]	]	PUNCT
admet-1622	59	51	.	.	PUNCT
admet-1622	60	1	the	the	DET
admet-1622	60	2	layers	layer	NOUN
admet-1622	60	3	must	must	AUX
admet-1622	60	4	coalesce	coalesce	VERB
admet-1622	60	5	with	with	ADP
admet-1622	60	6	each	each	DET
admet-1622	60	7	other	other	ADJ
admet-1622	60	8	,	,	PUNCT
admet-1622	60	9	and	and	CCONJ
admet-1622	60	10	they	they	PRON
admet-1622	60	11	must	must	AUX
admet-1622	60	12	also	also	ADV
admet-1622	60	13	harden	harden	VERB
admet-1622	60	14	rapidly	rapidly	ADV
admet-1622	60	15	enough	enough	ADV
admet-1622	60	16	that	that	SCONJ
admet-1622	60	17	the	the	DET
admet-1622	60	18	surface	surface	NOUN
admet-1622	60	19	,	,	PUNCT
admet-1622	60	20	shape	shape	NOUN
admet-1622	60	21	,	,	PUNCT
admet-1622	60	22	and	and	CCONJ
admet-1622	60	23	internal	internal	ADJ
admet-1622	60	24	structures	structure	NOUN
admet-1622	60	25	remain	remain	VERB
admet-1622	60	26	intact	intact	ADJ
admet-1622	60	27	as	as	SCONJ
admet-1622	60	28	the	the	DET
admet-1622	60	29	tablets	tablet	NOUN
admet-1622	60	30	are	be	AUX
admet-1622	60	31	built	build	VERB
admet-1622	60	32	by	by	ADP
admet-1622	60	33	depositing	deposit	VERB
admet-1622	60	34	one	one	NUM
admet-1622	60	35	layer	layer	NOUN
admet-1622	60	36	over	over	ADP
admet-1622	60	37	the	the	DET
admet-1622	60	38	other	other	ADJ
admet-1622	60	39	until	until	SCONJ
admet-1622	60	40	the	the	DET
admet-1622	60	41	printing	printing	NOUN
admet-1622	60	42	is	be	AUX
admet-1622	60	43	completed	complete	VERB
admet-1622	60	44	[	[	X
admet-1622	60	45	26	26	NUM
admet-1622	60	46	]	]	PUNCT
admet-1622	60	47	.	.	PUNCT
admet-1622	61	1	all	all	DET
admet-1622	61	2	these	these	DET
admet-1622	61	3	attributes	attribute	NOUN
admet-1622	61	4	of	of	ADP
admet-1622	61	5	filaments	filament	NOUN
admet-1622	61	6	and	and	CCONJ
admet-1622	61	7	tablets	tablet	NOUN
admet-1622	61	8	often	often	ADV
admet-1622	61	9	depend	depend	VERB
admet-1622	61	10	on	on	ADP
admet-1622	61	11	the	the	DET
admet-1622	61	12	properties	property	NOUN
admet-1622	61	13	of	of	ADP
admet-1622	61	14	the	the	DET
admet-1622	61	15	polymers	polymer	NOUN
admet-1622	61	16	used	use	VERB
admet-1622	61	17	.	.	PUNCT
admet-1622	62	1	for	for	ADP
admet-1622	62	2	this	this	DET
admet-1622	62	3	reason	reason	NOUN
admet-1622	62	4	,	,	PUNCT
admet-1622	62	5	henry	henry	PROPN
admet-1622	62	6	et	et	PROPN
admet-1622	62	7	al	al	PROPN
admet-1622	62	8	.	.	PUNCT
admet-1622	63	1	[	[	X
admet-1622	63	2	27	27	NUM
admet-1622	63	3	]	]	PUNCT
admet-1622	63	4	cautioned	caution	VERB
admet-1622	63	5	that	that	SCONJ
admet-1622	63	6	despite	despite	SCONJ
admet-1622	63	7	much	much	ADJ
admet-1622	63	8	academic	academic	ADJ
admet-1622	63	9	research	research	NOUN
admet-1622	63	10	and	and	CCONJ
admet-1622	63	11	many	many	ADJ
admet-1622	63	12	proof	proof	NOUN
admet-1622	63	13	-	-	PUNCT
admet-1622	63	14	of	of	ADP
admet-1622	63	15	-	-	PUNCT
admet-1622	63	16	concept	concept	NOUN
admet-1622	63	17	studies	study	NOUN
admet-1622	63	18	,	,	PUNCT
admet-1622	63	19	a	a	DET
admet-1622	63	20	more	more	ADV
admet-1622	63	21	thorough	thorough	ADJ
admet-1622	63	22	understanding	understanding	NOUN
admet-1622	63	23	of	of	ADP
admet-1622	63	24	polymer	polymer	NOUN
admet-1622	63	25	properties	property	NOUN
admet-1622	63	26	and	and	CCONJ
admet-1622	63	27	the	the	DET
admet-1622	63	28	interplay	interplay	NOUN
admet-1622	63	29	between	between	ADP
admet-1622	63	30	polymers	polymer	NOUN
admet-1622	63	31	and	and	CCONJ
admet-1622	63	32	processing	processing	NOUN
admet-1622	63	33	parameters	parameter	NOUN
admet-1622	63	34	are	be	AUX
admet-1622	63	35	needed	need	VERB
admet-1622	63	36	before	before	SCONJ
admet-1622	63	37	the	the	DET
admet-1622	63	38	fdm	fdm	NOUN
admet-1622	63	39	3d	3d	ADV
admet-1622	63	40	-	-	PUNCT
admet-1622	63	41	printing	print	VERB
admet-1622	63	42	technique	technique	NOUN
admet-1622	63	43	can	can	AUX
admet-1622	63	44	be	be	AUX
admet-1622	63	45	fully	fully	ADV
admet-1622	63	46	implemented	implement	VERB
admet-1622	63	47	in	in	ADP
admet-1622	63	48	the	the	DET
admet-1622	63	49	development	development	NOUN
admet-1622	63	50	of	of	ADP
admet-1622	63	51	personalized	personalized	ADJ
admet-1622	63	52	medicine	medicine	NOUN
admet-1622	63	53	.	.	PUNCT
admet-1622	64	1	currently	currently	ADV
admet-1622	64	2	,	,	PUNCT
admet-1622	64	3	the	the	DET
admet-1622	64	4	availability	availability	NOUN
admet-1622	64	5	of	of	ADP
admet-1622	64	6	pharmaceutical	pharmaceutical	NOUN
admet-1622	64	7	-	-	PUNCT
admet-1622	64	8	grade	grade	NOUN
admet-1622	64	9	polymers	polymer	NOUN
admet-1622	64	10	that	that	PRON
admet-1622	64	11	are	be	AUX
admet-1622	64	12	extrudable	extrudable	ADJ
admet-1622	64	13	and	and	CCONJ
admet-1622	64	14	printable	printable	NOUN
admet-1622	64	15	remains	remain	VERB
admet-1622	64	16	a	a	DET
admet-1622	64	17	major	major	ADJ
admet-1622	64	18	limitation	limitation	NOUN
admet-1622	64	19	in	in	ADP
admet-1622	64	20	the	the	DET
admet-1622	64	21	progress	progress	NOUN
admet-1622	64	22	of	of	ADP
admet-1622	64	23	fdm	fdm	NOUN
admet-1622	64	24	3d	3d	NUM
admet-1622	64	25	printing	printing	NOUN
admet-1622	64	26	technology	technology	NOUN
admet-1622	64	27	.	.	PUNCT
admet-1622	65	1	lack	lack	NOUN
admet-1622	65	2	of	of	ADP
admet-1622	65	3	drug	drug	NOUN
admet-1622	65	4	-	-	PUNCT
admet-1622	65	5	polymer	polymer	NOUN
admet-1622	65	6	miscibility	miscibility	NOUN
admet-1622	65	7	ensuring	ensure	VERB
admet-1622	65	8	drug	drug	NOUN
admet-1622	65	9	-	-	PUNCT
admet-1622	65	10	polymer	polymer	NOUN
admet-1622	65	11	miscibility	miscibility	NOUN
admet-1622	65	12	is	be	AUX
admet-1622	65	13	another	another	DET
admet-1622	65	14	major	major	ADJ
admet-1622	65	15	challenge	challenge	NOUN
admet-1622	65	16	in	in	ADP
admet-1622	65	17	the	the	DET
admet-1622	65	18	development	development	NOUN
admet-1622	65	19	of	of	ADP
admet-1622	65	20	fdm	fdm	NOUN
admet-1622	65	21	3d	3d	ADV
admet-1622	65	22	-	-	PUNCT
admet-1622	65	23	printed	print	VERB
admet-1622	65	24	tablets	tablet	NOUN
admet-1622	65	25	.	.	PUNCT
admet-1622	66	1	although	although	SCONJ
admet-1622	66	2	it	it	PRON
admet-1622	66	3	may	may	AUX
admet-1622	66	4	not	not	PART
admet-1622	66	5	be	be	AUX
admet-1622	66	6	a	a	DET
admet-1622	66	7	major	major	ADJ
admet-1622	66	8	issue	issue	NOUN
admet-1622	66	9	for	for	ADP
admet-1622	66	10	water	water	NOUN
admet-1622	66	11	-	-	PUNCT
admet-1622	66	12	soluble	soluble	ADJ
admet-1622	66	13	drugs	drug	NOUN
admet-1622	66	14	since	since	SCONJ
admet-1622	66	15	they	they	PRON
admet-1622	66	16	may	may	AUX
admet-1622	66	17	dissolve	dissolve	VERB
admet-1622	66	18	rapidly	rapidly	ADV
admet-1622	66	19	even	even	ADV
admet-1622	66	20	if	if	SCONJ
admet-1622	66	21	they	they	PRON
admet-1622	66	22	remain	remain	VERB
admet-1622	66	23	crystalline	crystalline	ADJ
admet-1622	66	24	and	and	CCONJ
admet-1622	66	25	phase	phase	NOUN
admet-1622	66	26	-	-	PUNCT
admet-1622	66	27	separated	separate	VERB
admet-1622	66	28	from	from	ADP
admet-1622	66	29	polymers	polymer	NOUN
admet-1622	66	30	,	,	PUNCT
admet-1622	66	31	one	one	PRON
admet-1622	66	32	must	must	AUX
admet-1622	66	33	consider	consider	VERB
admet-1622	66	34	that	that	PRON
admet-1622	66	35	approximately	approximately	ADV
admet-1622	66	36	3	3	NUM
admet-1622	66	37	out	out	ADP
admet-1622	66	38	of	of	ADP
admet-1622	66	39	4	4	NUM
admet-1622	66	40	chemical	chemical	NOUN
admet-1622	66	41	entities	entity	NOUN
admet-1622	66	42	under	under	ADP
admet-1622	66	43	development	development	NOUN
admet-1622	66	44	as	as	SCONJ
admet-1622	66	45	drug	drug	NOUN
admet-1622	66	46	candidates	candidate	NOUN
admet-1622	66	47	are	be	AUX
admet-1622	66	48	poorly	poorly	ADV
admet-1622	66	49	water	water	NOUN
admet-1622	66	50	-	-	PUNCT
admet-1622	66	51	soluble	soluble	ADJ
admet-1622	66	52	and	and	CCONJ
admet-1622	66	53	may	may	AUX
admet-1622	66	54	fall	fall	VERB
admet-1622	66	55	into	into	ADP
admet-1622	66	56	class	class	NOUN
admet-1622	66	57	ii	ii	PROPN
admet-1622	66	58	or	or	CCONJ
admet-1622	66	59	iv	iv	NUM
admet-1622	66	60	of	of	ADP
admet-1622	66	61	the	the	DET
admet-1622	66	62	biopharmaceutical	biopharmaceutical	ADJ
admet-1622	66	63	classification	classification	NOUN
admet-1622	66	64	system	system	NOUN
admet-1622	66	65	(	(	PUNCT
admet-1622	66	66	bcs	bcs	NOUN
admet-1622	66	67	)	)	PUNCT
admet-1622	67	1	[	[	X
admet-1622	67	2	28	28	NUM
admet-1622	67	3	]	]	PUNCT
admet-1622	67	4	.	.	PUNCT
admet-1622	68	1	this	this	PRON
admet-1622	68	2	is	be	AUX
admet-1622	68	3	reflected	reflect	VERB
admet-1622	68	4	in	in	ADP
admet-1622	68	5	the	the	DET
admet-1622	68	6	types	type	NOUN
admet-1622	68	7	of	of	ADP
admet-1622	68	8	drugs	drug	NOUN
admet-1622	68	9	used	use	VERB
admet-1622	68	10	for	for	ADP
admet-1622	68	11	3d	3d	NUM
admet-1622	68	12	printing	printing	NOUN
admet-1622	68	13	.	.	PUNCT
admet-1622	69	1	in	in	ADP
admet-1622	69	2	a	a	DET
admet-1622	69	3	survey	survey	NOUN
admet-1622	69	4	of	of	ADP
admet-1622	69	5	literature	literature	NOUN
admet-1622	69	6	for	for	ADP
admet-1622	69	7	37	37	NUM
admet-1622	69	8	drugs	drug	NOUN
admet-1622	69	9	used	use	VERB
admet-1622	69	10	for	for	ADP
admet-1622	69	11	fdm	fdm	NOUN
admet-1622	69	12	3d	3d	NUM
admet-1622	69	13	printing	printing	NOUN
admet-1622	69	14	,	,	PUNCT
admet-1622	69	15	pereira	pereira	PROPN
admet-1622	69	16	et	et	PROPN
admet-1622	69	17	al	al	PROPN
admet-1622	69	18	.	.	PROPN
admet-1622	70	1	(	(	PUNCT
admet-1622	70	2	29	29	NUM
admet-1622	70	3	)	)	PUNCT
admet-1622	70	4	observed	observe	VERB
admet-1622	70	5	that	that	SCONJ
admet-1622	70	6	28	28	NUM
admet-1622	70	7	(	(	PUNCT
admet-1622	70	8	74	74	NUM
admet-1622	70	9	%	%	NOUN
admet-1622	70	10	)	)	PUNCT
admet-1622	70	11	belonged	belong	VERB
admet-1622	70	12	to	to	ADP
admet-1622	70	13	bcs	bcs	NOUN
admet-1622	70	14	class	class	PROPN
admet-1622	70	15	ii	ii	PROPN
admet-1622	70	16	or	or	CCONJ
admet-1622	70	17	iv	iv	NUM
admet-1622	70	18	,	,	PUNCT
admet-1622	70	19	indicating	indicate	VERB
admet-1622	70	20	possible	possible	ADJ
admet-1622	70	21	solubility	solubility	NOUN
admet-1622	70	22	and	and	CCONJ
admet-1622	70	23	dissolution	dissolution	NOUN
admet-1622	70	24	issues	issue	NOUN
admet-1622	70	25	.	.	PUNCT
admet-1622	71	1	for	for	ADP
admet-1622	71	2	the	the	DET
admet-1622	71	3	rapid	rapid	ADJ
admet-1622	71	4	dissolution	dissolution	NOUN
admet-1622	71	5	of	of	ADP
admet-1622	71	6	such	such	ADJ
admet-1622	71	7	drugs	drug	NOUN
admet-1622	71	8	,	,	PUNCT
admet-1622	71	9	it	it	PRON
admet-1622	71	10	is	be	AUX
admet-1622	71	11	essential	essential	ADJ
admet-1622	71	12	that	that	SCONJ
admet-1622	71	13	the	the	DET
admet-1622	71	14	polymers	polymer	NOUN
admet-1622	71	15	used	use	VERB
admet-1622	71	16	for	for	ADP
admet-1622	71	17	fdm	fdm	NOUN
admet-1622	71	18	3d	3d	NOUN
admet-1622	71	19	-	-	PUNCT
admet-1622	71	20	printing	printing	NOUN
admet-1622	71	21	are	be	AUX
admet-1622	71	22	water	water	NOUN
admet-1622	71	23	-	-	PUNCT
admet-1622	71	24	soluble	soluble	ADJ
admet-1622	71	25	and	and	CCONJ
admet-1622	71	26	the	the	DET
admet-1622	71	27	drugs	drug	NOUN
admet-1622	71	28	are	be	AUX
admet-1622	71	29	molecularly	molecularly	ADV
admet-1622	71	30	or	or	CCONJ
admet-1622	71	31	amorphously	amorphously	ADV
admet-1622	71	32	dispersed	disperse	VERB
admet-1622	71	33	in	in	ADP
admet-1622	71	34	polymers	polymer	NOUN
admet-1622	71	35	during	during	ADP
admet-1622	71	36	hme	hme	NOUN
admet-1622	71	37	and	and	CCONJ
admet-1622	71	38	remain	remain	VERB
admet-1622	71	39	such	such	ADJ
admet-1622	71	40	in	in	ADP
admet-1622	71	41	the	the	DET
admet-1622	71	42	filaments	filament	NOUN
admet-1622	71	43	as	as	ADV
admet-1622	71	44	well	well	ADV
admet-1622	71	45	as	as	ADP
admet-1622	71	46	in	in	ADP
admet-1622	71	47	the	the	DET
admet-1622	71	48	tablets	tablet	NOUN
admet-1622	71	49	[	[	X
admet-1622	71	50	30	30	NUM
admet-1622	71	51	]	]	PUNCT
admet-1622	71	52	.	.	PUNCT
admet-1622	72	1	the	the	DET
admet-1622	72	2	tablets	tablet	NOUN
admet-1622	72	3	should	should	AUX
admet-1622	72	4	also	also	ADV
admet-1622	72	5	be	be	AUX
admet-1622	72	6	physically	physically	ADV
admet-1622	72	7	stable	stable	ADJ
admet-1622	72	8	during	during	ADP
admet-1622	72	9	their	their	PRON
admet-1622	72	10	shelf	shelf	NOUN
admet-1622	72	11	-	-	PUNCT
admet-1622	72	12	lives	life	NOUN
admet-1622	72	13	such	such	ADJ
admet-1622	72	14	that	that	SCONJ
admet-1622	72	15	no	no	DET
admet-1622	72	16	crystallization	crystallization	NOUN
admet-1622	72	17	of	of	ADP
admet-1622	72	18	drugs	drug	NOUN
admet-1622	72	19	occurs	occur	VERB
admet-1622	72	20	.	.	PUNCT
admet-1622	73	1	therefore	therefore	ADV
admet-1622	73	2	,	,	PUNCT
admet-1622	73	3	drug	drug	NOUN
admet-1622	73	4	-	-	PUNCT
admet-1622	73	5	polymer	polymer	NOUN
admet-1622	73	6	miscibility	miscibility	NOUN
admet-1622	73	7	is	be	AUX
admet-1622	73	8	critically	critically	ADV
admet-1622	73	9	important	important	ADJ
admet-1622	73	10	for	for	ADP
admet-1622	73	11	the	the	DET
admet-1622	73	12	development	development	NOUN
admet-1622	73	13	of	of	ADP
admet-1622	73	14	fdm	fdm	NOUN
admet-1622	73	15	3d	3d	ADV
admet-1622	73	16	-	-	PUNCT
admet-1622	73	17	printed	print	VERB
admet-1622	73	18	tablets	tablet	NOUN
admet-1622	73	19	,	,	PUNCT
admet-1622	73	20	especially	especially	ADV
admet-1622	73	21	for	for	ADP
admet-1622	73	22	drugs	drug	NOUN
admet-1622	73	23	with	with	ADP
admet-1622	73	24	poor	poor	ADJ
admet-1622	73	25	aqueous	aqueous	ADJ
admet-1622	73	26	solubility	solubility	NOUN
admet-1622	73	27	.	.	PUNCT
admet-1622	74	1	the	the	DET
admet-1622	74	2	drug	drug	NOUN
admet-1622	74	3	-	-	PUNCT
admet-1622	74	4	polymer	polymer	NOUN
admet-1622	74	5	miscibility	miscibility	NOUN
admet-1622	74	6	will	will	AUX
admet-1622	74	7	also	also	ADV
admet-1622	74	8	dictate	dictate	VERB
admet-1622	74	9	how	how	SCONJ
admet-1622	74	10	much	much	ADJ
admet-1622	74	11	drug	drug	NOUN
admet-1622	74	12	can	can	AUX
admet-1622	74	13	be	be	AUX
admet-1622	74	14	loaded	load	VERB
admet-1622	74	15	in	in	ADP
admet-1622	74	16	the	the	DET
admet-1622	74	17	filaments	filament	NOUN
admet-1622	74	18	and	and	CCONJ
admet-1622	74	19	then	then	ADV
admet-1622	74	20	in	in	ADP
admet-1622	74	21	the	the	DET
admet-1622	74	22	tablets	tablet	NOUN
admet-1622	74	23	.	.	PUNCT
admet-1622	75	1	however	however	ADV
admet-1622	75	2	,	,	PUNCT
admet-1622	75	3	in	in	ADP
admet-1622	75	4	most	most	ADJ
admet-1622	75	5	reported	report	VERB
admet-1622	75	6	studies	study	NOUN
admet-1622	75	7	on	on	ADP
admet-1622	75	8	fdm	fdm	NOUN
admet-1622	75	9	3d	3d	NOUN
admet-1622	75	10	-	-	PUNCT
admet-1622	75	11	printing	printing	NOUN
admet-1622	75	12	in	in	ADP
admet-1622	75	13	the	the	DET
admet-1622	75	14	literature	literature	NOUN
admet-1622	75	15	,	,	PUNCT
admet-1622	75	16	not	not	PART
admet-1622	75	17	much	much	ADJ
admet-1622	75	18	consideration	consideration	NOUN
admet-1622	75	19	of	of	ADP
admet-1622	75	20	drug	drug	NOUN
admet-1622	75	21	-	-	PUNCT
admet-1622	75	22	polymer	polymer	NOUN
admet-1622	75	23	miscibility	miscibility	NOUN
admet-1622	75	24	is	be	AUX
admet-1622	75	25	made	make	VERB
admet-1622	75	26	,	,	PUNCT
admet-1622	75	27	and	and	CCONJ
admet-1622	75	28	it	it	PRON
admet-1622	75	29	has	have	AUX
admet-1622	75	30	been	be	AUX
admet-1622	75	31	reported	report	VERB
admet-1622	75	32	that	that	SCONJ
admet-1622	75	33	the	the	DET
admet-1622	75	34	poorly	poorly	ADV
admet-1622	75	35	water	water	NOUN
admet-1622	75	36	-	-	PUNCT
admet-1622	75	37	soluble	soluble	ADJ
admet-1622	75	38	drugs	drug	NOUN
admet-1622	75	39	may	may	AUX
admet-1622	75	40	remain	remain	VERB
admet-1622	75	41	either	either	CCONJ
admet-1622	75	42	partially	partially	ADV
admet-1622	75	43	or	or	CCONJ
admet-1622	75	44	fully	fully	ADV
admet-1622	75	45	crystalline	crystalline	ADJ
admet-1622	75	46	in	in	ADP
admet-1622	75	47	the	the	DET
admet-1622	75	48	tablets	tablet	NOUN
admet-1622	75	49	[	[	X
admet-1622	75	50	31	31	NUM
admet-1622	75	51	]	]	PUNCT
admet-1622	75	52	.	.	PUNCT
admet-1622	76	1	in	in	ADP
admet-1622	76	2	one	one	NUM
admet-1622	76	3	of	of	ADP
admet-1622	76	4	the	the	DET
admet-1622	76	5	few	few	ADJ
admet-1622	76	6	studies	study	NOUN
admet-1622	76	7	where	where	SCONJ
admet-1622	76	8	drug	drug	NOUN
admet-1622	76	9	-	-	PUNCT
admet-1622	76	10	polymer	polymer	NOUN
admet-1622	76	11	miscibility	miscibility	NOUN
admet-1622	76	12	was	be	AUX
admet-1622	76	13	determined	determine	VERB
admet-1622	76	14	for	for	ADP
admet-1622	76	15	the	the	DET
admet-1622	76	16	development	development	NOUN
admet-1622	76	17	of	of	ADP
admet-1622	76	18	fdm	fdm	NOUN
admet-1622	76	19	3d	3d	ADV
admet-1622	76	20	-	-	PUNCT
admet-1622	76	21	printed	print	VERB
admet-1622	76	22	tablets	tablet	NOUN
admet-1622	76	23	,	,	PUNCT
admet-1622	76	24	solanki	solanki	PROPN
admet-1622	76	25	et	et	PROPN
admet-1622	76	26	al	al	PROPN
admet-1622	76	27	.	.	PUNCT
admet-1622	77	1	[	[	X
admet-1622	77	2	19	19	NUM
admet-1622	77	3	]	]	PUNCT
admet-1622	77	4	tested	test	VERB
admet-1622	77	5	the	the	DET
admet-1622	77	6	miscibility	miscibility	NOUN
admet-1622	77	7	of	of	ADP
admet-1622	77	8	haloperidol	haloperidol	NOUN
admet-1622	77	9	with	with	ADP
admet-1622	77	10	polyvinyl	polyvinyl	NOUN
admet-1622	77	11	pyrrolidone	pyrrolidone	NOUN
admet-1622	77	12	-	-	PUNCT
admet-1622	77	13	vinyl	vinyl	NOUN
admet-1622	77	14	acetate	acetate	NOUN
admet-1622	77	15	copolymer	copolymer	NOUN
admet-1622	77	16	(	(	PUNCT
admet-1622	77	17	kollidon	kollidon	PROPN
admet-1622	77	18	®	®	NOUN
admet-1622	77	19	va64	va64	PROPN
admet-1622	77	20	)	)	PUNCT
admet-1622	77	21	,	,	PUNCT
admet-1622	77	22	hydroxypropyl	hydroxypropyl	INTJ
admet-1622	77	23	methylcellulose	methylcellulose	NOUN
admet-1622	77	24	(	(	PUNCT
admet-1622	77	25	affinisol	affinisol	NOUN
admet-1622	77	26	®	®	NOUN
admet-1622	77	27	15cp	15cp	NOUN
admet-1622	77	28	)	)	PUNCT
admet-1622	77	29	and	and	CCONJ
admet-1622	77	30	the	the	DET
admet-1622	77	31	1:1	1:1	NUM
admet-1622	77	32	mixture	mixture	NOUN
admet-1622	77	33	of	of	ADP
admet-1622	77	34	the	the	DET
admet-1622	77	35	two	two	NUM
admet-1622	77	36	polymers	polymer	NOUN
admet-1622	77	37	by	by	ADP
admet-1622	77	38	applying	apply	VERB
admet-1622	77	39	the	the	DET
admet-1622	77	40	film	film	NOUN
admet-1622	77	41	casting	casting	NOUN
admet-1622	77	42	technique	technique	NOUN
admet-1622	77	43	previously	previously	ADV
admet-1622	77	44	developed	develop	VERB
admet-1622	77	45	by	by	ADP
admet-1622	77	46	parikh	parikh	PROPN
admet-1622	77	47	et	et	PROPN
admet-1622	77	48	al	al	PROPN
admet-1622	77	49	.	.	PUNCT
admet-1622	78	1	[	[	X
admet-1622	78	2	32	32	NUM
admet-1622	78	3	]	]	PUNCT
admet-1622	78	4	.	.	PUNCT
admet-1622	79	1	they	they	PRON
admet-1622	79	2	observed	observe	VERB
admet-1622	79	3	that	that	SCONJ
admet-1622	79	4	haloperidol	haloperidol	PROPN
admet-1622	79	5	was	be	AUX
admet-1622	79	6	miscible	miscible	ADJ
admet-1622	79	7	with	with	ADP
admet-1622	79	8	kollidon	kollidon	PROPN
admet-1622	79	9	®	®	NOUN
admet-1622	79	10	va64	va64	PROPN
admet-1622	79	11	,	,	PUNCT
admet-1622	79	12	affinisol	affinisol	NOUN
admet-1622	79	13	®	®	NOUN
admet-1622	79	14	15cp	15cp	PROPN
admet-1622	79	15	and	and	CCONJ
admet-1622	79	16	the	the	DET
admet-1622	79	17	1:1	1:1	NUM
admet-1622	79	18	kollidon	kollidon	ADJ
admet-1622	79	19	-	-	PUNCT
admet-1622	79	20	affinisol	affinisol	NOUN
admet-1622	79	21	mixture	mixture	NOUN
admet-1622	79	22	to	to	ADP
admet-1622	79	23	the	the	DET
admet-1622	79	24	extents	extent	NOUN
admet-1622	79	25	of	of	ADP
admet-1622	79	26	approximately	approximately	ADV
admet-1622	79	27	20	20	NUM
admet-1622	79	28	,	,	PUNCT
admet-1622	79	29	10	10	NUM
admet-1622	79	30	and	and	CCONJ
admet-1622	79	31	15	15	NUM
admet-1622	79	32	percent	percent	NOUN
admet-1622	79	33	,	,	PUNCT
admet-1622	79	34	respectively	respectively	ADV
admet-1622	79	35	.	.	PUNCT
admet-1622	80	1	in	in	ADP
admet-1622	80	2	another	another	DET
admet-1622	80	3	study	study	NOUN
admet-1622	80	4	,	,	PUNCT
admet-1622	80	5	wei	wei	PROPN
admet-1622	80	6	et	et	PROPN
admet-1622	80	7	al	al	PROPN
admet-1622	80	8	.	.	PUNCT
admet-1622	81	1	[	[	X
admet-1622	81	2	33	33	NUM
admet-1622	81	3	]	]	PUNCT
admet-1622	81	4	observed	observe	VERB
admet-1622	81	5	that	that	SCONJ
admet-1622	81	6	the	the	DET
admet-1622	81	7	miscibility	miscibility	NOUN
admet-1622	81	8	of	of	ADP
admet-1622	81	9	haloperidol	haloperidol	NOUN
admet-1622	81	10	with	with	ADP
admet-1622	81	11	another	another	DET
admet-1622	81	12	polymer	polymer	NOUN
admet-1622	81	13	,	,	PUNCT
admet-1622	81	14	polyvinyl	polyvinyl	NOUN
admet-1622	81	15	alcohol	alcohol	NOUN
admet-1622	81	16	(	(	PUNCT
admet-1622	81	17	pva	pva	NOUN
admet-1622	81	18	)	)	PUNCT
admet-1622	81	19	,	,	PUNCT
admet-1622	81	20	was	be	AUX
admet-1622	81	21	<	<	X
admet-1622	81	22	10	10	NUM
admet-1622	81	23	%	%	NOUN
admet-1622	81	24	w	w	PROPN
admet-1622	81	25	/	/	SYM
admet-1622	81	26	w	w	PROPN
admet-1622	81	27	,	,	PUNCT
admet-1622	81	28	while	while	SCONJ
admet-1622	81	29	a	a	DET
admet-1622	81	30	different	different	ADJ
admet-1622	81	31	drug	drug	NOUN
admet-1622	81	32	,	,	PUNCT
admet-1622	81	33	carvedilol	carvedilol	PROPN
admet-1622	81	34	,	,	PUNCT
admet-1622	81	35	was	be	AUX
admet-1622	81	36	miscible	miscible	ADJ
admet-1622	81	37	with	with	ADP
admet-1622	81	38	pva	pva	NOUN
admet-1622	81	39	up	up	ADV
admet-1622	81	40	to	to	PART
admet-1622	81	41	20	20	NUM
admet-1622	81	42	%	%	NOUN
admet-1622	81	43	w	w	PROPN
admet-1622	81	44	/	/	SYM
admet-1622	81	45	w.	w.	NOUN
admet-1622	81	46	these	these	DET
admet-1622	81	47	reports	report	NOUN
admet-1622	81	48	demonstrated	demonstrate	VERB
admet-1622	81	49	that	that	SCONJ
admet-1622	81	50	the	the	DET
admet-1622	81	51	miscibility	miscibility	NOUN
admet-1622	81	52	of	of	ADP
admet-1622	81	53	drugs	drug	NOUN
admet-1622	81	54	with	with	ADP
admet-1622	81	55	polymers	polymer	NOUN
admet-1622	81	56	could	could	AUX
admet-1622	81	57	be	be	AUX
admet-1622	81	58	rather	rather	ADV
admet-1622	81	59	limited	limited	ADJ
admet-1622	81	60	,	,	PUNCT
admet-1622	81	61	and	and	CCONJ
admet-1622	81	62	the	the	DET
admet-1622	81	63	extent	extent	NOUN
admet-1622	81	64	of	of	ADP
admet-1622	81	65	drug	drug	NOUN
admet-1622	81	66	-	-	PUNCT
admet-1622	81	67	polymer	polymer	NOUN
admet-1622	81	68	miscibility	miscibility	NOUN
admet-1622	81	69	may	may	AUX
admet-1622	81	70	depend	depend	VERB
admet-1622	81	71	on	on	ADP
admet-1622	81	72	the	the	DET
admet-1622	81	73	properties	property	NOUN
admet-1622	81	74	of	of	ADP
admet-1622	81	75	both	both	DET
admet-1622	81	76	drugs	drug	NOUN
admet-1622	81	77	and	and	CCONJ
admet-1622	81	78	polymers	polymer	NOUN
admet-1622	81	79	used	use	VERB
admet-1622	81	80	.	.	PUNCT
admet-1622	82	1	it	it	PRON
admet-1622	82	2	may	may	AUX
admet-1622	82	3	admet	admet	PROPN
admet-1622	82	4	&	&	CCONJ
admet-1622	82	5	dmpk	dmpk	PROPN
admet-1622	82	6	11(1	11(1	NUM
admet-1622	82	7	)	)	PUNCT
admet-1622	82	8	(	(	PUNCT
admet-1622	82	9	2023	2023	NUM
admet-1622	82	10	)	)	PUNCT
admet-1622	82	11	33	33	NUM
admet-1622	82	12	-	-	SYM
admet-1622	82	13	55	55	NUM
admet-1622	82	14	development	development	NOUN
admet-1622	82	15	of	of	ADP
admet-1622	82	16	rapidly	rapidly	ADV
admet-1622	82	17	dissolving	dissolve	VERB
admet-1622	82	18	fdm	fdm	NOUN
admet-1622	82	19	3d	3d	ADV
admet-1622	82	20	-	-	PUNCT
admet-1622	82	21	printed	print	VERB
admet-1622	82	22	tablets	tablet	NOUN
admet-1622	82	23	doi	doi	NOUN
admet-1622	82	24	:	:	PUNCT
admet-1622	82	25	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	82	26	37	37	NUM
admet-1622	82	27	also	also	ADV
admet-1622	82	28	be	be	AUX
admet-1622	82	29	noted	note	VERB
admet-1622	82	30	that	that	SCONJ
admet-1622	82	31	if	if	SCONJ
admet-1622	82	32	the	the	DET
admet-1622	82	33	drug	drug	NOUN
admet-1622	82	34	-	-	PUNCT
admet-1622	82	35	polymer	polymer	NOUN
admet-1622	82	36	miscibility	miscibility	NOUN
admet-1622	82	37	and	and	CCONJ
admet-1622	82	38	,	,	PUNCT
admet-1622	82	39	thereby	thereby	ADV
admet-1622	82	40	,	,	PUNCT
admet-1622	82	41	the	the	DET
admet-1622	82	42	drug	drug	NOUN
admet-1622	82	43	loading	loading	NOUN
admet-1622	82	44	is	be	AUX
admet-1622	82	45	low	low	ADJ
admet-1622	82	46	,	,	PUNCT
admet-1622	82	47	the	the	DET
admet-1622	82	48	size	size	NOUN
admet-1622	82	49	of	of	ADP
admet-1622	82	50	printed	print	VERB
admet-1622	82	51	tablets	tablet	NOUN
admet-1622	82	52	may	may	AUX
admet-1622	82	53	become	become	VERB
admet-1622	82	54	too	too	ADV
admet-1622	82	55	large	large	ADJ
admet-1622	82	56	for	for	ADP
admet-1622	82	57	certain	certain	ADJ
admet-1622	82	58	doses	dose	NOUN
admet-1622	82	59	.	.	PUNCT
admet-1622	83	1	need	need	VERB
admet-1622	83	2	for	for	ADP
admet-1622	83	3	high	high	ADJ
admet-1622	83	4	processing	processing	NOUN
admet-1622	83	5	temperature	temperature	NOUN
admet-1622	83	6	the	the	DET
admet-1622	83	7	hot	hot	ADJ
admet-1622	83	8	melt	melt	NOUN
admet-1622	83	9	extrusion	extrusion	NOUN
admet-1622	83	10	(	(	PUNCT
admet-1622	83	11	hme	hme	NOUN
admet-1622	83	12	)	)	PUNCT
admet-1622	83	13	temperature	temperature	NOUN
admet-1622	83	14	to	to	PART
admet-1622	83	15	prepare	prepare	VERB
admet-1622	83	16	filaments	filament	NOUN
admet-1622	83	17	for	for	ADP
admet-1622	83	18	fdm	fdm	NOUN
admet-1622	83	19	3d	3d	NOUN
admet-1622	83	20	-	-	PUNCT
admet-1622	83	21	printing	printing	NOUN
admet-1622	83	22	should	should	AUX
admet-1622	83	23	be	be	AUX
admet-1622	83	24	sufficiently	sufficiently	ADV
admet-1622	83	25	high	high	ADJ
admet-1622	83	26	that	that	SCONJ
admet-1622	83	27	the	the	DET
admet-1622	83	28	polymers	polymer	NOUN
admet-1622	83	29	must	must	AUX
admet-1622	83	30	exist	exist	VERB
admet-1622	83	31	in	in	ADP
admet-1622	83	32	the	the	DET
admet-1622	83	33	molten	molten	ADJ
admet-1622	83	34	state	state	NOUN
admet-1622	83	35	above	above	ADP
admet-1622	83	36	their	their	PRON
admet-1622	83	37	glass	glass	NOUN
admet-1622	83	38	transition	transition	NOUN
admet-1622	83	39	temperatures	temperature	NOUN
admet-1622	83	40	,	,	PUNCT
admet-1622	83	41	and	and	CCONJ
admet-1622	83	42	their	their	PRON
admet-1622	83	43	melt	melt	NOUN
admet-1622	83	44	viscosities	viscosity	NOUN
admet-1622	83	45	should	should	AUX
admet-1622	83	46	be	be	AUX
admet-1622	83	47	within	within	ADP
admet-1622	83	48	a	a	DET
admet-1622	83	49	certain	certain	ADJ
admet-1622	83	50	range	range	NOUN
admet-1622	83	51	such	such	ADJ
admet-1622	83	52	that	that	SCONJ
admet-1622	83	53	they	they	PRON
admet-1622	83	54	can	can	AUX
admet-1622	83	55	be	be	AUX
admet-1622	83	56	extruded	extrude	VERB
admet-1622	83	57	into	into	ADP
admet-1622	83	58	filaments	filament	NOUN
admet-1622	83	59	[	[	X
admet-1622	83	60	19,20,24,34	19,20,24,34	NUM
admet-1622	83	61	]	]	PUNCT
admet-1622	83	62	.	.	PUNCT
admet-1622	84	1	although	although	SCONJ
admet-1622	84	2	the	the	DET
admet-1622	84	3	presence	presence	NOUN
admet-1622	84	4	of	of	ADP
admet-1622	84	5	the	the	DET
admet-1622	84	6	drug	drug	NOUN
admet-1622	84	7	may	may	AUX
admet-1622	84	8	reduce	reduce	VERB
admet-1622	84	9	the	the	DET
admet-1622	84	10	melt	melt	NOUN
admet-1622	84	11	viscosity	viscosity	NOUN
admet-1622	84	12	and	and	CCONJ
admet-1622	84	13	thus	thus	ADV
admet-1622	84	14	the	the	DET
admet-1622	84	15	extrusion	extrusion	ADJ
admet-1622	84	16	temperature	temperature	NOUN
admet-1622	84	17	by	by	ADP
admet-1622	84	18	the	the	DET
admet-1622	84	19	plasticization	plasticization	NOUN
admet-1622	84	20	of	of	ADP
admet-1622	84	21	polymers	polymer	NOUN
admet-1622	84	22	[	[	X
admet-1622	84	23	34,35	34,35	NOUN
admet-1622	84	24	]	]	PUNCT
admet-1622	84	25	,	,	PUNCT
admet-1622	84	26	the	the	DET
admet-1622	84	27	melt	melt	NOUN
admet-1622	84	28	extrusion	extrusion	NOUN
admet-1622	84	29	temperatures	temperature	NOUN
admet-1622	84	30	in	in	ADP
admet-1622	84	31	most	most	ADJ
admet-1622	84	32	of	of	ADP
admet-1622	84	33	the	the	DET
admet-1622	84	34	reported	report	VERB
admet-1622	84	35	studies	study	NOUN
admet-1622	84	36	in	in	ADP
admet-1622	84	37	the	the	DET
admet-1622	84	38	literature	literature	NOUN
admet-1622	84	39	are	be	AUX
admet-1622	84	40	still	still	ADV
admet-1622	84	41	high	high	ADJ
admet-1622	84	42	.	.	PUNCT
admet-1622	85	1	when	when	SCONJ
admet-1622	85	2	the	the	DET
admet-1622	85	3	filaments	filament	NOUN
admet-1622	85	4	are	be	AUX
admet-1622	85	5	passed	pass	VERB
admet-1622	85	6	through	through	ADP
admet-1622	85	7	the	the	DET
admet-1622	85	8	printer	printer	NOUN
admet-1622	85	9	,	,	PUNCT
admet-1622	85	10	as	as	SCONJ
admet-1622	85	11	mentioned	mention	VERB
admet-1622	85	12	earlier	early	ADV
admet-1622	85	13	,	,	PUNCT
admet-1622	85	14	the	the	DET
admet-1622	85	15	temperature	temperature	NOUN
admet-1622	85	16	within	within	ADP
admet-1622	85	17	the	the	DET
admet-1622	85	18	printer	printer	NOUN
admet-1622	85	19	nozzle	nozzle	NOUN
admet-1622	85	20	must	must	AUX
admet-1622	85	21	be	be	AUX
admet-1622	85	22	even	even	ADV
admet-1622	85	23	higher	high	ADJ
admet-1622	85	24	to	to	PART
admet-1622	85	25	further	far	ADV
admet-1622	85	26	soften	soften	VERB
admet-1622	85	27	the	the	DET
admet-1622	85	28	filaments	filament	NOUN
admet-1622	85	29	such	such	ADJ
admet-1622	85	30	that	that	SCONJ
admet-1622	85	31	they	they	PRON
admet-1622	85	32	can	can	AUX
admet-1622	85	33	be	be	AUX
admet-1622	85	34	deposited	deposit	VERB
admet-1622	85	35	layer	layer	NOUN
admet-1622	85	36	by	by	ADP
admet-1622	85	37	layer	layer	NOUN
admet-1622	85	38	into	into	ADP
admet-1622	85	39	tablets	tablet	NOUN
admet-1622	85	40	.	.	PUNCT
admet-1622	86	1	by	by	ADP
admet-1622	86	2	surveying	survey	VERB
admet-1622	86	3	58	58	NUM
admet-1622	86	4	fdm	fdm	NOUN
admet-1622	86	5	3d	3d	ADV
admet-1622	86	6	-	-	PUNCT
admet-1622	86	7	printed	print	VERB
admet-1622	86	8	tablets	tablet	NOUN
admet-1622	86	9	reported	report	VERB
admet-1622	86	10	in	in	ADP
admet-1622	86	11	the	the	DET
admet-1622	86	12	literature	literature	NOUN
admet-1622	86	13	,	,	PUNCT
admet-1622	86	14	cailleaux	cailleaux	ADP
admet-1622	86	15	et	et	PROPN
admet-1622	86	16	al	al	PROPN
admet-1622	86	17	.	.	PUNCT
admet-1622	87	1	[	[	X
admet-1622	87	2	26	26	NUM
admet-1622	87	3	]	]	PUNCT
admet-1622	87	4	reported	report	VERB
admet-1622	87	5	that	that	SCONJ
admet-1622	87	6	filaments	filament	NOUN
admet-1622	87	7	for	for	ADP
admet-1622	87	8	50	50	NUM
admet-1622	87	9	of	of	ADP
admet-1622	87	10	them	they	PRON
admet-1622	87	11	were	be	AUX
admet-1622	87	12	melt	melt	VERB
admet-1622	87	13	extruded	extrude	VERB
admet-1622	87	14	at	at	ADP
admet-1622	87	15	temperatures	temperature	NOUN
admet-1622	87	16	ranging	range	VERB
admet-1622	87	17	from	from	ADP
admet-1622	87	18	100	100	NUM
admet-1622	87	19	to	to	PART
admet-1622	87	20	210	210	NUM
admet-1622	87	21	°	°	NOUN
admet-1622	87	22	c	c	NOUN
admet-1622	87	23	,	,	PUNCT
admet-1622	87	24	where	where	SCONJ
admet-1622	87	25	temperatures	temperature	NOUN
admet-1622	87	26	of	of	ADP
admet-1622	87	27	140	140	NUM
admet-1622	87	28	-	-	SYM
admet-1622	87	29	180	180	NUM
admet-1622	87	30	°	°	NOUN
admet-1622	87	31	c	c	NOUN
admet-1622	87	32	were	be	AUX
admet-1622	87	33	common	common	ADJ
admet-1622	87	34	.	.	PUNCT
admet-1622	88	1	among	among	ADP
admet-1622	88	2	these	these	DET
admet-1622	88	3	tablets	tablet	NOUN
admet-1622	88	4	,	,	PUNCT
admet-1622	88	5	47	47	NUM
admet-1622	88	6	were	be	AUX
admet-1622	88	7	printed	print	VERB
admet-1622	88	8	in	in	ADP
admet-1622	88	9	the	the	DET
admet-1622	88	10	temperature	temperature	NOUN
admet-1622	88	11	range	range	NOUN
admet-1622	88	12	of	of	ADP
admet-1622	88	13	150	150	NUM
admet-1622	88	14	to	to	PART
admet-1622	88	15	250	250	NUM
admet-1622	88	16	°	°	NOUN
admet-1622	88	17	c	c	NOUN
admet-1622	88	18	,	,	PUNCT
admet-1622	88	19	where	where	SCONJ
admet-1622	88	20	temperatures	temperature	NOUN
admet-1622	88	21	around	around	ADP
admet-1622	88	22	200	200	NUM
admet-1622	88	23	°	°	NOUN
admet-1622	88	24	c	c	NOUN
admet-1622	88	25	were	be	AUX
admet-1622	88	26	the	the	DET
admet-1622	88	27	most	most	ADV
admet-1622	88	28	used	use	VERB
admet-1622	88	29	.	.	PUNCT
admet-1622	89	1	thus	thus	ADV
admet-1622	89	2	,	,	PUNCT
admet-1622	89	3	high	high	ADJ
admet-1622	89	4	temperatures	temperature	NOUN
admet-1622	89	5	required	require	VERB
admet-1622	89	6	for	for	ADP
admet-1622	89	7	the	the	DET
admet-1622	89	8	hme	hme	NOUN
admet-1622	89	9	of	of	ADP
admet-1622	89	10	filaments	filament	NOUN
admet-1622	89	11	and	and	CCONJ
admet-1622	89	12	even	even	ADV
admet-1622	89	13	higher	high	ADJ
admet-1622	89	14	temperatures	temperature	NOUN
admet-1622	89	15	needed	need	VERB
admet-1622	89	16	for	for	ADP
admet-1622	89	17	3d	3d	NUM
admet-1622	89	18	printing	printing	NOUN
admet-1622	89	19	could	could	AUX
admet-1622	89	20	be	be	AUX
admet-1622	89	21	major	major	ADJ
admet-1622	89	22	issues	issue	NOUN
admet-1622	89	23	for	for	ADP
admet-1622	89	24	the	the	DET
admet-1622	89	25	thermal	thermal	ADJ
admet-1622	89	26	stability	stability	NOUN
admet-1622	89	27	of	of	ADP
admet-1622	89	28	drugs	drug	NOUN
admet-1622	89	29	and	and	CCONJ
admet-1622	89	30	polymers	polymer	NOUN
admet-1622	89	31	.	.	PUNCT
admet-1622	90	1	at	at	ADP
admet-1622	90	2	such	such	ADJ
admet-1622	90	3	high	high	ADJ
admet-1622	90	4	melt	melt	NOUN
admet-1622	90	5	extrusion	extrusion	NOUN
admet-1622	90	6	and	and	CCONJ
admet-1622	90	7	printing	printing	NOUN
admet-1622	90	8	temperatures	temperature	NOUN
admet-1622	90	9	,	,	PUNCT
admet-1622	90	10	drugs	drug	NOUN
admet-1622	90	11	,	,	PUNCT
admet-1622	90	12	polymers	polymer	NOUN
admet-1622	90	13	,	,	PUNCT
admet-1622	90	14	or	or	CCONJ
admet-1622	90	15	both	both	PRON
admet-1622	90	16	may	may	AUX
admet-1622	90	17	be	be	AUX
admet-1622	90	18	thermally	thermally	ADV
admet-1622	90	19	unstable	unstable	ADJ
admet-1622	90	20	.	.	PUNCT
admet-1622	91	1	it	it	PRON
admet-1622	91	2	is	be	AUX
admet-1622	91	3	essential	essential	ADJ
admet-1622	91	4	that	that	SCONJ
admet-1622	91	5	the	the	DET
admet-1622	91	6	processing	processing	NOUN
admet-1622	91	7	temperatures	temperature	NOUN
admet-1622	91	8	are	be	AUX
admet-1622	91	9	lowered	lower	VERB
admet-1622	91	10	to	to	PART
admet-1622	91	11	make	make	VERB
admet-1622	91	12	fdm	fdm	NOUN
admet-1622	91	13	3d	3d	NOUN
admet-1622	91	14	-	-	PUNCT
admet-1622	91	15	printing	print	VERB
admet-1622	91	16	more	more	ADV
admet-1622	91	17	widely	widely	ADV
admet-1622	91	18	applicable	applicable	ADJ
admet-1622	91	19	to	to	ADP
admet-1622	91	20	drug	drug	NOUN
admet-1622	91	21	product	product	NOUN
admet-1622	91	22	development	development	NOUN
admet-1622	91	23	.	.	PUNCT
admet-1622	92	1	drug	drug	NOUN
admet-1622	92	2	release	release	NOUN
admet-1622	92	3	rate	rate	NOUN
admet-1622	92	4	lastly	lastly	ADV
admet-1622	92	5	,	,	PUNCT
admet-1622	92	6	the	the	DET
admet-1622	92	7	most	most	ADV
admet-1622	92	8	difficult	difficult	ADJ
admet-1622	92	9	challenge	challenge	NOUN
admet-1622	92	10	in	in	ADP
admet-1622	92	11	the	the	DET
admet-1622	92	12	development	development	NOUN
admet-1622	92	13	of	of	ADP
admet-1622	92	14	fdm	fdm	NOUN
admet-1622	92	15	3d	3d	ADV
admet-1622	92	16	-	-	PUNCT
admet-1622	92	17	printed	print	VERB
admet-1622	92	18	tablets	tablet	NOUN
admet-1622	92	19	is	be	AUX
admet-1622	92	20	to	to	PART
admet-1622	92	21	ensure	ensure	VERB
admet-1622	92	22	rapid	rapid	ADJ
admet-1622	92	23	drug	drug	NOUN
admet-1622	92	24	release	release	NOUN
admet-1622	92	25	from	from	ADP
admet-1622	92	26	the	the	DET
admet-1622	92	27	tablets	tablet	NOUN
admet-1622	92	28	.	.	PUNCT
admet-1622	93	1	the	the	DET
admet-1622	93	2	drug	drug	NOUN
admet-1622	93	3	-	-	PUNCT
admet-1622	93	4	loaded	load	VERB
admet-1622	93	5	filaments	filament	NOUN
admet-1622	93	6	produced	produce	VERB
admet-1622	93	7	by	by	ADP
admet-1622	93	8	hme	hme	PROPN
admet-1622	93	9	are	be	AUX
admet-1622	93	10	essentially	essentially	ADV
admet-1622	93	11	nonporous	nonporous	ADJ
admet-1622	93	12	masses	masse	NOUN
admet-1622	93	13	,	,	PUNCT
admet-1622	93	14	which	which	PRON
admet-1622	93	15	are	be	AUX
admet-1622	93	16	then	then	ADV
admet-1622	93	17	printed	print	VERB
admet-1622	93	18	into	into	ADP
admet-1622	93	19	compact	compact	ADJ
admet-1622	93	20	and	and	CCONJ
admet-1622	93	21	hard	hard	ADJ
admet-1622	93	22	tablets	tablet	NOUN
admet-1622	93	23	.	.	PUNCT
admet-1622	94	1	therefore	therefore	ADV
admet-1622	94	2	,	,	PUNCT
admet-1622	94	3	the	the	DET
admet-1622	94	4	tablets	tablet	NOUN
admet-1622	94	5	dissolve	dissolve	VERB
admet-1622	94	6	in	in	ADP
admet-1622	94	7	aqueous	aqueous	ADJ
admet-1622	94	8	media	medium	NOUN
admet-1622	94	9	by	by	ADP
admet-1622	94	10	erosion	erosion	NOUN
admet-1622	94	11	from	from	ADP
admet-1622	94	12	the	the	DET
admet-1622	94	13	surface	surface	NOUN
admet-1622	94	14	without	without	ADP
admet-1622	94	15	any	any	DET
admet-1622	94	16	disintegration	disintegration	NOUN
admet-1622	94	17	into	into	ADP
admet-1622	94	18	particles	particle	NOUN
admet-1622	94	19	,	,	PUNCT
admet-1622	94	20	which	which	PRON
admet-1622	94	21	often	often	ADV
admet-1622	94	22	leads	lead	VERB
admet-1622	94	23	to	to	ADP
admet-1622	94	24	slow	slow	VERB
admet-1622	94	25	drug	drug	NOUN
admet-1622	94	26	release	release	NOUN
admet-1622	94	27	rate	rate	NOUN
admet-1622	94	28	.	.	PUNCT
admet-1622	95	1	indeed	indeed	ADV
admet-1622	95	2	,	,	PUNCT
admet-1622	95	3	cailleaux	cailleaux	ADP
admet-1622	95	4	et	et	PROPN
admet-1622	95	5	al	al	PROPN
admet-1622	95	6	.	.	PUNCT
admet-1622	96	1	[	[	X
admet-1622	96	2	26	26	NUM
admet-1622	96	3	]	]	PUNCT
admet-1622	96	4	reported	report	VERB
admet-1622	96	5	that	that	SCONJ
admet-1622	96	6	out	out	ADP
admet-1622	96	7	of	of	ADP
admet-1622	96	8	56	56	NUM
admet-1622	96	9	fdm	fdm	NOUN
admet-1622	96	10	3d	3d	ADV
admet-1622	96	11	-	-	PUNCT
admet-1622	96	12	printed	print	VERB
admet-1622	96	13	drug	drug	NOUN
admet-1622	96	14	products	product	NOUN
admet-1622	96	15	for	for	ADP
admet-1622	96	16	which	which	PRON
admet-1622	96	17	drug	drug	NOUN
admet-1622	96	18	release	release	NOUN
admet-1622	96	19	rates	rate	NOUN
admet-1622	96	20	were	be	AUX
admet-1622	96	21	reported	report	VERB
admet-1622	96	22	in	in	ADP
admet-1622	96	23	the	the	DET
admet-1622	96	24	literature	literature	NOUN
admet-1622	96	25	,	,	PUNCT
admet-1622	96	26	43	43	NUM
admet-1622	96	27	were	be	AUX
admet-1622	96	28	slow	slow	ADJ
admet-1622	96	29	-	-	PUNCT
admet-1622	96	30	release	release	NOUN
admet-1622	96	31	dosage	dosage	NOUN
admet-1622	96	32	forms	form	NOUN
admet-1622	96	33	,	,	PUNCT
admet-1622	96	34	4	4	NUM
admet-1622	96	35	were	be	AUX
admet-1622	96	36	both	both	PRON
admet-1622	96	37	sustained	sustain	VERB
admet-1622	96	38	and	and	CCONJ
admet-1622	96	39	immediate	immediate	ADJ
admet-1622	96	40	release	release	NOUN
admet-1622	96	41	dosage	dosage	NOUN
admet-1622	96	42	forms	form	NOUN
admet-1622	96	43	,	,	PUNCT
admet-1622	96	44	and	and	CCONJ
admet-1622	96	45	9	9	NUM
admet-1622	96	46	were	be	AUX
admet-1622	96	47	for	for	ADP
admet-1622	96	48	immediate	immediate	ADJ
admet-1622	96	49	release	release	NOUN
admet-1622	96	50	.	.	PUNCT
admet-1622	97	1	however	however	ADV
admet-1622	97	2	,	,	PUNCT
admet-1622	97	3	as	as	SCONJ
admet-1622	97	4	will	will	AUX
admet-1622	97	5	be	be	AUX
admet-1622	97	6	discussed	discuss	VERB
admet-1622	97	7	in	in	ADP
admet-1622	97	8	the	the	DET
admet-1622	97	9	next	next	ADJ
admet-1622	97	10	section	section	NOUN
admet-1622	97	11	,	,	PUNCT
admet-1622	97	12	the	the	DET
admet-1622	97	13	rapid	rapid	ADJ
admet-1622	97	14	drug	drug	NOUN
admet-1622	97	15	release	release	NOUN
admet-1622	97	16	rate	rate	NOUN
admet-1622	97	17	is	be	AUX
admet-1622	97	18	critically	critically	ADV
admet-1622	97	19	important	important	ADJ
admet-1622	97	20	for	for	ADP
admet-1622	97	21	most	most	ADJ
admet-1622	97	22	drugs	drug	NOUN
admet-1622	97	23	for	for	ADP
admet-1622	97	24	optimal	optimal	ADJ
admet-1622	97	25	therapy	therapy	NOUN
admet-1622	97	26	[	[	X
admet-1622	97	27	17,18	17,18	X
admet-1622	97	28	]	]	X
admet-1622	97	29	.	.	PUNCT
admet-1622	98	1	therefore	therefore	ADV
admet-1622	98	2	,	,	PUNCT
admet-1622	98	3	as	as	SCONJ
admet-1622	98	4	mentioned	mention	VERB
admet-1622	98	5	earlier	early	ADV
admet-1622	98	6	,	,	PUNCT
admet-1622	98	7	the	the	DET
admet-1622	98	8	primary	primary	ADJ
admet-1622	98	9	focus	focus	NOUN
admet-1622	98	10	of	of	ADP
admet-1622	98	11	the	the	DET
admet-1622	98	12	present	present	ADJ
admet-1622	98	13	commentary	commentary	NOUN
admet-1622	98	14	is	be	AUX
admet-1622	98	15	to	to	PART
admet-1622	98	16	assess	assess	VERB
admet-1622	98	17	the	the	DET
admet-1622	98	18	status	status	NOUN
admet-1622	98	19	of	of	ADP
admet-1622	98	20	the	the	DET
admet-1622	98	21	development	development	NOUN
admet-1622	98	22	of	of	ADP
admet-1622	98	23	rapidly	rapidly	ADV
admet-1622	98	24	dissolving	dissolve	VERB
admet-1622	98	25	fdm	fdm	NOUN
admet-1622	98	26	3d	3d	ADV
admet-1622	98	27	-	-	PUNCT
admet-1622	98	28	printed	print	VERB
admet-1622	98	29	tablets	tablet	NOUN
admet-1622	98	30	.	.	PUNCT
admet-1622	99	1	the	the	DET
admet-1622	99	2	significance	significance	NOUN
admet-1622	99	3	of	of	ADP
admet-1622	99	4	rapid	rapid	ADJ
admet-1622	99	5	drug	drug	NOUN
admet-1622	99	6	release	release	NOUN
admet-1622	99	7	in	in	ADP
admet-1622	99	8	drug	drug	NOUN
admet-1622	99	9	therapy	therapy	NOUN
admet-1622	99	10	will	will	AUX
admet-1622	99	11	also	also	ADV
admet-1622	99	12	be	be	AUX
admet-1622	99	13	discussed	discuss	VERB
admet-1622	99	14	,	,	PUNCT
admet-1622	99	15	which	which	PRON
admet-1622	99	16	will	will	AUX
admet-1622	99	17	then	then	ADV
admet-1622	99	18	be	be	AUX
admet-1622	99	19	followed	follow	VERB
admet-1622	99	20	by	by	ADP
admet-1622	99	21	the	the	DET
admet-1622	99	22	discussion	discussion	NOUN
admet-1622	99	23	of	of	ADP
admet-1622	99	24	various	various	ADJ
admet-1622	99	25	strategies	strategy	NOUN
admet-1622	99	26	employed	employ	VERB
admet-1622	99	27	to	to	PART
admet-1622	99	28	increase	increase	VERB
admet-1622	99	29	drug	drug	NOUN
admet-1622	99	30	release	release	NOUN
admet-1622	99	31	rates	rate	NOUN
admet-1622	99	32	from	from	ADP
admet-1622	99	33	fdm	fdm	NOUN
admet-1622	99	34	3d	3d	ADV
admet-1622	99	35	-	-	PUNCT
admet-1622	99	36	printed	print	VERB
admet-1622	99	37	tablets	tablet	NOUN
admet-1622	99	38	.	.	PUNCT
admet-1622	100	1	why	why	SCONJ
admet-1622	100	2	rapid	rapid	ADJ
admet-1622	100	3	drug	drug	NOUN
admet-1622	100	4	release	release	NOUN
admet-1622	100	5	?	?	PUNCT
admet-1622	101	1	the	the	DET
admet-1622	101	2	therapeutic	therapeutic	ADJ
admet-1622	101	3	outcome	outcome	NOUN
admet-1622	101	4	of	of	ADP
admet-1622	101	5	drug	drug	NOUN
admet-1622	101	6	products	product	NOUN
admet-1622	101	7	and	and	CCONJ
admet-1622	101	8	optimal	optimal	ADJ
admet-1622	101	9	patient	patient	NOUN
admet-1622	101	10	benefits	benefit	NOUN
admet-1622	101	11	depend	depend	VERB
admet-1622	101	12	greatly	greatly	ADV
admet-1622	101	13	on	on	ADP
admet-1622	101	14	how	how	SCONJ
admet-1622	101	15	drugs	drug	NOUN
admet-1622	101	16	are	be	AUX
admet-1622	101	17	released	release	VERB
admet-1622	101	18	from	from	ADP
admet-1622	101	19	dosage	dosage	NOUN
admet-1622	101	20	forms	form	NOUN
admet-1622	101	21	and	and	CCONJ
admet-1622	101	22	reach	reach	VERB
admet-1622	101	23	the	the	DET
admet-1622	101	24	target	target	NOUN
admet-1622	101	25	sites	site	NOUN
admet-1622	101	26	after	after	ADP
admet-1622	101	27	oral	oral	ADJ
admet-1622	101	28	administration	administration	NOUN
admet-1622	101	29	and	and	CCONJ
admet-1622	101	30	how	how	SCONJ
admet-1622	101	31	the	the	DET
admet-1622	101	32	drug	drug	NOUN
admet-1622	101	33	levels	level	NOUN
admet-1622	101	34	are	be	AUX
admet-1622	101	35	maintained	maintain	VERB
admet-1622	101	36	in	in	ADP
admet-1622	101	37	the	the	DET
admet-1622	101	38	body	body	NOUN
admet-1622	101	39	.	.	PUNCT
admet-1622	102	1	therefore	therefore	ADV
admet-1622	102	2	,	,	PUNCT
admet-1622	102	3	it	it	PRON
admet-1622	102	4	is	be	AUX
admet-1622	102	5	essential	essential	ADJ
admet-1622	102	6	that	that	SCONJ
admet-1622	102	7	the	the	DET
admet-1622	102	8	optimal	optimal	ADJ
admet-1622	102	9	drug	drug	NOUN
admet-1622	102	10	release	release	NOUN
admet-1622	102	11	attributes	attribute	NOUN
admet-1622	102	12	must	must	AUX
admet-1622	102	13	be	be	AUX
admet-1622	102	14	built	build	VERB
admet-1622	102	15	into	into	ADP
admet-1622	102	16	dosage	dosage	NOUN
admet-1622	102	17	forms	form	NOUN
admet-1622	102	18	.	.	PUNCT
admet-1622	103	1	in	in	ADP
admet-1622	103	2	2014	2014	NUM
admet-1622	103	3	,	,	PUNCT
admet-1622	103	4	an	an	DET
admet-1622	103	5	international	international	ADJ
admet-1622	103	6	panel	panel	NOUN
admet-1622	103	7	of	of	ADP
admet-1622	103	8	experts	expert	NOUN
admet-1622	103	9	representing	represent	VERB
admet-1622	103	10	the	the	DET
admet-1622	103	11	food	food	NOUN
admet-1622	103	12	and	and	CCONJ
admet-1622	103	13	drug	drug	PROPN
admet-1622	103	14	administration	administration	NOUN
admet-1622	103	15	(	(	PUNCT
admet-1622	103	16	fda	fda	PROPN
admet-1622	103	17	)	)	PUNCT
admet-1622	103	18	,	,	PUNCT
admet-1622	103	19	academia	academia	NOUN
admet-1622	103	20	,	,	PUNCT
admet-1622	103	21	and	and	CCONJ
admet-1622	103	22	the	the	DET
admet-1622	103	23	pharmaceutical	pharmaceutical	NOUN
admet-1622	103	24	industry	industry	NOUN
admet-1622	103	25	from	from	ADP
admet-1622	103	26	the	the	DET
admet-1622	103	27	us	us	PROPN
admet-1622	103	28	and	and	CCONJ
admet-1622	103	29	europe	europe	PROPN
admet-1622	103	30	,	,	PUNCT
admet-1622	103	31	headed	head	VERB
admet-1622	103	32	by	by	ADP
admet-1622	103	33	dr	dr	PROPN
admet-1622	103	34	.	.	PROPN
admet-1622	103	35	arzu	arzu	PROPN
admet-1622	103	36	selen	selen	VERB
admet-1622	103	37	from	from	ADP
admet-1622	103	38	the	the	DET
admet-1622	103	39	fda	fda	PROPN
admet-1622	103	40	,	,	PUNCT
admet-1622	103	41	developed	develop	VERB
admet-1622	103	42	a	a	DET
admet-1622	103	43	biopharmaceutical	biopharmaceutical	ADJ
admet-1622	103	44	risk	risk	NOUN
admet-1622	103	45	assessment	assessment	NOUN
admet-1622	103	46	roadmap	roadmap	NOUN
admet-1622	103	47	(	(	PUNCT
admet-1622	103	48	bioram	bioram	PROPN
admet-1622	103	49	)	)	PUNCT
admet-1622	103	50	to	to	PART
admet-1622	103	51	delineate	delineate	VERB
admet-1622	103	52	optimal	optimal	ADJ
admet-1622	103	53	drug	drug	NOUN
admet-1622	103	54	delivery	delivery	NOUN
admet-1622	103	55	rates	rate	NOUN
admet-1622	103	56	and	and	CCONJ
admet-1622	103	57	patterns	pattern	NOUN
admet-1622	103	58	for	for	ADP
admet-1622	103	59	achieving	achieve	VERB
admet-1622	103	60	the	the	DET
admet-1622	103	61	desired	desire	VERB
admet-1622	103	62	therapeutic	therapeutic	ADJ
admet-1622	103	63	outcomes	outcome	NOUN
admet-1622	103	64	[	[	X
admet-1622	103	65	18	18	NUM
admet-1622	103	66	]	]	PUNCT
admet-1622	103	67	.	.	PUNCT
admet-1622	104	1	the	the	DET
admet-1622	104	2	team	team	NOUN
admet-1622	104	3	also	also	ADV
admet-1622	104	4	described	describe	VERB
admet-1622	104	5	different	different	ADJ
admet-1622	104	6	biopharmaceutics	biopharmaceutics	NOUN
admet-1622	104	7	tools	tool	NOUN
admet-1622	104	8	that	that	PRON
admet-1622	104	9	may	may	AUX
admet-1622	104	10	be	be	AUX
admet-1622	104	11	applied	apply	VERB
admet-1622	104	12	to	to	PART
admet-1622	104	13	identify	identify	VERB
admet-1622	104	14	and	and	CCONJ
admet-1622	104	15	address	address	VERB
admet-1622	104	16	potential	potential	ADJ
admet-1622	104	17	challenges	challenge	NOUN
admet-1622	104	18	to	to	PART
admet-1622	104	19	optimize	optimize	VERB
admet-1622	104	20	drug	drug	NOUN
admet-1622	104	21	products	product	NOUN
admet-1622	104	22	for	for	ADP
admet-1622	104	23	patient	patient	ADJ
admet-1622	104	24	benefits	benefit	NOUN
admet-1622	104	25	[	[	X
admet-1622	104	26	17	17	NUM
admet-1622	104	27	]	]	PUNCT
admet-1622	104	28	.	.	PUNCT
admet-1622	105	1	according	accord	VERB
admet-1622	105	2	to	to	ADP
admet-1622	105	3	bioram	bioram	PROPN
admet-1622	105	4	,	,	PUNCT
admet-1622	105	5	blood	blood	NOUN
admet-1622	105	6	levels	level	NOUN
admet-1622	105	7	of	of	ADP
admet-1622	105	8	different	different	ADJ
admet-1622	105	9	drugs	drug	NOUN
admet-1622	105	10	in	in	ADP
admet-1622	105	11	the	the	DET
admet-1622	105	12	body	body	NOUN
admet-1622	105	13	may	may	AUX
admet-1622	105	14	be	be	AUX
admet-1622	105	15	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	VERB
admet-1622	105	16	abu	abu	PROPN
admet-1622	105	17	t.m	t.m	PROPN
admet-1622	105	18	.	.	PUNCT
admet-1622	106	1	serajuddin	serajuddin	VERB
admet-1622	106	2	admet	admet	PROPN
admet-1622	106	3	&	&	CCONJ
admet-1622	106	4	dmpk	dmpk	PROPN
admet-1622	106	5	11(1	11(1	NUM
admet-1622	106	6	)	)	PUNCT
admet-1622	106	7	(	(	PUNCT
admet-1622	106	8	2023	2023	NUM
admet-1622	106	9	)	)	PUNCT
admet-1622	106	10	33	33	NUM
admet-1622	106	11	-	-	SYM
admet-1622	106	12	55	55	NUM
admet-1622	106	13	38	38	NUM
admet-1622	106	14	classified	classify	VERB
admet-1622	106	15	into	into	ADP
admet-1622	106	16	four	four	NUM
admet-1622	106	17	scenarios	scenario	NOUN
admet-1622	106	18	,	,	PUNCT
admet-1622	106	19	as	as	SCONJ
admet-1622	106	20	shown	show	VERB
admet-1622	106	21	in	in	ADP
admet-1622	106	22	figure	figure	NOUN
admet-1622	106	23	2	2	NUM
admet-1622	106	24	,	,	PUNCT
admet-1622	106	25	to	to	PART
admet-1622	106	26	achieve	achieve	VERB
admet-1622	106	27	the	the	DET
admet-1622	106	28	desired	desire	VERB
admet-1622	106	29	therapeutic	therapeutic	ADJ
admet-1622	106	30	outcomes	outcome	NOUN
admet-1622	106	31	:	:	PUNCT
admet-1622	106	32	figure	figure	VERB
admet-1622	106	33	2	2	NUM
admet-1622	106	34	.	.	NOUN
admet-1622	106	35	four	four	NUM
admet-1622	106	36	scenarios	scenario	NOUN
admet-1622	106	37	of	of	ADP
admet-1622	106	38	drug	drug	NOUN
admet-1622	106	39	product	product	NOUN
admet-1622	106	40	development	development	NOUN
admet-1622	106	41	according	accord	VERB
admet-1622	106	42	to	to	ADP
admet-1622	106	43	the	the	DET
admet-1622	106	44	biopharmaceutical	biopharmaceutical	ADJ
admet-1622	106	45	roadmap	roadmap	NOUN
admet-1622	106	46	(	(	PUNCT
admet-1622	106	47	bioram	bioram	PROPN
admet-1622	106	48	)	)	PUNCT
admet-1622	106	49	.	.	PUNCT
admet-1622	107	1	adapted	adapt	VERB
admet-1622	107	2	from	from	ADP
admet-1622	107	3	selen	selen	PROPN
admet-1622	107	4	et	et	PROPN
admet-1622	107	5	al	al	PROPN
admet-1622	107	6	.	.	PUNCT
admet-1622	108	1	[	[	X
admet-1622	108	2	17	17	NUM
admet-1622	108	3	]	]	PUNCT
admet-1622	108	4	with	with	ADP
admet-1622	108	5	permission	permission	NOUN
admet-1622	108	6	.	.	PUNCT
admet-1622	109	1	a	a	DET
admet-1622	109	2	)	)	PUNCT
admet-1622	109	3	scenario	scenario	NOUN
admet-1622	109	4	1	1	NUM
admet-1622	109	5	represents	represent	VERB
admet-1622	109	6	drugs	drug	NOUN
admet-1622	109	7	where	where	SCONJ
admet-1622	109	8	very	very	ADV
admet-1622	109	9	rapid	rapid	ADJ
admet-1622	109	10	drug	drug	NOUN
admet-1622	109	11	absorption	absorption	NOUN
admet-1622	109	12	and	and	CCONJ
admet-1622	109	13	therapeutic	therapeutic	ADJ
admet-1622	109	14	action	action	NOUN
admet-1622	109	15	are	be	AUX
admet-1622	109	16	needed	need	VERB
admet-1622	109	17	for	for	ADP
admet-1622	109	18	such	such	ADJ
admet-1622	109	19	therapies	therapy	NOUN
admet-1622	109	20	as	as	ADP
admet-1622	109	21	breakthrough	breakthrough	NOUN
admet-1622	109	22	pain	pain	NOUN
admet-1622	109	23	,	,	PUNCT
admet-1622	109	24	analgesia	analgesia	PROPN
admet-1622	109	25	,	,	PUNCT
admet-1622	109	26	acute	acute	ADJ
admet-1622	109	27	angina	angina	PROPN
admet-1622	109	28	pectoris	pectoris	PROPN
admet-1622	109	29	,	,	PUNCT
admet-1622	109	30	insomnia	insomnia	NOUN
admet-1622	109	31	,	,	PUNCT
admet-1622	109	32	etc	etc	X
admet-1622	109	33	.	.	X
admet-1622	109	34	b	b	X
admet-1622	109	35	)	)	PUNCT
admet-1622	109	36	scenario	scenario	NOUN
admet-1622	109	37	2	2	NUM
admet-1622	109	38	represents	represent	VERB
admet-1622	109	39	multiphasic	multiphasic	NOUN
admet-1622	109	40	delivery	delivery	NOUN
admet-1622	109	41	of	of	ADP
admet-1622	109	42	a	a	DET
admet-1622	109	43	single	single	ADJ
admet-1622	109	44	drug	drug	NOUN
admet-1622	109	45	or	or	CCONJ
admet-1622	109	46	multiple	multiple	ADJ
admet-1622	109	47	drugs	drug	NOUN
admet-1622	109	48	from	from	ADP
admet-1622	109	49	the	the	DET
admet-1622	109	50	same	same	ADJ
admet-1622	109	51	dosage	dosage	NOUN
admet-1622	109	52	form	form	NOUN
admet-1622	109	53	that	that	PRON
admet-1622	109	54	has	have	VERB
admet-1622	109	55	both	both	CCONJ
admet-1622	109	56	rapid	rapid	ADJ
admet-1622	109	57	action	action	NOUN
admet-1622	109	58	and	and	CCONJ
admet-1622	109	59	sustained	sustained	ADJ
admet-1622	109	60	action	action	NOUN
admet-1622	109	61	,	,	PUNCT
admet-1622	109	62	and	and	CCONJ
admet-1622	109	63	this	this	DET
admet-1622	109	64	scenario	scenario	NOUN
admet-1622	109	65	may	may	AUX
admet-1622	109	66	include	include	VERB
admet-1622	109	67	drug	drug	NOUN
admet-1622	109	68	products	product	NOUN
admet-1622	109	69	for	for	ADP
admet-1622	109	70	attention	attention	NOUN
admet-1622	109	71	deficit	deficit	NOUN
admet-1622	109	72	hyperactivity	hyperactivity	NOUN
admet-1622	109	73	disorder	disorder	NOUN
admet-1622	109	74	(	(	PUNCT
admet-1622	109	75	adhd	adhd	NOUN
admet-1622	109	76	)	)	PUNCT
admet-1622	109	77	,	,	PUNCT
admet-1622	109	78	combination	combination	NOUN
admet-1622	109	79	histamines	histamine	NOUN
admet-1622	109	80	,	,	PUNCT
admet-1622	109	81	antimigraine	antimigraine	NOUN
admet-1622	109	82	drugs	drug	NOUN
admet-1622	109	83	,	,	PUNCT
admet-1622	109	84	drugs	drug	NOUN
admet-1622	109	85	for	for	ADP
admet-1622	109	86	sleep	sleep	NOUN
admet-1622	109	87	disorders	disorder	NOUN
admet-1622	109	88	where	where	SCONJ
admet-1622	109	89	the	the	DET
admet-1622	109	90	rapid	rapid	ADJ
admet-1622	109	91	onset	onset	NOUN
admet-1622	109	92	must	must	AUX
admet-1622	109	93	be	be	AUX
admet-1622	109	94	combined	combine	VERB
admet-1622	109	95	with	with	ADP
admet-1622	109	96	sustained	sustained	ADJ
admet-1622	109	97	sleep	sleep	NOUN
admet-1622	109	98	,	,	PUNCT
admet-1622	109	99	and	and	CCONJ
admet-1622	109	100	so	so	ADV
admet-1622	109	101	forth	forth	ADV
admet-1622	109	102	.	.	PUNCT
admet-1622	110	1	c	c	X
admet-1622	110	2	)	)	PUNCT
admet-1622	110	3	scenario	scenario	NOUN
admet-1622	110	4	3	3	NUM
admet-1622	110	5	represents	represent	VERB
admet-1622	110	6	drug	drug	NOUN
admet-1622	110	7	products	product	NOUN
admet-1622	110	8	where	where	SCONJ
admet-1622	110	9	the	the	DET
admet-1622	110	10	drugs	drug	NOUN
admet-1622	110	11	must	must	AUX
admet-1622	110	12	be	be	AUX
admet-1622	110	13	rapidly	rapidly	ADV
admet-1622	110	14	released	release	VERB
admet-1622	110	15	and	and	CCONJ
admet-1622	110	16	absorbed	absorb	VERB
admet-1622	110	17	at	at	ADP
admet-1622	110	18	a	a	DET
admet-1622	110	19	predetermined	predetermined	ADJ
admet-1622	110	20	time	time	NOUN
admet-1622	110	21	and	and	CCONJ
admet-1622	110	22	then	then	ADV
admet-1622	110	23	the	the	DET
admet-1622	110	24	exposures	exposure	NOUN
admet-1622	110	25	are	be	AUX
admet-1622	110	26	maintained	maintain	VERB
admet-1622	110	27	,	,	PUNCT
admet-1622	110	28	and	and	CCONJ
admet-1622	110	29	this	this	DET
admet-1622	110	30	scenario	scenario	NOUN
admet-1622	110	31	may	may	AUX
admet-1622	110	32	include	include	VERB
admet-1622	110	33	drug	drug	NOUN
admet-1622	110	34	products	product	NOUN
admet-1622	110	35	for	for	ADP
admet-1622	110	36	the	the	DET
admet-1622	110	37	maintenance	maintenance	NOUN
admet-1622	110	38	of	of	ADP
admet-1622	110	39	blood	blood	NOUN
admet-1622	110	40	glucose	glucose	NOUN
admet-1622	110	41	levels	level	NOUN
admet-1622	110	42	to	to	PART
admet-1622	110	43	match	match	VERB
admet-1622	110	44	the	the	DET
admet-1622	110	45	physiological	physiological	ADJ
admet-1622	110	46	effects	effect	NOUN
admet-1622	110	47	of	of	ADP
admet-1622	110	48	food	food	NOUN
admet-1622	110	49	intake	intake	NOUN
admet-1622	110	50	,	,	PUNCT
admet-1622	110	51	certain	certain	ADJ
admet-1622	110	52	oncology	oncology	NOUN
admet-1622	110	53	drugs	drug	NOUN
admet-1622	110	54	targeted	target	VERB
admet-1622	110	55	for	for	ADP
admet-1622	110	56	tumor	tumor	NOUN
admet-1622	110	57	growth	growth	NOUN
admet-1622	110	58	,	,	PUNCT
admet-1622	110	59	antihypertensive	antihypertensive	ADJ
admet-1622	110	60	agents	agent	NOUN
admet-1622	110	61	targeted	target	VERB
admet-1622	110	62	to	to	PART
admet-1622	110	63	address	address	VERB
admet-1622	110	64	circadian	circadian	ADJ
admet-1622	110	65	relief	relief	NOUN
admet-1622	110	66	of	of	ADP
admet-1622	110	67	blood	blood	NOUN
admet-1622	110	68	pressure	pressure	NOUN
admet-1622	110	69	,	,	PUNCT
admet-1622	110	70	etc	etc	X
admet-1622	110	71	.	.	X
admet-1622	111	1	d	d	X
admet-1622	111	2	)	)	PUNCT
admet-1622	111	3	scenario	scenario	NOUN
admet-1622	111	4	4	4	NUM
admet-1622	111	5	includes	include	VERB
admet-1622	111	6	drug	drug	NOUN
admet-1622	111	7	products	product	NOUN
admet-1622	111	8	where	where	SCONJ
admet-1622	111	9	the	the	DET
admet-1622	111	10	targeted	target	VERB
admet-1622	111	11	exposure	exposure	NOUN
admet-1622	111	12	in	in	ADP
admet-1622	111	13	the	the	DET
admet-1622	111	14	body	body	NOUN
admet-1622	111	15	is	be	AUX
admet-1622	111	16	maintained	maintain	VERB
admet-1622	111	17	by	by	ADP
admet-1622	111	18	repeated	repeat	VERB
admet-1622	111	19	dosing	dosing	NOUN
admet-1622	111	20	,	,	PUNCT
admet-1622	111	21	and	and	CCONJ
admet-1622	111	22	the	the	DET
admet-1622	111	23	drug	drug	NOUN
admet-1622	111	24	must	must	AUX
admet-1622	111	25	be	be	AUX
admet-1622	111	26	absorbed	absorb	VERB
admet-1622	111	27	rapidly	rapidly	ADV
admet-1622	111	28	enough	enough	ADV
admet-1622	111	29	that	that	SCONJ
admet-1622	111	30	its	its	PRON
admet-1622	111	31	concentration	concentration	NOUN
admet-1622	111	32	after	after	SCONJ
admet-1622	111	33	each	each	DET
admet-1622	111	34	dose	dose	NOUN
admet-1622	111	35	reaches	reach	VERB
admet-1622	111	36	the	the	DET
admet-1622	111	37	therapeutic	therapeutic	ADJ
admet-1622	111	38	level	level	NOUN
admet-1622	111	39	.	.	PUNCT
admet-1622	112	1	many	many	ADJ
admet-1622	112	2	oral	oral	ADJ
admet-1622	112	3	antibiotics	antibiotic	NOUN
admet-1622	112	4	,	,	PUNCT
admet-1622	112	5	antihypertensives	antihypertensive	NOUN
admet-1622	112	6	,	,	PUNCT
admet-1622	112	7	antiepileptics	antiepileptic	NOUN
admet-1622	112	8	,	,	PUNCT
admet-1622	112	9	anti	anti	ADJ
admet-1622	112	10	-	-	ADJ
admet-1622	112	11	alzheimer	alzheimer	ADJ
admet-1622	112	12	’s	’s	PART
admet-1622	112	13	disease	disease	NOUN
admet-1622	112	14	drugs	drug	NOUN
admet-1622	112	15	,	,	PUNCT
admet-1622	112	16	chronic	chronic	ADJ
admet-1622	112	17	pain	pain	NOUN
admet-1622	112	18	medications	medication	NOUN
admet-1622	112	19	,	,	PUNCT
admet-1622	112	20	antispasmodics	antispasmodic	NOUN
admet-1622	112	21	,	,	PUNCT
admet-1622	112	22	etc	etc	X
admet-1622	112	23	.	.	X
admet-1622	112	24	,	,	PUNCT
admet-1622	112	25	belong	belong	VERB
admet-1622	112	26	to	to	ADP
admet-1622	112	27	this	this	DET
admet-1622	112	28	scenario	scenario	NOUN
admet-1622	112	29	.	.	PUNCT
admet-1622	113	1	it	it	PRON
admet-1622	113	2	is	be	AUX
admet-1622	113	3	evident	evident	ADJ
admet-1622	113	4	from	from	ADP
admet-1622	113	5	the	the	DET
admet-1622	113	6	above	above	ADV
admet-1622	113	7	-	-	PUNCT
admet-1622	113	8	mentioned	mention	VERB
admet-1622	113	9	scenarios	scenario	NOUN
admet-1622	113	10	that	that	SCONJ
admet-1622	113	11	drugs	drug	NOUN
admet-1622	113	12	must	must	AUX
admet-1622	113	13	be	be	AUX
admet-1622	113	14	rapidly	rapidly	ADV
admet-1622	113	15	released	release	VERB
admet-1622	113	16	from	from	ADP
admet-1622	113	17	products	product	NOUN
admet-1622	113	18	that	that	PRON
admet-1622	113	19	fall	fall	VERB
admet-1622	113	20	under	under	ADP
admet-1622	113	21	scenarios	scenario	NOUN
admet-1622	113	22	1	1	NUM
admet-1622	113	23	and	and	CCONJ
admet-1622	113	24	2	2	NUM
admet-1622	113	25	,	,	PUNCT
admet-1622	113	26	and	and	CCONJ
admet-1622	113	27	drugs	drug	NOUN
admet-1622	113	28	must	must	AUX
admet-1622	113	29	also	also	ADV
admet-1622	113	30	be	be	AUX
admet-1622	113	31	released	release	VERB
admet-1622	113	32	rapidly	rapidly	ADV
admet-1622	113	33	under	under	ADP
admet-1622	113	34	scenario	scenario	NOUN
admet-1622	113	35	3	3	NUM
admet-1622	113	36	after	after	ADP
admet-1622	113	37	a	a	DET
admet-1622	113	38	certain	certain	ADJ
admet-1622	113	39	initial	initial	ADJ
admet-1622	113	40	lag	lag	NOUN
admet-1622	113	41	time	time	NOUN
admet-1622	113	42	.	.	PUNCT
admet-1622	114	1	even	even	ADV
admet-1622	114	2	when	when	SCONJ
admet-1622	114	3	a	a	DET
admet-1622	114	4	drug	drug	NOUN
admet-1622	114	5	product	product	NOUN
admet-1622	114	6	is	be	AUX
admet-1622	114	7	developed	develop	VERB
admet-1622	114	8	for	for	ADP
admet-1622	114	9	prolonged	prolonged	ADJ
admet-1622	114	10	or	or	CCONJ
admet-1622	114	11	sustained	sustained	ADJ
admet-1622	114	12	release	release	NOUN
admet-1622	114	13	,	,	PUNCT
admet-1622	114	14	as	as	SCONJ
admet-1622	114	15	depicted	depict	VERB
admet-1622	114	16	by	by	ADP
admet-1622	114	17	scenario	scenario	NOUN
admet-1622	114	18	4	4	NUM
admet-1622	114	19	,	,	PUNCT
admet-1622	114	20	there	there	PRON
admet-1622	114	21	is	be	VERB
admet-1622	114	22	usually	usually	ADV
admet-1622	114	23	a	a	DET
admet-1622	114	24	rapid	rapid	ADJ
admet-1622	114	25	-	-	PUNCT
admet-1622	114	26	release	release	NOUN
admet-1622	114	27	aspect	aspect	NOUN
admet-1622	114	28	of	of	ADP
admet-1622	114	29	a	a	DET
admet-1622	114	30	drug	drug	NOUN
admet-1622	114	31	product	product	NOUN
admet-1622	114	32	so	so	SCONJ
admet-1622	114	33	that	that	SCONJ
admet-1622	114	34	the	the	DET
admet-1622	114	35	therapeutic	therapeutic	ADJ
admet-1622	114	36	blood	blood	NOUN
admet-1622	114	37	levels	level	NOUN
admet-1622	114	38	are	be	AUX
admet-1622	114	39	attained	attain	VERB
admet-1622	114	40	rapidly	rapidly	ADV
admet-1622	114	41	after	after	ADP
admet-1622	114	42	initial	initial	ADJ
admet-1622	114	43	or	or	CCONJ
admet-1622	114	44	repeated	repeat	VERB
admet-1622	114	45	dosing	dosing	NOUN
admet-1622	114	46	.	.	PUNCT
admet-1622	115	1	thus	thus	ADV
admet-1622	115	2	,	,	PUNCT
admet-1622	115	3	whatever	whatever	PRON
admet-1622	115	4	is	be	AUX
admet-1622	115	5	the	the	DET
admet-1622	115	6	scenario	scenario	NOUN
admet-1622	115	7	of	of	ADP
admet-1622	115	8	drug	drug	NOUN
admet-1622	115	9	product	product	NOUN
admet-1622	115	10	development	development	NOUN
admet-1622	115	11	,	,	PUNCT
admet-1622	115	12	a	a	DET
admet-1622	115	13	rapidrelease	rapidrelease	NOUN
admet-1622	115	14	attribute	attribute	NOUN
admet-1622	115	15	must	must	AUX
admet-1622	115	16	be	be	AUX
admet-1622	115	17	built	build	VERB
admet-1622	115	18	into	into	ADP
admet-1622	115	19	the	the	DET
admet-1622	115	20	product	product	NOUN
admet-1622	115	21	.	.	PUNCT
admet-1622	116	1	since	since	SCONJ
admet-1622	116	2	most	most	ADJ
admet-1622	116	3	fdm	fdm	VERB
admet-1622	116	4	3d	3d	ADV
admet-1622	116	5	-	-	PUNCT
admet-1622	116	6	printed	print	VERB
admet-1622	116	7	tablets	tablet	NOUN
admet-1622	116	8	result	result	VERB
admet-1622	116	9	in	in	ADP
admet-1622	116	10	slow	slow	ADJ
admet-1622	116	11	-	-	PUNCT
admet-1622	116	12	release	release	NOUN
admet-1622	116	13	products	product	NOUN
admet-1622	116	14	,	,	PUNCT
admet-1622	116	15	further	further	ADJ
admet-1622	116	16	development	development	NOUN
admet-1622	116	17	of	of	ADP
admet-1622	116	18	the	the	DET
admet-1622	116	19	technology	technology	NOUN
admet-1622	116	20	to	to	PART
admet-1622	116	21	achieve	achieve	VERB
admet-1622	116	22	rapid	rapid	ADJ
admet-1622	116	23	drug	drug	NOUN
admet-1622	116	24	release	release	NOUN
admet-1622	116	25	is	be	AUX
admet-1622	116	26	needed	need	VERB
admet-1622	116	27	before	before	SCONJ
admet-1622	116	28	it	it	PRON
admet-1622	116	29	can	can	AUX
admet-1622	116	30	be	be	AUX
admet-1622	116	31	applied	apply	VERB
admet-1622	116	32	for	for	ADP
admet-1622	116	33	the	the	DET
admet-1622	116	34	development	development	NOUN
admet-1622	116	35	of	of	ADP
admet-1622	116	36	therapeutically	therapeutically	ADV
admet-1622	116	37	effective	effective	ADJ
admet-1622	116	38	drug	drug	NOUN
admet-1622	116	39	products	product	NOUN
admet-1622	116	40	according	accord	VERB
admet-1622	116	41	to	to	ADP
admet-1622	116	42	different	different	ADJ
admet-1622	116	43	bioram	bioram	NOUN
admet-1622	116	44	scenarios	scenario	NOUN
admet-1622	116	45	.	.	PUNCT
admet-1622	117	1	admet	admet	PROPN
admet-1622	117	2	&	&	CCONJ
admet-1622	117	3	dmpk	dmpk	PROPN
admet-1622	117	4	11(1	11(1	NUM
admet-1622	117	5	)	)	PUNCT
admet-1622	117	6	(	(	PUNCT
admet-1622	117	7	2023	2023	NUM
admet-1622	117	8	)	)	PUNCT
admet-1622	117	9	33	33	NUM
admet-1622	117	10	-	-	SYM
admet-1622	117	11	55	55	NUM
admet-1622	117	12	development	development	NOUN
admet-1622	117	13	of	of	ADP
admet-1622	117	14	rapidly	rapidly	ADV
admet-1622	117	15	dissolving	dissolve	VERB
admet-1622	117	16	fdm	fdm	NOUN
admet-1622	117	17	3d	3d	ADV
admet-1622	117	18	-	-	PUNCT
admet-1622	117	19	printed	print	VERB
admet-1622	117	20	tablets	tablet	NOUN
admet-1622	117	21	doi	doi	NOUN
admet-1622	117	22	:	:	PUNCT
admet-1622	117	23	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	117	24	39	39	NUM
admet-1622	117	25	current	current	ADJ
admet-1622	117	26	strategies	strategy	NOUN
admet-1622	117	27	for	for	ADP
admet-1622	117	28	the	the	DET
admet-1622	117	29	development	development	NOUN
admet-1622	117	30	of	of	ADP
admet-1622	117	31	rapid	rapid	ADJ
admet-1622	117	32	-	-	PUNCT
admet-1622	117	33	release	release	NOUN
admet-1622	117	34	fdm	fdm	NOUN
admet-1622	117	35	3d	3d	ADV
admet-1622	117	36	-	-	PUNCT
admet-1622	117	37	printed	print	VERB
admet-1622	117	38	tablets	tablet	NOUN
admet-1622	117	39	several	several	ADJ
admet-1622	117	40	strategies	strategy	NOUN
admet-1622	117	41	for	for	ADP
admet-1622	117	42	the	the	DET
admet-1622	117	43	development	development	NOUN
admet-1622	117	44	of	of	ADP
admet-1622	117	45	rapidly	rapidly	ADV
admet-1622	117	46	dissolving	dissolve	VERB
admet-1622	117	47	fdm	fdm	NOUN
admet-1622	117	48	3d	3d	ADV
admet-1622	117	49	-	-	PUNCT
admet-1622	117	50	printed	print	VERB
admet-1622	117	51	tablets	tablet	NOUN
admet-1622	117	52	have	have	AUX
admet-1622	117	53	been	be	AUX
admet-1622	117	54	reported	report	VERB
admet-1622	117	55	in	in	ADP
admet-1622	117	56	the	the	DET
admet-1622	117	57	literature	literature	NOUN
admet-1622	117	58	.	.	PUNCT
admet-1622	118	1	they	they	PRON
admet-1622	118	2	include	include	VERB
admet-1622	118	3	selection	selection	NOUN
admet-1622	118	4	of	of	ADP
admet-1622	118	5	rapidly	rapidly	ADV
admet-1622	118	6	dissolving	dissolve	VERB
admet-1622	118	7	polymers	polymer	NOUN
admet-1622	118	8	with	with	ADP
admet-1622	118	9	optimum	optimum	ADJ
admet-1622	118	10	attributes	attribute	NOUN
admet-1622	118	11	for	for	ADP
admet-1622	118	12	3d	3d	NUM
admet-1622	118	13	printing	printing	NOUN
admet-1622	118	14	,	,	PUNCT
admet-1622	118	15	use	use	NOUN
admet-1622	118	16	of	of	ADP
admet-1622	118	17	polymer	polymer	NOUN
admet-1622	118	18	-	-	PUNCT
admet-1622	118	19	polymer	polymer	NOUN
admet-1622	118	20	mixtures	mixture	NOUN
admet-1622	118	21	,	,	PUNCT
admet-1622	118	22	incorporation	incorporation	NOUN
admet-1622	118	23	of	of	ADP
admet-1622	118	24	additives	additive	NOUN
admet-1622	118	25	,	,	PUNCT
admet-1622	118	26	modification	modification	NOUN
admet-1622	118	27	of	of	ADP
admet-1622	118	28	internal	internal	ADJ
admet-1622	118	29	patterns	pattern	NOUN
admet-1622	118	30	of	of	ADP
admet-1622	118	31	tablets	tablet	NOUN
admet-1622	118	32	and	and	CCONJ
admet-1622	118	33	tablet	tablet	NOUN
admet-1622	118	34	geometry	geometry	NOUN
admet-1622	118	35	,	,	PUNCT
admet-1622	118	36	and	and	CCONJ
admet-1622	118	37	supersolubilization	supersolubilization	NOUN
admet-1622	118	38	of	of	ADP
admet-1622	118	39	a	a	DET
admet-1622	118	40	drug	drug	NOUN
admet-1622	118	41	by	by	ADP
admet-1622	118	42	acid	acid	NOUN
admet-1622	118	43	-	-	PUNCT
admet-1622	118	44	base	base	NOUN
admet-1622	118	45	interaction	interaction	NOUN
admet-1622	118	46	.	.	PUNCT
admet-1622	119	1	selection	selection	NOUN
admet-1622	119	2	of	of	ADP
admet-1622	119	3	rapidly	rapidly	ADV
admet-1622	119	4	dissolving	dissolve	VERB
admet-1622	119	5	polymers	polymer	NOUN
admet-1622	119	6	the	the	DET
admet-1622	119	7	most	most	ADV
admet-1622	119	8	convenient	convenient	ADJ
admet-1622	119	9	approach	approach	NOUN
admet-1622	119	10	to	to	PART
admet-1622	119	11	increase	increase	VERB
admet-1622	119	12	the	the	DET
admet-1622	119	13	dissolution	dissolution	NOUN
admet-1622	119	14	rates	rate	NOUN
admet-1622	119	15	of	of	ADP
admet-1622	119	16	drugs	drug	NOUN
admet-1622	119	17	from	from	ADP
admet-1622	119	18	the	the	DET
admet-1622	119	19	fdm	fdm	NOUN
admet-1622	119	20	3d	3d	ADV
admet-1622	119	21	-	-	PUNCT
admet-1622	119	22	printed	print	VERB
admet-1622	119	23	tablets	tablet	NOUN
admet-1622	119	24	could	could	AUX
admet-1622	119	25	be	be	AUX
admet-1622	119	26	the	the	DET
admet-1622	119	27	use	use	NOUN
admet-1622	119	28	of	of	ADP
admet-1622	119	29	highly	highly	ADV
admet-1622	119	30	water	water	NOUN
admet-1622	119	31	-	-	PUNCT
admet-1622	119	32	soluble	soluble	ADJ
admet-1622	119	33	and	and	CCONJ
admet-1622	119	34	rapidly	rapidly	ADV
admet-1622	119	35	dissolving	dissolve	VERB
admet-1622	119	36	polymers	polymer	NOUN
admet-1622	119	37	.	.	PUNCT
admet-1622	120	1	however	however	ADV
admet-1622	120	2	,	,	PUNCT
admet-1622	120	3	as	as	SCONJ
admet-1622	120	4	mentioned	mention	VERB
admet-1622	120	5	earlier	early	ADV
admet-1622	120	6	,	,	PUNCT
admet-1622	120	7	there	there	PRON
admet-1622	120	8	is	be	VERB
admet-1622	120	9	only	only	ADV
admet-1622	120	10	a	a	DET
admet-1622	120	11	limited	limited	ADJ
admet-1622	120	12	number	number	NOUN
admet-1622	120	13	of	of	ADP
admet-1622	120	14	polymers	polymer	NOUN
admet-1622	120	15	available	available	ADJ
admet-1622	120	16	that	that	PRON
admet-1622	120	17	are	be	AUX
admet-1622	120	18	water	water	NOUN
admet-1622	120	19	-	-	PUNCT
admet-1622	120	20	soluble	soluble	ADJ
admet-1622	120	21	and	and	CCONJ
admet-1622	120	22	printable	printable	NOUN
admet-1622	120	23	.	.	PUNCT
admet-1622	121	1	polyvinylpyrrolidone	polyvinylpyrrolidone	NOUN
admet-1622	121	2	(	(	PUNCT
admet-1622	121	3	pvp	pvp	PROPN
admet-1622	121	4	)	)	PUNCT
admet-1622	121	5	and	and	CCONJ
admet-1622	121	6	related	related	ADJ
admet-1622	121	7	polymers	polymer	NOUN
admet-1622	121	8	,	,	PUNCT
admet-1622	121	9	which	which	PRON
admet-1622	121	10	are	be	AUX
admet-1622	121	11	highly	highly	ADV
admet-1622	121	12	water	water	NOUN
admet-1622	121	13	-	-	PUNCT
admet-1622	121	14	soluble	soluble	ADJ
admet-1622	121	15	,	,	PUNCT
admet-1622	121	16	may	may	AUX
admet-1622	121	17	not	not	PART
admet-1622	121	18	be	be	AUX
admet-1622	121	19	used	use	VERB
admet-1622	121	20	for	for	ADP
admet-1622	121	21	fdm	fdm	NOUN
admet-1622	121	22	3d	3d	NOUN
admet-1622	121	23	printing	printing	NOUN
admet-1622	121	24	as	as	SCONJ
admet-1622	121	25	they	they	PRON
admet-1622	121	26	produce	produce	VERB
admet-1622	121	27	brittle	brittle	ADJ
admet-1622	121	28	filaments	filament	NOUN
admet-1622	121	29	that	that	PRON
admet-1622	121	30	are	be	AUX
admet-1622	121	31	not	not	PART
admet-1622	121	32	printable	printable	ADJ
admet-1622	122	1	[	[	X
admet-1622	122	2	19	19	NUM
admet-1622	122	3	-	-	SYM
admet-1622	122	4	21	21	NUM
admet-1622	122	5	]	]	PUNCT
admet-1622	122	6	.	.	PUNCT
admet-1622	123	1	funk	funk	PROPN
admet-1622	123	2	et	et	PROPN
admet-1622	123	3	al	al	PROPN
admet-1622	123	4	.	.	PUNCT
admet-1622	124	1	[	[	X
admet-1622	124	2	36	36	NUM
admet-1622	124	3	]	]	PUNCT
admet-1622	124	4	reviewed	review	VERB
admet-1622	124	5	the	the	DET
admet-1622	124	6	literature	literature	NOUN
admet-1622	124	7	to	to	PART
admet-1622	124	8	determine	determine	VERB
admet-1622	124	9	the	the	DET
admet-1622	124	10	effects	effect	NOUN
admet-1622	124	11	of	of	ADP
admet-1622	124	12	polymers	polymer	NOUN
admet-1622	124	13	on	on	ADP
admet-1622	124	14	drug	drug	NOUN
admet-1622	124	15	release	release	NOUN
admet-1622	124	16	rates	rate	NOUN
admet-1622	124	17	from	from	ADP
admet-1622	124	18	3d	3d	NOUN
admet-1622	124	19	-	-	PUNCT
admet-1622	124	20	printed	print	VERB
admet-1622	124	21	tablets	tablet	NOUN
admet-1622	124	22	and	and	CCONJ
admet-1622	124	23	observed	observe	VERB
admet-1622	124	24	that	that	SCONJ
admet-1622	124	25	among	among	ADP
admet-1622	124	26	various	various	ADJ
admet-1622	124	27	polymers	polymer	NOUN
admet-1622	124	28	,	,	PUNCT
admet-1622	124	29	only	only	ADV
admet-1622	124	30	eudragit	eudragit	VERB
admet-1622	124	31	®	®	NOUN
admet-1622	124	32	e	e	NOUN
admet-1622	124	33	,	,	PUNCT
admet-1622	124	34	which	which	PRON
admet-1622	124	35	is	be	AUX
admet-1622	124	36	a	a	DET
admet-1622	124	37	polymethacrylate	polymethacrylate	NOUN
admet-1622	124	38	polymer	polymer	NOUN
admet-1622	124	39	,	,	PUNCT
admet-1622	124	40	could	could	AUX
admet-1622	124	41	possibly	possibly	ADV
admet-1622	124	42	provide	provide	VERB
admet-1622	124	43	the	the	DET
admet-1622	124	44	most	most	ADV
admet-1622	124	45	rapid	rapid	ADJ
admet-1622	124	46	drug	drug	NOUN
admet-1622	124	47	release	release	NOUN
admet-1622	124	48	rate	rate	NOUN
admet-1622	124	49	.	.	PUNCT
admet-1622	125	1	the	the	DET
admet-1622	125	2	authors	author	NOUN
admet-1622	125	3	observed	observe	VERB
admet-1622	125	4	that	that	SCONJ
admet-1622	125	5	,	,	PUNCT
admet-1622	125	6	among	among	ADP
admet-1622	125	7	other	other	ADJ
admet-1622	125	8	polymer	polymer	NOUN
admet-1622	125	9	types	type	NOUN
admet-1622	125	10	,	,	PUNCT
admet-1622	125	11	celluloses	cellulose	NOUN
admet-1622	125	12	and	and	CCONJ
admet-1622	125	13	polyvinyl	polyvinyl	NOUN
admet-1622	125	14	alcohols	alcohol	NOUN
admet-1622	125	15	(	(	PUNCT
admet-1622	125	16	pva	pva	NOUN
admet-1622	125	17	)	)	PUNCT
admet-1622	125	18	usually	usually	ADV
admet-1622	125	19	provide	provide	VERB
admet-1622	125	20	slow	slow	ADJ
admet-1622	125	21	drug	drug	NOUN
admet-1622	125	22	release	release	NOUN
admet-1622	125	23	rates	rate	NOUN
admet-1622	125	24	from	from	ADP
admet-1622	125	25	the	the	DET
admet-1622	125	26	fdm	fdm	NOUN
admet-1622	125	27	3d	3d	ADV
admet-1622	125	28	-	-	PUNCT
admet-1622	125	29	printed	print	VERB
admet-1622	125	30	tablets	tablet	NOUN
admet-1622	125	31	,	,	PUNCT
admet-1622	125	32	and	and	CCONJ
admet-1622	125	33	alternative	alternative	ADJ
admet-1622	125	34	3d	3d	NOUN
admet-1622	125	35	-	-	PUNCT
admet-1622	125	36	printing	print	VERB
admet-1622	125	37	techniques	technique	NOUN
admet-1622	125	38	like	like	ADP
admet-1622	125	39	semisolid	semisolid	NOUN
admet-1622	125	40	extrusion	extrusion	NOUN
admet-1622	125	41	(	(	PUNCT
admet-1622	125	42	sse	sse	NOUN
admet-1622	125	43	)	)	PUNCT
admet-1622	125	44	,	,	PUNCT
admet-1622	125	45	selective	selective	ADJ
admet-1622	125	46	laser	laser	NOUN
admet-1622	125	47	sintering	sinter	VERB
admet-1622	125	48	(	(	PUNCT
admet-1622	125	49	sls	sls	PROPN
admet-1622	125	50	)	)	PUNCT
admet-1622	125	51	,	,	PUNCT
admet-1622	125	52	digital	digital	ADJ
admet-1622	125	53	light	light	NOUN
admet-1622	125	54	processing	processing	NOUN
admet-1622	125	55	(	(	PUNCT
admet-1622	125	56	dlp	dlp	PROPN
admet-1622	125	57	)	)	PUNCT
admet-1622	125	58	,	,	PUNCT
admet-1622	125	59	etc	etc	X
admet-1622	125	60	.	.	X
admet-1622	125	61	,	,	PUNCT
admet-1622	125	62	are	be	AUX
admet-1622	125	63	necessary	necessary	ADJ
admet-1622	125	64	to	to	PART
admet-1622	125	65	increase	increase	VERB
admet-1622	125	66	dissolution	dissolution	ADJ
admet-1622	125	67	rates	rate	NOUN
admet-1622	125	68	of	of	ADP
admet-1622	125	69	drugs	drug	NOUN
admet-1622	125	70	from	from	ADP
admet-1622	125	71	such	such	ADJ
admet-1622	125	72	polymers	polymer	NOUN
admet-1622	125	73	.	.	PUNCT
admet-1622	126	1	the	the	DET
admet-1622	126	2	reported	report	VERB
admet-1622	126	3	high	high	ADJ
admet-1622	126	4	dissolution	dissolution	NOUN
admet-1622	126	5	rate	rate	NOUN
admet-1622	126	6	of	of	ADP
admet-1622	126	7	drugs	drug	NOUN
admet-1622	126	8	from	from	ADP
admet-1622	126	9	tablets	tablet	NOUN
admet-1622	126	10	containing	contain	VERB
admet-1622	126	11	eudragit	eudragit	NOUN
admet-1622	126	12	®	®	NOUN
admet-1622	126	13	e	e	NOUN
admet-1622	126	14	and	and	CCONJ
admet-1622	126	15	its	its	PRON
admet-1622	126	16	impact	impact	NOUN
admet-1622	126	17	on	on	ADP
admet-1622	126	18	drug	drug	NOUN
admet-1622	126	19	absorption	absorption	NOUN
admet-1622	126	20	after	after	ADP
admet-1622	126	21	oral	oral	ADJ
admet-1622	126	22	administration	administration	NOUN
admet-1622	126	23	,	,	PUNCT
admet-1622	126	24	however	however	ADV
admet-1622	126	25	,	,	PUNCT
admet-1622	126	26	need	need	VERB
admet-1622	126	27	further	further	ADJ
admet-1622	126	28	scrutiny	scrutiny	NOUN
admet-1622	126	29	before	before	SCONJ
admet-1622	126	30	it	it	PRON
admet-1622	126	31	is	be	AUX
admet-1622	126	32	selected	select	VERB
admet-1622	126	33	for	for	ADP
admet-1622	126	34	fdm	fdm	NOUN
admet-1622	126	35	3d	3d	NOUN
admet-1622	126	36	-	-	PUNCT
admet-1622	126	37	printing	print	VERB
admet-1622	126	38	.	.	PUNCT
admet-1622	126	39	eudragit	eudragit	PROPN
admet-1622	126	40	®	®	PROPN
admet-1622	126	41	e	e	X
admet-1622	126	42	(	(	PUNCT
admet-1622	126	43	orally	orally	ADV
admet-1622	126	44	administered	administer	VERB
admet-1622	126	45	grade	grade	NOUN
admet-1622	126	46	known	know	VERB
admet-1622	126	47	as	as	ADP
admet-1622	126	48	eudragit	eudragit	NOUN
admet-1622	126	49	®	®	NOUN
admet-1622	126	50	epo	epo	NOUN
admet-1622	126	51	)	)	PUNCT
admet-1622	126	52	is	be	AUX
admet-1622	126	53	a	a	DET
admet-1622	126	54	cationic	cationic	ADJ
admet-1622	126	55	polymer	polymer	NOUN
admet-1622	126	56	comprised	comprise	VERB
admet-1622	126	57	of	of	ADP
admet-1622	126	58	dimethyl	dimethyl	PROPN
admet-1622	126	59	aminoethyl	aminoethyl	PROPN
admet-1622	126	60	methacrylate	methacrylate	NOUN
admet-1622	126	61	,	,	PUNCT
admet-1622	126	62	butyl	butyl	NOUN
admet-1622	126	63	methacrylate	methacrylate	NOUN
admet-1622	126	64	and	and	CCONJ
admet-1622	126	65	methyl	methyl	NOUN
admet-1622	126	66	methacrylate	methacrylate	NOUN
admet-1622	126	67	at	at	ADP
admet-1622	126	68	a	a	DET
admet-1622	126	69	ratio	ratio	NOUN
admet-1622	126	70	of	of	ADP
admet-1622	126	71	2:1:1	2:1:1	NUM
admet-1622	126	72	in	in	ADP
admet-1622	126	73	the	the	DET
admet-1622	126	74	polymeric	polymeric	ADJ
admet-1622	126	75	chain	chain	NOUN
admet-1622	127	1	[	[	X
admet-1622	127	2	37	37	NUM
admet-1622	127	3	]	]	PUNCT
admet-1622	127	4	.	.	PUNCT
admet-1622	128	1	because	because	SCONJ
admet-1622	128	2	of	of	ADP
admet-1622	128	3	the	the	DET
admet-1622	128	4	protonation	protonation	NOUN
admet-1622	128	5	of	of	ADP
admet-1622	128	6	the	the	DET
admet-1622	128	7	basic	basic	ADJ
admet-1622	128	8	amino	amino	NOUN
admet-1622	128	9	group	group	NOUN
admet-1622	128	10	in	in	ADP
admet-1622	128	11	the	the	DET
admet-1622	128	12	structure	structure	NOUN
admet-1622	128	13	,	,	PUNCT
admet-1622	128	14	it	it	PRON
admet-1622	128	15	is	be	AUX
admet-1622	128	16	soluble	soluble	ADJ
admet-1622	128	17	at	at	ADP
admet-1622	128	18	low	low	ADJ
admet-1622	128	19	acidic	acidic	ADJ
admet-1622	128	20	ph	ph	NOUN
admet-1622	128	21	and	and	CCONJ
admet-1622	128	22	insoluble	insoluble	ADJ
admet-1622	128	23	at	at	ADP
admet-1622	128	24	ph>5	ph>5	PROPN
admet-1622	128	25	.	.	PUNCT
admet-1622	129	1	several	several	ADJ
admet-1622	129	2	investigators	investigator	NOUN
admet-1622	129	3	reported	report	VERB
admet-1622	129	4	relatively	relatively	ADV
admet-1622	129	5	rapid	rapid	ADJ
admet-1622	129	6	drug	drug	NOUN
admet-1622	129	7	release	release	NOUN
admet-1622	129	8	(	(	PUNCT
admet-1622	129	9	<	<	NOUN
admet-1622	129	10	1	1	NUM
admet-1622	129	11	h	h	NOUN
admet-1622	129	12	)	)	PUNCT
admet-1622	129	13	when	when	SCONJ
admet-1622	129	14	the	the	DET
admet-1622	129	15	dissolution	dissolution	NOUN
admet-1622	129	16	testing	testing	NOUN
admet-1622	129	17	of	of	ADP
admet-1622	129	18	the	the	DET
admet-1622	129	19	fdm	fdm	NOUN
admet-1622	129	20	3d	3d	ADV
admet-1622	129	21	-	-	PUNCT
admet-1622	129	22	printed	print	VERB
admet-1622	129	23	tablets	tablet	NOUN
admet-1622	129	24	containing	contain	VERB
admet-1622	129	25	eudragit	eudragit	NOUN
admet-1622	129	26	®	®	NOUN
admet-1622	129	27	e	e	NOUN
admet-1622	129	28	was	be	AUX
admet-1622	129	29	conducted	conduct	VERB
admet-1622	129	30	in	in	ADP
admet-1622	129	31	0.1	0.1	NUM
admet-1622	129	32	m	m	NOUN
admet-1622	129	33	hcl	hcl	PROPN
admet-1622	129	34	(	(	PUNCT
admet-1622	129	35	ph~1.1	ph~1.1	NOUN
admet-1622	129	36	)	)	PUNCT
admet-1622	129	37	,	,	PUNCT
admet-1622	129	38	and	and	CCONJ
admet-1622	129	39	they	they	PRON
admet-1622	129	40	did	do	AUX
admet-1622	129	41	not	not	PART
admet-1622	129	42	study	study	VERB
admet-1622	129	43	the	the	DET
admet-1622	129	44	dissolution	dissolution	NOUN
admet-1622	129	45	of	of	ADP
admet-1622	129	46	the	the	DET
admet-1622	129	47	tablets	tablet	NOUN
admet-1622	129	48	at	at	ADP
admet-1622	129	49	higher	high	ADJ
admet-1622	129	50	intestinal	intestinal	ADJ
admet-1622	129	51	ph	ph	NOUN
admet-1622	129	52	conditions	condition	NOUN
admet-1622	129	53	(	(	PUNCT
admet-1622	129	54	ph>5	ph>5	NOUN
admet-1622	129	55	)	)	PUNCT
admet-1622	129	56	,	,	PUNCT
admet-1622	129	57	where	where	SCONJ
admet-1622	129	58	the	the	DET
admet-1622	129	59	polymer	polymer	NOUN
admet-1622	129	60	is	be	AUX
admet-1622	129	61	insoluble	insoluble	ADJ
admet-1622	129	62	[	[	PUNCT
admet-1622	129	63	38	38	NUM
admet-1622	129	64	-	-	SYM
admet-1622	129	65	40	40	NUM
admet-1622	129	66	]	]	PUNCT
admet-1622	129	67	.	.	PUNCT
admet-1622	130	1	the	the	DET
admet-1622	130	2	dissolution	dissolution	NOUN
admet-1622	130	3	testing	testing	NOUN
admet-1622	130	4	was	be	AUX
admet-1622	130	5	often	often	ADV
admet-1622	130	6	conducted	conduct	VERB
admet-1622	130	7	in	in	ADP
admet-1622	130	8	0.1	0.1	NUM
admet-1622	130	9	m	m	NOUN
admet-1622	130	10	hcl	hcl	PROPN
admet-1622	130	11	,	,	PUNCT
admet-1622	130	12	even	even	ADV
admet-1622	130	13	for	for	SCONJ
admet-1622	130	14	the	the	DET
admet-1622	130	15	amorphous	amorphous	ADJ
admet-1622	130	16	solid	solid	ADJ
admet-1622	130	17	dispersion	dispersion	NOUN
admet-1622	130	18	formulations	formulation	NOUN
admet-1622	130	19	of	of	ADP
admet-1622	130	20	drugs	drug	NOUN
admet-1622	130	21	in	in	ADP
admet-1622	130	22	eudragit	eudragit	NOUN
admet-1622	130	23	®	®	NOUN
admet-1622	130	24	e	e	NOUN
admet-1622	130	25	reported	report	VERB
admet-1622	130	26	in	in	ADP
admet-1622	130	27	the	the	DET
admet-1622	130	28	literature	literature	NOUN
admet-1622	130	29	[	[	X
admet-1622	130	30	41,42	41,42	PROPN
admet-1622	130	31	]	]	PUNCT
admet-1622	130	32	.	.	PUNCT
admet-1622	131	1	in	in	ADP
admet-1622	131	2	a	a	DET
admet-1622	131	3	few	few	ADJ
admet-1622	131	4	cases	case	NOUN
admet-1622	131	5	where	where	SCONJ
admet-1622	131	6	the	the	DET
admet-1622	131	7	dissolution	dissolution	NOUN
admet-1622	131	8	was	be	AUX
admet-1622	131	9	studied	study	VERB
admet-1622	131	10	at	at	ADP
admet-1622	131	11	both	both	CCONJ
admet-1622	131	12	lower	low	ADJ
admet-1622	131	13	gastric	gastric	ADJ
admet-1622	131	14	and	and	CCONJ
admet-1622	131	15	higher	high	ADJ
admet-1622	131	16	intestinal	intestinal	ADJ
admet-1622	131	17	ph	ph	ADJ
admet-1622	131	18	conditions	condition	NOUN
admet-1622	131	19	,	,	PUNCT
admet-1622	131	20	dissolution	dissolution	NOUN
admet-1622	131	21	rates	rate	NOUN
admet-1622	131	22	and	and	CCONJ
admet-1622	131	23	extents	extent	NOUN
admet-1622	131	24	of	of	ADP
admet-1622	131	25	drug	drug	NOUN
admet-1622	131	26	release	release	NOUN
admet-1622	131	27	at	at	ADP
admet-1622	131	28	the	the	DET
admet-1622	131	29	higher	high	ADJ
admet-1622	131	30	ph	ph	NOUN
admet-1622	131	31	of	of	ADP
admet-1622	131	32	6.8	6.8	NUM
admet-1622	131	33	were	be	AUX
admet-1622	131	34	much	much	ADV
admet-1622	131	35	lower	low	ADJ
admet-1622	131	36	than	than	ADP
admet-1622	131	37	that	that	PRON
admet-1622	131	38	at	at	ADP
admet-1622	131	39	the	the	DET
admet-1622	131	40	lower	low	ADJ
admet-1622	131	41	ph	ph	NOUN
admet-1622	132	1	[	[	X
admet-1622	132	2	43,44	43,44	X
admet-1622	132	3	]	]	X
admet-1622	132	4	.	.	PUNCT
admet-1622	133	1	considering	consider	VERB
admet-1622	133	2	that	that	SCONJ
admet-1622	133	3	the	the	DET
admet-1622	133	4	average	average	ADJ
admet-1622	133	5	ph	ph	NOUN
admet-1622	133	6	of	of	ADP
admet-1622	133	7	the	the	DET
admet-1622	133	8	gastric	gastric	ADJ
admet-1622	133	9	fluid	fluid	NOUN
admet-1622	133	10	is	be	AUX
admet-1622	133	11	around	around	ADV
admet-1622	133	12	2	2	NUM
admet-1622	133	13	in	in	ADP
admet-1622	133	14	the	the	DET
admet-1622	133	15	fasted	fasted	ADJ
admet-1622	133	16	state	state	NOUN
admet-1622	133	17	,	,	PUNCT
admet-1622	133	18	which	which	PRON
admet-1622	133	19	may	may	AUX
admet-1622	133	20	increase	increase	VERB
admet-1622	133	21	to	to	ADP
admet-1622	133	22	>	>	X
admet-1622	133	23	5	5	NUM
admet-1622	133	24	in	in	ADP
admet-1622	133	25	the	the	DET
admet-1622	133	26	fed	fed	PROPN
admet-1622	133	27	state	state	NOUN
admet-1622	133	28	[	[	X
admet-1622	133	29	45	45	NUM
admet-1622	133	30	]	]	PUNCT
admet-1622	133	31	,	,	PUNCT
admet-1622	133	32	the	the	DET
admet-1622	133	33	ph	ph	VERB
admet-1622	133	34	-	-	ADJ
admet-1622	133	35	dependent	dependent	ADJ
admet-1622	133	36	solubility	solubility	NOUN
admet-1622	133	37	of	of	ADP
admet-1622	133	38	eudragit	eudragit	NOUN
admet-1622	133	39	®	®	NOUN
admet-1622	133	40	e	e	NOUN
admet-1622	133	41	may	may	AUX
admet-1622	133	42	have	have	VERB
admet-1622	133	43	a	a	DET
admet-1622	133	44	major	major	ADJ
admet-1622	133	45	impact	impact	NOUN
admet-1622	133	46	on	on	ADP
admet-1622	133	47	drug	drug	NOUN
admet-1622	133	48	release	release	NOUN
admet-1622	133	49	from	from	ADP
admet-1622	133	50	the	the	DET
admet-1622	133	51	fdm	fdm	NOUN
admet-1622	133	52	3d	3d	ADV
admet-1622	133	53	-	-	PUNCT
admet-1622	133	54	printed	print	VERB
admet-1622	133	55	tablets	tablet	NOUN
admet-1622	133	56	after	after	ADP
admet-1622	133	57	oral	oral	ADJ
admet-1622	133	58	administration	administration	NOUN
admet-1622	133	59	.	.	PUNCT
admet-1622	134	1	the	the	DET
admet-1622	134	2	shorter	short	ADJ
admet-1622	134	3	gastric	gastric	ADJ
admet-1622	134	4	residence	residence	NOUN
admet-1622	134	5	time	time	NOUN
admet-1622	134	6	in	in	ADP
admet-1622	134	7	the	the	DET
admet-1622	134	8	fasted	fasted	ADJ
admet-1622	134	9	state	state	NOUN
admet-1622	134	10	(	(	PUNCT
admet-1622	134	11	~30	~30	X
admet-1622	134	12	min	min	NOUN
admet-1622	134	13	)	)	PUNCT
admet-1622	134	14	could	could	AUX
admet-1622	134	15	also	also	ADV
admet-1622	134	16	be	be	AUX
admet-1622	134	17	a	a	DET
admet-1622	134	18	factor	factor	NOUN
admet-1622	134	19	in	in	ADP
admet-1622	134	20	drug	drug	NOUN
admet-1622	134	21	dissolution	dissolution	NOUN
admet-1622	134	22	and	and	CCONJ
admet-1622	134	23	absorption	absorption	NOUN
admet-1622	134	24	since	since	SCONJ
admet-1622	134	25	the	the	DET
admet-1622	134	26	tablet	tablet	NOUN
admet-1622	134	27	may	may	AUX
admet-1622	134	28	pass	pass	VERB
admet-1622	134	29	rapidly	rapidly	ADV
admet-1622	134	30	through	through	ADP
admet-1622	134	31	the	the	DET
admet-1622	134	32	stomach	stomach	NOUN
admet-1622	134	33	before	before	SCONJ
admet-1622	134	34	all	all	DET
admet-1622	134	35	the	the	DET
admet-1622	134	36	drugs	drug	NOUN
admet-1622	134	37	could	could	AUX
admet-1622	134	38	be	be	AUX
admet-1622	134	39	released	release	VERB
admet-1622	134	40	,	,	PUNCT
admet-1622	134	41	and	and	CCONJ
admet-1622	134	42	then	then	ADV
admet-1622	134	43	it	it	PRON
admet-1622	134	44	may	may	AUX
admet-1622	134	45	not	not	PART
admet-1622	134	46	dissolve	dissolve	VERB
admet-1622	134	47	in	in	ADP
admet-1622	134	48	the	the	DET
admet-1622	134	49	intestine	intestine	NOUN
admet-1622	134	50	since	since	SCONJ
admet-1622	134	51	the	the	DET
admet-1622	134	52	polymer	polymer	NOUN
admet-1622	134	53	is	be	AUX
admet-1622	134	54	not	not	PART
admet-1622	134	55	soluble	soluble	ADJ
admet-1622	134	56	at	at	ADP
admet-1622	134	57	the	the	DET
admet-1622	134	58	higher	high	ADJ
admet-1622	134	59	ph	ph	NOUN
admet-1622	134	60	.	.	PUNCT
admet-1622	134	61	careful	careful	ADJ
admet-1622	134	62	consideration	consideration	NOUN
admet-1622	134	63	must	must	AUX
admet-1622	134	64	also	also	ADV
admet-1622	134	65	be	be	AUX
admet-1622	134	66	given	give	VERB
admet-1622	134	67	to	to	ADP
admet-1622	134	68	the	the	DET
admet-1622	134	69	printability	printability	NOUN
admet-1622	134	70	of	of	ADP
admet-1622	134	71	filaments	filament	NOUN
admet-1622	134	72	containing	contain	VERB
admet-1622	134	73	eudragit	eudragit	PROPN
admet-1622	134	74	®	®	PROPN
admet-1622	134	75	e.	e.	PROPN
admet-1622	134	76	since	since	SCONJ
admet-1622	134	77	the	the	DET
admet-1622	134	78	polymer	polymer	NOUN
admet-1622	134	79	has	have	VERB
admet-1622	134	80	a	a	DET
admet-1622	134	81	low	low	ADJ
admet-1622	134	82	glass	glass	NOUN
admet-1622	134	83	transition	transition	NOUN
admet-1622	134	84	temperature	temperature	NOUN
admet-1622	134	85	(	(	PUNCT
admet-1622	134	86	52	52	NUM
admet-1622	134	87	°	°	NOUN
admet-1622	134	88	c	c	NOUN
admet-1622	134	89	)	)	PUNCT
admet-1622	134	90	,	,	PUNCT
admet-1622	134	91	the	the	DET
admet-1622	134	92	filaments	filament	NOUN
admet-1622	134	93	could	could	AUX
admet-1622	134	94	be	be	AUX
admet-1622	134	95	very	very	ADV
admet-1622	134	96	soft	soft	ADJ
admet-1622	134	97	at	at	ADP
admet-1622	134	98	the	the	DET
admet-1622	134	99	relatively	relatively	ADV
admet-1622	134	100	high	high	ADJ
admet-1622	134	101	printing	printing	NOUN
admet-1622	134	102	temperatures	temperature	NOUN
admet-1622	134	103	used	use	VERB
admet-1622	134	104	.	.	PUNCT
admet-1622	135	1	in	in	ADP
admet-1622	135	2	most	most	ADJ
admet-1622	135	3	of	of	ADP
admet-1622	135	4	the	the	DET
admet-1622	135	5	reported	report	VERB
admet-1622	135	6	studies	study	NOUN
admet-1622	135	7	,	,	PUNCT
admet-1622	135	8	high	high	ADJ
admet-1622	135	9	amounts	amount	NOUN
admet-1622	135	10	of	of	ADP
admet-1622	135	11	solid	solid	ADJ
admet-1622	135	12	drugs	drug	NOUN
admet-1622	135	13	and	and	CCONJ
admet-1622	135	14	solid	solid	ADJ
admet-1622	135	15	additives	additive	NOUN
admet-1622	135	16	were	be	AUX
admet-1622	135	17	added	add	VERB
admet-1622	135	18	to	to	ADP
admet-1622	135	19	the	the	DET
admet-1622	135	20	polymer	polymer	NOUN
admet-1622	135	21	to	to	PART
admet-1622	135	22	reduce	reduce	VERB
admet-1622	135	23	its	its	PRON
admet-1622	135	24	fluidity	fluidity	NOUN
admet-1622	135	25	after	after	ADP
admet-1622	135	26	melting	melt	VERB
admet-1622	135	27	.	.	PUNCT
admet-1622	136	1	for	for	ADP
admet-1622	136	2	example	example	NOUN
admet-1622	136	3	,	,	PUNCT
admet-1622	136	4	yang	yang	PROPN
admet-1622	136	5	et	et	PROPN
admet-1622	136	6	al	al	PROPN
admet-1622	136	7	.	.	PUNCT
admet-1622	137	1	[	[	X
admet-1622	137	2	46	46	NUM
admet-1622	137	3	]	]	PUNCT
admet-1622	137	4	added	add	VERB
admet-1622	137	5	37.5	37.5	NUM
admet-1622	137	6	-	-	SYM
admet-1622	137	7	50	50	NUM
admet-1622	137	8	%	%	NOUN
admet-1622	137	9	talc	talc	NOUN
admet-1622	137	10	to	to	PART
admet-1622	137	11	eudragit	eudragit	VERB
admet-1622	137	12	®	®	NOUN
admet-1622	137	13	e	e	NOUN
admet-1622	137	14	-	-	PUNCT
admet-1622	137	15	based	base	VERB
admet-1622	137	16	formulations	formulation	NOUN
admet-1622	137	17	to	to	PART
admet-1622	137	18	make	make	VERB
admet-1622	137	19	the	the	DET
admet-1622	137	20	filaments	filament	NOUN
admet-1622	137	21	harder	hard	ADV
admet-1622	137	22	and	and	CCONJ
admet-1622	137	23	printable	printable	NOUN
admet-1622	137	24	.	.	PUNCT
admet-1622	138	1	use	use	NOUN
admet-1622	138	2	of	of	ADP
admet-1622	138	3	polymer	polymer	NOUN
admet-1622	138	4	mixtures	mixture	NOUN
admet-1622	138	5	another	another	DET
admet-1622	138	6	approach	approach	NOUN
admet-1622	138	7	to	to	PART
admet-1622	138	8	increase	increase	VERB
admet-1622	138	9	the	the	DET
admet-1622	138	10	drug	drug	NOUN
admet-1622	138	11	release	release	NOUN
admet-1622	138	12	rate	rate	NOUN
admet-1622	138	13	from	from	ADP
admet-1622	138	14	fdm	fdm	NOUN
admet-1622	138	15	3d	3d	ADV
admet-1622	138	16	-	-	PUNCT
admet-1622	138	17	printed	print	VERB
admet-1622	138	18	tablets	tablet	NOUN
admet-1622	138	19	that	that	PRON
admet-1622	138	20	has	have	AUX
admet-1622	138	21	been	be	AUX
admet-1622	138	22	introduced	introduce	VERB
admet-1622	138	23	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	138	24	abu	abu	PROPN
admet-1622	138	25	t.m	t.m	PROPN
admet-1622	138	26	.	.	PUNCT
admet-1622	138	27	serajuddin	serajuddin	VERB
admet-1622	138	28	admet	admet	PROPN
admet-1622	138	29	&	&	CCONJ
admet-1622	138	30	dmpk	dmpk	PROPN
admet-1622	138	31	11(1	11(1	NUM
admet-1622	138	32	)	)	PUNCT
admet-1622	138	33	(	(	PUNCT
admet-1622	138	34	2023	2023	NUM
admet-1622	138	35	)	)	PUNCT
admet-1622	138	36	33	33	NUM
admet-1622	138	37	-	-	SYM
admet-1622	138	38	55	55	NUM
admet-1622	138	39	40	40	NUM
admet-1622	138	40	by	by	ADP
admet-1622	138	41	solanki	solanki	PROPN
admet-1622	138	42	et	et	PROPN
admet-1622	138	43	al	al	PROPN
admet-1622	138	44	.	.	PUNCT
admet-1622	139	1	[	[	X
admet-1622	139	2	19	19	NUM
admet-1622	139	3	]	]	PUNCT
admet-1622	139	4	is	be	AUX
admet-1622	139	5	using	use	VERB
admet-1622	139	6	mixtures	mixture	NOUN
admet-1622	139	7	of	of	ADP
admet-1622	139	8	polymers	polymer	NOUN
admet-1622	139	9	.	.	PUNCT
admet-1622	140	1	in	in	ADP
admet-1622	140	2	this	this	DET
admet-1622	140	3	way	way	NOUN
admet-1622	140	4	,	,	PUNCT
admet-1622	140	5	the	the	DET
admet-1622	140	6	polymers	polymer	NOUN
admet-1622	140	7	that	that	PRON
admet-1622	140	8	are	be	AUX
admet-1622	140	9	water	water	NOUN
admet-1622	140	10	-	-	PUNCT
admet-1622	140	11	soluble	soluble	ADJ
admet-1622	140	12	but	but	CCONJ
admet-1622	140	13	not	not	PART
admet-1622	140	14	normally	normally	ADV
admet-1622	140	15	printable	printable	NOUN
admet-1622	140	16	could	could	AUX
admet-1622	140	17	be	be	AUX
admet-1622	140	18	printed	print	VERB
admet-1622	140	19	by	by	ADP
admet-1622	140	20	mixing	mix	VERB
admet-1622	140	21	with	with	ADP
admet-1622	140	22	other	other	ADJ
admet-1622	140	23	polymers	polymer	NOUN
admet-1622	140	24	.	.	PUNCT
admet-1622	141	1	the	the	DET
admet-1622	141	2	authors	author	NOUN
admet-1622	141	3	mixed	mix	VERB
admet-1622	141	4	polyvinylpyrrolidonevinyl	polyvinylpyrrolidonevinyl	NOUN
admet-1622	141	5	acetate	acetate	NOUN
admet-1622	141	6	copolymer	copolymer	NOUN
admet-1622	141	7	(	(	PUNCT
admet-1622	141	8	kollidon	kollidon	PROPN
admet-1622	141	9	®	®	NOUN
admet-1622	141	10	va64	va64	PROPN
admet-1622	141	11	)	)	PUNCT
admet-1622	141	12	with	with	ADP
admet-1622	141	13	hydroxypropyl	hydroxypropyl	ADJ
admet-1622	141	14	methylcellulose	methylcellulose	NOUN
admet-1622	141	15	(	(	PUNCT
admet-1622	141	16	affinisol	affinisol	PROPN
admet-1622	141	17	®	®	NOUN
admet-1622	141	18	hme	hme	PROPN
admet-1622	141	19	15	15	NUM
admet-1622	141	20	cp	cp	NOUN
admet-1622	141	21	)	)	PUNCT
admet-1622	141	22	at	at	ADP
admet-1622	141	23	1:1	1:1	NUM
admet-1622	141	24	w	w	PROPN
admet-1622	141	25	/	/	SYM
admet-1622	141	26	w	w	NOUN
admet-1622	141	27	ratio	ratio	NOUN
admet-1622	141	28	to	to	PART
admet-1622	141	29	increase	increase	VERB
admet-1622	141	30	the	the	DET
admet-1622	141	31	dissolution	dissolution	NOUN
admet-1622	141	32	rate	rate	NOUN
admet-1622	141	33	of	of	ADP
admet-1622	141	34	a	a	DET
admet-1622	141	35	model	model	NOUN
admet-1622	141	36	drug	drug	NOUN
admet-1622	141	37	haloperidol	haloperidol	VERB
admet-1622	141	38	as	as	ADP
admet-1622	141	39	compared	compare	VERB
admet-1622	141	40	to	to	ADP
admet-1622	141	41	that	that	PRON
admet-1622	141	42	with	with	ADP
admet-1622	141	43	cellulose	cellulose	NOUN
admet-1622	141	44	alone	alone	ADV
admet-1622	141	45	.	.	PUNCT
admet-1622	142	1	they	they	PRON
admet-1622	142	2	obtained	obtain	VERB
admet-1622	142	3	complete	complete	ADJ
admet-1622	142	4	drug	drug	NOUN
admet-1622	142	5	release	release	NOUN
admet-1622	142	6	in	in	ADP
admet-1622	142	7	<	<	X
admet-1622	142	8	1	1	NUM
admet-1622	142	9	h	h	NOUN
admet-1622	142	10	at	at	ADP
admet-1622	142	11	ph	ph	PROPN
admet-1622	142	12	2	2	NUM
admet-1622	142	13	,	,	PUNCT
admet-1622	142	14	and	and	CCONJ
admet-1622	142	15	it	it	PRON
admet-1622	142	16	took	take	VERB
admet-1622	142	17	~3	~3	NOUN
admet-1622	142	18	h	h	NOUN
admet-1622	142	19	to	to	PART
admet-1622	142	20	completely	completely	ADV
admet-1622	142	21	dissolve	dissolve	VERB
admet-1622	142	22	the	the	DET
admet-1622	142	23	drug	drug	NOUN
admet-1622	142	24	at	at	ADP
admet-1622	142	25	ph	ph	PROPN
admet-1622	142	26	6.8	6.8	NUM
admet-1622	142	27	because	because	SCONJ
admet-1622	142	28	of	of	ADP
admet-1622	142	29	the	the	DET
admet-1622	142	30	ph	ph	ADJ
admet-1622	142	31	-	-	ADJ
admet-1622	142	32	dependent	dependent	ADJ
admet-1622	142	33	solubility	solubility	NOUN
admet-1622	142	34	of	of	ADP
admet-1622	142	35	the	the	DET
admet-1622	142	36	drug	drug	NOUN
admet-1622	142	37	used	use	VERB
admet-1622	142	38	.	.	PUNCT
admet-1622	143	1	while	while	SCONJ
admet-1622	143	2	kollidon	kollidon	ADJ
admet-1622	143	3	®	®	NOUN
admet-1622	143	4	va64	va64	PROPN
admet-1622	143	5	is	be	AUX
admet-1622	143	6	not	not	PART
admet-1622	143	7	printable	printable	NOUN
admet-1622	143	8	due	due	ADJ
admet-1622	143	9	to	to	ADP
admet-1622	143	10	the	the	DET
admet-1622	143	11	brittleness	brittleness	NOUN
admet-1622	143	12	of	of	ADP
admet-1622	143	13	filaments	filament	NOUN
admet-1622	143	14	,	,	PUNCT
admet-1622	143	15	mixing	mix	VERB
admet-1622	143	16	with	with	ADP
admet-1622	143	17	affinisol	affinisol	NOUN
admet-1622	143	18	®	®	NOUN
admet-1622	143	19	hme	hme	PROPN
admet-1622	143	20	15	15	NUM
admet-1622	143	21	cp	cp	INTJ
admet-1622	143	22	made	make	VERB
admet-1622	143	23	the	the	DET
admet-1622	143	24	formulations	formulation	NOUN
admet-1622	143	25	printable	printable	ADJ
admet-1622	143	26	.	.	PUNCT
admet-1622	144	1	this	this	DET
admet-1622	144	2	study	study	NOUN
admet-1622	144	3	will	will	AUX
admet-1622	144	4	be	be	AUX
admet-1622	144	5	further	far	ADV
admet-1622	144	6	elaborated	elaborate	VERB
admet-1622	144	7	in	in	ADP
admet-1622	144	8	a	a	DET
admet-1622	144	9	later	later	ADJ
admet-1622	144	10	section	section	NOUN
admet-1622	144	11	of	of	ADP
admet-1622	144	12	this	this	DET
admet-1622	144	13	article	article	NOUN
admet-1622	144	14	as	as	ADP
admet-1622	144	15	a	a	DET
admet-1622	144	16	case	case	NOUN
admet-1622	144	17	study	study	NOUN
admet-1622	144	18	for	for	ADP
admet-1622	144	19	a	a	DET
admet-1622	144	20	systematic	systematic	ADJ
admet-1622	144	21	approach	approach	NOUN
admet-1622	144	22	to	to	ADP
admet-1622	144	23	the	the	DET
admet-1622	144	24	development	development	NOUN
admet-1622	144	25	of	of	ADP
admet-1622	144	26	fdm	fdm	NOUN
admet-1622	144	27	3d	3d	ADV
admet-1622	144	28	-	-	PUNCT
admet-1622	144	29	printed	print	VERB
admet-1622	144	30	tablets	tablet	NOUN
admet-1622	144	31	.	.	PUNCT
admet-1622	145	1	in	in	ADP
admet-1622	145	2	another	another	DET
admet-1622	145	3	study	study	NOUN
admet-1622	145	4	,	,	PUNCT
admet-1622	145	5	saydam	saydam	NOUN
admet-1622	145	6	and	and	CCONJ
admet-1622	145	7	takka	takka	X
admet-1622	145	8	[	[	X
admet-1622	145	9	47	47	NUM
admet-1622	145	10	]	]	PUNCT
admet-1622	145	11	used	use	VERB
admet-1622	145	12	20	20	NUM
admet-1622	145	13	%	%	NOUN
admet-1622	145	14	kollidon	kollidon	ADJ
admet-1622	145	15	®	®	NOUN
admet-1622	145	16	va64	va64	PROPN
admet-1622	145	17	,	,	PUNCT
admet-1622	145	18	20	20	NUM
admet-1622	145	19	%	%	NOUN
admet-1622	145	20	hpmc	hpmc	ADJ
admet-1622	145	21	and	and	CCONJ
admet-1622	145	22	34	34	NUM
admet-1622	145	23	%	%	NOUN
admet-1622	145	24	soluplus	soluplus	ADJ
admet-1622	145	25	®	®	NOUN
admet-1622	145	26	along	along	ADP
admet-1622	145	27	with	with	ADP
admet-1622	145	28	different	different	ADJ
admet-1622	145	29	drugs	drug	NOUN
admet-1622	145	30	(	(	PUNCT
admet-1622	145	31	15	15	NUM
admet-1622	145	32	%	%	NOUN
admet-1622	145	33	)	)	PUNCT
admet-1622	145	34	and	and	CCONJ
admet-1622	145	35	several	several	ADJ
admet-1622	145	36	excipients	excipient	NOUN
admet-1622	145	37	like	like	ADP
admet-1622	145	38	tween	tween	NOUN
admet-1622	145	39	80	80	NUM
admet-1622	145	40	,	,	PUNCT
admet-1622	145	41	gelucire	gelucire	VERB
admet-1622	145	42	44/14	44/14	NUM
admet-1622	145	43	,	,	PUNCT
admet-1622	145	44	gelucire	gelucire	NOUN
admet-1622	145	45	48/16	48/16	NUM
admet-1622	145	46	,	,	PUNCT
admet-1622	145	47	triacetin	triacetin	ADJ
admet-1622	145	48	,	,	PUNCT
admet-1622	145	49	etc	etc	X
admet-1622	145	50	.	.	X
admet-1622	145	51	,	,	PUNCT
admet-1622	145	52	to	to	PART
admet-1622	145	53	increase	increase	VERB
admet-1622	145	54	dissolution	dissolution	ADJ
admet-1622	145	55	rate	rate	NOUN
admet-1622	145	56	and	and	CCONJ
admet-1622	145	57	printability	printability	NOUN
admet-1622	145	58	of	of	ADP
admet-1622	145	59	formulations	formulation	NOUN
admet-1622	145	60	.	.	PUNCT
admet-1622	146	1	up	up	ADP
admet-1622	146	2	to	to	PART
admet-1622	146	3	80	80	NUM
admet-1622	146	4	%	%	NOUN
admet-1622	146	5	drug	drug	NOUN
admet-1622	146	6	release	release	NOUN
admet-1622	146	7	in	in	ADP
admet-1622	146	8	<	<	NOUN
admet-1622	146	9	1	1	NUM
admet-1622	146	10	h	h	NOUN
admet-1622	146	11	was	be	AUX
admet-1622	146	12	obtained	obtain	VERB
admet-1622	146	13	from	from	ADP
admet-1622	146	14	several	several	ADJ
admet-1622	146	15	formulations	formulation	NOUN
admet-1622	146	16	for	for	ADP
admet-1622	146	17	tablets	tablet	NOUN
admet-1622	146	18	with	with	ADP
admet-1622	146	19	50	50	NUM
admet-1622	146	20	%	%	NOUN
admet-1622	146	21	infill	infill	NOUN
admet-1622	146	22	,	,	PUNCT
admet-1622	146	23	while	while	SCONJ
admet-1622	146	24	the	the	DET
admet-1622	146	25	dissolution	dissolution	NOUN
admet-1622	146	26	from	from	ADP
admet-1622	146	27	other	other	ADJ
admet-1622	146	28	formulations	formulation	NOUN
admet-1622	146	29	took	take	VERB
admet-1622	146	30	longer	long	ADV
admet-1622	146	31	.	.	PUNCT
admet-1622	147	1	incorporation	incorporation	NOUN
admet-1622	147	2	of	of	ADP
admet-1622	147	3	additives	additive	NOUN
admet-1622	147	4	it	it	PRON
admet-1622	147	5	has	have	AUX
admet-1622	147	6	been	be	AUX
admet-1622	147	7	reported	report	VERB
admet-1622	147	8	in	in	ADP
admet-1622	147	9	the	the	DET
admet-1622	147	10	literature	literature	NOUN
admet-1622	147	11	that	that	PRON
admet-1622	147	12	the	the	DET
admet-1622	147	13	incorporation	incorporation	NOUN
admet-1622	147	14	of	of	ADP
admet-1622	147	15	certain	certain	ADJ
admet-1622	147	16	fillers	filler	NOUN
admet-1622	147	17	in	in	ADP
admet-1622	147	18	fdm	fdm	NOUN
admet-1622	147	19	3d	3d	ADV
admet-1622	147	20	-	-	PUNCT
admet-1622	147	21	printed	print	VERB
admet-1622	147	22	tablets	tablet	NOUN
admet-1622	147	23	could	could	AUX
admet-1622	147	24	also	also	ADV
admet-1622	147	25	increase	increase	VERB
admet-1622	147	26	the	the	DET
admet-1622	147	27	dissolution	dissolution	NOUN
admet-1622	147	28	rate	rate	NOUN
admet-1622	147	29	of	of	ADP
admet-1622	147	30	drugs	drug	NOUN
admet-1622	147	31	from	from	ADP
admet-1622	147	32	tablets	tablet	NOUN
admet-1622	147	33	.	.	PUNCT
admet-1622	148	1	okwuosa	okwuosa	ADV
admet-1622	148	2	et	et	PROPN
admet-1622	148	3	al	al	PROPN
admet-1622	148	4	.	.	PUNCT
admet-1622	149	1	[	[	X
admet-1622	149	2	48	48	NUM
admet-1622	149	3	]	]	PUNCT
admet-1622	149	4	observed	observe	VERB
admet-1622	149	5	complete	complete	ADJ
admet-1622	149	6	release	release	NOUN
admet-1622	149	7	of	of	ADP
admet-1622	149	8	theophylline	theophylline	NOUN
admet-1622	149	9	or	or	CCONJ
admet-1622	149	10	dipyridamole	dipyridamole	NOUN
admet-1622	149	11	in	in	ADP
admet-1622	149	12	30	30	NUM
admet-1622	149	13	min	min	NOUN
admet-1622	149	14	from	from	ADP
admet-1622	149	15	tablets	tablet	NOUN
admet-1622	149	16	containing	contain	VERB
admet-1622	149	17	50	50	NUM
admet-1622	149	18	%	%	NOUN
admet-1622	149	19	polyvinylpyrrolidone	polyvinylpyrrolidone	NOUN
admet-1622	149	20	(	(	PUNCT
admet-1622	149	21	pvp	pvp	NOUN
admet-1622	149	22	;	;	PUNCT
admet-1622	149	23	mw	mw	VERB
admet-1622	149	24	40,000	40,000	NUM
admet-1622	149	25	)	)	PUNCT
admet-1622	149	26	as	as	ADP
admet-1622	149	27	the	the	DET
admet-1622	149	28	polymer	polymer	NOUN
admet-1622	149	29	,	,	PUNCT
admet-1622	149	30	12.5	12.5	NUM
admet-1622	149	31	%	%	NOUN
admet-1622	149	32	triethyl	triethyl	NOUN
admet-1622	149	33	citrate	citrate	PROPN
admet-1622	149	34	(	(	PUNCT
admet-1622	149	35	tec	tec	NOUN
admet-1622	149	36	)	)	PUNCT
admet-1622	149	37	as	as	ADP
admet-1622	149	38	the	the	DET
admet-1622	149	39	plasticizer	plasticizer	NOUN
admet-1622	149	40	,	,	PUNCT
admet-1622	149	41	27.5	27.5	NUM
admet-1622	149	42	%	%	NOUN
admet-1622	149	43	talc	talc	NOUN
admet-1622	149	44	as	as	ADP
admet-1622	149	45	the	the	DET
admet-1622	149	46	filler	filler	NOUN
admet-1622	149	47	,	,	PUNCT
admet-1622	149	48	along	along	ADP
admet-1622	149	49	with	with	ADP
admet-1622	149	50	10	10	NUM
admet-1622	149	51	%	%	NOUN
admet-1622	149	52	drug	drug	NOUN
admet-1622	149	53	load	load	NOUN
admet-1622	149	54	.	.	PUNCT
admet-1622	150	1	talc	talc	NOUN
admet-1622	150	2	remained	remain	VERB
admet-1622	150	3	solid	solid	ADJ
admet-1622	150	4	and	and	CCONJ
admet-1622	150	5	fully	fully	ADV
admet-1622	150	6	crystalline	crystalline	ADJ
admet-1622	150	7	,	,	PUNCT
admet-1622	150	8	and	and	CCONJ
admet-1622	150	9	the	the	DET
admet-1622	150	10	drugs	drug	NOUN
admet-1622	150	11	were	be	AUX
admet-1622	150	12	partially	partially	ADV
admet-1622	150	13	crystalline	crystalline	ADJ
admet-1622	150	14	in	in	ADP
admet-1622	150	15	the	the	DET
admet-1622	150	16	tablets	tablet	NOUN
admet-1622	150	17	.	.	PUNCT
admet-1622	151	1	the	the	DET
admet-1622	151	2	exact	exact	ADJ
admet-1622	151	3	mechanism	mechanism	NOUN
admet-1622	151	4	of	of	ADP
admet-1622	151	5	how	how	SCONJ
admet-1622	151	6	the	the	DET
admet-1622	151	7	additives	additive	NOUN
admet-1622	151	8	increased	increase	VERB
admet-1622	151	9	drug	drug	NOUN
admet-1622	151	10	release	release	NOUN
admet-1622	151	11	rates	rate	NOUN
admet-1622	151	12	has	have	AUX
admet-1622	151	13	not	not	PART
admet-1622	151	14	been	be	AUX
admet-1622	151	15	elucidated	elucidate	VERB
admet-1622	151	16	in	in	ADP
admet-1622	151	17	the	the	DET
admet-1622	151	18	study	study	NOUN
admet-1622	151	19	.	.	PUNCT
admet-1622	152	1	it	it	PRON
admet-1622	152	2	has	have	AUX
admet-1622	152	3	been	be	AUX
admet-1622	152	4	postulated	postulate	VERB
admet-1622	152	5	that	that	SCONJ
admet-1622	152	6	the	the	DET
admet-1622	152	7	matrix	matrix	NOUN
admet-1622	152	8	structure	structure	NOUN
admet-1622	152	9	of	of	ADP
admet-1622	152	10	tablet	tablet	NOUN
admet-1622	152	11	influenced	influence	VERB
admet-1622	152	12	the	the	DET
admet-1622	152	13	drug	drug	NOUN
admet-1622	152	14	release	release	NOUN
admet-1622	152	15	rate	rate	NOUN
admet-1622	152	16	.	.	PUNCT
admet-1622	153	1	sadia	sadia	PROPN
admet-1622	153	2	et	et	PROPN
admet-1622	153	3	al	al	PROPN
admet-1622	153	4	.	.	PUNCT
admet-1622	154	1	[	[	X
admet-1622	154	2	49	49	NUM
admet-1622	154	3	]	]	PUNCT
admet-1622	154	4	also	also	ADV
admet-1622	154	5	observed	observe	VERB
admet-1622	154	6	similar	similar	ADJ
admet-1622	154	7	results	result	NOUN
admet-1622	154	8	in	in	ADP
admet-1622	154	9	the	the	DET
admet-1622	154	10	presence	presence	NOUN
admet-1622	154	11	of	of	ADP
admet-1622	154	12	tec	tec	NOUN
admet-1622	154	13	and	and	CCONJ
admet-1622	154	14	a	a	DET
admet-1622	154	15	different	different	ADJ
admet-1622	154	16	filler	filler	NOUN
admet-1622	154	17	,	,	PUNCT
admet-1622	154	18	tricalcium	tricalcium	NOUN
admet-1622	154	19	phosphate	phosphate	NOUN
admet-1622	154	20	(	(	PUNCT
admet-1622	154	21	tcp	tcp	PROPN
admet-1622	154	22	)	)	PUNCT
admet-1622	154	23	,	,	PUNCT
admet-1622	154	24	where	where	SCONJ
admet-1622	154	25	over	over	ADP
admet-1622	154	26	80	80	NUM
admet-1622	154	27	%	%	NOUN
admet-1622	154	28	release	release	NOUN
admet-1622	154	29	of	of	ADP
admet-1622	154	30	four	four	NUM
admet-1622	154	31	model	model	NOUN
admet-1622	154	32	drugs	drug	NOUN
admet-1622	154	33	(	(	PUNCT
admet-1622	154	34	5	5	NUM
admet-1622	154	35	-	-	PUNCT
admet-1622	154	36	acetyl	acetyl	NOUN
admet-1622	154	37	salicylic	salicylic	NOUN
admet-1622	154	38	acid	acid	NOUN
admet-1622	154	39	,	,	PUNCT
admet-1622	154	40	captopril	captopril	NOUN
admet-1622	154	41	,	,	PUNCT
admet-1622	154	42	prednisolone	prednisolone	NOUN
admet-1622	154	43	,	,	PUNCT
admet-1622	154	44	or	or	CCONJ
admet-1622	154	45	theophylline	theophylline	NOUN
admet-1622	154	46	)	)	PUNCT
admet-1622	154	47	was	be	AUX
admet-1622	154	48	obtained	obtain	VERB
admet-1622	154	49	in	in	ADP
admet-1622	154	50	<	<	PROPN
admet-1622	154	51	30	30	NUM
admet-1622	154	52	min	min	NOUN
admet-1622	154	53	from	from	ADP
admet-1622	154	54	tablets	tablet	NOUN
admet-1622	154	55	containing	contain	VERB
admet-1622	154	56	eudragit	eudragit	PROPN
admet-1622	154	57	®	®	NOUN
admet-1622	154	58	epo	epo	NOUN
admet-1622	154	59	,	,	PUNCT
admet-1622	154	60	tec	tec	ADJ
admet-1622	154	61	,	,	PUNCT
admet-1622	154	62	tcp	tcp	ADJ
admet-1622	154	63	,	,	PUNCT
admet-1622	154	64	and	and	CCONJ
admet-1622	154	65	drug	drug	NOUN
admet-1622	154	66	at	at	ADP
admet-1622	154	67	the	the	DET
admet-1622	154	68	ratio	ratio	NOUN
admet-1622	154	69	of	of	ADP
admet-1622	154	70	46.75:3.25:37.5:12.5	46.75:3.25:37.5:12.5	NUM
admet-1622	154	71	.	.	PUNCT
admet-1622	155	1	the	the	DET
admet-1622	155	2	amorphous	amorphous	ADJ
admet-1622	155	3	tricalcium	tricalcium	NOUN
admet-1622	155	4	phosphate	phosphate	NOUN
admet-1622	155	5	dispersed	disperse	VERB
admet-1622	155	6	in	in	ADP
admet-1622	155	7	the	the	DET
admet-1622	155	8	tablet	tablet	NOUN
admet-1622	155	9	as	as	ADP
admet-1622	155	10	separate	separate	ADJ
admet-1622	155	11	particles	particle	NOUN
admet-1622	155	12	,	,	PUNCT
admet-1622	155	13	and	and	CCONJ
admet-1622	155	14	the	the	DET
admet-1622	155	15	drug	drug	NOUN
admet-1622	155	16	was	be	AUX
admet-1622	155	17	partially	partially	ADV
admet-1622	155	18	crystalline	crystalline	ADJ
admet-1622	155	19	.	.	PUNCT
admet-1622	156	1	the	the	DET
admet-1622	156	2	exact	exact	ADJ
admet-1622	156	3	mechanism	mechanism	NOUN
admet-1622	156	4	for	for	ADP
admet-1622	156	5	the	the	DET
admet-1622	156	6	improvement	improvement	NOUN
admet-1622	156	7	of	of	ADP
admet-1622	156	8	dissolution	dissolution	NOUN
admet-1622	156	9	rates	rate	NOUN
admet-1622	156	10	by	by	ADP
admet-1622	156	11	these	these	DET
admet-1622	156	12	additives	additive	NOUN
admet-1622	156	13	has	have	AUX
admet-1622	156	14	also	also	ADV
admet-1622	156	15	not	not	PART
admet-1622	156	16	been	be	AUX
admet-1622	156	17	elucidated	elucidate	VERB
admet-1622	156	18	.	.	PUNCT
admet-1622	157	1	in	in	ADP
admet-1622	157	2	addition	addition	NOUN
admet-1622	157	3	to	to	ADP
admet-1622	157	4	increasing	increase	VERB
admet-1622	157	5	the	the	DET
admet-1622	157	6	drug	drug	NOUN
admet-1622	157	7	dissolution	dissolution	NOUN
admet-1622	157	8	rate	rate	NOUN
admet-1622	157	9	,	,	PUNCT
admet-1622	157	10	the	the	DET
admet-1622	157	11	presence	presence	NOUN
admet-1622	157	12	of	of	ADP
admet-1622	157	13	tcp	tcp	NOUN
admet-1622	157	14	in	in	ADP
admet-1622	157	15	the	the	DET
admet-1622	157	16	formulation	formulation	NOUN
admet-1622	157	17	helped	help	VERB
admet-1622	157	18	in	in	ADP
admet-1622	157	19	the	the	DET
admet-1622	157	20	printing	printing	NOUN
admet-1622	157	21	process	process	NOUN
admet-1622	157	22	by	by	ADP
admet-1622	157	23	enhancing	enhance	VERB
admet-1622	157	24	the	the	DET
admet-1622	157	25	solidification	solidification	NOUN
admet-1622	157	26	of	of	ADP
admet-1622	157	27	different	different	ADJ
admet-1622	157	28	printing	printing	NOUN
admet-1622	157	29	layers	layer	NOUN
admet-1622	157	30	after	after	ADP
admet-1622	157	31	extrusion	extrusion	NOUN
admet-1622	157	32	.	.	PUNCT
admet-1622	158	1	in	in	ADP
admet-1622	158	2	another	another	DET
admet-1622	158	3	study	study	NOUN
admet-1622	158	4	of	of	ADP
admet-1622	158	5	the	the	DET
admet-1622	158	6	effect	effect	NOUN
admet-1622	158	7	of	of	ADP
admet-1622	158	8	additives	additive	NOUN
admet-1622	158	9	,	,	PUNCT
admet-1622	158	10	fanous	fanous	ADJ
admet-1622	158	11	et	et	PROPN
admet-1622	158	12	al	al	PROPN
admet-1622	158	13	.	.	PUNCT
admet-1622	159	1	[	[	X
admet-1622	159	2	50	50	NUM
admet-1622	159	3	]	]	PUNCT
admet-1622	159	4	observed	observe	VERB
admet-1622	159	5	that	that	SCONJ
admet-1622	159	6	the	the	DET
admet-1622	159	7	incorporation	incorporation	NOUN
admet-1622	159	8	of	of	ADP
admet-1622	159	9	the	the	DET
admet-1622	159	10	hydrophilic	hydrophilic	ADJ
admet-1622	159	11	plasticizer	plasticizer	NOUN
admet-1622	159	12	xylitol	xylitol	NOUN
admet-1622	159	13	(	(	PUNCT
admet-1622	159	14	13.5	13.5	NUM
admet-1622	159	15	%	%	NOUN
admet-1622	159	16	]	]	PUNCT
admet-1622	159	17	and	and	CCONJ
admet-1622	159	18	the	the	DET
admet-1622	159	19	pore	pore	ADJ
admet-1622	159	20	former	former	ADJ
admet-1622	159	21	maltodextrin	maltodextrin	NOUN
admet-1622	159	22	(	(	PUNCT
admet-1622	159	23	9.5	9.5	NUM
admet-1622	159	24	%	%	NOUN
admet-1622	159	25	)	)	PUNCT
admet-1622	159	26	in	in	ADP
admet-1622	159	27	a	a	DET
admet-1622	159	28	eudragit	eudragit	NOUN
admet-1622	159	29	®	®	NOUN
admet-1622	159	30	epo	epo	NOUN
admet-1622	159	31	-	-	PUNCT
admet-1622	159	32	based	base	VERB
admet-1622	159	33	formulation	formulation	NOUN
admet-1622	159	34	could	could	AUX
admet-1622	159	35	enhance	enhance	VERB
admet-1622	159	36	drug	drug	NOUN
admet-1622	159	37	release	release	NOUN
admet-1622	159	38	from	from	ADP
admet-1622	159	39	the	the	DET
admet-1622	159	40	fdm	fdm	NOUN
admet-1622	159	41	3d	3d	ADV
admet-1622	159	42	-	-	PUNCT
admet-1622	159	43	printed	print	VERB
admet-1622	159	44	tablets	tablet	NOUN
admet-1622	159	45	.	.	PUNCT
admet-1622	160	1	by	by	ADP
admet-1622	160	2	using	use	VERB
admet-1622	160	3	these	these	DET
admet-1622	160	4	additives	additive	NOUN
admet-1622	160	5	along	along	ADP
admet-1622	160	6	with	with	ADP
admet-1622	160	7	the	the	DET
admet-1622	160	8	modification	modification	NOUN
admet-1622	160	9	of	of	ADP
admet-1622	160	10	infill	infill	NOUN
admet-1622	160	11	density	density	NOUN
admet-1622	160	12	,	,	PUNCT
admet-1622	160	13	they	they	PRON
admet-1622	160	14	developed	develop	VERB
admet-1622	160	15	tablets	tablet	NOUN
admet-1622	160	16	with	with	ADP
admet-1622	160	17	complete	complete	ADJ
admet-1622	160	18	dissolution	dissolution	NOUN
admet-1622	160	19	in	in	ADP
admet-1622	160	20	30	30	NUM
admet-1622	160	21	to	to	PART
admet-1622	160	22	60	60	NUM
admet-1622	160	23	min	min	NOUN
admet-1622	160	24	.	.	PUNCT
admet-1622	161	1	there	there	PRON
admet-1622	161	2	are	be	VERB
admet-1622	161	3	also	also	ADV
admet-1622	161	4	reports	report	NOUN
admet-1622	161	5	on	on	ADP
admet-1622	161	6	the	the	DET
admet-1622	161	7	increase	increase	NOUN
admet-1622	161	8	in	in	ADP
admet-1622	161	9	drug	drug	NOUN
admet-1622	161	10	dissolution	dissolution	NOUN
admet-1622	161	11	rates	rate	NOUN
admet-1622	161	12	by	by	ADP
admet-1622	161	13	the	the	DET
admet-1622	161	14	incorporation	incorporation	NOUN
admet-1622	161	15	of	of	ADP
admet-1622	161	16	polyethylene	polyethylene	NOUN
admet-1622	161	17	oxide	oxide	NOUN
admet-1622	161	18	as	as	ADP
admet-1622	161	19	the	the	DET
admet-1622	161	20	additive	additive	NOUN
admet-1622	161	21	[	[	X
admet-1622	161	22	38,43,51,52	38,43,51,52	NUM
admet-1622	161	23	]	]	PUNCT
admet-1622	161	24	.	.	PUNCT
admet-1622	162	1	for	for	ADP
admet-1622	162	2	example	example	NOUN
admet-1622	162	3	,	,	PUNCT
admet-1622	162	4	gultekin	gultekin	PROPN
admet-1622	162	5	et	et	PROPN
admet-1622	162	6	al	al	PROPN
admet-1622	162	7	.	.	PUNCT
admet-1622	163	1	[	[	X
admet-1622	163	2	38	38	NUM
admet-1622	163	3	]	]	PUNCT
admet-1622	163	4	used	use	VERB
admet-1622	163	5	mixtures	mixture	NOUN
admet-1622	163	6	of	of	ADP
admet-1622	163	7	eudragit	eudragit	ADJ
admet-1622	163	8	®	®	NOUN
admet-1622	163	9	epo	epo	NOUN
admet-1622	163	10	and	and	CCONJ
admet-1622	163	11	polyethylene	polyethylene	NOUN
admet-1622	163	12	oxide	oxide	NOUN
admet-1622	163	13	(	(	PUNCT
admet-1622	163	14	peo	peo	PROPN
admet-1622	163	15	)	)	PUNCT
admet-1622	163	16	n80	n80	NOUN
admet-1622	163	17	at	at	ADP
admet-1622	163	18	70:30	70:30	NUM
admet-1622	163	19	,	,	PUNCT
admet-1622	163	20	60:40	60:40	NUM
admet-1622	163	21	and	and	CCONJ
admet-1622	163	22	50:50	50:50	NUM
admet-1622	163	23	w	w	NOUN
admet-1622	163	24	/	/	SYM
admet-1622	163	25	w	w	NOUN
admet-1622	163	26	ratios	ratio	NOUN
admet-1622	163	27	for	for	ADP
admet-1622	163	28	a	a	DET
admet-1622	163	29	low	low	ADJ
admet-1622	163	30	-	-	PUNCT
admet-1622	163	31	dose	dose	NOUN
admet-1622	163	32	drug	drug	NOUN
admet-1622	163	33	(	(	PUNCT
admet-1622	163	34	0.25	0.25	NUM
admet-1622	163	35	to	to	PART
admet-1622	163	36	1	1	NUM
admet-1622	163	37	mg	mg	NUM
admet-1622	163	38	)	)	PUNCT
admet-1622	163	39	and	and	CCONJ
admet-1622	163	40	observed	observe	VERB
admet-1622	163	41	complete	complete	ADJ
admet-1622	163	42	drug	drug	NOUN
admet-1622	163	43	release	release	NOUN
admet-1622	163	44	in	in	ADP
admet-1622	163	45	a	a	DET
admet-1622	163	46	ph	ph	ADJ
admet-1622	163	47	1.2	1.2	NUM
admet-1622	163	48	medium	medium	NOUN
admet-1622	163	49	(	(	PUNCT
admet-1622	163	50	0.1	0.1	NUM
admet-1622	163	51	m	m	NOUN
admet-1622	163	52	hcl	hcl	NOUN
admet-1622	163	53	)	)	PUNCT
admet-1622	163	54	in	in	ADP
admet-1622	163	55	20	20	NUM
admet-1622	163	56	min	min	NOUN
admet-1622	163	57	.	.	PUNCT
admet-1622	164	1	the	the	DET
admet-1622	164	2	authors	author	NOUN
admet-1622	164	3	reported	report	VERB
admet-1622	164	4	that	that	SCONJ
admet-1622	164	5	,	,	PUNCT
admet-1622	164	6	when	when	SCONJ
admet-1622	164	7	extruded	extrude	VERB
admet-1622	164	8	at	at	ADP
admet-1622	164	9	130	130	NUM
admet-1622	164	10	°	°	NOUN
admet-1622	164	11	c	c	NOUN
admet-1622	164	12	,	,	PUNCT
admet-1622	164	13	the	the	DET
admet-1622	164	14	filaments	filament	NOUN
admet-1622	164	15	were	be	AUX
admet-1622	164	16	flexible	flexible	ADJ
admet-1622	164	17	,	,	PUNCT
admet-1622	164	18	smooth	smooth	ADJ
admet-1622	164	19	,	,	PUNCT
admet-1622	164	20	and	and	CCONJ
admet-1622	164	21	extrudable	extrudable	ADJ
admet-1622	164	22	.	.	PUNCT
admet-1622	165	1	it	it	PRON
admet-1622	165	2	is	be	AUX
admet-1622	165	3	,	,	PUNCT
admet-1622	165	4	however	however	ADV
admet-1622	165	5	,	,	PUNCT
admet-1622	165	6	not	not	PART
admet-1622	165	7	clear	clear	ADJ
admet-1622	165	8	from	from	ADP
admet-1622	165	9	the	the	DET
admet-1622	165	10	paper	paper	NOUN
admet-1622	165	11	whether	whether	SCONJ
admet-1622	165	12	the	the	DET
admet-1622	165	13	high	high	ADJ
admet-1622	165	14	ratios	ratio	NOUN
admet-1622	165	15	of	of	ADP
admet-1622	165	16	polymer	polymer	NOUN
admet-1622	165	17	and	and	CCONJ
admet-1622	165	18	peo	peo	PROPN
admet-1622	165	19	used	use	VERB
admet-1622	165	20	(	(	PUNCT
admet-1622	165	21	70:30	70:30	NUM
admet-1622	165	22	,	,	PUNCT
admet-1622	165	23	60:40	60:40	NUM
admet-1622	165	24	and	and	CCONJ
admet-1622	165	25	50:50	50:50	NUM
admet-1622	165	26	w	w	PROPN
admet-1622	165	27	/	/	SYM
admet-1622	165	28	w	w	NOUN
admet-1622	165	29	)	)	PUNCT
admet-1622	165	30	were	be	AUX
admet-1622	165	31	miscible	miscible	ADJ
admet-1622	165	32	with	with	ADP
admet-1622	165	33	each	each	DET
admet-1622	165	34	other	other	ADJ
admet-1622	165	35	or	or	CCONJ
admet-1622	165	36	whether	whether	SCONJ
admet-1622	165	37	they	they	PRON
admet-1622	165	38	were	be	AUX
admet-1622	165	39	phase	phase	NOUN
admet-1622	165	40	separated	separate	VERB
admet-1622	165	41	,	,	PUNCT
admet-1622	165	42	which	which	PRON
admet-1622	165	43	could	could	AUX
admet-1622	165	44	be	be	AUX
admet-1622	165	45	an	an	DET
admet-1622	165	46	issue	issue	NOUN
admet-1622	165	47	on	on	ADP
admet-1622	165	48	the	the	DET
admet-1622	165	49	physical	physical	ADJ
admet-1622	165	50	stability	stability	NOUN
admet-1622	165	51	of	of	ADP
admet-1622	165	52	filaments	filament	NOUN
admet-1622	165	53	and	and	CCONJ
admet-1622	165	54	tablets	tablet	NOUN
admet-1622	165	55	.	.	PUNCT
admet-1622	166	1	also	also	ADV
admet-1622	166	2	,	,	PUNCT
admet-1622	166	3	the	the	DET
admet-1622	166	4	dissolution	dissolution	NOUN
admet-1622	166	5	testing	testing	NOUN
admet-1622	166	6	was	be	AUX
admet-1622	166	7	conducted	conduct	VERB
admet-1622	166	8	at	at	ADP
admet-1622	166	9	ph	ph	ADJ
admet-1622	166	10	1.2	1.2	NUM
admet-1622	166	11	,	,	PUNCT
admet-1622	166	12	where	where	SCONJ
admet-1622	166	13	the	the	DET
admet-1622	166	14	polymer	polymer	NOUN
admet-1622	166	15	eudragit	eudragit	NOUN
admet-1622	166	16	®	®	NOUN
admet-1622	166	17	epo	epo	NOUN
admet-1622	166	18	is	be	AUX
admet-1622	166	19	soluble	soluble	ADJ
admet-1622	166	20	;	;	PUNCT
admet-1622	166	21	it	it	PRON
admet-1622	166	22	is	be	AUX
admet-1622	166	23	not	not	PART
admet-1622	166	24	known	know	VERB
admet-1622	166	25	what	what	PRON
admet-1622	166	26	the	the	DET
admet-1622	166	27	dissolution	dissolution	NOUN
admet-1622	166	28	rates	rate	NOUN
admet-1622	166	29	of	of	ADP
admet-1622	166	30	formulations	formulation	NOUN
admet-1622	166	31	at	at	ADP
admet-1622	166	32	higher	high	ADJ
admet-1622	166	33	intestinal	intestinal	ADJ
admet-1622	166	34	ph	ph	ADJ
admet-1622	166	35	conditions	condition	NOUN
admet-1622	166	36	admet	admet	X
admet-1622	166	37	&	&	CCONJ
admet-1622	166	38	dmpk	dmpk	PROPN
admet-1622	166	39	11(1	11(1	NUM
admet-1622	166	40	)	)	PUNCT
admet-1622	166	41	(	(	PUNCT
admet-1622	166	42	2023	2023	NUM
admet-1622	166	43	)	)	PUNCT
admet-1622	166	44	33	33	NUM
admet-1622	166	45	-	-	SYM
admet-1622	166	46	55	55	NUM
admet-1622	166	47	development	development	NOUN
admet-1622	166	48	of	of	ADP
admet-1622	166	49	rapidly	rapidly	ADV
admet-1622	166	50	dissolving	dissolve	VERB
admet-1622	166	51	fdm	fdm	NOUN
admet-1622	166	52	3d	3d	ADV
admet-1622	166	53	-	-	PUNCT
admet-1622	166	54	printed	print	VERB
admet-1622	166	55	tablets	tablet	NOUN
admet-1622	166	56	doi	doi	NOUN
admet-1622	166	57	:	:	PUNCT
admet-1622	166	58	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	166	59	41	41	NUM
admet-1622	166	60	(	(	PUNCT
admet-1622	166	61	ph	ph	PROPN
admet-1622	166	62	5.5	5.5	NUM
admet-1622	166	63	to	to	PART
admet-1622	166	64	7.5	7.5	NUM
admet-1622	166	65	)	)	PUNCT
admet-1622	166	66	would	would	AUX
admet-1622	166	67	be	be	AUX
admet-1622	166	68	since	since	SCONJ
admet-1622	166	69	the	the	DET
admet-1622	166	70	polymer	polymer	NOUN
admet-1622	166	71	is	be	AUX
admet-1622	166	72	not	not	PART
admet-1622	166	73	soluble	soluble	ADJ
admet-1622	166	74	at	at	ADP
admet-1622	166	75	such	such	ADJ
admet-1622	166	76	ph	ph	ADJ
admet-1622	166	77	.	.	PROPN
admet-1622	167	1	unlike	unlike	ADP
admet-1622	167	2	gultekin	gultekin	PROPN
admet-1622	167	3	et	et	PROPN
admet-1622	167	4	al	al	PROPN
admet-1622	167	5	.	.	PUNCT
admet-1622	168	1	[	[	X
admet-1622	168	2	38	38	NUM
admet-1622	168	3	]	]	PUNCT
admet-1622	168	4	,	,	PUNCT
admet-1622	168	5	the	the	DET
admet-1622	168	6	experience	experience	NOUN
admet-1622	168	7	of	of	ADP
admet-1622	168	8	alhijjaj	alhijjaj	PROPN
admet-1622	168	9	et	et	PROPN
admet-1622	168	10	al	al	PROPN
admet-1622	168	11	.	.	PUNCT
admet-1622	169	1	[	[	X
admet-1622	169	2	43	43	NUM
admet-1622	169	3	]	]	PUNCT
admet-1622	169	4	in	in	ADP
admet-1622	169	5	using	use	VERB
admet-1622	169	6	peo	peo	PROPN
admet-1622	169	7	and	and	CCONJ
admet-1622	169	8	related	related	ADJ
admet-1622	169	9	additives	additive	NOUN
admet-1622	169	10	was	be	AUX
admet-1622	169	11	quite	quite	ADV
admet-1622	169	12	mixed	mixed	ADJ
admet-1622	169	13	.	.	PUNCT
admet-1622	170	1	they	they	PRON
admet-1622	170	2	prepared	prepare	VERB
admet-1622	170	3	fdm	fdm	NOUN
admet-1622	170	4	3d	3d	ADV
admet-1622	170	5	-	-	PUNCT
admet-1622	170	6	printed	print	VERB
admet-1622	170	7	discs	disc	NOUN
admet-1622	170	8	containing	contain	VERB
admet-1622	170	9	10	10	NUM
admet-1622	170	10	%	%	NOUN
admet-1622	170	11	felodipine	felodipine	NOUN
admet-1622	170	12	by	by	ADP
admet-1622	170	13	using	use	VERB
admet-1622	170	14	50	50	NUM
admet-1622	170	15	%	%	NOUN
admet-1622	170	16	of	of	ADP
admet-1622	170	17	either	either	PRON
admet-1622	170	18	eudragit	eudragit	NOUN
admet-1622	170	19	®	®	NOUN
admet-1622	170	20	epo	epo	NOUN
admet-1622	170	21	or	or	CCONJ
admet-1622	170	22	soluplus	soluplus	ADJ
admet-1622	170	23	as	as	ADP
admet-1622	170	24	the	the	DET
admet-1622	170	25	polymeric	polymeric	ADJ
admet-1622	170	26	matrix	matrix	NOUN
admet-1622	170	27	and	and	CCONJ
admet-1622	170	28	adding	add	VERB
admet-1622	170	29	15	15	NUM
admet-1622	170	30	%	%	NOUN
admet-1622	170	31	peo	peo	NOUN
admet-1622	170	32	,	,	PUNCT
admet-1622	170	33	15	15	NUM
admet-1622	170	34	%	%	NOUN
admet-1622	170	35	tween	tween	NOUN
admet-1622	170	36	80	80	NUM
admet-1622	170	37	and	and	CCONJ
admet-1622	170	38	10	10	NUM
admet-1622	170	39	%	%	NOUN
admet-1622	170	40	polyethylene	polyethylene	NOUN
admet-1622	170	41	glycol	glycol	NOUN
admet-1622	170	42	(	(	PUNCT
admet-1622	170	43	peg	peg	NOUN
admet-1622	170	44	)	)	PUNCT
admet-1622	170	45	4000	4000	NUM
admet-1622	170	46	to	to	ADP
admet-1622	170	47	the	the	DET
admet-1622	170	48	formulations	formulation	NOUN
admet-1622	170	49	.	.	PUNCT
admet-1622	171	1	the	the	DET
admet-1622	171	2	effects	effect	NOUN
admet-1622	171	3	of	of	ADP
admet-1622	171	4	peo	peo	PROPN
admet-1622	171	5	and	and	CCONJ
admet-1622	171	6	the	the	DET
admet-1622	171	7	other	other	ADJ
admet-1622	171	8	additives	additive	NOUN
admet-1622	171	9	on	on	ADP
admet-1622	171	10	drug	drug	NOUN
admet-1622	171	11	release	release	NOUN
admet-1622	171	12	from	from	ADP
admet-1622	171	13	eudragit	eudragit	NOUN
admet-1622	171	14	®	®	NOUN
admet-1622	171	15	epo	epo	NOUN
admet-1622	171	16	and	and	CCONJ
admet-1622	171	17	soluplus	soluplus	ADJ
admet-1622	171	18	®	®	NOUN
admet-1622	171	19	-based	-base	VERB
admet-1622	171	20	3d	3d	NOUN
admet-1622	171	21	-	-	PUNCT
admet-1622	171	22	printed	print	VERB
admet-1622	171	23	discs	disc	NOUN
admet-1622	171	24	were	be	AUX
admet-1622	171	25	different	different	ADJ
admet-1622	171	26	.	.	PUNCT
admet-1622	172	1	while	while	SCONJ
admet-1622	172	2	complete	complete	ADJ
admet-1622	172	3	drug	drug	NOUN
admet-1622	172	4	dissolution	dissolution	NOUN
admet-1622	172	5	was	be	AUX
admet-1622	172	6	observed	observe	VERB
admet-1622	172	7	from	from	ADP
admet-1622	172	8	the	the	DET
admet-1622	172	9	eudragit	eudragit	NOUN
admet-1622	172	10	®	®	NOUN
admet-1622	172	11	epo	epo	NOUN
admet-1622	172	12	-	-	PUNCT
admet-1622	172	13	based	base	VERB
admet-1622	172	14	formulation	formulation	NOUN
admet-1622	172	15	at	at	ADP
admet-1622	172	16	the	the	DET
admet-1622	172	17	gastric	gastric	ADJ
admet-1622	172	18	ph	ph	NOUN
admet-1622	172	19	condition	condition	NOUN
admet-1622	172	20	of	of	ADP
admet-1622	172	21	1.2	1.2	NUM
admet-1622	172	22	in	in	ADP
admet-1622	172	23	<	<	PROPN
admet-1622	172	24	30	30	NUM
admet-1622	172	25	min	min	NOUN
admet-1622	172	26	,	,	PUNCT
admet-1622	172	27	the	the	DET
admet-1622	172	28	drug	drug	NOUN
admet-1622	172	29	release	release	NOUN
admet-1622	172	30	from	from	ADP
admet-1622	172	31	the	the	DET
admet-1622	172	32	same	same	ADJ
admet-1622	172	33	formulation	formulation	NOUN
admet-1622	172	34	was	be	AUX
admet-1622	172	35	much	much	ADV
admet-1622	172	36	lower	low	ADJ
admet-1622	172	37	at	at	ADP
admet-1622	172	38	the	the	DET
admet-1622	172	39	intestinal	intestinal	ADJ
admet-1622	172	40	ph	ph	NOUN
admet-1622	172	41	condition	condition	NOUN
admet-1622	172	42	of	of	ADP
admet-1622	172	43	6.8	6.8	NUM
admet-1622	172	44	as	as	SCONJ
admet-1622	172	45	only	only	ADV
admet-1622	172	46	~20	~20	NUM
admet-1622	172	47	%	%	NOUN
admet-1622	172	48	drug	drug	NOUN
admet-1622	172	49	dissolution	dissolution	NOUN
admet-1622	172	50	was	be	AUX
admet-1622	172	51	observed	observe	VERB
admet-1622	172	52	in	in	ADP
admet-1622	172	53	6h	6h	NUM
admet-1622	172	54	,	,	PUNCT
admet-1622	172	55	thus	thus	ADV
admet-1622	172	56	showing	show	VERB
admet-1622	172	57	the	the	DET
admet-1622	172	58	effect	effect	NOUN
admet-1622	172	59	of	of	ADP
admet-1622	172	60	ph	ph	NOUN
admet-1622	172	61	on	on	ADP
admet-1622	172	62	drug	drug	NOUN
admet-1622	172	63	release	release	NOUN
admet-1622	172	64	.	.	PUNCT
admet-1622	173	1	for	for	ADP
admet-1622	173	2	the	the	DET
admet-1622	173	3	soluplus	soluplus	ADJ
admet-1622	173	4	®	®	NOUN
admet-1622	173	5	-based	-base	VERB
admet-1622	173	6	discs	disc	NOUN
admet-1622	173	7	,	,	PUNCT
admet-1622	173	8	on	on	ADP
admet-1622	173	9	the	the	DET
admet-1622	173	10	other	other	ADJ
admet-1622	173	11	hand	hand	NOUN
admet-1622	173	12	,	,	PUNCT
admet-1622	173	13	the	the	DET
admet-1622	173	14	drug	drug	NOUN
admet-1622	173	15	release	release	NOUN
admet-1622	173	16	rates	rate	NOUN
admet-1622	173	17	were	be	AUX
admet-1622	173	18	extremely	extremely	ADV
admet-1622	173	19	low	low	ADJ
admet-1622	173	20	at	at	ADP
admet-1622	173	21	both	both	DET
admet-1622	173	22	ph	ph	ADJ
admet-1622	173	23	1.2	1.2	NUM
admet-1622	173	24	and	and	CCONJ
admet-1622	173	25	6.8	6.8	NUM
admet-1622	173	26	despite	despite	SCONJ
admet-1622	173	27	the	the	DET
admet-1622	173	28	presence	presence	NOUN
admet-1622	173	29	of	of	ADP
admet-1622	173	30	peo	peo	PROPN
admet-1622	173	31	.	.	PUNCT
admet-1622	174	1	moreover	moreover	ADV
admet-1622	174	2	,	,	PUNCT
admet-1622	174	3	peo	peo	PROPN
admet-1622	174	4	and	and	CCONJ
admet-1622	174	5	peg	peg	NOUN
admet-1622	174	6	400	400	NUM
admet-1622	174	7	were	be	AUX
admet-1622	174	8	not	not	PART
admet-1622	174	9	miscible	miscible	ADJ
admet-1622	174	10	with	with	ADP
admet-1622	174	11	polymers	polymer	NOUN
admet-1622	174	12	like	like	ADP
admet-1622	174	13	eudragit	eudragit	NOUN
admet-1622	174	14	®	®	NOUN
admet-1622	174	15	epo	epo	NOUN
admet-1622	174	16	and	and	CCONJ
admet-1622	174	17	soluplus	soluplus	ADJ
admet-1622	174	18	®	®	NOUN
admet-1622	174	19	as	as	ADP
admet-1622	174	20	differential	differential	ADJ
admet-1622	174	21	scanning	scan	VERB
admet-1622	174	22	calorimetric	calorimetric	ADJ
admet-1622	174	23	(	(	PUNCT
admet-1622	174	24	dsc	dsc	NOUN
admet-1622	174	25	)	)	PUNCT
admet-1622	174	26	and	and	CCONJ
admet-1622	174	27	powder	powder	NOUN
admet-1622	174	28	x	x	NOUN
admet-1622	174	29	-	-	NOUN
admet-1622	174	30	ray	ray	NOUN
admet-1622	174	31	diffraction	diffraction	NOUN
admet-1622	174	32	(	(	PUNCT
admet-1622	174	33	pxrd	pxrd	NOUN
admet-1622	174	34	)	)	PUNCT
admet-1622	174	35	analyses	analysis	NOUN
admet-1622	174	36	indicated	indicate	VERB
admet-1622	174	37	the	the	DET
admet-1622	174	38	existence	existence	NOUN
admet-1622	174	39	of	of	ADP
admet-1622	174	40	separate	separate	ADJ
admet-1622	174	41	phases	phase	NOUN
admet-1622	174	42	in	in	ADP
admet-1622	174	43	the	the	DET
admet-1622	174	44	tablets	tablet	NOUN
admet-1622	174	45	(	(	PUNCT
admet-1622	174	46	discs	disc	NOUN
admet-1622	174	47	)	)	PUNCT
admet-1622	174	48	.	.	PUNCT
admet-1622	175	1	such	such	ADJ
admet-1622	175	2	results	result	NOUN
admet-1622	175	3	indicated	indicate	VERB
admet-1622	175	4	that	that	SCONJ
admet-1622	175	5	the	the	DET
admet-1622	175	6	incorporation	incorporation	NOUN
admet-1622	175	7	of	of	ADP
admet-1622	175	8	low	low	ADJ
admet-1622	175	9	-	-	PUNCT
admet-1622	175	10	melting	melt	VERB
admet-1622	175	11	peo	peo	NOUN
admet-1622	175	12	and	and	CCONJ
admet-1622	175	13	other	other	ADJ
admet-1622	175	14	additives	additive	NOUN
admet-1622	175	15	might	might	AUX
admet-1622	175	16	not	not	PART
admet-1622	175	17	be	be	AUX
admet-1622	175	18	the	the	DET
admet-1622	175	19	solution	solution	NOUN
admet-1622	175	20	to	to	ADP
admet-1622	175	21	the	the	DET
admet-1622	175	22	dissolution	dissolution	NOUN
admet-1622	175	23	issue	issue	NOUN
admet-1622	175	24	with	with	ADP
admet-1622	175	25	fdm	fdm	NOUN
admet-1622	175	26	3d	3d	ADV
admet-1622	175	27	-	-	PUNCT
admet-1622	175	28	printed	print	VERB
admet-1622	175	29	tablets	tablet	NOUN
admet-1622	175	30	.	.	PUNCT
admet-1622	176	1	in	in	ADP
admet-1622	176	2	a	a	DET
admet-1622	176	3	different	different	ADJ
admet-1622	176	4	study	study	NOUN
admet-1622	176	5	,	,	PUNCT
admet-1622	176	6	kollamaram	kollamaram	PROPN
admet-1622	176	7	et	et	PROPN
admet-1622	176	8	al	al	PROPN
admet-1622	176	9	.	.	PUNCT
admet-1622	177	1	[	[	X
admet-1622	177	2	53	53	NUM
admet-1622	177	3	]	]	PUNCT
admet-1622	177	4	increased	increase	VERB
admet-1622	177	5	the	the	DET
admet-1622	177	6	dissolution	dissolution	NOUN
admet-1622	177	7	rate	rate	NOUN
admet-1622	177	8	and	and	CCONJ
admet-1622	177	9	decreased	decrease	VERB
admet-1622	177	10	the	the	DET
admet-1622	177	11	printing	printing	NOUN
admet-1622	177	12	temperature	temperature	NOUN
admet-1622	177	13	of	of	ADP
admet-1622	177	14	the	the	DET
admet-1622	177	15	fdm	fdm	NOUN
admet-1622	177	16	3d	3d	ADV
admet-1622	177	17	-	-	PUNCT
admet-1622	177	18	printed	print	VERB
admet-1622	177	19	tablets	tablet	NOUN
admet-1622	177	20	by	by	ADP
admet-1622	177	21	incorporating	incorporate	VERB
admet-1622	177	22	20	20	NUM
admet-1622	177	23	%	%	NOUN
admet-1622	177	24	peg	peg	NOUN
admet-1622	177	25	1500	1500	NUM
admet-1622	177	26	and	and	CCONJ
admet-1622	177	27	10	10	NUM
admet-1622	177	28	%	%	NOUN
admet-1622	177	29	mannitol	mannitol	NOUN
admet-1622	177	30	in	in	ADP
admet-1622	177	31	a	a	DET
admet-1622	177	32	formulation	formulation	NOUN
admet-1622	177	33	containing	contain	VERB
admet-1622	177	34	3	3	NUM
admet-1622	177	35	%	%	NOUN
admet-1622	177	36	ramipril	ramipril	NOUN
admet-1622	177	37	(	(	PUNCT
admet-1622	177	38	drug	drug	NOUN
admet-1622	177	39	)	)	PUNCT
admet-1622	177	40	and	and	CCONJ
admet-1622	177	41	65	65	NUM
admet-1622	177	42	%	%	NOUN
admet-1622	177	43	kollidon	kollidon	ADJ
admet-1622	177	44	®	®	NOUN
admet-1622	177	45	va64	va64	PROPN
admet-1622	177	46	or	or	CCONJ
admet-1622	177	47	a	a	DET
admet-1622	177	48	mixture	mixture	NOUN
admet-1622	177	49	of	of	ADP
admet-1622	177	50	kollidon	kollidon	ADJ
admet-1622	177	51	®	®	NOUN
admet-1622	177	52	va64	va64	PROPN
admet-1622	177	53	and	and	CCONJ
admet-1622	177	54	kollidon	kollidon	ADJ
admet-1622	177	55	®	®	PROPN
admet-1622	177	56	12pf	12pf	NOUN
admet-1622	177	57	.	.	PUNCT
admet-1622	178	1	the	the	DET
admet-1622	178	2	authors	author	NOUN
admet-1622	178	3	reported	report	VERB
admet-1622	178	4	almost	almost	ADV
admet-1622	178	5	complete	complete	ADJ
admet-1622	178	6	drug	drug	NOUN
admet-1622	178	7	release	release	NOUN
admet-1622	178	8	in	in	ADP
admet-1622	178	9	<	<	PROPN
admet-1622	178	10	30	30	NUM
admet-1622	178	11	min	min	NOUN
admet-1622	178	12	when	when	SCONJ
admet-1622	178	13	the	the	DET
admet-1622	178	14	filaments	filament	NOUN
admet-1622	178	15	were	be	AUX
admet-1622	178	16	extruded	extrude	VERB
admet-1622	178	17	at	at	ADP
admet-1622	178	18	65	65	NUM
admet-1622	178	19	-	-	SYM
admet-1622	178	20	70	70	NUM
admet-1622	178	21	°	°	PROPN
admet-1622	178	22	c	c	NOUN
admet-1622	178	23	and	and	CCONJ
admet-1622	178	24	the	the	DET
admet-1622	178	25	tablets	tablet	NOUN
admet-1622	178	26	were	be	AUX
admet-1622	178	27	printed	print	VERB
admet-1622	178	28	at	at	ADP
admet-1622	178	29	90	90	NUM
admet-1622	178	30	°	°	NOUN
admet-1622	178	31	c	c	NOUN
admet-1622	178	32	.	.	PUNCT
admet-1622	179	1	however	however	ADV
admet-1622	179	2	,	,	PUNCT
admet-1622	179	3	since	since	SCONJ
admet-1622	179	4	the	the	DET
admet-1622	179	5	glass	glass	NOUN
admet-1622	179	6	transition	transition	NOUN
admet-1622	179	7	temperature	temperature	NOUN
admet-1622	179	8	of	of	ADP
admet-1622	179	9	both	both	CCONJ
admet-1622	179	10	the	the	DET
admet-1622	179	11	polymers	polymer	NOUN
admet-1622	179	12	was	be	AUX
admet-1622	179	13	109	109	NUM
admet-1622	179	14	°	°	NOUN
admet-1622	179	15	c	c	NOUN
admet-1622	179	16	[	[	X
admet-1622	179	17	54	54	NUM
admet-1622	179	18	]	]	PUNCT
admet-1622	179	19	,	,	PUNCT
admet-1622	179	20	which	which	PRON
admet-1622	179	21	is	be	AUX
admet-1622	179	22	much	much	ADV
admet-1622	179	23	higher	high	ADJ
admet-1622	179	24	than	than	ADP
admet-1622	179	25	the	the	DET
admet-1622	179	26	processing	processing	NOUN
admet-1622	179	27	temperatures	temperature	NOUN
admet-1622	179	28	of	of	ADP
admet-1622	179	29	filaments	filament	NOUN
admet-1622	179	30	and	and	CCONJ
admet-1622	179	31	tablets	tablet	NOUN
admet-1622	179	32	,	,	PUNCT
admet-1622	179	33	it	it	PRON
admet-1622	179	34	is	be	AUX
admet-1622	179	35	not	not	PART
admet-1622	179	36	clear	clear	ADJ
admet-1622	179	37	from	from	ADP
admet-1622	179	38	the	the	DET
admet-1622	179	39	report	report	NOUN
admet-1622	179	40	whether	whether	SCONJ
admet-1622	179	41	the	the	DET
admet-1622	179	42	relatively	relatively	ADV
admet-1622	179	43	low	low	ADJ
admet-1622	179	44	melting	melting	NOUN
admet-1622	179	45	peg	peg	NOUN
admet-1622	179	46	1500	1500	NUM
admet-1622	179	47	(	(	PUNCT
admet-1622	179	48	m.p	m.p	PROPN
admet-1622	179	49	.	.	PROPN
admet-1622	179	50	:	:	PUNCT
admet-1622	180	1	43	43	NUM
admet-1622	180	2	-	-	SYM
admet-1622	180	3	49	49	NUM
admet-1622	180	4	°	°	NOUN
admet-1622	180	5	c	c	NOUN
admet-1622	180	6	)	)	PUNCT
admet-1622	180	7	was	be	AUX
admet-1622	180	8	miscible	miscible	ADJ
admet-1622	180	9	with	with	ADP
admet-1622	180	10	kollidon	kollidon	ADJ
admet-1622	180	11	®	®	NOUN
admet-1622	180	12	va64	va64	PROPN
admet-1622	180	13	and	and	CCONJ
admet-1622	180	14	kollidon	kollidon	ADJ
admet-1622	180	15	®	®	NOUN
admet-1622	180	16	12pf	12pf	NOUN
admet-1622	180	17	at	at	SCONJ
admet-1622	180	18	extrusion	extrusion	NOUN
admet-1622	180	19	and	and	CCONJ
admet-1622	180	20	printing	printing	NOUN
admet-1622	180	21	temperatures	temperature	NOUN
admet-1622	180	22	used	use	VERB
admet-1622	180	23	.	.	PUNCT
admet-1622	181	1	it	it	PRON
admet-1622	181	2	could	could	AUX
admet-1622	181	3	be	be	AUX
admet-1622	181	4	possible	possible	ADJ
admet-1622	181	5	that	that	SCONJ
admet-1622	181	6	peg	peg	NOUN
admet-1622	181	7	and	and	CCONJ
admet-1622	181	8	polymers	polymer	NOUN
admet-1622	181	9	were	be	AUX
admet-1622	181	10	only	only	ADV
admet-1622	181	11	physically	physically	ADV
admet-1622	181	12	mixed	mix	VERB
admet-1622	181	13	together	together	ADV
admet-1622	181	14	in	in	ADP
admet-1622	181	15	the	the	DET
admet-1622	181	16	filaments	filament	NOUN
admet-1622	181	17	due	due	ADP
admet-1622	181	18	to	to	ADP
admet-1622	181	19	the	the	DET
admet-1622	181	20	melting	melting	NOUN
admet-1622	181	21	of	of	ADP
admet-1622	181	22	peg	peg	NOUN
admet-1622	181	23	,	,	PUNCT
admet-1622	181	24	and	and	CCONJ
admet-1622	181	25	it	it	PRON
admet-1622	181	26	could	could	AUX
admet-1622	181	27	also	also	ADV
admet-1622	181	28	be	be	AUX
admet-1622	181	29	possible	possible	ADJ
admet-1622	181	30	that	that	SCONJ
admet-1622	181	31	the	the	DET
admet-1622	181	32	rapid	rapid	ADJ
admet-1622	181	33	drug	drug	NOUN
admet-1622	181	34	release	release	NOUN
admet-1622	181	35	was	be	AUX
admet-1622	181	36	observed	observe	VERB
admet-1622	181	37	because	because	SCONJ
admet-1622	181	38	of	of	ADP
admet-1622	181	39	the	the	DET
admet-1622	181	40	dispersion	dispersion	NOUN
admet-1622	181	41	of	of	ADP
admet-1622	181	42	the	the	DET
admet-1622	181	43	low	low	ADJ
admet-1622	181	44	concentration	concentration	NOUN
admet-1622	181	45	drug	drug	NOUN
admet-1622	181	46	(	(	PUNCT
admet-1622	181	47	3	3	NUM
admet-1622	181	48	%	%	NOUN
admet-1622	181	49	)	)	PUNCT
admet-1622	181	50	in	in	ADP
admet-1622	181	51	the	the	DET
admet-1622	181	52	higher	high	ADJ
admet-1622	181	53	amount	amount	NOUN
admet-1622	181	54	of	of	ADP
admet-1622	181	55	peg	peg	NOUN
admet-1622	181	56	(	(	PUNCT
admet-1622	181	57	20	20	NUM
admet-1622	181	58	%	%	NOUN
admet-1622	181	59	)	)	PUNCT
admet-1622	181	60	and	and	CCONJ
admet-1622	181	61	the	the	DET
admet-1622	181	62	polymers	polymer	NOUN
admet-1622	181	63	did	do	AUX
admet-1622	181	64	not	not	PART
admet-1622	181	65	play	play	VERB
admet-1622	181	66	any	any	DET
admet-1622	181	67	role	role	NOUN
admet-1622	181	68	in	in	ADP
admet-1622	181	69	the	the	DET
admet-1622	181	70	dissolution	dissolution	NOUN
admet-1622	181	71	process	process	NOUN
admet-1622	181	72	.	.	PUNCT
admet-1622	182	1	attempts	attempt	NOUN
admet-1622	182	2	were	be	AUX
admet-1622	182	3	also	also	ADV
admet-1622	182	4	made	make	VERB
admet-1622	182	5	to	to	PART
admet-1622	182	6	increase	increase	VERB
admet-1622	182	7	dissolution	dissolution	ADJ
admet-1622	182	8	rates	rate	NOUN
admet-1622	182	9	of	of	ADP
admet-1622	182	10	drugs	drug	NOUN
admet-1622	182	11	from	from	ADP
admet-1622	182	12	the	the	DET
admet-1622	182	13	fdm	fdm	NOUN
admet-1622	182	14	3d	3d	ADV
admet-1622	182	15	-	-	PUNCT
admet-1622	182	16	printed	print	VERB
admet-1622	182	17	tablets	tablet	NOUN
admet-1622	182	18	by	by	ADP
admet-1622	182	19	the	the	DET
admet-1622	182	20	incorporation	incorporation	NOUN
admet-1622	182	21	of	of	ADP
admet-1622	182	22	such	such	ADJ
admet-1622	182	23	super	super	ADJ
admet-1622	182	24	-	-	ADJ
admet-1622	182	25	disintegrants	disintegrant	NOUN
admet-1622	182	26	as	as	ADP
admet-1622	182	27	sodium	sodium	NOUN
admet-1622	182	28	starch	starch	NOUN
admet-1622	182	29	glycolate	glycolate	NOUN
admet-1622	182	30	,	,	PUNCT
admet-1622	182	31	croscarmellose	croscarmellose	ADJ
admet-1622	182	32	sodium	sodium	NOUN
admet-1622	182	33	,	,	PUNCT
admet-1622	182	34	and	and	CCONJ
admet-1622	182	35	crosslinked	crosslinke	VERB
admet-1622	182	36	polyvinylpyrrolidone	polyvinylpyrrolidone	PROPN
admet-1622	182	37	(	(	PUNCT
admet-1622	182	38	kollidon	kollidon	PROPN
admet-1622	182	39	®	®	NOUN
admet-1622	182	40	cl	cl	NOUN
admet-1622	182	41	)	)	PUNCT
admet-1622	182	42	with	with	ADP
admet-1622	182	43	a	a	DET
admet-1622	182	44	mixture	mixture	NOUN
admet-1622	182	45	of	of	ADP
admet-1622	182	46	pva	pva	NOUN
admet-1622	182	47	and	and	CCONJ
admet-1622	182	48	hpmc	hpmc	PROPN
admet-1622	182	49	used	use	VERB
admet-1622	182	50	as	as	ADP
admet-1622	182	51	the	the	DET
admet-1622	182	52	polymeric	polymeric	ADJ
admet-1622	182	53	matrix	matrix	NOUN
admet-1622	182	54	[	[	X
admet-1622	182	55	55	55	NUM
admet-1622	182	56	]	]	PUNCT
admet-1622	182	57	.	.	PUNCT
admet-1622	183	1	although	although	SCONJ
admet-1622	183	2	the	the	DET
admet-1622	183	3	drug	drug	NOUN
admet-1622	183	4	release	release	NOUN
admet-1622	183	5	rate	rate	NOUN
admet-1622	183	6	in	in	ADP
admet-1622	183	7	aqueous	aqueous	ADJ
admet-1622	183	8	media	medium	NOUN
admet-1622	183	9	could	could	AUX
admet-1622	183	10	be	be	AUX
admet-1622	183	11	increased	increase	VERB
admet-1622	183	12	from	from	ADP
admet-1622	183	13	58	58	NUM
admet-1622	183	14	%	%	NOUN
admet-1622	183	15	in	in	ADP
admet-1622	183	16	5	5	NUM
admet-1622	183	17	h	h	NOUN
admet-1622	183	18	to	to	PART
admet-1622	183	19	almost	almost	ADV
admet-1622	183	20	complete	complete	VERB
admet-1622	183	21	release	release	NOUN
admet-1622	183	22	in	in	ADP
admet-1622	183	23	2	2	NUM
admet-1622	183	24	h	h	NOUN
admet-1622	183	25	by	by	ADP
admet-1622	183	26	this	this	DET
admet-1622	183	27	approach	approach	NOUN
admet-1622	183	28	,	,	PUNCT
admet-1622	183	29	it	it	PRON
admet-1622	183	30	was	be	AUX
admet-1622	183	31	not	not	PART
admet-1622	183	32	a	a	DET
admet-1622	183	33	sufficient	sufficient	ADJ
admet-1622	183	34	increase	increase	NOUN
admet-1622	183	35	in	in	ADP
admet-1622	183	36	dissolution	dissolution	ADJ
admet-1622	183	37	rate	rate	NOUN
admet-1622	183	38	for	for	ADP
admet-1622	183	39	the	the	DET
admet-1622	183	40	development	development	NOUN
admet-1622	183	41	of	of	ADP
admet-1622	183	42	a	a	DET
admet-1622	183	43	rapidly	rapidly	ADV
admet-1622	183	44	dissolving	dissolve	VERB
admet-1622	183	45	tablet	tablet	NOUN
admet-1622	183	46	.	.	PUNCT
admet-1622	184	1	a	a	DET
admet-1622	184	2	faster	fast	ADJ
admet-1622	184	3	drug	drug	NOUN
admet-1622	184	4	release	release	NOUN
admet-1622	184	5	could	could	AUX
admet-1622	184	6	not	not	PART
admet-1622	184	7	be	be	AUX
admet-1622	184	8	obtained	obtain	VERB
admet-1622	184	9	possibly	possibly	ADV
admet-1622	184	10	because	because	SCONJ
admet-1622	184	11	when	when	SCONJ
admet-1622	184	12	the	the	DET
admet-1622	184	13	disintegrants	disintegrant	NOUN
admet-1622	184	14	were	be	AUX
admet-1622	184	15	extruded	extrude	VERB
admet-1622	184	16	with	with	ADP
admet-1622	184	17	the	the	DET
admet-1622	184	18	polymers	polymer	NOUN
admet-1622	184	19	,	,	PUNCT
admet-1622	184	20	they	they	PRON
admet-1622	184	21	lost	lose	VERB
admet-1622	184	22	their	their	PRON
admet-1622	184	23	swelling	swell	VERB
admet-1622	184	24	properties	property	NOUN
admet-1622	184	25	and	and	CCONJ
admet-1622	184	26	disintegration	disintegration	NOUN
admet-1622	184	27	efficiency	efficiency	NOUN
admet-1622	184	28	since	since	SCONJ
admet-1622	184	29	the	the	DET
admet-1622	184	30	disintegrants	disintegrant	NOUN
admet-1622	184	31	were	be	AUX
admet-1622	184	32	completely	completely	ADV
admet-1622	184	33	surrounded	surround	VERB
admet-1622	184	34	by	by	ADP
admet-1622	184	35	the	the	DET
admet-1622	184	36	polymers	polymer	NOUN
admet-1622	184	37	preventing	prevent	VERB
admet-1622	184	38	any	any	DET
admet-1622	184	39	penetration	penetration	NOUN
admet-1622	184	40	of	of	ADP
admet-1622	184	41	water	water	NOUN
admet-1622	184	42	to	to	ADP
admet-1622	184	43	the	the	DET
admet-1622	184	44	disintegrants	disintegrant	NOUN
admet-1622	184	45	and	and	CCONJ
admet-1622	184	46	there	there	PRON
admet-1622	184	47	was	be	VERB
admet-1622	184	48	also	also	ADV
admet-1622	184	49	no	no	DET
admet-1622	184	50	porosity	porosity	NOUN
admet-1622	184	51	within	within	ADP
admet-1622	184	52	the	the	DET
admet-1622	184	53	filaments	filament	NOUN
admet-1622	184	54	for	for	ADP
admet-1622	184	55	swelling	swelling	NOUN
admet-1622	184	56	of	of	ADP
admet-1622	184	57	the	the	DET
admet-1622	184	58	disintegrants	disintegrant	NOUN
admet-1622	184	59	.	.	PUNCT
admet-1622	185	1	shi	shi	PROPN
admet-1622	185	2	et	et	PROPN
admet-1622	185	3	al	al	PROPN
admet-1622	185	4	.	.	PUNCT
admet-1622	186	1	[	[	X
admet-1622	186	2	56	56	NUM
admet-1622	186	3	]	]	PUNCT
admet-1622	186	4	observed	observe	VERB
admet-1622	186	5	that	that	SCONJ
admet-1622	186	6	the	the	DET
admet-1622	186	7	incorporation	incorporation	NOUN
admet-1622	186	8	of	of	ADP
admet-1622	186	9	release	release	NOUN
admet-1622	186	10	-	-	PUNCT
admet-1622	186	11	modifying	modify	VERB
admet-1622	186	12	excipients	excipient	NOUN
admet-1622	186	13	like	like	ADP
admet-1622	186	14	poly(vinyl	poly(vinyl	PROPN
admet-1622	186	15	alcohol	alcohol	NOUN
admet-1622	186	16	)	)	PUNCT
admet-1622	186	17	(	(	PUNCT
admet-1622	186	18	pva	pva	NOUN
admet-1622	186	19	)	)	PUNCT
admet-1622	186	20	,	,	PUNCT
admet-1622	186	21	soluplus	soluplus	ADJ
admet-1622	186	22	®	®	NOUN
admet-1622	186	23	,	,	PUNCT
admet-1622	186	24	polyethylene	polyethylene	NOUN
admet-1622	186	25	glycol	glycol	NOUN
admet-1622	186	26	(	(	PUNCT
admet-1622	186	27	peg	peg	NOUN
admet-1622	186	28	)	)	PUNCT
admet-1622	186	29	6000	6000	NUM
admet-1622	186	30	,	,	PUNCT
admet-1622	186	31	eudragit	eudragit	VERB
admet-1622	186	32	®	®	NOUN
admet-1622	186	33	rlpo	rlpo	NOUN
admet-1622	186	34	/	/	SYM
admet-1622	186	35	rspo	rspo	PROPN
admet-1622	186	36	,	,	PUNCT
admet-1622	186	37	hpmc	hpmc	PROPN
admet-1622	186	38	k4m	k4m	PROPN
admet-1622	186	39	/	/	SYM
admet-1622	186	40	e10m	e10m	PROPN
admet-1622	186	41	/	/	SYM
admet-1622	186	42	k100	k100	PROPN
admet-1622	186	43	m	m	PROPN
admet-1622	186	44	,	,	PUNCT
admet-1622	186	45	kollidon	kollidon	PROPN
admet-1622	186	46	®	®	NOUN
admet-1622	186	47	va64	va64	PROPN
admet-1622	186	48	,	,	PUNCT
admet-1622	186	49	etc	etc	X
admet-1622	186	50	.	.	X
admet-1622	186	51	,	,	PUNCT
admet-1622	186	52	may	may	AUX
admet-1622	186	53	also	also	ADV
admet-1622	186	54	not	not	PART
admet-1622	186	55	be	be	AUX
admet-1622	186	56	the	the	DET
admet-1622	186	57	solution	solution	NOUN
admet-1622	186	58	to	to	PART
admet-1622	186	59	slow	slow	VERB
admet-1622	186	60	drug	drug	NOUN
admet-1622	186	61	release	release	NOUN
admet-1622	186	62	from	from	ADP
admet-1622	186	63	fdm	fdm	NOUN
admet-1622	186	64	3d	3d	ADV
admet-1622	186	65	-	-	PUNCT
admet-1622	186	66	printed	print	VERB
admet-1622	186	67	tablets	tablet	NOUN
admet-1622	186	68	.	.	PUNCT
admet-1622	187	1	they	they	PRON
admet-1622	187	2	used	use	VERB
admet-1622	187	3	various	various	ADJ
admet-1622	187	4	release	release	NOUN
admet-1622	187	5	modifiers	modifier	NOUN
admet-1622	187	6	to	to	PART
admet-1622	187	7	modulate	modulate	VERB
admet-1622	187	8	dissolution	dissolution	ADJ
admet-1622	187	9	rates	rate	NOUN
admet-1622	187	10	of	of	ADP
admet-1622	187	11	ibuprofen	ibuprofen	NOUN
admet-1622	187	12	from	from	ADP
admet-1622	187	13	the	the	DET
admet-1622	187	14	fdm	fdm	NOUN
admet-1622	187	15	3d	3d	ADV
admet-1622	187	16	-	-	PUNCT
admet-1622	187	17	printed	print	VERB
admet-1622	187	18	tablets	tablet	NOUN
admet-1622	187	19	containing	contain	VERB
admet-1622	187	20	ethyl	ethyl	PROPN
admet-1622	187	21	cellulose	cellulose	NOUN
admet-1622	187	22	as	as	ADP
admet-1622	187	23	the	the	DET
admet-1622	187	24	polymeric	polymeric	ADJ
admet-1622	187	25	matrix	matrix	NOUN
admet-1622	187	26	.	.	PUNCT
admet-1622	188	1	it	it	PRON
admet-1622	188	2	took	take	VERB
admet-1622	188	3	over	over	ADP
admet-1622	188	4	24	24	NUM
admet-1622	188	5	h	h	NOUN
admet-1622	188	6	for	for	ADP
admet-1622	188	7	the	the	DET
admet-1622	188	8	complete	complete	ADJ
admet-1622	188	9	release	release	NOUN
admet-1622	188	10	of	of	ADP
admet-1622	188	11	the	the	DET
admet-1622	188	12	drug	drug	NOUN
admet-1622	188	13	because	because	SCONJ
admet-1622	188	14	of	of	ADP
admet-1622	188	15	the	the	DET
admet-1622	188	16	nature	nature	NOUN
admet-1622	188	17	of	of	ADP
admet-1622	188	18	the	the	DET
admet-1622	188	19	polymer	polymer	NOUN
admet-1622	188	20	and	and	CCONJ
admet-1622	188	21	release	release	NOUN
admet-1622	188	22	modifiers	modifier	NOUN
admet-1622	188	23	used	use	VERB
admet-1622	188	24	.	.	PUNCT
admet-1622	189	1	the	the	DET
admet-1622	189	2	incorporation	incorporation	NOUN
admet-1622	189	3	of	of	ADP
admet-1622	189	4	additives	additive	NOUN
admet-1622	189	5	is	be	AUX
admet-1622	189	6	a	a	DET
admet-1622	189	7	promising	promising	ADJ
admet-1622	189	8	and	and	CCONJ
admet-1622	189	9	potentially	potentially	ADV
admet-1622	189	10	viable	viable	ADJ
admet-1622	189	11	approach	approach	NOUN
admet-1622	189	12	for	for	ADP
admet-1622	189	13	increasing	increase	VERB
admet-1622	189	14	the	the	DET
admet-1622	189	15	dissolution	dissolution	NOUN
admet-1622	189	16	rates	rate	NOUN
admet-1622	189	17	of	of	ADP
admet-1622	189	18	drugs	drug	NOUN
admet-1622	189	19	from	from	ADP
admet-1622	189	20	the	the	DET
admet-1622	189	21	fdm	fdm	NOUN
admet-1622	189	22	3d	3d	ADV
admet-1622	189	23	-	-	PUNCT
admet-1622	189	24	printed	print	VERB
admet-1622	189	25	tablets	tablet	NOUN
admet-1622	189	26	.	.	PUNCT
admet-1622	190	1	indeed	indeed	ADV
admet-1622	190	2	,	,	PUNCT
admet-1622	190	3	krueger	krueger	PROPN
admet-1622	190	4	et	et	PROPN
admet-1622	190	5	al	al	PROPN
admet-1622	190	6	.	.	PUNCT
admet-1622	191	1	[	[	X
admet-1622	191	2	57	57	NUM
admet-1622	191	3	]	]	PUNCT
admet-1622	191	4	called	call	VERB
admet-1622	191	5	the	the	DET
admet-1622	191	6	polymer	polymer	NOUN
admet-1622	191	7	-	-	PUNCT
admet-1622	191	8	additive	additive	NOUN
admet-1622	191	9	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	VERB
admet-1622	191	10	abu	abu	PROPN
admet-1622	191	11	t.m	t.m	PROPN
admet-1622	191	12	.	.	PUNCT
admet-1622	191	13	serajuddin	serajuddin	VERB
admet-1622	191	14	admet	admet	PROPN
admet-1622	191	15	&	&	CCONJ
admet-1622	191	16	dmpk	dmpk	PROPN
admet-1622	191	17	11(1	11(1	NUM
admet-1622	191	18	)	)	PUNCT
admet-1622	191	19	(	(	PUNCT
admet-1622	191	20	2023	2023	NUM
admet-1622	191	21	)	)	PUNCT
admet-1622	191	22	33	33	NUM
admet-1622	191	23	-	-	SYM
admet-1622	191	24	55	55	NUM
admet-1622	191	25	42	42	NUM
admet-1622	191	26	adducts	adduct	VERB
admet-1622	191	27	hybrid	hybrid	ADJ
admet-1622	191	28	materials	material	NOUN
admet-1622	191	29	since	since	SCONJ
admet-1622	191	30	the	the	DET
admet-1622	191	31	additives	additive	NOUN
admet-1622	191	32	can	can	AUX
admet-1622	191	33	impart	impart	VERB
admet-1622	191	34	new	new	ADJ
admet-1622	191	35	properties	property	NOUN
admet-1622	191	36	to	to	ADP
admet-1622	191	37	the	the	DET
admet-1622	191	38	polymers	polymer	NOUN
admet-1622	191	39	.	.	PUNCT
admet-1622	192	1	resulting	result	VERB
admet-1622	192	2	in	in	ADP
admet-1622	192	3	better	well	ADJ
admet-1622	192	4	performance	performance	NOUN
admet-1622	192	5	.	.	PUNCT
admet-1622	193	1	however	however	ADV
admet-1622	193	2	,	,	PUNCT
admet-1622	193	3	further	further	ADJ
admet-1622	193	4	research	research	NOUN
admet-1622	193	5	is	be	AUX
admet-1622	193	6	necessary	necessary	ADJ
admet-1622	193	7	for	for	ADP
admet-1622	193	8	a	a	DET
admet-1622	193	9	better	well	ADJ
admet-1622	193	10	understanding	understanding	NOUN
admet-1622	193	11	of	of	ADP
admet-1622	193	12	the	the	DET
admet-1622	193	13	interaction	interaction	NOUN
admet-1622	193	14	between	between	ADP
admet-1622	193	15	polymers	polymer	NOUN
admet-1622	193	16	and	and	CCONJ
admet-1622	193	17	different	different	ADJ
admet-1622	193	18	additives	additive	NOUN
admet-1622	193	19	and	and	CCONJ
admet-1622	193	20	its	its	PRON
admet-1622	193	21	effects	effect	NOUN
admet-1622	193	22	on	on	ADP
admet-1622	193	23	the	the	DET
admet-1622	193	24	drug	drug	NOUN
admet-1622	193	25	release	release	NOUN
admet-1622	193	26	rate	rate	NOUN
admet-1622	193	27	.	.	PUNCT
admet-1622	194	1	from	from	ADP
admet-1622	194	2	the	the	DET
admet-1622	194	3	above	above	ADJ
admet-1622	194	4	brief	brief	ADJ
admet-1622	194	5	review	review	NOUN
admet-1622	194	6	of	of	ADP
admet-1622	194	7	the	the	DET
admet-1622	194	8	literature	literature	NOUN
admet-1622	194	9	,	,	PUNCT
admet-1622	194	10	it	it	PRON
admet-1622	194	11	is	be	AUX
admet-1622	194	12	apparent	apparent	ADJ
admet-1622	194	13	that	that	SCONJ
admet-1622	194	14	certain	certain	ADJ
admet-1622	194	15	additives	additive	NOUN
admet-1622	194	16	can	can	AUX
admet-1622	194	17	plasticize	plasticize	VERB
admet-1622	194	18	polymers	polymer	NOUN
admet-1622	194	19	to	to	PART
admet-1622	194	20	make	make	VERB
admet-1622	194	21	them	they	PRON
admet-1622	194	22	extrudable	extrudable	ADJ
admet-1622	194	23	and	and	CCONJ
admet-1622	194	24	printable	printable	ADJ
admet-1622	194	25	,	,	PUNCT
admet-1622	194	26	and	and	CCONJ
admet-1622	194	27	some	some	DET
admet-1622	194	28	other	other	ADJ
admet-1622	194	29	additives	additive	NOUN
admet-1622	194	30	,	,	PUNCT
admet-1622	194	31	especially	especially	ADV
admet-1622	194	32	the	the	DET
admet-1622	194	33	solid	solid	ADJ
admet-1622	194	34	ones	one	NOUN
admet-1622	194	35	like	like	ADP
admet-1622	194	36	talc	talc	NOUN
admet-1622	194	37	and	and	CCONJ
admet-1622	194	38	tcp	tcp	VERB
admet-1622	194	39	,	,	PUNCT
admet-1622	194	40	may	may	AUX
admet-1622	194	41	also	also	ADV
admet-1622	194	42	improve	improve	VERB
admet-1622	194	43	the	the	DET
admet-1622	194	44	printability	printability	NOUN
admet-1622	194	45	of	of	ADP
admet-1622	194	46	filaments	filament	NOUN
admet-1622	194	47	by	by	ADP
admet-1622	194	48	making	make	VERB
admet-1622	194	49	them	they	PRON
admet-1622	194	50	harder	hard	ADV
admet-1622	194	51	.	.	PUNCT
admet-1622	195	1	care	care	NOUN
admet-1622	195	2	must	must	AUX
admet-1622	195	3	,	,	PUNCT
admet-1622	195	4	however	however	ADV
admet-1622	195	5	,	,	PUNCT
admet-1622	195	6	be	be	AUX
admet-1622	195	7	taken	take	VERB
admet-1622	195	8	in	in	ADP
admet-1622	195	9	selecting	select	VERB
admet-1622	195	10	additives	additive	NOUN
admet-1622	195	11	for	for	ADP
admet-1622	195	12	such	such	ADJ
admet-1622	195	13	effects	effect	NOUN
admet-1622	195	14	since	since	SCONJ
admet-1622	195	15	they	they	PRON
admet-1622	195	16	do	do	AUX
admet-1622	195	17	not	not	PART
admet-1622	195	18	always	always	ADV
admet-1622	195	19	exert	exert	VERB
admet-1622	195	20	desired	desire	VERB
admet-1622	195	21	effects	effect	NOUN
admet-1622	195	22	.	.	PUNCT
admet-1622	196	1	in	in	ADP
admet-1622	196	2	one	one	NUM
admet-1622	196	3	study	study	NOUN
admet-1622	196	4	,	,	PUNCT
admet-1622	196	5	wei	wei	PROPN
admet-1622	196	6	et	et	PROPN
admet-1622	196	7	al	al	PROPN
admet-1622	196	8	.	.	PUNCT
admet-1622	197	1	[	[	X
admet-1622	197	2	33	33	NUM
admet-1622	197	3	]	]	PUNCT
admet-1622	197	4	observed	observe	VERB
admet-1622	197	5	that	that	SCONJ
admet-1622	197	6	when	when	SCONJ
admet-1622	197	7	relatively	relatively	ADV
admet-1622	197	8	low	low	ADJ
admet-1622	197	9	melting	melting	NOUN
admet-1622	197	10	additives	additive	NOUN
admet-1622	197	11	like	like	ADP
admet-1622	197	12	peg	peg	NOUN
admet-1622	197	13	3350	3350	NUM
admet-1622	197	14	or	or	CCONJ
admet-1622	197	15	peg	peg	NOUN
admet-1622	197	16	8000	8000	NUM
admet-1622	197	17	were	be	AUX
admet-1622	197	18	mixed	mix	VERB
admet-1622	197	19	with	with	ADP
admet-1622	197	20	polyvinyl	polyvinyl	NOUN
admet-1622	197	21	alcohol	alcohol	NOUN
admet-1622	197	22	for	for	ADP
admet-1622	197	23	plasticization	plasticization	NOUN
admet-1622	197	24	of	of	ADP
admet-1622	197	25	the	the	DET
admet-1622	197	26	polymer	polymer	NOUN
admet-1622	197	27	during	during	ADP
admet-1622	197	28	melt	melt	NOUN
admet-1622	197	29	extrusion	extrusion	NOUN
admet-1622	197	30	into	into	ADP
admet-1622	197	31	filaments	filament	NOUN
admet-1622	197	32	,	,	PUNCT
admet-1622	197	33	the	the	DET
admet-1622	197	34	additives	additive	NOUN
admet-1622	197	35	melted	melt	VERB
admet-1622	197	36	and	and	CCONJ
admet-1622	197	37	oozed	ooze	VERB
admet-1622	197	38	out	out	ADP
admet-1622	197	39	the	the	DET
admet-1622	197	40	extruder	extruder	NOUN
admet-1622	197	41	before	before	ADP
admet-1622	197	42	exerting	exert	VERB
admet-1622	197	43	any	any	DET
admet-1622	197	44	plasticization	plasticization	NOUN
admet-1622	197	45	effects	effect	NOUN
admet-1622	197	46	.	.	PUNCT
admet-1622	198	1	there	there	PRON
admet-1622	198	2	could	could	AUX
admet-1622	198	3	also	also	ADV
admet-1622	198	4	be	be	AUX
admet-1622	198	5	phase	phase	NOUN
admet-1622	198	6	separation	separation	NOUN
admet-1622	198	7	of	of	ADP
admet-1622	198	8	additives	additive	NOUN
admet-1622	198	9	during	during	ADP
admet-1622	198	10	the	the	DET
admet-1622	198	11	stability	stability	NOUN
admet-1622	198	12	testing	testing	NOUN
admet-1622	198	13	of	of	ADP
admet-1622	198	14	filaments	filament	NOUN
admet-1622	198	15	and	and	CCONJ
admet-1622	198	16	tablets	tablet	NOUN
admet-1622	198	17	.	.	PUNCT
admet-1622	199	1	for	for	ADP
admet-1622	199	2	these	these	DET
admet-1622	199	3	reasons	reason	NOUN
admet-1622	199	4	,	,	PUNCT
admet-1622	199	5	it	it	PRON
admet-1622	199	6	is	be	AUX
admet-1622	199	7	essential	essential	ADJ
admet-1622	199	8	that	that	SCONJ
admet-1622	199	9	the	the	DET
admet-1622	199	10	additives	additive	NOUN
admet-1622	199	11	,	,	PUNCT
admet-1622	199	12	especially	especially	ADV
admet-1622	199	13	the	the	DET
admet-1622	199	14	low	low	ADJ
admet-1622	199	15	-	-	PUNCT
admet-1622	199	16	melting	melt	VERB
admet-1622	199	17	ones	one	NOUN
admet-1622	199	18	,	,	PUNCT
admet-1622	199	19	are	be	AUX
admet-1622	199	20	miscible	miscible	ADJ
admet-1622	199	21	with	with	ADP
admet-1622	199	22	the	the	DET
admet-1622	199	23	polymers	polymer	NOUN
admet-1622	199	24	.	.	PUNCT
admet-1622	200	1	modification	modification	NOUN
admet-1622	200	2	of	of	ADP
admet-1622	200	3	tablet	tablet	NOUN
admet-1622	200	4	pattern	pattern	NOUN
admet-1622	200	5	and	and	CCONJ
admet-1622	200	6	geometry	geometry	NOUN
admet-1622	200	7	as	as	SCONJ
admet-1622	200	8	mentioned	mention	VERB
admet-1622	200	9	earlier	early	ADV
admet-1622	200	10	,	,	PUNCT
admet-1622	200	11	the	the	DET
admet-1622	200	12	fdm	fdm	NOUN
admet-1622	200	13	3d	3d	ADV
admet-1622	200	14	-	-	PUNCT
admet-1622	200	15	printed	print	VERB
admet-1622	200	16	tablets	tablet	NOUN
admet-1622	200	17	are	be	AUX
admet-1622	200	18	hard	hard	ADJ
admet-1622	200	19	and	and	CCONJ
admet-1622	200	20	non	non	ADJ
admet-1622	200	21	-	-	ADJ
admet-1622	200	22	disintegrating	disintegrating	ADJ
admet-1622	200	23	compacts	compact	NOUN
admet-1622	200	24	that	that	PRON
admet-1622	200	25	usually	usually	ADV
admet-1622	200	26	dissolve	dissolve	VERB
admet-1622	200	27	by	by	ADP
admet-1622	200	28	erosion	erosion	NOUN
admet-1622	200	29	.	.	PUNCT
admet-1622	201	1	therefore	therefore	ADV
admet-1622	201	2	,	,	PUNCT
admet-1622	201	3	one	one	NUM
admet-1622	201	4	common	common	ADJ
admet-1622	201	5	strategy	strategy	NOUN
admet-1622	201	6	to	to	PART
admet-1622	201	7	increase	increase	VERB
admet-1622	201	8	the	the	DET
admet-1622	201	9	dissolution	dissolution	ADJ
admet-1622	201	10	rate	rate	NOUN
admet-1622	201	11	of	of	ADP
admet-1622	201	12	drugs	drug	NOUN
admet-1622	201	13	from	from	ADP
admet-1622	201	14	the	the	DET
admet-1622	201	15	tablets	tablet	NOUN
admet-1622	201	16	is	be	AUX
admet-1622	201	17	to	to	PART
admet-1622	201	18	increase	increase	VERB
admet-1622	201	19	the	the	DET
admet-1622	201	20	dissolving	dissolve	VERB
admet-1622	201	21	surface	surface	NOUN
admet-1622	201	22	area	area	NOUN
admet-1622	201	23	of	of	ADP
admet-1622	201	24	tablets	tablet	NOUN
admet-1622	201	25	by	by	ADP
admet-1622	201	26	modifying	modify	VERB
admet-1622	201	27	tablet	tablet	NOUN
admet-1622	201	28	geometry	geometry	NOUN
admet-1622	201	29	.	.	PUNCT
admet-1622	202	1	some	some	PRON
admet-1622	202	2	of	of	ADP
admet-1622	202	3	these	these	DET
admet-1622	202	4	approaches	approach	NOUN
admet-1622	202	5	,	,	PUNCT
admet-1622	202	6	as	as	SCONJ
admet-1622	202	7	shown	show	VERB
admet-1622	202	8	in	in	ADP
admet-1622	202	9	figure	figure	NOUN
admet-1622	202	10	3	3	NUM
admet-1622	202	11	,	,	PUNCT
admet-1622	202	12	are	be	AUX
admet-1622	202	13	described	describe	VERB
admet-1622	202	14	below	below	ADP
admet-1622	202	15	:	:	PUNCT
admet-1622	202	16	figure	figure	VERB
admet-1622	202	17	3	3	NUM
admet-1622	202	18	.	.	PUNCT
admet-1622	203	1	different	different	ADJ
admet-1622	203	2	methods	method	NOUN
admet-1622	203	3	of	of	ADP
admet-1622	203	4	increasing	increase	VERB
admet-1622	203	5	surface	surface	NOUN
admet-1622	203	6	area	area	NOUN
admet-1622	203	7	by	by	ADP
admet-1622	203	8	modifying	modify	VERB
admet-1622	203	9	tablet	tablet	NOUN
admet-1622	203	10	patterns	pattern	NOUN
admet-1622	203	11	and	and	CCONJ
admet-1622	203	12	geometry	geometry	NOUN
admet-1622	203	13	:	:	PUNCT
admet-1622	203	14	i	i	PRON
admet-1622	203	15	,	,	PUNCT
admet-1622	203	16	changing	change	VERB
admet-1622	203	17	tablet	tablet	NOUN
admet-1622	203	18	infill	infill	NOUN
admet-1622	203	19	;	;	PUNCT
admet-1622	203	20	ii	ii	NOUN
admet-1622	203	21	,	,	PUNCT
admet-1622	203	22	geometric	geometric	ADJ
admet-1622	203	23	modification	modification	NOUN
admet-1622	203	24	by	by	ADP
admet-1622	203	25	connecting	connect	VERB
admet-1622	203	26	blocks	block	NOUN
admet-1622	203	27	of	of	ADP
admet-1622	203	28	fill	fill	NOUN
admet-1622	203	29	materials	material	NOUN
admet-1622	203	30	;	;	PUNCT
admet-1622	203	31	iii	iii	X
admet-1622	203	32	,	,	PUNCT
admet-1622	203	33	introduction	introduction	NOUN
admet-1622	203	34	of	of	ADP
admet-1622	203	35	perforated	perforated	ADJ
admet-1622	203	36	channels	channel	NOUN
admet-1622	203	37	;	;	PUNCT
admet-1622	203	38	and	and	CCONJ
admet-1622	203	39	iv	iv	X
admet-1622	203	40	,	,	PUNCT
admet-1622	203	41	connection	connection	NOUN
admet-1622	203	42	of	of	ADP
admet-1622	203	43	parallel	parallel	ADJ
admet-1622	203	44	plates	plate	NOUN
admet-1622	203	45	in	in	ADP
admet-1622	203	46	a	a	DET
admet-1622	203	47	radiator	radiator	NOUN
admet-1622	203	48	-	-	PUNCT
admet-1622	203	49	like	like	ADJ
admet-1622	203	50	design	design	NOUN
admet-1622	203	51	.	.	PUNCT
admet-1622	204	1	changing	change	VERB
admet-1622	204	2	tablet	tablet	ADJ
admet-1622	204	3	infill	infill	NOUN
admet-1622	204	4	the	the	DET
admet-1622	204	5	most	most	ADV
admet-1622	204	6	common	common	ADJ
admet-1622	204	7	approach	approach	NOUN
admet-1622	204	8	to	to	PART
admet-1622	204	9	increase	increase	VERB
admet-1622	204	10	the	the	DET
admet-1622	204	11	dissolving	dissolve	VERB
admet-1622	204	12	surface	surface	NOUN
admet-1622	204	13	area	area	NOUN
admet-1622	204	14	of	of	ADP
admet-1622	204	15	the	the	DET
admet-1622	204	16	fdm	fdm	NOUN
admet-1622	204	17	3dprinted	3dprinted	NUM
admet-1622	204	18	tablet	tablet	NOUN
admet-1622	204	19	is	be	AUX
admet-1622	204	20	to	to	PART
admet-1622	204	21	decrease	decrease	VERB
admet-1622	204	22	the	the	DET
admet-1622	204	23	infill	infill	NOUN
admet-1622	204	24	of	of	ADP
admet-1622	204	25	tablets	tablet	NOUN
admet-1622	204	26	,	,	PUNCT
admet-1622	204	27	where	where	SCONJ
admet-1622	204	28	,	,	PUNCT
admet-1622	204	29	as	as	SCONJ
admet-1622	204	30	shown	show	VERB
admet-1622	204	31	in	in	ADP
admet-1622	204	32	fig	fig	NOUN
admet-1622	204	33	.	.	PUNCT
admet-1622	205	1	3	3	X
admet-1622	205	2	-	-	SYM
admet-1622	205	3	i	i	PRON
admet-1622	205	4	,	,	PUNCT
admet-1622	205	5	the	the	DET
admet-1622	205	6	infill	infill	NOUN
admet-1622	205	7	represents	represent	VERB
admet-1622	205	8	the	the	DET
admet-1622	205	9	volume	volume	NOUN
admet-1622	205	10	of	of	ADP
admet-1622	205	11	a	a	DET
admet-1622	205	12	tablet	tablet	NOUN
admet-1622	205	13	taken	take	VERB
admet-1622	205	14	up	up	ADP
admet-1622	205	15	by	by	ADP
admet-1622	205	16	the	the	DET
admet-1622	205	17	fill	fill	NOUN
admet-1622	205	18	material	material	NOUN
admet-1622	205	19	during	during	ADP
admet-1622	205	20	the	the	DET
admet-1622	205	21	printing	printing	NOUN
admet-1622	205	22	of	of	ADP
admet-1622	205	23	the	the	DET
admet-1622	205	24	tablet	tablet	NOUN
admet-1622	205	25	.	.	PUNCT
admet-1622	206	1	the	the	DET
admet-1622	206	2	infill	infill	NOUN
admet-1622	206	3	of	of	ADP
admet-1622	206	4	an	an	DET
admet-1622	206	5	fdm	fdm	NOUN
admet-1622	206	6	3d	3d	NOUN
admet-1622	206	7	-	-	PUNCT
admet-1622	206	8	printed	print	VERB
admet-1622	206	9	tablet	tablet	NOUN
admet-1622	206	10	may	may	AUX
admet-1622	206	11	vary	vary	VERB
admet-1622	206	12	from	from	ADP
admet-1622	206	13	less	less	ADJ
admet-1622	206	14	than	than	ADP
admet-1622	206	15	10	10	NUM
admet-1622	206	16	%	%	NOUN
admet-1622	206	17	to	to	PART
admet-1622	206	18	100	100	NUM
admet-1622	206	19	%	%	NOUN
admet-1622	206	20	,	,	PUNCT
admet-1622	206	21	indicating	indicate	VERB
admet-1622	206	22	that	that	SCONJ
admet-1622	206	23	a	a	DET
admet-1622	206	24	tablet	tablet	NOUN
admet-1622	206	25	with	with	ADP
admet-1622	206	26	,	,	PUNCT
admet-1622	206	27	for	for	ADP
admet-1622	206	28	example	example	NOUN
admet-1622	206	29	,	,	PUNCT
admet-1622	206	30	30	30	NUM
admet-1622	206	31	%	%	NOUN
admet-1622	206	32	and	and	CCONJ
admet-1622	206	33	80	80	NUM
admet-1622	206	34	%	%	NOUN
admet-1622	206	35	infills	infill	NOUN
admet-1622	206	36	will	will	AUX
admet-1622	206	37	have	have	VERB
admet-1622	206	38	30	30	NUM
admet-1622	206	39	%	%	NOUN
admet-1622	206	40	and	and	CCONJ
admet-1622	206	41	80	80	NUM
admet-1622	206	42	%	%	NOUN
admet-1622	206	43	filled	fill	VERB
admet-1622	206	44	and	and	CCONJ
admet-1622	206	45	the	the	DET
admet-1622	206	46	remaining	remain	VERB
admet-1622	206	47	70	70	NUM
admet-1622	206	48	%	%	NOUN
admet-1622	206	49	and	and	CCONJ
admet-1622	206	50	20	20	NUM
admet-1622	206	51	%	%	NOUN
admet-1622	206	52	will	will	NOUN
admet-1622	206	53	,	,	PUNCT
admet-1622	206	54	respectively	respectively	ADV
admet-1622	206	55	,	,	PUNCT
admet-1622	206	56	be	be	AUX
admet-1622	206	57	empty	empty	ADJ
admet-1622	206	58	spaces	space	NOUN
admet-1622	206	59	or	or	CCONJ
admet-1622	206	60	voids	voids	NOUN
admet-1622	206	61	within	within	ADP
admet-1622	206	62	the	the	DET
admet-1622	206	63	tablets	tablet	NOUN
admet-1622	206	64	,	,	PUNCT
admet-1622	206	65	while	while	SCONJ
admet-1622	206	66	a	a	DET
admet-1622	206	67	tablet	tablet	NOUN
admet-1622	206	68	with	with	ADP
admet-1622	206	69	100	100	NUM
admet-1622	206	70	%	%	NOUN
admet-1622	206	71	infill	infill	NOUN
admet-1622	206	72	will	will	AUX
admet-1622	206	73	be	be	AUX
admet-1622	206	74	totally	totally	ADV
admet-1622	206	75	filled	fill	VERB
admet-1622	206	76	and	and	CCONJ
admet-1622	206	77	there	there	PRON
admet-1622	206	78	would	would	AUX
admet-1622	206	79	not	not	PART
admet-1622	206	80	be	be	AUX
admet-1622	206	81	any	any	DET
admet-1622	206	82	empty	empty	ADJ
admet-1622	206	83	space	space	NOUN
admet-1622	206	84	inside	inside	ADV
admet-1622	206	85	.	.	PUNCT
admet-1622	207	1	thus	thus	ADV
admet-1622	207	2	,	,	PUNCT
admet-1622	207	3	the	the	DET
admet-1622	207	4	same	same	ADJ
admet-1622	207	5	weight	weight	NOUN
admet-1622	207	6	of	of	ADP
admet-1622	207	7	tablet	tablet	NOUN
admet-1622	207	8	with	with	ADP
admet-1622	207	9	a	a	DET
admet-1622	207	10	lower	low	ADJ
admet-1622	207	11	infill	infill	NOUN
admet-1622	207	12	will	will	AUX
admet-1622	207	13	have	have	VERB
admet-1622	207	14	a	a	DET
admet-1622	207	15	higher	high	ADJ
admet-1622	207	16	dissolving	dissolve	VERB
admet-1622	207	17	surface	surface	NOUN
admet-1622	207	18	and	and	CCONJ
admet-1622	207	19	,	,	PUNCT
admet-1622	207	20	therefore	therefore	ADV
admet-1622	207	21	,	,	PUNCT
admet-1622	207	22	a	a	DET
admet-1622	207	23	higher	high	ADJ
admet-1622	207	24	dissolution	dissolution	NOUN
admet-1622	207	25	rate	rate	NOUN
admet-1622	207	26	in	in	ADP
admet-1622	207	27	the	the	DET
admet-1622	207	28	dissolution	dissolution	NOUN
admet-1622	207	29	medium	medium	NOUN
admet-1622	207	30	than	than	ADP
admet-1622	207	31	a	a	DET
admet-1622	207	32	tablet	tablet	NOUN
admet-1622	207	33	with	with	ADP
admet-1622	207	34	a	a	DET
admet-1622	207	35	higher	high	ADJ
admet-1622	207	36	infill	infill	NOUN
admet-1622	207	37	[	[	X
admet-1622	207	38	58	58	NUM
admet-1622	207	39	]	]	PUNCT
admet-1622	207	40	.	.	PUNCT
admet-1622	208	1	although	although	SCONJ
admet-1622	208	2	the	the	DET
admet-1622	208	3	lowering	lowering	NOUN
admet-1622	208	4	of	of	ADP
admet-1622	208	5	infill	infill	NOUN
admet-1622	208	6	density	density	NOUN
admet-1622	208	7	may	may	AUX
admet-1622	208	8	increase	increase	VERB
admet-1622	208	9	dissolution	dissolution	ADJ
admet-1622	208	10	rates	rate	NOUN
admet-1622	208	11	of	of	ADP
admet-1622	208	12	drugs	drug	NOUN
admet-1622	208	13	from	from	ADP
admet-1622	208	14	fdm	fdm	NOUN
admet-1622	208	15	3d	3d	ADV
admet-1622	208	16	-	-	PUNCT
admet-1622	208	17	printed	print	VERB
admet-1622	208	18	tablets	tablet	NOUN
admet-1622	208	19	,	,	PUNCT
admet-1622	208	20	it	it	PRON
admet-1622	208	21	may	may	AUX
admet-1622	208	22	not	not	PART
admet-1622	208	23	necessarily	necessarily	ADV
admet-1622	208	24	lead	lead	VERB
admet-1622	208	25	to	to	ADP
admet-1622	208	26	a	a	DET
admet-1622	208	27	product	product	NOUN
admet-1622	208	28	that	that	PRON
admet-1622	208	29	may	may	AUX
admet-1622	208	30	be	be	AUX
admet-1622	208	31	called	call	VERB
admet-1622	208	32	rapid	rapid	ADJ
admet-1622	208	33	or	or	CCONJ
admet-1622	208	34	immediate	immediate	ADJ
admet-1622	208	35	release	release	NOUN
admet-1622	208	36	.	.	PUNCT
admet-1622	209	1	in	in	ADP
admet-1622	209	2	a	a	DET
admet-1622	209	3	study	study	NOUN
admet-1622	209	4	of	of	ADP
admet-1622	209	5	the	the	DET
admet-1622	209	6	effect	effect	NOUN
admet-1622	209	7	of	of	ADP
admet-1622	209	8	infill	infill	NOUN
admet-1622	209	9	density	density	NOUN
admet-1622	209	10	on	on	ADP
admet-1622	209	11	the	the	DET
admet-1622	209	12	admet	admet	PROPN
admet-1622	209	13	&	&	CCONJ
admet-1622	209	14	dmpk	dmpk	PROPN
admet-1622	209	15	11(1	11(1	NUM
admet-1622	209	16	)	)	PUNCT
admet-1622	209	17	(	(	PUNCT
admet-1622	209	18	2023	2023	NUM
admet-1622	209	19	)	)	PUNCT
admet-1622	209	20	33	33	NUM
admet-1622	209	21	-	-	SYM
admet-1622	209	22	55	55	NUM
admet-1622	209	23	development	development	NOUN
admet-1622	209	24	of	of	ADP
admet-1622	209	25	rapidly	rapidly	ADV
admet-1622	209	26	dissolving	dissolve	VERB
admet-1622	209	27	fdm	fdm	NOUN
admet-1622	209	28	3d	3d	ADV
admet-1622	209	29	-	-	PUNCT
admet-1622	209	30	printed	print	VERB
admet-1622	209	31	tablets	tablet	NOUN
admet-1622	209	32	doi	doi	NOUN
admet-1622	209	33	:	:	PUNCT
admet-1622	209	34	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	209	35	43	43	NUM
admet-1622	209	36	dissolution	dissolution	NOUN
admet-1622	209	37	of	of	ADP
admet-1622	209	38	a	a	DET
admet-1622	209	39	weakly	weakly	ADJ
admet-1622	209	40	acidic	acidic	ADJ
admet-1622	209	41	compound	compound	NOUN
admet-1622	209	42	,	,	PUNCT
admet-1622	209	43	2-(4	2-(4	NOUN
admet-1622	209	44	-	-	PUNCT
admet-1622	209	45	isobutylphenyl	isobutylphenyl	ADJ
admet-1622	209	46	)	)	PUNCT
admet-1622	209	47	propionic	propionic	ADJ
admet-1622	209	48	acid	acid	NOUN
admet-1622	209	49	,	,	PUNCT
admet-1622	209	50	from	from	ADP
admet-1622	209	51	fdm	fdm	NOUN
admet-1622	209	52	3d	3d	ADV
admet-1622	209	53	-	-	PUNCT
admet-1622	209	54	printed	print	VERB
admet-1622	209	55	tablets	tablet	NOUN
admet-1622	209	56	containing	contain	VERB
admet-1622	209	57	hydroxypropyl	hydroxypropyl	NOUN
admet-1622	209	58	methyl	methyl	PROPN
admet-1622	209	59	acetate	acetate	PROPN
admet-1622	209	60	succinate	succinate	NOUN
admet-1622	209	61	(	(	PUNCT
admet-1622	209	62	hpmcas	hpmca	NOUN
admet-1622	209	63	-	-	PUNCT
admet-1622	209	64	mg	mg	NUM
admet-1622	209	65	)	)	PUNCT
admet-1622	209	66	,	,	PUNCT
admet-1622	209	67	thakkar	thakkar	NOUN
admet-1622	209	68	et	et	PROPN
admet-1622	209	69	al	al	PROPN
admet-1622	209	70	.	.	PUNCT
admet-1622	210	1	[	[	X
admet-1622	210	2	58	58	NUM
admet-1622	210	3	]	]	PUNCT
admet-1622	210	4	observed	observe	VERB
admet-1622	210	5	that	that	SCONJ
admet-1622	210	6	it	it	PRON
admet-1622	210	7	took	take	VERB
admet-1622	210	8	~7h	~7h	NOUN
admet-1622	210	9	for	for	ADP
admet-1622	210	10	80	80	NUM
admet-1622	210	11	%	%	NOUN
admet-1622	210	12	drug	drug	NOUN
admet-1622	210	13	release	release	NOUN
admet-1622	210	14	at	at	ADP
admet-1622	210	15	ph	ph	PROPN
admet-1622	210	16	6.8	6.8	NUM
admet-1622	210	17	from	from	ADP
admet-1622	210	18	tablets	tablet	NOUN
admet-1622	210	19	with	with	ADP
admet-1622	210	20	80	80	NUM
admet-1622	210	21	%	%	NOUN
admet-1622	210	22	infill	infill	NOUN
admet-1622	210	23	.	.	PUNCT
admet-1622	211	1	the	the	DET
admet-1622	211	2	drug	drug	NOUN
admet-1622	211	3	release	release	NOUN
admet-1622	211	4	rate	rate	NOUN
admet-1622	211	5	increased	increase	VERB
admet-1622	211	6	progressively	progressively	ADV
admet-1622	211	7	when	when	SCONJ
admet-1622	211	8	the	the	DET
admet-1622	211	9	fill	fill	NOUN
admet-1622	211	10	densities	density	NOUN
admet-1622	211	11	were	be	AUX
admet-1622	211	12	decreased	decrease	VERB
admet-1622	211	13	to	to	ADP
admet-1622	211	14	60	60	NUM
admet-1622	211	15	,	,	PUNCT
admet-1622	211	16	40	40	NUM
admet-1622	211	17	and	and	CCONJ
admet-1622	211	18	20	20	NUM
admet-1622	211	19	%	%	NOUN
admet-1622	211	20	.	.	PUNCT
admet-1622	212	1	however	however	ADV
admet-1622	212	2	,	,	PUNCT
admet-1622	212	3	even	even	ADV
admet-1622	212	4	at	at	ADP
admet-1622	212	5	20	20	NUM
admet-1622	212	6	%	%	NOUN
admet-1622	212	7	infill	infill	NOUN
admet-1622	212	8	,	,	PUNCT
admet-1622	212	9	the	the	DET
admet-1622	212	10	drug	drug	NOUN
admet-1622	212	11	release	release	NOUN
admet-1622	212	12	rate	rate	NOUN
admet-1622	212	13	was	be	AUX
admet-1622	212	14	relatively	relatively	ADV
admet-1622	212	15	slow	slow	ADJ
admet-1622	212	16	(	(	PUNCT
admet-1622	212	17	80	80	NUM
admet-1622	212	18	%	%	NOUN
admet-1622	212	19	drug	drug	NOUN
admet-1622	212	20	release	release	NOUN
admet-1622	212	21	in	in	ADP
admet-1622	212	22	~2	~2	NOUN
admet-1622	212	23	h	h	NOUN
admet-1622	212	24	)	)	PUNCT
admet-1622	212	25	.	.	PUNCT
admet-1622	213	1	considering	consider	VERB
admet-1622	213	2	that	that	SCONJ
admet-1622	213	3	hpmcas	hpmca	NOUN
admet-1622	213	4	-	-	PUNCT
admet-1622	213	5	mg	mg	PROPN
admet-1622	213	6	is	be	AUX
admet-1622	213	7	soluble	soluble	ADJ
admet-1622	213	8	at	at	ADP
admet-1622	213	9	ph	ph	PROPN
admet-1622	213	10	6.8	6.8	NUM
admet-1622	213	11	,	,	PUNCT
admet-1622	213	12	such	such	ADJ
admet-1622	213	13	release	release	NOUN
admet-1622	213	14	rates	rate	NOUN
admet-1622	213	15	are	be	AUX
admet-1622	213	16	not	not	PART
admet-1622	213	17	optimal	optimal	ADJ
admet-1622	213	18	for	for	ADP
admet-1622	213	19	the	the	DET
admet-1622	213	20	development	development	NOUN
admet-1622	213	21	of	of	ADP
admet-1622	213	22	rapidly	rapidly	ADV
admet-1622	213	23	dissolving	dissolve	VERB
admet-1622	213	24	drug	drug	NOUN
admet-1622	213	25	products	product	NOUN
admet-1622	213	26	.	.	PUNCT
admet-1622	214	1	in	in	ADP
admet-1622	214	2	another	another	DET
admet-1622	214	3	study	study	NOUN
admet-1622	214	4	from	from	ADP
admet-1622	214	5	the	the	DET
admet-1622	214	6	same	same	ADJ
admet-1622	214	7	laboratory	laboratory	NOUN
admet-1622	214	8	,	,	PUNCT
admet-1622	214	9	zhang	zhang	PROPN
admet-1622	214	10	et	et	PROPN
admet-1622	214	11	al	al	PROPN
admet-1622	214	12	.	.	PUNCT
admet-1622	215	1	[	[	X
admet-1622	215	2	59	59	NUM
admet-1622	215	3	]	]	PUNCT
admet-1622	215	4	obtained	obtain	VERB
admet-1622	215	5	complete	complete	ADJ
admet-1622	215	6	drug	drug	NOUN
admet-1622	215	7	release	release	NOUN
admet-1622	215	8	from	from	ADP
admet-1622	215	9	ibuprofen	ibuprofen	NOUN
admet-1622	215	10	-	-	PUNCT
admet-1622	215	11	hpmc	hpmc	ADJ
admet-1622	215	12	-	-	PUNCT
admet-1622	215	13	mg	mg	ADJ
admet-1622	215	14	tablets	tablet	NOUN
admet-1622	215	15	in	in	ADP
admet-1622	215	16	3	3	NUM
admet-1622	215	17	-	-	SYM
admet-1622	215	18	4	4	NUM
admet-1622	215	19	h	h	NOUN
admet-1622	215	20	from	from	ADP
admet-1622	215	21	fdm	fdm	NOUN
admet-1622	215	22	3d	3d	ADV
admet-1622	215	23	-	-	PUNCT
admet-1622	215	24	printed	print	VERB
admet-1622	215	25	tablets	tablet	NOUN
admet-1622	215	26	with	with	ADP
admet-1622	215	27	25	25	NUM
admet-1622	215	28	to	to	PART
admet-1622	215	29	75	75	NUM
admet-1622	215	30	%	%	NOUN
admet-1622	215	31	infill	infill	NOUN
admet-1622	215	32	density	density	NOUN
admet-1622	215	33	.	.	PUNCT
admet-1622	216	1	such	such	ADJ
admet-1622	216	2	slow	slow	ADJ
admet-1622	216	3	-	-	PUNCT
admet-1622	216	4	release	release	NOUN
admet-1622	216	5	rates	rate	NOUN
admet-1622	216	6	were	be	AUX
admet-1622	216	7	also	also	ADV
admet-1622	216	8	observed	observe	VERB
admet-1622	216	9	by	by	ADP
admet-1622	216	10	goyanes	goyane	NOUN
admet-1622	216	11	et	et	PROPN
admet-1622	216	12	al	al	PROPN
admet-1622	216	13	.	.	PUNCT
admet-1622	217	1	[	[	X
admet-1622	217	2	60	60	NUM
admet-1622	217	3	]	]	PUNCT
admet-1622	217	4	from	from	ADP
admet-1622	217	5	fdm	fdm	NOUN
admet-1622	217	6	3d	3d	ADV
admet-1622	217	7	-	-	PUNCT
admet-1622	217	8	printed	print	VERB
admet-1622	217	9	tablets	tablet	NOUN
admet-1622	217	10	of	of	ADP
admet-1622	217	11	the	the	DET
admet-1622	217	12	organic	organic	ADJ
admet-1622	217	13	dye	dye	NOUN
admet-1622	217	14	fluorescein	fluorescein	NOUN
admet-1622	217	15	containing	contain	VERB
admet-1622	217	16	polyvinyl	polyvinyl	NOUN
admet-1622	217	17	alcohol	alcohol	NOUN
admet-1622	217	18	,	,	PUNCT
admet-1622	217	19	a	a	DET
admet-1622	217	20	water	water	NOUN
admet-1622	217	21	-	-	PUNCT
admet-1622	217	22	soluble	soluble	ADJ
admet-1622	217	23	polymer	polymer	NOUN
admet-1622	217	24	,	,	PUNCT
admet-1622	217	25	as	as	ADP
admet-1622	217	26	the	the	DET
admet-1622	217	27	matrix	matrix	NOUN
admet-1622	217	28	.	.	PUNCT
admet-1622	218	1	they	they	PRON
admet-1622	218	2	observed	observe	VERB
admet-1622	218	3	complete	complete	ADJ
admet-1622	218	4	release	release	NOUN
admet-1622	218	5	of	of	ADP
admet-1622	218	6	the	the	DET
admet-1622	218	7	dye	dye	NOUN
admet-1622	218	8	in	in	ADP
admet-1622	218	9	aqueous	aqueous	ADJ
admet-1622	218	10	media	medium	NOUN
admet-1622	218	11	from	from	ADP
admet-1622	218	12	tablets	tablet	NOUN
admet-1622	218	13	with	with	ADP
admet-1622	218	14	10	10	NUM
admet-1622	218	15	%	%	NOUN
admet-1622	218	16	infill	infill	NOUN
admet-1622	218	17	in	in	ADP
admet-1622	218	18	6	6	NUM
admet-1622	218	19	h	h	NOUN
admet-1622	218	20	,	,	PUNCT
admet-1622	218	21	while	while	SCONJ
admet-1622	218	22	only	only	ADV
admet-1622	218	23	about	about	ADV
admet-1622	218	24	70	70	NUM
admet-1622	218	25	%	%	NOUN
admet-1622	218	26	release	release	NOUN
admet-1622	218	27	was	be	AUX
admet-1622	218	28	observed	observe	VERB
admet-1622	218	29	at	at	ADP
admet-1622	218	30	the	the	DET
admet-1622	218	31	same	same	ADJ
admet-1622	218	32	period	period	NOUN
admet-1622	218	33	from	from	ADP
admet-1622	218	34	tablets	tablet	NOUN
admet-1622	218	35	with	with	ADP
admet-1622	218	36	50	50	NUM
admet-1622	218	37	and	and	CCONJ
admet-1622	218	38	90	90	NUM
admet-1622	218	39	%	%	NOUN
admet-1622	218	40	infills	infill	NOUN
admet-1622	218	41	.	.	PUNCT
admet-1622	219	1	geometric	geometric	ADJ
admet-1622	219	2	modification	modification	NOUN
admet-1622	219	3	by	by	ADP
admet-1622	219	4	connecting	connect	VERB
admet-1622	219	5	blocks	block	NOUN
admet-1622	219	6	of	of	ADP
admet-1622	219	7	fill	fill	NOUN
admet-1622	219	8	materials	material	NOUN
admet-1622	219	9	in	in	ADP
admet-1622	219	10	addition	addition	NOUN
admet-1622	219	11	to	to	ADP
admet-1622	219	12	changing	change	VERB
admet-1622	219	13	the	the	DET
admet-1622	219	14	infill	infill	NOUN
admet-1622	219	15	density	density	NOUN
admet-1622	219	16	,	,	PUNCT
admet-1622	219	17	several	several	ADJ
admet-1622	219	18	other	other	ADJ
admet-1622	219	19	geometrical	geometrical	ADJ
admet-1622	219	20	modifications	modification	NOUN
admet-1622	219	21	to	to	PART
admet-1622	219	22	increase	increase	VERB
admet-1622	219	23	drug	drug	NOUN
admet-1622	219	24	release	release	NOUN
admet-1622	219	25	rates	rate	NOUN
admet-1622	219	26	have	have	AUX
admet-1622	219	27	also	also	ADV
admet-1622	219	28	been	be	AUX
admet-1622	219	29	reported	report	VERB
admet-1622	219	30	in	in	ADP
admet-1622	219	31	the	the	DET
admet-1622	219	32	literature	literature	NOUN
admet-1622	219	33	.	.	PUNCT
admet-1622	220	1	in	in	ADP
admet-1622	220	2	one	one	NUM
admet-1622	220	3	such	such	ADJ
admet-1622	220	4	geometric	geometric	ADJ
admet-1622	220	5	modification	modification	NOUN
admet-1622	220	6	shown	show	VERB
admet-1622	220	7	in	in	ADP
admet-1622	220	8	fig	fig	NOUN
admet-1622	220	9	.	.	PUNCT
admet-1622	221	1	3	3	NUM
admet-1622	221	2	-	-	SYM
admet-1622	221	3	ii	ii	NOUN
admet-1622	221	4	,	,	PUNCT
admet-1622	221	5	arafat	arafat	PROPN
admet-1622	221	6	et	et	PROPN
admet-1622	221	7	al	al	PROPN
admet-1622	221	8	.	.	PUNCT
admet-1622	222	1	[	[	X
admet-1622	222	2	61	61	NUM
admet-1622	222	3	]	]	PUNCT
admet-1622	222	4	used	use	VERB
admet-1622	222	5	a	a	DET
admet-1622	222	6	blend	blend	NOUN
admet-1622	222	7	of	of	ADP
admet-1622	222	8	theophylline	theophylline	NOUN
admet-1622	222	9	,	,	PUNCT
admet-1622	222	10	hydroxypropyl	hydroxypropyl	NOUN
admet-1622	222	11	cellulose	cellulose	NOUN
admet-1622	222	12	and	and	CCONJ
admet-1622	222	13	triacetin	triacetin	ADJ
admet-1622	222	14	(	(	PUNCT
admet-1622	222	15	50:45:5	50:45:5	NUM
admet-1622	222	16	)	)	PUNCT
admet-1622	222	17	for	for	ADP
admet-1622	222	18	the	the	DET
admet-1622	222	19	development	development	NOUN
admet-1622	222	20	of	of	ADP
admet-1622	222	21	fdm	fdm	NOUN
admet-1622	222	22	3d	3d	ADV
admet-1622	222	23	-	-	PUNCT
admet-1622	222	24	printed	print	VERB
admet-1622	222	25	tablets	tablet	NOUN
admet-1622	222	26	,	,	PUNCT
admet-1622	222	27	where	where	SCONJ
admet-1622	222	28	they	they	PRON
admet-1622	222	29	connected	connect	VERB
admet-1622	222	30	9	9	NUM
admet-1622	222	31	blocks	block	NOUN
admet-1622	222	32	of	of	ADP
admet-1622	222	33	fill	fill	NOUN
admet-1622	222	34	materials	material	NOUN
admet-1622	222	35	with	with	ADP
admet-1622	222	36	3	3	NUM
admet-1622	222	37	bridges	bridge	NOUN
admet-1622	222	38	within	within	ADP
admet-1622	222	39	a	a	DET
admet-1622	222	40	tablet	tablet	NOUN
admet-1622	222	41	by	by	ADP
admet-1622	222	42	leaving	leave	VERB
admet-1622	222	43	gaps	gap	NOUN
admet-1622	222	44	ranging	range	VERB
admet-1622	222	45	from	from	ADP
admet-1622	222	46	0	0	NUM
admet-1622	222	47	to	to	ADP
admet-1622	222	48	1.2	1.2	NUM
admet-1622	222	49	mm	mm	NOUN
admet-1622	222	50	between	between	ADP
admet-1622	222	51	the	the	DET
admet-1622	222	52	blocks	block	NOUN
admet-1622	222	53	.	.	PUNCT
admet-1622	223	1	the	the	DET
admet-1622	223	2	drug	drug	NOUN
admet-1622	223	3	release	release	NOUN
admet-1622	223	4	rate	rate	NOUN
admet-1622	223	5	from	from	ADP
admet-1622	223	6	tablets	tablet	NOUN
admet-1622	223	7	depended	depend	VERB
admet-1622	223	8	on	on	ADP
admet-1622	223	9	the	the	DET
admet-1622	223	10	size	size	NOUN
admet-1622	223	11	of	of	ADP
admet-1622	223	12	the	the	DET
admet-1622	223	13	block	block	NOUN
admet-1622	223	14	,	,	PUNCT
admet-1622	223	15	the	the	DET
admet-1622	223	16	number	number	NOUN
admet-1622	223	17	of	of	ADP
admet-1622	223	18	bridges	bridge	NOUN
admet-1622	223	19	and	and	CCONJ
admet-1622	223	20	the	the	DET
admet-1622	223	21	spacing	spacing	NOUN
admet-1622	223	22	between	between	ADP
admet-1622	223	23	the	the	DET
admet-1622	223	24	blocks	block	NOUN
admet-1622	223	25	.	.	PUNCT
admet-1622	224	1	it	it	PRON
admet-1622	224	2	took	take	VERB
admet-1622	224	3	almost	almost	ADV
admet-1622	224	4	2	2	NUM
admet-1622	224	5	h	h	NOUN
admet-1622	224	6	for	for	ADP
admet-1622	224	7	the	the	DET
admet-1622	224	8	complete	complete	ADJ
admet-1622	224	9	dissolution	dissolution	NOUN
admet-1622	224	10	of	of	ADP
admet-1622	224	11	the	the	DET
admet-1622	224	12	drug	drug	NOUN
admet-1622	224	13	when	when	SCONJ
admet-1622	224	14	the	the	DET
admet-1622	224	15	gap	gap	NOUN
admet-1622	224	16	in	in	ADP
admet-1622	224	17	between	between	ADP
admet-1622	224	18	blocks	block	NOUN
admet-1622	224	19	was	be	AUX
admet-1622	224	20	0.2	0.2	NUM
admet-1622	224	21	mm	mm	NOUN
admet-1622	224	22	.	.	PUNCT
admet-1622	225	1	on	on	ADP
admet-1622	225	2	the	the	DET
admet-1622	225	3	other	other	ADJ
admet-1622	225	4	hand	hand	NOUN
admet-1622	225	5	,	,	PUNCT
admet-1622	225	6	when	when	SCONJ
admet-1622	225	7	the	the	DET
admet-1622	225	8	gap	gap	NOUN
admet-1622	225	9	was	be	AUX
admet-1622	225	10	increased	increase	VERB
admet-1622	225	11	to	to	ADP
admet-1622	225	12	1	1	NUM
admet-1622	225	13	mm	mm	NOUN
admet-1622	225	14	or	or	CCONJ
admet-1622	225	15	higher	high	ADJ
admet-1622	225	16	,	,	PUNCT
admet-1622	225	17	over	over	ADP
admet-1622	225	18	80	80	NUM
admet-1622	225	19	%	%	NOUN
admet-1622	225	20	theophylline	theophylline	NOUN
admet-1622	225	21	dissolved	dissolve	VERB
admet-1622	225	22	in	in	ADP
admet-1622	225	23	30	30	NUM
admet-1622	225	24	min	min	NOUN
admet-1622	225	25	;	;	PUNCT
admet-1622	225	26	the	the	DET
admet-1622	225	27	higher	high	ADJ
admet-1622	225	28	gap	gap	NOUN
admet-1622	225	29	was	be	AUX
admet-1622	225	30	necessary	necessary	ADJ
admet-1622	225	31	for	for	ADP
admet-1622	225	32	the	the	DET
admet-1622	225	33	collapse	collapse	NOUN
admet-1622	225	34	of	of	ADP
admet-1622	225	35	the	the	DET
admet-1622	225	36	bridge	bridge	NOUN
admet-1622	225	37	and	and	CCONJ
admet-1622	225	38	the	the	DET
admet-1622	225	39	disintegration	disintegration	NOUN
admet-1622	225	40	of	of	ADP
admet-1622	225	41	tablet	tablet	NOUN
admet-1622	225	42	.	.	PUNCT
admet-1622	226	1	introduction	introduction	NOUN
admet-1622	226	2	of	of	ADP
admet-1622	226	3	perforated	perforated	ADJ
admet-1622	226	4	channels	channel	NOUN
admet-1622	226	5	in	in	ADP
admet-1622	226	6	another	another	DET
admet-1622	226	7	approach	approach	NOUN
admet-1622	226	8	to	to	PART
admet-1622	226	9	increase	increase	VERB
admet-1622	226	10	the	the	DET
admet-1622	226	11	dissolution	dissolution	ADJ
admet-1622	226	12	rate	rate	NOUN
admet-1622	226	13	of	of	ADP
admet-1622	226	14	tablets	tablet	NOUN
admet-1622	226	15	,	,	PUNCT
admet-1622	226	16	sadia	sadia	PROPN
admet-1622	226	17	et	et	PROPN
admet-1622	226	18	al	al	PROPN
admet-1622	226	19	.	.	PUNCT
admet-1622	227	1	[	[	X
admet-1622	227	2	62	62	NUM
admet-1622	227	3	]	]	PUNCT
admet-1622	227	4	introduced	introduce	VERB
admet-1622	227	5	perforated	perforate	VERB
admet-1622	227	6	channels	channel	NOUN
admet-1622	227	7	within	within	ADP
admet-1622	227	8	the	the	DET
admet-1622	227	9	fdm	fdm	NOUN
admet-1622	227	10	3d	3d	ADV
admet-1622	227	11	-	-	PUNCT
admet-1622	227	12	printed	print	VERB
admet-1622	227	13	tablets	tablet	NOUN
admet-1622	227	14	for	for	ADP
admet-1622	227	15	exposure	exposure	NOUN
admet-1622	227	16	of	of	ADP
admet-1622	227	17	the	the	DET
admet-1622	227	18	larger	large	ADJ
admet-1622	227	19	surface	surface	NOUN
admet-1622	227	20	area	area	NOUN
admet-1622	227	21	to	to	ADP
admet-1622	227	22	dissolution	dissolution	NOUN
admet-1622	227	23	media	medium	NOUN
admet-1622	227	24	(	(	PUNCT
admet-1622	227	25	fig	fig	NOUN
admet-1622	227	26	.	.	PUNCT
admet-1622	228	1	3	3	NUM
admet-1622	228	2	-	-	SYM
admet-1622	228	3	iii	iii	NUM
admet-1622	228	4	)	)	PUNCT
admet-1622	228	5	.	.	PUNCT
admet-1622	229	1	the	the	DET
admet-1622	229	2	capsule	capsule	NOUN
admet-1622	229	3	-	-	PUNCT
admet-1622	229	4	shaped	shape	VERB
admet-1622	229	5	tablets	tablet	NOUN
admet-1622	229	6	(	(	PUNCT
admet-1622	229	7	caplets	caplet	NOUN
admet-1622	229	8	)	)	PUNCT
admet-1622	229	9	contained	contain	VERB
admet-1622	229	10	channels	channel	NOUN
admet-1622	229	11	of	of	ADP
admet-1622	229	12	increasing	increase	VERB
admet-1622	229	13	width	width	NOUN
admet-1622	229	14	(	(	PUNCT
admet-1622	229	15	0.2	0.2	NUM
admet-1622	229	16	,	,	PUNCT
admet-1622	229	17	0.4	0.4	NUM
admet-1622	229	18	,	,	PUNCT
admet-1622	229	19	0.6	0.6	NUM
admet-1622	229	20	,	,	PUNCT
admet-1622	229	21	0.8	0.8	NUM
admet-1622	229	22	or	or	CCONJ
admet-1622	229	23	1.0	1.0	NUM
admet-1622	229	24	mm	mm	NOUN
admet-1622	229	25	)	)	PUNCT
admet-1622	229	26	and	and	CCONJ
admet-1622	229	27	variable	variable	ADJ
admet-1622	229	28	length	length	NOUN
admet-1622	229	29	that	that	PRON
admet-1622	229	30	were	be	AUX
admet-1622	229	31	aligned	align	VERB
admet-1622	229	32	parallel	parallel	ADJ
admet-1622	229	33	or	or	CCONJ
admet-1622	229	34	at	at	ADP
admet-1622	229	35	a	a	DET
admet-1622	229	36	right	right	ADJ
admet-1622	229	37	angle	angle	NOUN
admet-1622	229	38	to	to	ADP
admet-1622	229	39	the	the	DET
admet-1622	229	40	long	long	ADJ
admet-1622	229	41	axis	axis	NOUN
admet-1622	229	42	of	of	ADP
admet-1622	229	43	tablet	tablet	NOUN
admet-1622	229	44	.	.	PUNCT
admet-1622	230	1	over	over	ADP
admet-1622	230	2	80	80	NUM
admet-1622	230	3	%	%	NOUN
admet-1622	230	4	of	of	ADP
admet-1622	230	5	drug	drug	NOUN
admet-1622	230	6	release	release	NOUN
admet-1622	230	7	in	in	ADP
admet-1622	230	8	30	30	NUM
admet-1622	230	9	min	min	NOUN
admet-1622	230	10	at	at	ADP
admet-1622	230	11	ph	ph	PROPN
admet-1622	230	12	1.2	1.2	NUM
admet-1622	230	13	was	be	AUX
admet-1622	230	14	observed	observe	VERB
admet-1622	230	15	when	when	SCONJ
admet-1622	230	16	the	the	DET
admet-1622	230	17	channel	channel	NOUN
admet-1622	230	18	width	width	NOUN
admet-1622	230	19	was	be	AUX
admet-1622	230	20	≥	≥	NOUN
admet-1622	231	1	0.6	0.6	NUM
admet-1622	231	2	mm	mm	INTJ
admet-1622	231	3	.	.	PUNCT
admet-1622	232	1	however	however	ADV
admet-1622	232	2	,	,	PUNCT
admet-1622	232	3	the	the	DET
admet-1622	232	4	formulation	formulation	NOUN
admet-1622	232	5	for	for	ADP
admet-1622	232	6	the	the	DET
admet-1622	232	7	tablet	tablet	NOUN
admet-1622	232	8	was	be	AUX
admet-1622	232	9	composed	compose	VERB
admet-1622	232	10	of	of	ADP
admet-1622	232	11	a	a	DET
admet-1622	232	12	mixture	mixture	NOUN
admet-1622	232	13	of	of	ADP
admet-1622	232	14	hydrochlorothiazide	hydrochlorothiazide	PROPN
admet-1622	232	15	(	(	PUNCT
admet-1622	232	16	hct	hct	PROPN
admet-1622	232	17	)	)	PUNCT
admet-1622	232	18	,	,	PUNCT
admet-1622	232	19	eudragit	eudragit	VERB
admet-1622	232	20	®	®	NOUN
admet-1622	232	21	e	e	NOUN
admet-1622	232	22	,	,	PUNCT
admet-1622	232	23	tricalcium	tricalcium	NOUN
admet-1622	232	24	phosphate	phosphate	NOUN
admet-1622	232	25	(	(	PUNCT
admet-1622	232	26	tcp	tcp	PROPN
admet-1622	232	27	)	)	PUNCT
admet-1622	232	28	and	and	CCONJ
admet-1622	232	29	triethyl	triethyl	PROPN
admet-1622	232	30	citrate	citrate	PROPN
admet-1622	232	31	(	(	PUNCT
admet-1622	232	32	tec	tec	NOUN
admet-1622	232	33	)	)	PUNCT
admet-1622	232	34	at	at	ADP
admet-1622	232	35	the	the	DET
admet-1622	232	36	ratio	ratio	NOUN
admet-1622	232	37	12.5:46.75:25.37:3.25	12.5:46.75:25.37:3.25	NUM
admet-1622	232	38	w	w	PROPN
admet-1622	232	39	/	/	SYM
admet-1622	232	40	w.	w.	NOUN
admet-1622	232	41	as	as	SCONJ
admet-1622	232	42	was	be	AUX
admet-1622	232	43	discussed	discuss	VERB
admet-1622	232	44	earlier	early	ADV
admet-1622	232	45	,	,	PUNCT
admet-1622	232	46	tcp	tcp	X
admet-1622	232	47	plays	play	VERB
admet-1622	232	48	a	a	DET
admet-1622	232	49	major	major	ADJ
admet-1622	232	50	role	role	NOUN
admet-1622	232	51	in	in	ADP
admet-1622	232	52	increasing	increase	VERB
admet-1622	232	53	dissolution	dissolution	ADJ
admet-1622	232	54	rates	rate	NOUN
admet-1622	232	55	of	of	ADP
admet-1622	232	56	drugs	drug	NOUN
admet-1622	232	57	from	from	ADP
admet-1622	232	58	3d	3d	NOUN
admet-1622	232	59	-	-	PUNCT
admet-1622	232	60	printed	print	VERB
admet-1622	232	61	tablets	tablet	NOUN
admet-1622	232	62	,	,	PUNCT
admet-1622	232	63	and	and	CCONJ
admet-1622	232	64	it	it	PRON
admet-1622	232	65	is	be	AUX
admet-1622	232	66	not	not	PART
admet-1622	232	67	clear	clear	ADJ
admet-1622	232	68	what	what	PRON
admet-1622	232	69	roles	role	NOUN
admet-1622	232	70	tcp	tcp	AUX
admet-1622	232	71	played	play	VERB
admet-1622	232	72	in	in	ADP
admet-1622	232	73	increasing	increase	VERB
admet-1622	232	74	dissolution	dissolution	ADJ
admet-1622	232	75	rates	rate	NOUN
admet-1622	232	76	of	of	ADP
admet-1622	232	77	hct	hct	NOUN
admet-1622	232	78	from	from	ADP
admet-1622	232	79	this	this	DET
admet-1622	232	80	formulation	formulation	NOUN
admet-1622	232	81	.	.	PUNCT
admet-1622	233	1	further	far	ADV
admet-1622	233	2	,	,	PUNCT
admet-1622	233	3	eudragit	eudragit	VERB
admet-1622	233	4	®	®	NOUN
admet-1622	233	5	e	e	NOUN
admet-1622	233	6	is	be	AUX
admet-1622	233	7	soluble	soluble	ADJ
admet-1622	233	8	under	under	ADP
admet-1622	233	9	gastric	gastric	ADJ
admet-1622	233	10	ph	ph	NOUN
admet-1622	233	11	conditions	condition	NOUN
admet-1622	233	12	(	(	PUNCT
admet-1622	233	13	ph<5	ph<5	NUM
admet-1622	233	14	)	)	PUNCT
admet-1622	233	15	but	but	CCONJ
admet-1622	233	16	insoluble	insoluble	ADJ
admet-1622	233	17	at	at	ADP
admet-1622	233	18	higher	high	ADJ
admet-1622	233	19	intestinal	intestinal	ADJ
admet-1622	233	20	ph	ph	ADJ
admet-1622	233	21	conditions	condition	NOUN
admet-1622	233	22	.	.	PUNCT
admet-1622	234	1	therefore	therefore	ADV
admet-1622	234	2	,	,	PUNCT
admet-1622	234	3	it	it	PRON
admet-1622	234	4	is	be	AUX
admet-1622	234	5	also	also	ADV
admet-1622	234	6	essential	essential	ADJ
admet-1622	234	7	to	to	PART
admet-1622	234	8	consider	consider	VERB
admet-1622	234	9	how	how	SCONJ
admet-1622	234	10	much	much	ADJ
admet-1622	234	11	improvement	improvement	NOUN
admet-1622	234	12	in	in	ADP
admet-1622	234	13	dissolution	dissolution	NOUN
admet-1622	234	14	rate	rate	NOUN
admet-1622	234	15	the	the	DET
admet-1622	234	16	perforated	perforate	VERB
admet-1622	234	17	channels	channel	NOUN
admet-1622	234	18	may	may	AUX
admet-1622	234	19	provide	provide	VERB
admet-1622	234	20	at	at	ADP
admet-1622	234	21	ph>5	ph>5	PROPN
admet-1622	234	22	from	from	ADP
admet-1622	234	23	formulations	formulation	NOUN
admet-1622	234	24	containing	contain	VERB
admet-1622	234	25	eudragit	eudragit	PROPN
admet-1622	234	26	®	®	NOUN
admet-1622	234	27	e.	e.	PROPN
admet-1622	234	28	additionally	additionally	ADV
admet-1622	234	29	,	,	PUNCT
admet-1622	234	30	the	the	DET
admet-1622	234	31	dissolution	dissolution	NOUN
admet-1622	234	32	rate	rate	NOUN
admet-1622	234	33	improvements	improvement	NOUN
admet-1622	234	34	from	from	ADP
admet-1622	234	35	tablets	tablet	NOUN
admet-1622	234	36	by	by	ADP
admet-1622	234	37	low	low	ADJ
admet-1622	234	38	infill	infill	NOUN
admet-1622	234	39	density	density	NOUN
admet-1622	234	40	and	and	CCONJ
admet-1622	234	41	by	by	ADP
admet-1622	234	42	perforated	perforated	ADJ
admet-1622	234	43	channels	channel	NOUN
admet-1622	234	44	appear	appear	VERB
admet-1622	234	45	to	to	PART
admet-1622	234	46	be	be	AUX
admet-1622	234	47	based	base	VERB
admet-1622	234	48	on	on	ADP
admet-1622	234	49	similar	similar	ADJ
admet-1622	234	50	principles	principle	NOUN
admet-1622	234	51	,	,	PUNCT
admet-1622	234	52	and	and	CCONJ
admet-1622	234	53	it	it	PRON
admet-1622	234	54	is	be	AUX
admet-1622	234	55	essential	essential	ADJ
admet-1622	234	56	to	to	PART
admet-1622	234	57	determine	determine	VERB
admet-1622	234	58	whether	whether	SCONJ
admet-1622	234	59	one	one	NUM
admet-1622	234	60	method	method	NOUN
admet-1622	234	61	would	would	AUX
admet-1622	234	62	have	have	VERB
admet-1622	234	63	an	an	DET
admet-1622	234	64	advantage	advantage	NOUN
admet-1622	234	65	over	over	ADP
admet-1622	234	66	the	the	DET
admet-1622	234	67	other	other	ADJ
admet-1622	234	68	.	.	PUNCT
admet-1622	235	1	connection	connection	NOUN
admet-1622	235	2	of	of	ADP
admet-1622	235	3	parallel	parallel	ADJ
admet-1622	235	4	plates	plate	NOUN
admet-1622	235	5	in	in	ADP
admet-1622	235	6	yet	yet	ADV
admet-1622	235	7	another	another	DET
admet-1622	235	8	geometric	geometric	ADJ
admet-1622	235	9	modification	modification	NOUN
admet-1622	235	10	to	to	PART
admet-1622	235	11	increase	increase	VERB
admet-1622	235	12	dissolution	dissolution	ADJ
admet-1622	235	13	rates	rate	NOUN
admet-1622	235	14	of	of	ADP
admet-1622	235	15	tablets	tablet	NOUN
admet-1622	235	16	,	,	PUNCT
admet-1622	235	17	isreb	isreb	PROPN
admet-1622	235	18	et	et	PROPN
admet-1622	235	19	al	al	PROPN
admet-1622	235	20	.	.	PUNCT
admet-1622	236	1	[	[	X
admet-1622	236	2	63	63	NUM
admet-1622	236	3	]	]	PUNCT
admet-1622	236	4	connected	connected	ADJ
admet-1622	236	5	parallel	parallel	ADJ
admet-1622	236	6	plates	plate	NOUN
admet-1622	236	7	of	of	ADP
admet-1622	236	8	infill	infill	NOUN
admet-1622	236	9	in	in	ADP
admet-1622	236	10	a	a	DET
admet-1622	236	11	radiator	radiator	NOUN
admet-1622	236	12	-	-	PUNCT
admet-1622	236	13	like	like	ADJ
admet-1622	236	14	design	design	NOUN
admet-1622	236	15	with	with	ADP
admet-1622	236	16	inter	inter	ADJ
admet-1622	236	17	-	-	ADJ
admet-1622	236	18	plate	plate	ADJ
admet-1622	236	19	spacings	spacing	NOUN
admet-1622	236	20	of	of	ADP
admet-1622	236	21	0.5	0.5	NUM
admet-1622	236	22	,	,	PUNCT
admet-1622	236	23	1	1	NUM
admet-1622	236	24	,	,	PUNCT
admet-1622	236	25	1.5	1.5	NUM
admet-1622	236	26	,	,	PUNCT
admet-1622	236	27	or	or	CCONJ
admet-1622	236	28	2.0	2.0	NUM
admet-1622	236	29	mm	mm	NOUN
admet-1622	236	30	(	(	PUNCT
admet-1622	236	31	fig	fig	NOUN
admet-1622	236	32	.	.	PUNCT
admet-1622	237	1	3	3	NUM
admet-1622	237	2	-	-	SYM
admet-1622	237	3	iv	iv	NUM
admet-1622	237	4	)	)	PUNCT
admet-1622	237	5	.	.	PUNCT
admet-1622	238	1	filaments	filament	NOUN
admet-1622	238	2	used	use	VERB
admet-1622	238	3	for	for	ADP
admet-1622	238	4	this	this	DET
admet-1622	238	5	study	study	NOUN
admet-1622	238	6	contained	contain	VERB
admet-1622	238	7	30:35:35	30:35:35	NUM
admet-1622	238	8	w	w	PROPN
admet-1622	238	9	/	/	SYM
admet-1622	238	10	w	w	NOUN
admet-1622	238	11	mixtures	mixture	NOUN
admet-1622	238	12	of	of	ADP
admet-1622	238	13	theophylline	theophylline	NOUN
admet-1622	238	14	,	,	PUNCT
admet-1622	238	15	polyethylene	polyethylene	NOUN
admet-1622	238	16	glycol	glycol	NOUN
admet-1622	238	17	(	(	PUNCT
admet-1622	238	18	peg	peg	NOUN
admet-1622	238	19	)	)	PUNCT
admet-1622	238	20	6000	6000	NUM
admet-1622	238	21	,	,	PUNCT
admet-1622	238	22	and	and	CCONJ
admet-1622	238	23	different	different	ADJ
admet-1622	238	24	grades	grade	NOUN
admet-1622	238	25	of	of	ADP
admet-1622	238	26	polyethylene	polyethylene	NOUN
admet-1622	238	27	oxide	oxide	NOUN
admet-1622	238	28	(	(	PUNCT
admet-1622	238	29	peo	peo	PROPN
admet-1622	238	30	)	)	PUNCT
admet-1622	238	31	with	with	ADP
admet-1622	238	32	molecular	molecular	ADJ
admet-1622	238	33	weights	weight	NOUN
admet-1622	238	34	ranging	range	VERB
admet-1622	238	35	from	from	ADP
admet-1622	238	36	100,000	100,000	NUM
admet-1622	238	37	to	to	ADP
admet-1622	238	38	900,000	900,000	NUM
admet-1622	238	39	,	,	PUNCT
admet-1622	238	40	where	where	SCONJ
admet-1622	238	41	theophylline	theophylline	NOUN
admet-1622	238	42	was	be	AUX
admet-1622	238	43	not	not	PART
admet-1622	238	44	completely	completely	ADV
admet-1622	238	45	miscible	miscible	ADJ
admet-1622	238	46	with	with	ADP
admet-1622	238	47	other	other	ADJ
admet-1622	238	48	components	component	NOUN
admet-1622	238	49	and	and	CCONJ
admet-1622	238	50	remained	remain	VERB
admet-1622	238	51	mostly	mostly	ADV
admet-1622	238	52	crystalline	crystalline	ADJ
admet-1622	238	53	.	.	PUNCT
admet-1622	239	1	a	a	DET
admet-1622	239	2	minimum	minimum	ADJ
admet-1622	239	3	inter	inter	ADJ
admet-1622	239	4	-	-	ADJ
admet-1622	239	5	plate	plate	ADJ
admet-1622	239	6	spacing	spacing	NOUN
admet-1622	239	7	of	of	ADP
admet-1622	239	8	1	1	NUM
admet-1622	239	9	mm	mm	NOUN
admet-1622	239	10	was	be	AUX
admet-1622	239	11	deemed	deem	VERB
admet-1622	239	12	necessary	necessary	ADJ
admet-1622	239	13	for	for	ADP
admet-1622	239	14	increasing	increase	VERB
admet-1622	239	15	the	the	DET
admet-1622	239	16	drug	drug	NOUN
admet-1622	239	17	release	release	NOUN
admet-1622	239	18	rate	rate	NOUN
admet-1622	239	19	,	,	PUNCT
admet-1622	239	20	where	where	SCONJ
admet-1622	239	21	over	over	ADP
admet-1622	239	22	80	80	NUM
admet-1622	239	23	%	%	NOUN
admet-1622	239	24	of	of	ADP
admet-1622	239	25	theophylline	theophylline	NOUN
admet-1622	239	26	was	be	AUX
admet-1622	239	27	released	release	VERB
admet-1622	239	28	from	from	ADP
admet-1622	239	29	fdm	fdm	NOUN
admet-1622	239	30	3dhttps://doi.org/10.5599/admet.1622	3dhttps://doi.org/10.5599/admet.1622	NUM
admet-1622	239	31	abu	abu	PROPN
admet-1622	239	32	t.m	t.m	PROPN
admet-1622	239	33	.	.	PUNCT
admet-1622	240	1	serajuddin	serajuddin	VERB
admet-1622	240	2	admet	admet	PROPN
admet-1622	240	3	&	&	CCONJ
admet-1622	240	4	dmpk	dmpk	PROPN
admet-1622	240	5	11(1	11(1	NUM
admet-1622	240	6	)	)	PUNCT
admet-1622	240	7	(	(	PUNCT
admet-1622	240	8	2023	2023	NUM
admet-1622	240	9	)	)	PUNCT
admet-1622	240	10	33	33	NUM
admet-1622	240	11	-	-	SYM
admet-1622	240	12	55	55	NUM
admet-1622	240	13	44	44	NUM
admet-1622	240	14	printed	print	VERB
admet-1622	240	15	tablets	tablet	NOUN
admet-1622	240	16	in	in	ADP
admet-1622	240	17	<	<	PROPN
admet-1622	240	18	30	30	NUM
admet-1622	240	19	min	min	NOUN
admet-1622	240	20	at	at	ADP
admet-1622	240	21	ph	ph	PROPN
admet-1622	240	22	1.2	1.2	NUM
admet-1622	240	23	.	.	PUNCT
admet-1622	241	1	the	the	DET
admet-1622	241	2	radiator	radiator	NOUN
admet-1622	241	3	-	-	PUNCT
admet-1622	241	4	like	like	ADJ
admet-1622	241	5	design	design	NOUN
admet-1622	241	6	possibly	possibly	ADV
admet-1622	241	7	helped	help	VERB
admet-1622	241	8	in	in	ADP
admet-1622	241	9	the	the	DET
admet-1622	241	10	swelling	swelling	NOUN
admet-1622	241	11	and	and	CCONJ
admet-1622	241	12	disintegration	disintegration	NOUN
admet-1622	241	13	of	of	ADP
admet-1622	241	14	tablets	tablet	NOUN
admet-1622	241	15	,	,	PUNCT
admet-1622	241	16	whereby	whereby	SCONJ
admet-1622	241	17	crystalline	crystalline	NOUN
admet-1622	241	18	theophylline	theophylline	NOUN
admet-1622	241	19	was	be	AUX
admet-1622	241	20	liberated	liberate	VERB
admet-1622	241	21	in	in	ADP
admet-1622	241	22	the	the	DET
admet-1622	241	23	dissolution	dissolution	NOUN
admet-1622	241	24	medium	medium	NOUN
admet-1622	241	25	.	.	PUNCT
admet-1622	242	1	among	among	ADP
admet-1622	242	2	other	other	ADJ
admet-1622	242	3	variations	variation	NOUN
admet-1622	242	4	of	of	ADP
admet-1622	242	5	tablet	tablet	NOUN
admet-1622	242	6	patterns	pattern	NOUN
admet-1622	242	7	and	and	CCONJ
admet-1622	242	8	geometry	geometry	NOUN
admet-1622	242	9	,	,	PUNCT
admet-1622	242	10	khaled	khale	VERB
admet-1622	242	11	et	et	PROPN
admet-1622	242	12	al	al	PROPN
admet-1622	242	13	.	.	PUNCT
admet-1622	243	1	[	[	X
admet-1622	243	2	64	64	NUM
admet-1622	243	3	]	]	PUNCT
admet-1622	243	4	introduced	introduce	VERB
admet-1622	243	5	mesh	mesh	NOUN
admet-1622	243	6	structures	structure	NOUN
admet-1622	243	7	within	within	ADP
admet-1622	243	8	tablets	tablet	NOUN
admet-1622	243	9	to	to	PART
admet-1622	243	10	increase	increase	VERB
admet-1622	243	11	surface	surface	NOUN
admet-1622	243	12	area	area	NOUN
admet-1622	243	13	and	and	CCONJ
admet-1622	243	14	dissolution	dissolution	NOUN
admet-1622	243	15	rates	rate	NOUN
admet-1622	243	16	of	of	ADP
admet-1622	243	17	3d	3d	NOUN
admet-1622	243	18	-	-	PUNCT
admet-1622	243	19	printed	print	VERB
admet-1622	243	20	paracetamol	paracetamol	NOUN
admet-1622	243	21	tablets	tablet	NOUN
admet-1622	243	22	that	that	PRON
admet-1622	243	23	appear	appear	VERB
admet-1622	243	24	to	to	PART
admet-1622	243	25	be	be	AUX
admet-1622	243	26	analogous	analogous	ADJ
admet-1622	243	27	to	to	ADP
admet-1622	243	28	changing	change	VERB
admet-1622	243	29	the	the	DET
admet-1622	243	30	infill	infill	NOUN
admet-1622	243	31	density	density	NOUN
admet-1622	243	32	.	.	PUNCT
admet-1622	244	1	other	other	ADJ
admet-1622	244	2	investigators	investigator	NOUN
admet-1622	244	3	changed	change	VERB
admet-1622	244	4	tablet	tablet	ADJ
admet-1622	244	5	shapes	shape	NOUN
admet-1622	244	6	and	and	CCONJ
admet-1622	244	7	dimensions	dimension	NOUN
admet-1622	244	8	to	to	PART
admet-1622	244	9	increase	increase	VERB
admet-1622	244	10	the	the	DET
admet-1622	244	11	dissolution	dissolution	NOUN
admet-1622	244	12	rates	rate	NOUN
admet-1622	244	13	of	of	ADP
admet-1622	244	14	tablets	tablet	NOUN
admet-1622	244	15	[	[	X
admet-1622	244	16	65,66	65,66	NOUN
admet-1622	244	17	]	]	X
admet-1622	244	18	.	.	PUNCT
admet-1622	245	1	for	for	ADP
admet-1622	245	2	example	example	NOUN
admet-1622	245	3	,	,	PUNCT
admet-1622	245	4	goyanes	goyane	NOUN
admet-1622	245	5	et	et	NOUN
admet-1622	245	6	al	al	PROPN
admet-1622	245	7	.	.	PUNCT
admet-1622	246	1	[	[	X
admet-1622	246	2	65	65	NUM
admet-1622	246	3	]	]	X
admet-1622	246	4	printed	print	VERB
admet-1622	246	5	tablets	tablet	NOUN
admet-1622	246	6	with	with	ADP
admet-1622	246	7	five	five	NUM
admet-1622	246	8	different	different	ADJ
admet-1622	246	9	geometries	geometry	NOUN
admet-1622	246	10	,	,	PUNCT
admet-1622	246	11	namely	namely	ADV
admet-1622	246	12	,	,	PUNCT
admet-1622	246	13	cube	cube	NOUN
admet-1622	246	14	,	,	PUNCT
admet-1622	246	15	pyramid	pyramid	NOUN
admet-1622	246	16	,	,	PUNCT
admet-1622	246	17	cylinder	cylinder	NOUN
admet-1622	246	18	,	,	PUNCT
admet-1622	246	19	sphere	sphere	ADV
admet-1622	246	20	,	,	PUNCT
admet-1622	246	21	and	and	CCONJ
admet-1622	246	22	torus	torus	NOUN
admet-1622	246	23	,	,	PUNCT
admet-1622	246	24	and	and	CCONJ
admet-1622	246	25	observed	observe	VERB
admet-1622	246	26	that	that	SCONJ
admet-1622	246	27	the	the	DET
admet-1622	246	28	drug	drug	NOUN
admet-1622	246	29	release	release	NOUN
admet-1622	246	30	rate	rate	NOUN
admet-1622	246	31	from	from	ADP
admet-1622	246	32	the	the	DET
admet-1622	246	33	tablets	tablet	NOUN
admet-1622	246	34	was	be	AUX
admet-1622	246	35	dependent	dependent	ADJ
admet-1622	246	36	on	on	ADP
admet-1622	246	37	the	the	DET
admet-1622	246	38	surface	surface	NOUN
admet-1622	246	39	area	area	NOUN
admet-1622	246	40	to	to	PART
admet-1622	246	41	volume	volume	VERB
admet-1622	246	42	ratio	ratio	NOUN
admet-1622	246	43	since	since	SCONJ
admet-1622	246	44	,	,	PUNCT
admet-1622	246	45	as	as	SCONJ
admet-1622	246	46	expected	expect	VERB
admet-1622	246	47	,	,	PUNCT
admet-1622	246	48	the	the	PRON
admet-1622	246	49	higher	high	ADJ
admet-1622	246	50	the	the	DET
admet-1622	246	51	surface	surface	NOUN
admet-1622	246	52	to	to	PART
admet-1622	246	53	volume	volume	VERB
admet-1622	246	54	ratio	ratio	NOUN
admet-1622	246	55	was	be	AUX
admet-1622	246	56	,	,	PUNCT
admet-1622	246	57	so	so	ADV
admet-1622	246	58	was	be	AUX
admet-1622	246	59	the	the	DET
admet-1622	246	60	dissolution	dissolution	ADJ
admet-1622	246	61	rate	rate	NOUN
admet-1622	246	62	.	.	PUNCT
admet-1622	247	1	raje	raje	PROPN
admet-1622	247	2	et	et	PROPN
admet-1622	247	3	al	al	PROPN
admet-1622	247	4	.	.	PUNCT
admet-1622	248	1	[	[	X
admet-1622	248	2	67	67	NUM
admet-1622	248	3	]	]	PUNCT
admet-1622	248	4	introduced	introduce	VERB
admet-1622	248	5	a	a	DET
admet-1622	248	6	new	new	ADJ
admet-1622	248	7	tablet	tablet	NOUN
admet-1622	248	8	geometry	geometry	NOUN
admet-1622	248	9	where	where	SCONJ
admet-1622	248	10	they	they	PRON
admet-1622	248	11	applied	apply	VERB
admet-1622	248	12	different	different	ADJ
admet-1622	248	13	numbers	number	NOUN
admet-1622	248	14	of	of	ADP
admet-1622	248	15	outer	outer	ADJ
admet-1622	248	16	shells	shell	NOUN
admet-1622	248	17	to	to	ADP
admet-1622	248	18	the	the	DET
admet-1622	248	19	fdm	fdm	NOUN
admet-1622	248	20	3d	3d	ADV
admet-1622	248	21	-	-	PUNCT
admet-1622	248	22	printed	print	VERB
admet-1622	248	23	tablets	tablet	NOUN
admet-1622	248	24	to	to	PART
admet-1622	248	25	modulate	modulate	VERB
admet-1622	248	26	drug	drug	NOUN
admet-1622	248	27	release	release	NOUN
admet-1622	248	28	from	from	ADP
admet-1622	248	29	tablets	tablet	NOUN
admet-1622	248	30	containing	contain	VERB
admet-1622	248	31	a	a	DET
admet-1622	248	32	water	water	NOUN
admet-1622	248	33	-	-	PUNCT
admet-1622	248	34	soluble	soluble	ADJ
admet-1622	248	35	polymer	polymer	NOUN
admet-1622	248	36	,	,	PUNCT
admet-1622	248	37	poly(2	poly(2	NOUN
admet-1622	248	38	-	-	PUNCT
admet-1622	248	39	ethyl	ethyl	NOUN
admet-1622	248	40	-	-	PUNCT
admet-1622	248	41	tetra	tetra	NOUN
admet-1622	248	42	-	-	PUNCT
admet-1622	248	43	oxazoline	oxazoline	NOUN
admet-1622	248	44	)	)	PUNCT
admet-1622	249	1	[	[	X
admet-1622	249	2	petox	petox	NOUN
admet-1622	249	3	]	]	X
admet-1622	249	4	,	,	PUNCT
admet-1622	249	5	and	and	CCONJ
admet-1622	249	6	two	two	NUM
admet-1622	249	7	different	different	ADJ
admet-1622	249	8	drugs	drug	NOUN
admet-1622	249	9	(	(	PUNCT
admet-1622	249	10	dextromethorphan	dextromethorphan	PROPN
admet-1622	249	11	hydrobromide	hydrobromide	NOUN
admet-1622	249	12	and	and	CCONJ
admet-1622	249	13	hydrochlorothiazide	hydrochlorothiazide	NOUN
admet-1622	249	14	)	)	PUNCT
admet-1622	249	15	.	.	PUNCT
admet-1622	250	1	the	the	DET
admet-1622	250	2	drug	drug	NOUN
admet-1622	250	3	release	release	NOUN
admet-1622	250	4	rate	rate	NOUN
admet-1622	250	5	increased	increase	VERB
admet-1622	250	6	with	with	ADP
admet-1622	250	7	the	the	DET
admet-1622	250	8	decrease	decrease	NOUN
admet-1622	250	9	in	in	ADP
admet-1622	250	10	the	the	DET
admet-1622	250	11	number	number	NOUN
admet-1622	250	12	of	of	ADP
admet-1622	250	13	outer	outer	ADJ
admet-1622	250	14	shells	shell	NOUN
admet-1622	250	15	.	.	PUNCT
admet-1622	251	1	the	the	DET
admet-1622	251	2	release	release	NOUN
admet-1622	251	3	rates	rate	NOUN
admet-1622	251	4	of	of	ADP
admet-1622	251	5	dextromethorphan	dextromethorphan	ADJ
admet-1622	251	6	hydrobromide	hydrobromide	NOUN
admet-1622	251	7	from	from	ADP
admet-1622	251	8	one	one	NUM
admet-1622	251	9	-	-	PUNCT
admet-1622	251	10	shell	shell	NOUN
admet-1622	251	11	and	and	CCONJ
admet-1622	251	12	five	five	NUM
admet-1622	251	13	-	-	PUNCT
admet-1622	251	14	shell	shell	NOUN
admet-1622	251	15	tablets	tablet	NOUN
admet-1622	251	16	were	be	AUX
admet-1622	251	17	,	,	PUNCT
admet-1622	251	18	respectively	respectively	ADV
admet-1622	251	19	,	,	PUNCT
admet-1622	251	20	>	>	X
admet-1622	251	21	80	80	NUM
admet-1622	251	22	%	%	NOUN
admet-1622	251	23	and	and	CCONJ
admet-1622	251	24	>	>	SYM
admet-1622	251	25	60	60	NUM
admet-1622	251	26	%	%	NOUN
admet-1622	251	27	in	in	ADP
admet-1622	251	28	1	1	NUM
admet-1622	251	29	h	h	NOUN
admet-1622	251	30	,	,	PUNCT
admet-1622	251	31	and	and	CCONJ
admet-1622	251	32	because	because	SCONJ
admet-1622	251	33	of	of	ADP
admet-1622	251	34	the	the	DET
admet-1622	251	35	lower	low	ADJ
admet-1622	251	36	solubility	solubility	NOUN
admet-1622	251	37	of	of	ADP
admet-1622	251	38	hydrochlorothiazide	hydrochlorothiazide	NOUN
admet-1622	251	39	,	,	PUNCT
admet-1622	251	40	the	the	DET
admet-1622	251	41	release	release	NOUN
admet-1622	251	42	rate	rate	NOUN
admet-1622	251	43	was	be	AUX
admet-1622	251	44	much	much	ADV
admet-1622	251	45	lower	low	ADJ
admet-1622	251	46	as	as	SCONJ
admet-1622	251	47	it	it	PRON
admet-1622	251	48	took	take	VERB
admet-1622	251	49	2	2	NUM
admet-1622	251	50	h	h	NOUN
admet-1622	251	51	for	for	ADP
admet-1622	251	52	80	80	NUM
admet-1622	251	53	%	%	NOUN
admet-1622	251	54	drug	drug	NOUN
admet-1622	251	55	release	release	NOUN
admet-1622	251	56	from	from	ADP
admet-1622	251	57	a	a	DET
admet-1622	251	58	one	one	NUM
admet-1622	251	59	-	-	PUNCT
admet-1622	251	60	shell	shell	NOUN
admet-1622	251	61	tablet	tablet	NOUN
admet-1622	251	62	.	.	PUNCT
admet-1622	252	1	although	although	SCONJ
admet-1622	252	2	the	the	DET
admet-1622	252	3	modification	modification	NOUN
admet-1622	252	4	of	of	ADP
admet-1622	252	5	tablet	tablet	NOUN
admet-1622	252	6	geometry	geometry	NOUN
admet-1622	252	7	could	could	AUX
admet-1622	252	8	be	be	AUX
admet-1622	252	9	an	an	DET
admet-1622	252	10	attractive	attractive	ADJ
admet-1622	252	11	approach	approach	NOUN
admet-1622	252	12	to	to	PART
admet-1622	252	13	increase	increase	VERB
admet-1622	252	14	dissolution	dissolution	ADJ
admet-1622	252	15	rates	rate	NOUN
admet-1622	252	16	of	of	ADP
admet-1622	252	17	fdm	fdm	NOUN
admet-1622	252	18	3d	3d	ADV
admet-1622	252	19	-	-	PUNCT
admet-1622	252	20	printed	print	VERB
admet-1622	252	21	tablet	tablet	NOUN
admet-1622	252	22	,	,	PUNCT
admet-1622	252	23	melocchi	melocchi	PROPN
admet-1622	252	24	et	et	PROPN
admet-1622	252	25	al	al	PROPN
admet-1622	252	26	.	.	PUNCT
admet-1622	253	1	[	[	X
admet-1622	253	2	68	68	NUM
admet-1622	253	3	]	]	PUNCT
admet-1622	253	4	reported	report	VERB
admet-1622	253	5	that	that	SCONJ
admet-1622	253	6	computer	computer	NOUN
admet-1622	253	7	-	-	PUNCT
admet-1622	253	8	aided	aid	VERB
admet-1622	253	9	design	design	NOUN
admet-1622	253	10	(	(	PUNCT
admet-1622	253	11	cad	cad	NOUN
admet-1622	253	12	)	)	PUNCT
admet-1622	253	13	of	of	ADP
admet-1622	253	14	such	such	ADJ
admet-1622	253	15	tablets	tablet	NOUN
admet-1622	253	16	could	could	AUX
admet-1622	253	17	be	be	AUX
admet-1622	253	18	very	very	ADV
admet-1622	253	19	challenging	challenging	ADJ
admet-1622	253	20	as	as	SCONJ
admet-1622	253	21	they	they	PRON
admet-1622	253	22	involve	involve	VERB
admet-1622	253	23	detailed	detailed	ADJ
admet-1622	253	24	and	and	CCONJ
admet-1622	253	25	complex	complex	ADJ
admet-1622	253	26	digital	digital	ADJ
admet-1622	253	27	models	model	NOUN
admet-1622	253	28	,	,	PUNCT
admet-1622	253	29	and	and	CCONJ
admet-1622	253	30	the	the	DET
admet-1622	253	31	users	user	NOUN
admet-1622	253	32	may	may	AUX
admet-1622	253	33	need	need	VERB
admet-1622	253	34	extensive	extensive	ADJ
admet-1622	253	35	training	training	NOUN
admet-1622	253	36	and	and	CCONJ
admet-1622	253	37	years	year	NOUN
admet-1622	253	38	of	of	ADP
admet-1622	253	39	experience	experience	NOUN
admet-1622	253	40	to	to	PART
admet-1622	253	41	master	master	VERB
admet-1622	253	42	all	all	DET
admet-1622	253	43	the	the	DET
admet-1622	253	44	functionalities	functionality	NOUN
admet-1622	253	45	.	.	PUNCT
admet-1622	254	1	this	this	PRON
admet-1622	254	2	is	be	AUX
admet-1622	254	3	possibly	possibly	ADV
admet-1622	254	4	the	the	DET
admet-1622	254	5	reason	reason	NOUN
admet-1622	254	6	why	why	SCONJ
admet-1622	254	7	each	each	DET
admet-1622	254	8	geometric	geometric	ADJ
admet-1622	254	9	design	design	NOUN
admet-1622	254	10	of	of	ADP
admet-1622	254	11	3d	3d	NOUN
admet-1622	254	12	-	-	PUNCT
admet-1622	254	13	printed	print	VERB
admet-1622	254	14	tablets	tablet	NOUN
admet-1622	254	15	reported	report	VERB
admet-1622	254	16	in	in	ADP
admet-1622	254	17	the	the	DET
admet-1622	254	18	literature	literature	NOUN
admet-1622	254	19	,	,	PUNCT
admet-1622	254	20	except	except	SCONJ
admet-1622	254	21	for	for	ADP
admet-1622	254	22	the	the	DET
admet-1622	254	23	infill	infill	NOUN
admet-1622	254	24	density	density	NOUN
admet-1622	254	25	,	,	PUNCT
admet-1622	254	26	is	be	AUX
admet-1622	254	27	essentially	essentially	ADV
admet-1622	254	28	one	one	NUM
admet-1622	254	29	of	of	ADP
admet-1622	254	30	a	a	DET
admet-1622	254	31	kind	kind	NOUN
admet-1622	254	32	and	and	CCONJ
admet-1622	254	33	there	there	PRON
admet-1622	254	34	is	be	VERB
admet-1622	254	35	not	not	PART
admet-1622	254	36	much	much	ADJ
admet-1622	254	37	follow	follow	NOUN
admet-1622	254	38	-	-	PUNCT
admet-1622	254	39	up	up	NOUN
admet-1622	254	40	of	of	ADP
admet-1622	254	41	the	the	DET
admet-1622	254	42	technique	technique	NOUN
admet-1622	254	43	by	by	ADP
admet-1622	254	44	other	other	ADJ
admet-1622	254	45	investigators	investigator	NOUN
admet-1622	254	46	.	.	PUNCT
admet-1622	255	1	hopefully	hopefully	ADV
admet-1622	255	2	,	,	PUNCT
admet-1622	255	3	the	the	DET
admet-1622	255	4	technology	technology	NOUN
admet-1622	255	5	will	will	AUX
admet-1622	255	6	grow	grow	VERB
admet-1622	255	7	rapidly	rapidly	ADV
admet-1622	255	8	enough	enough	ADV
admet-1622	255	9	that	that	SCONJ
admet-1622	255	10	the	the	DET
admet-1622	255	11	geometric	geometric	ADJ
admet-1622	255	12	modification	modification	NOUN
admet-1622	255	13	will	will	AUX
admet-1622	255	14	be	be	AUX
admet-1622	255	15	easy	easy	ADJ
admet-1622	255	16	to	to	PART
admet-1622	255	17	design	design	VERB
admet-1622	255	18	and	and	CCONJ
admet-1622	255	19	will	will	AUX
admet-1622	255	20	become	become	VERB
admet-1622	255	21	more	more	ADJ
admet-1622	255	22	user	user	NOUN
admet-1622	255	23	-	-	PUNCT
admet-1622	255	24	friendly	friendly	ADJ
admet-1622	255	25	.	.	PUNCT
admet-1622	256	1	in	in	ADP
admet-1622	256	2	addition	addition	NOUN
admet-1622	256	3	to	to	ADP
admet-1622	256	4	the	the	DET
admet-1622	256	5	complexity	complexity	NOUN
admet-1622	256	6	of	of	ADP
admet-1622	256	7	designing	design	VERB
admet-1622	256	8	tablets	tablet	NOUN
admet-1622	256	9	,	,	PUNCT
admet-1622	256	10	one	one	PRON
admet-1622	256	11	should	should	AUX
admet-1622	256	12	keep	keep	VERB
admet-1622	256	13	in	in	ADP
admet-1622	256	14	mind	mind	NOUN
admet-1622	256	15	that	that	SCONJ
admet-1622	256	16	the	the	DET
admet-1622	256	17	geometric	geometric	ADJ
admet-1622	256	18	modification	modification	NOUN
admet-1622	256	19	may	may	AUX
admet-1622	256	20	improve	improve	VERB
admet-1622	256	21	the	the	DET
admet-1622	256	22	dissolution	dissolution	NOUN
admet-1622	256	23	rate	rate	NOUN
admet-1622	256	24	only	only	ADV
admet-1622	256	25	to	to	ADP
admet-1622	256	26	a	a	DET
admet-1622	256	27	certain	certain	ADJ
admet-1622	256	28	extent	extent	NOUN
admet-1622	256	29	,	,	PUNCT
admet-1622	256	30	and	and	CCONJ
admet-1622	256	31	it	it	PRON
admet-1622	256	32	may	may	AUX
admet-1622	256	33	not	not	PART
admet-1622	256	34	always	always	ADV
admet-1622	256	35	lead	lead	VERB
admet-1622	256	36	to	to	PART
admet-1622	256	37	immediately	immediately	ADV
admet-1622	256	38	dissolving	dissolve	VERB
admet-1622	256	39	or	or	CCONJ
admet-1622	256	40	rapidly	rapidly	ADV
admet-1622	256	41	dissolving	dissolve	VERB
admet-1622	256	42	tablets	tablet	NOUN
admet-1622	256	43	,	,	PUNCT
admet-1622	256	44	which	which	PRON
admet-1622	256	45	also	also	ADV
admet-1622	256	46	depends	depend	VERB
admet-1622	256	47	on	on	ADP
admet-1622	256	48	types	type	NOUN
admet-1622	256	49	of	of	ADP
admet-1622	256	50	polymers	polymer	NOUN
admet-1622	256	51	used	use	VERB
admet-1622	256	52	and	and	CCONJ
admet-1622	256	53	compositions	composition	NOUN
admet-1622	256	54	of	of	ADP
admet-1622	256	55	formulations	formulation	NOUN
admet-1622	256	56	.	.	PUNCT
admet-1622	257	1	application	application	NOUN
admet-1622	257	2	of	of	ADP
admet-1622	257	3	acid	acid	NOUN
admet-1622	257	4	-	-	PUNCT
admet-1622	257	5	base	base	NOUN
admet-1622	257	6	supersolubilization	supersolubilization	NOUN
admet-1622	257	7	principle	principle	NOUN
admet-1622	257	8	another	another	DET
admet-1622	257	9	promising	promising	ADJ
admet-1622	257	10	approach	approach	NOUN
admet-1622	257	11	to	to	PART
admet-1622	257	12	increase	increase	VERB
admet-1622	257	13	dissolution	dissolution	ADJ
admet-1622	257	14	rates	rate	NOUN
admet-1622	257	15	of	of	ADP
admet-1622	257	16	fdm	fdm	NOUN
admet-1622	257	17	3d	3d	ADV
admet-1622	257	18	-	-	PUNCT
admet-1622	257	19	printed	print	VERB
admet-1622	257	20	tablets	tablet	NOUN
admet-1622	257	21	that	that	PRON
admet-1622	257	22	has	have	AUX
admet-1622	257	23	been	be	AUX
admet-1622	257	24	recently	recently	ADV
admet-1622	257	25	introduced	introduce	VERB
admet-1622	257	26	by	by	ADP
admet-1622	257	27	patel	patel	NOUN
admet-1622	257	28	and	and	CCONJ
admet-1622	257	29	serajuddin	serajuddin	VERB
admet-1622	257	30	[	[	X
admet-1622	257	31	20,21	20,21	NUM
admet-1622	257	32	]	]	PUNCT
admet-1622	257	33	is	be	AUX
admet-1622	257	34	the	the	DET
admet-1622	257	35	application	application	NOUN
admet-1622	257	36	of	of	ADP
admet-1622	257	37	acid	acid	NOUN
admet-1622	257	38	-	-	PUNCT
admet-1622	257	39	based	base	VERB
admet-1622	257	40	supersolubilization	supersolubilization	NOUN
admet-1622	257	41	or	or	CCONJ
admet-1622	257	42	abs	ab	NOUN
admet-1622	257	43	principle	principle	NOUN
admet-1622	257	44	in	in	ADP
admet-1622	257	45	the	the	DET
admet-1622	257	46	development	development	NOUN
admet-1622	257	47	of	of	ADP
admet-1622	257	48	rapidly	rapidly	ADV
admet-1622	257	49	dissolving	dissolve	VERB
admet-1622	257	50	haloperidol	haloperidol	NOUN
admet-1622	257	51	-	-	PUNCT
admet-1622	257	52	glutaric	glutaric	ADJ
admet-1622	257	53	acid	acid	NOUN
admet-1622	257	54	and	and	CCONJ
admet-1622	257	55	haloperidol	haloperidol	NOUN
admet-1622	257	56	-	-	PUNCT
admet-1622	257	57	malic	malic	ADJ
admet-1622	257	58	acid	acid	NOUN
admet-1622	257	59	tablets	tablet	NOUN
admet-1622	257	60	,	,	PUNCT
admet-1622	257	61	where	where	SCONJ
admet-1622	257	62	an	an	DET
admet-1622	257	63	otherwise	otherwise	ADV
admet-1622	257	64	brittle	brittle	ADJ
admet-1622	257	65	polymer	polymer	NOUN
admet-1622	257	66	,	,	PUNCT
admet-1622	257	67	kollidon	kollidon	ADJ
admet-1622	257	68	®	®	NOUN
admet-1622	257	69	va64	va64	PROPN
admet-1622	257	70	,	,	PUNCT
admet-1622	257	71	was	be	AUX
admet-1622	257	72	made	make	VERB
admet-1622	257	73	printable	printable	ADJ
admet-1622	257	74	,	,	PUNCT
admet-1622	257	75	the	the	DET
admet-1622	257	76	loading	loading	NOUN
admet-1622	257	77	in	in	ADP
admet-1622	257	78	the	the	DET
admet-1622	257	79	tablet	tablet	NOUN
admet-1622	257	80	was	be	AUX
admet-1622	257	81	increased	increase	VERB
admet-1622	257	82	,	,	PUNCT
admet-1622	257	83	melt	melt	VERB
admet-1622	257	84	extrusion	extrusion	NOUN
admet-1622	257	85	and	and	CCONJ
admet-1622	257	86	printing	printing	NOUN
admet-1622	257	87	temperatures	temperature	NOUN
admet-1622	257	88	were	be	AUX
admet-1622	257	89	lowered	lower	VERB
admet-1622	257	90	,	,	PUNCT
admet-1622	257	91	and	and	CCONJ
admet-1622	257	92	the	the	DET
admet-1622	257	93	drug	drug	NOUN
admet-1622	257	94	release	release	NOUN
admet-1622	257	95	rate	rate	NOUN
admet-1622	257	96	was	be	AUX
admet-1622	257	97	increased	increase	VERB
admet-1622	257	98	.	.	PUNCT
admet-1622	258	1	the	the	DET
admet-1622	258	2	abs	ab	NOUN
admet-1622	258	3	principle	principle	VERB
admet-1622	258	4	,	,	PUNCT
admet-1622	258	5	as	as	SCONJ
admet-1622	258	6	described	describe	VERB
admet-1622	258	7	in	in	ADP
admet-1622	258	8	figure	figure	NOUN
admet-1622	258	9	4	4	NUM
admet-1622	258	10	,	,	PUNCT
admet-1622	258	11	represents	represent	VERB
admet-1622	258	12	a	a	DET
admet-1622	258	13	novel	novel	ADJ
admet-1622	258	14	strategy	strategy	NOUN
admet-1622	258	15	of	of	ADP
admet-1622	258	16	greatly	greatly	ADV
admet-1622	258	17	increasing	increase	VERB
admet-1622	258	18	the	the	DET
admet-1622	258	19	aqueous	aqueous	ADJ
admet-1622	258	20	solubility	solubility	NOUN
admet-1622	258	21	of	of	ADP
admet-1622	258	22	weakly	weakly	ADJ
admet-1622	258	23	basic	basic	ADJ
admet-1622	258	24	drugs	drug	NOUN
admet-1622	258	25	and	and	CCONJ
admet-1622	258	26	thereby	thereby	ADV
admet-1622	258	27	increasing	increase	VERB
admet-1622	258	28	drug	drug	NOUN
admet-1622	258	29	dissolution	dissolution	NOUN
admet-1622	258	30	rates	rate	NOUN
admet-1622	258	31	by	by	ADP
admet-1622	258	32	interaction	interaction	NOUN
admet-1622	258	33	with	with	ADP
admet-1622	258	34	weak	weak	ADJ
admet-1622	258	35	acids	acid	NOUN
admet-1622	258	36	that	that	PRON
admet-1622	258	37	would	would	AUX
admet-1622	258	38	not	not	PART
admet-1622	258	39	normally	normally	ADV
admet-1622	258	40	form	form	VERB
admet-1622	258	41	salts	salt	NOUN
admet-1622	258	42	with	with	ADP
admet-1622	258	43	the	the	DET
admet-1622	258	44	drugs	drug	NOUN
admet-1622	258	45	[	[	X
admet-1622	258	46	69	69	NUM
admet-1622	258	47	-	-	SYM
admet-1622	258	48	71	71	NUM
admet-1622	258	49	]	]	PUNCT
admet-1622	258	50	.	.	PUNCT
admet-1622	259	1	this	this	DET
admet-1622	259	2	principle	principle	NOUN
admet-1622	259	3	is	be	AUX
admet-1622	259	4	based	base	VERB
admet-1622	259	5	on	on	ADP
admet-1622	259	6	classical	classical	ADJ
admet-1622	259	7	phsolubility	phsolubility	NOUN
admet-1622	259	8	theory	theory	NOUN
admet-1622	259	9	[	[	X
admet-1622	259	10	72,73	72,73	NUM
admet-1622	259	11	]	]	PUNCT
admet-1622	259	12	,	,	PUNCT
admet-1622	259	13	where	where	SCONJ
admet-1622	259	14	,	,	PUNCT
admet-1622	259	15	as	as	SCONJ
admet-1622	259	16	shown	show	VERB
admet-1622	259	17	in	in	ADP
admet-1622	259	18	fig	fig	NOUN
admet-1622	259	19	.	.	PUNCT
admet-1622	260	1	4	4	NUM
admet-1622	260	2	-	-	SYM
admet-1622	260	3	i	i	PRON
admet-1622	260	4	,	,	PUNCT
admet-1622	260	5	the	the	DET
admet-1622	260	6	aqueous	aqueous	ADJ
admet-1622	260	7	solubility	solubility	NOUN
admet-1622	260	8	of	of	ADP
admet-1622	260	9	a	a	DET
admet-1622	260	10	basic	basic	ADJ
admet-1622	260	11	drug	drug	NOUN
admet-1622	260	12	increases	increase	NOUN
admet-1622	260	13	according	accord	VERB
admet-1622	260	14	to	to	ADP
admet-1622	260	15	line	line	NOUN
admet-1622	260	16	a→b	a→b	NUM
admet-1622	260	17	when	when	SCONJ
admet-1622	260	18	the	the	DET
admet-1622	260	19	ph	ph	NOUN
admet-1622	260	20	of	of	ADP
admet-1622	260	21	an	an	DET
admet-1622	260	22	aqueous	aqueous	ADJ
admet-1622	260	23	medium	medium	NOUN
admet-1622	260	24	is	be	AUX
admet-1622	260	25	lowered	lower	VERB
admet-1622	260	26	by	by	ADP
admet-1622	260	27	the	the	DET
admet-1622	260	28	addition	addition	NOUN
admet-1622	260	29	of	of	ADP
admet-1622	260	30	acid	acid	NOUN
admet-1622	260	31	until	until	ADP
admet-1622	260	32	phmax	phmax	NOUN
admet-1622	260	33	or	or	CCONJ
admet-1622	260	34	the	the	DET
admet-1622	260	35	ph	ph	NOUN
admet-1622	260	36	of	of	ADP
admet-1622	260	37	maximum	maximum	ADJ
admet-1622	260	38	solubility	solubility	NOUN
admet-1622	260	39	(	(	PUNCT
admet-1622	260	40	pont	pont	PROPN
admet-1622	260	41	b	b	NOUN
admet-1622	260	42	)	)	PUNCT
admet-1622	260	43	,	,	PUNCT
admet-1622	260	44	is	be	AUX
admet-1622	260	45	reached	reach	VERB
admet-1622	260	46	.	.	PUNCT
admet-1622	261	1	a	a	DET
admet-1622	261	2	salt	salt	NOUN
admet-1622	261	3	is	be	AUX
admet-1622	261	4	formed	form	VERB
admet-1622	261	5	below	below	ADP
admet-1622	261	6	phmax	phmax	NOUN
admet-1622	261	7	,	,	PUNCT
admet-1622	261	8	where	where	SCONJ
admet-1622	261	9	the	the	DET
admet-1622	261	10	drug	drug	NOUN
admet-1622	261	11	solubility	solubility	NOUN
admet-1622	261	12	is	be	AUX
admet-1622	261	13	dictated	dictate	VERB
admet-1622	261	14	by	by	ADP
admet-1622	261	15	the	the	DET
admet-1622	261	16	solubility	solubility	NOUN
admet-1622	261	17	of	of	ADP
admet-1622	261	18	its	its	PRON
admet-1622	261	19	salt	salt	NOUN
admet-1622	261	20	(	(	PUNCT
admet-1622	261	21	line	line	NOUN
admet-1622	261	22	b→c	b→c	NUM
admet-1622	261	23	)	)	PUNCT
admet-1622	261	24	.	.	PUNCT
admet-1622	262	1	however	however	ADV
admet-1622	262	2	,	,	PUNCT
admet-1622	262	3	as	as	SCONJ
admet-1622	262	4	shown	show	VERB
admet-1622	262	5	in	in	ADP
admet-1622	262	6	fig	fig	NOUN
admet-1622	262	7	.	.	PUNCT
admet-1622	263	1	4	4	NUM
admet-1622	263	2	-	-	SYM
admet-1622	263	3	ii	ii	NOUN
admet-1622	263	4	,	,	PUNCT
admet-1622	263	5	if	if	SCONJ
admet-1622	263	6	the	the	DET
admet-1622	263	7	added	add	VERB
admet-1622	263	8	acid	acid	NOUN
admet-1622	263	9	is	be	AUX
admet-1622	263	10	not	not	PART
admet-1622	263	11	strong	strong	ADJ
admet-1622	263	12	enough	enough	ADV
admet-1622	263	13	to	to	PART
admet-1622	263	14	lower	lower	VERB
admet-1622	263	15	ph	ph	NOUN
admet-1622	263	16	below	below	ADP
admet-1622	263	17	phmax	phmax	NOUN
admet-1622	263	18	,	,	PUNCT
admet-1622	263	19	no	no	DET
admet-1622	263	20	salt	salt	NOUN
admet-1622	263	21	is	be	AUX
admet-1622	263	22	formed	form	VERB
admet-1622	263	23	,	,	PUNCT
admet-1622	263	24	and	and	CCONJ
admet-1622	263	25	the	the	DET
admet-1622	263	26	solubility	solubility	NOUN
admet-1622	263	27	of	of	ADP
admet-1622	263	28	the	the	DET
admet-1622	263	29	basic	basic	ADJ
admet-1622	263	30	drug	drug	NOUN
admet-1622	263	31	keeps	keep	VERB
admet-1622	263	32	on	on	ADP
admet-1622	263	33	increasing	increase	VERB
admet-1622	263	34	,	,	PUNCT
admet-1622	263	35	leading	lead	VERB
admet-1622	263	36	to	to	ADP
admet-1622	263	37	supersolubilization	supersolubilization	NOUN
admet-1622	263	38	.	.	PUNCT
admet-1622	264	1	singh	singh	PROPN
admet-1622	264	2	et	et	PROPN
admet-1622	264	3	al	al	PROPN
admet-1622	264	4	.	.	PUNCT
admet-1622	265	1	[	[	X
admet-1622	265	2	70	70	NUM
admet-1622	265	3	]	]	PUNCT
admet-1622	265	4	observed	observe	VERB
admet-1622	265	5	that	that	SCONJ
admet-1622	265	6	the	the	DET
admet-1622	265	7	aqueous	aqueous	ADJ
admet-1622	265	8	solubility	solubility	NOUN
admet-1622	265	9	of	of	ADP
admet-1622	265	10	the	the	DET
admet-1622	265	11	model	model	NOUN
admet-1622	265	12	drug	drug	NOUN
admet-1622	265	13	,	,	PUNCT
admet-1622	265	14	haloperidol	haloperidol	NOUN
admet-1622	265	15	,	,	PUNCT
admet-1622	265	16	could	could	AUX
admet-1622	265	17	be	be	AUX
admet-1622	265	18	increased	increase	VERB
admet-1622	265	19	from	from	ADP
admet-1622	265	20	the	the	DET
admet-1622	265	21	free	free	ADJ
admet-1622	265	22	base	base	NOUN
admet-1622	265	23	solubility	solubility	NOUN
admet-1622	265	24	of	of	ADP
admet-1622	265	25	1	1	NUM
admet-1622	265	26	µg	µg	NOUN
admet-1622	265	27	/	/	SYM
admet-1622	265	28	ml	ml	NOUN
admet-1622	265	29	to	to	ADP
admet-1622	265	30	>	>	SYM
admet-1622	265	31	300	300	NUM
admet-1622	265	32	mg	mg	NUM
admet-1622	265	33	/	/	SYM
admet-1622	265	34	ml	ml	NOUN
admet-1622	265	35	when	when	SCONJ
admet-1622	265	36	weak	weak	ADJ
admet-1622	265	37	acids	acid	NOUN
admet-1622	265	38	like	like	ADP
admet-1622	265	39	malic	malic	NOUN
admet-1622	265	40	,	,	PUNCT
admet-1622	265	41	admet	admet	PROPN
admet-1622	265	42	&	&	CCONJ
admet-1622	265	43	dmpk	dmpk	PROPN
admet-1622	265	44	11(1	11(1	NUM
admet-1622	265	45	)	)	PUNCT
admet-1622	265	46	(	(	PUNCT
admet-1622	265	47	2023	2023	NUM
admet-1622	265	48	)	)	PUNCT
admet-1622	265	49	33	33	NUM
admet-1622	265	50	-	-	SYM
admet-1622	265	51	55	55	NUM
admet-1622	265	52	development	development	NOUN
admet-1622	265	53	of	of	ADP
admet-1622	265	54	rapidly	rapidly	ADV
admet-1622	265	55	dissolving	dissolve	VERB
admet-1622	265	56	fdm	fdm	NOUN
admet-1622	265	57	3d	3d	ADV
admet-1622	265	58	-	-	PUNCT
admet-1622	265	59	printed	print	VERB
admet-1622	265	60	tablets	tablet	NOUN
admet-1622	265	61	doi	doi	NOUN
admet-1622	265	62	:	:	PUNCT
admet-1622	265	63	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	265	64	45	45	NUM
admet-1622	265	65	tartaric	tartaric	ADJ
admet-1622	265	66	,	,	PUNCT
admet-1622	265	67	and	and	CCONJ
admet-1622	265	68	citric	citric	ADJ
admet-1622	265	69	acids	acid	NOUN
admet-1622	265	70	were	be	AUX
admet-1622	265	71	used	use	VERB
admet-1622	265	72	to	to	PART
admet-1622	265	73	decrease	decrease	VERB
admet-1622	265	74	ph	ph	PROPN
admet-1622	265	75	.	.	PROPN
admet-1622	265	76	when	when	SCONJ
admet-1622	265	77	the	the	DET
admet-1622	265	78	highly	highly	ADV
admet-1622	265	79	concentrated	concentrated	ADJ
admet-1622	265	80	solutions	solution	NOUN
admet-1622	265	81	were	be	AUX
admet-1622	265	82	dried	dry	VERB
admet-1622	265	83	,	,	PUNCT
admet-1622	265	84	they	they	PRON
admet-1622	265	85	formed	form	VERB
admet-1622	265	86	amorphous	amorphous	ADJ
admet-1622	265	87	solids	solid	NOUN
admet-1622	265	88	.	.	PUNCT
admet-1622	266	1	parikh	parikh	PROPN
admet-1622	266	2	et	et	PROPN
admet-1622	266	3	al	al	PROPN
admet-1622	266	4	.	.	PUNCT
admet-1622	267	1	[	[	X
admet-1622	267	2	74	74	NUM
admet-1622	267	3	]	]	PUNCT
admet-1622	267	4	demonstrated	demonstrate	VERB
admet-1622	267	5	that	that	SCONJ
admet-1622	267	6	such	such	DET
admet-1622	267	7	an	an	DET
admet-1622	267	8	acid	acid	ADJ
admet-1622	267	9	-	-	PUNCT
admet-1622	267	10	base	base	NOUN
admet-1622	267	11	interaction	interaction	NOUN
admet-1622	267	12	leading	lead	VERB
admet-1622	267	13	to	to	ADP
admet-1622	267	14	the	the	DET
admet-1622	267	15	formation	formation	NOUN
admet-1622	267	16	of	of	ADP
admet-1622	267	17	amorphous	amorphous	ADJ
admet-1622	267	18	drugs	drug	NOUN
admet-1622	267	19	can	can	AUX
admet-1622	267	20	also	also	ADV
admet-1622	267	21	occur	occur	VERB
admet-1622	267	22	in	in	ADP
admet-1622	267	23	a	a	DET
admet-1622	267	24	solid	solid	ADJ
admet-1622	267	25	state	state	NOUN
admet-1622	267	26	when	when	SCONJ
admet-1622	267	27	mixtures	mixture	NOUN
admet-1622	267	28	of	of	ADP
admet-1622	267	29	basic	basic	ADJ
admet-1622	267	30	drugs	drug	NOUN
admet-1622	267	31	with	with	ADP
admet-1622	267	32	weak	weak	ADJ
admet-1622	267	33	acids	acid	NOUN
admet-1622	267	34	are	be	AUX
admet-1622	267	35	heated	heat	VERB
admet-1622	267	36	together	together	ADV
admet-1622	267	37	or	or	CCONJ
admet-1622	267	38	when	when	SCONJ
admet-1622	267	39	the	the	DET
admet-1622	267	40	acid	acid	NOUN
admet-1622	267	41	-	-	PUNCT
admet-1622	267	42	base	base	NOUN
admet-1622	267	43	mixtures	mixture	NOUN
admet-1622	267	44	were	be	AUX
admet-1622	267	45	melt	melt	VERB
admet-1622	267	46	extruded	extrude	VERB
admet-1622	267	47	along	along	ADP
admet-1622	267	48	with	with	ADP
admet-1622	267	49	polymers	polymer	NOUN
admet-1622	267	50	.	.	PUNCT
admet-1622	268	1	in	in	ADP
admet-1622	268	2	contact	contact	NOUN
admet-1622	268	3	with	with	ADP
admet-1622	268	4	water	water	NOUN
admet-1622	268	5	,	,	PUNCT
admet-1622	268	6	the	the	DET
admet-1622	268	7	amorphous	amorphous	ADJ
admet-1622	268	8	drugs	drug	NOUN
admet-1622	268	9	can	can	AUX
admet-1622	268	10	exhibit	exhibit	VERB
admet-1622	268	11	supersolubilization	supersolubilization	NOUN
admet-1622	268	12	and	and	CCONJ
admet-1622	268	13	high	high	ADJ
admet-1622	268	14	dissolution	dissolution	NOUN
admet-1622	268	15	rates	rate	NOUN
admet-1622	268	16	.	.	PUNCT
admet-1622	269	1	the	the	DET
admet-1622	269	2	application	application	NOUN
admet-1622	269	3	of	of	ADP
admet-1622	269	4	such	such	ADJ
admet-1622	269	5	findings	finding	NOUN
admet-1622	269	6	in	in	ADP
admet-1622	269	7	greatly	greatly	ADV
admet-1622	269	8	increasing	increase	VERB
admet-1622	269	9	dissolution	dissolution	ADJ
admet-1622	269	10	rates	rate	NOUN
admet-1622	269	11	of	of	ADP
admet-1622	269	12	basic	basic	ADJ
admet-1622	269	13	drugs	drug	NOUN
admet-1622	269	14	from	from	ADP
admet-1622	269	15	the	the	DET
admet-1622	269	16	fdm	fdm	NOUN
admet-1622	269	17	3d	3d	ADV
admet-1622	269	18	-	-	PUNCT
admet-1622	269	19	printed	print	VERB
admet-1622	269	20	tablets	tablet	NOUN
admet-1622	269	21	will	will	AUX
admet-1622	269	22	be	be	AUX
admet-1622	269	23	illustrated	illustrate	VERB
admet-1622	269	24	later	later	ADV
admet-1622	269	25	in	in	ADP
admet-1622	269	26	case	case	NOUN
admet-1622	269	27	study	study	NOUN
admet-1622	269	28	2	2	NUM
admet-1622	269	29	.	.	PUNCT
admet-1622	270	1	some	some	DET
admet-1622	270	2	recent	recent	ADJ
admet-1622	270	3	findings	finding	NOUN
admet-1622	270	4	in	in	ADP
admet-1622	270	5	our	our	PRON
admet-1622	270	6	laboratory	laboratory	NOUN
admet-1622	270	7	demonstrated	demonstrate	VERB
admet-1622	270	8	that	that	SCONJ
admet-1622	270	9	the	the	DET
admet-1622	270	10	abs	ab	NOUN
admet-1622	270	11	principle	principle	NOUN
admet-1622	270	12	is	be	AUX
admet-1622	270	13	also	also	ADV
admet-1622	270	14	applicable	applicable	ADJ
admet-1622	270	15	to	to	ADP
admet-1622	270	16	increasing	increase	VERB
admet-1622	270	17	dissolution	dissolution	ADJ
admet-1622	270	18	rates	rate	NOUN
admet-1622	270	19	of	of	ADP
admet-1622	270	20	acidic	acidic	ADJ
admet-1622	270	21	drugs	drug	NOUN
admet-1622	270	22	from	from	ADP
admet-1622	270	23	fdm	fdm	NOUN
admet-1622	270	24	3d	3d	ADV
admet-1622	270	25	-	-	PUNCT
admet-1622	270	26	printed	print	VERB
admet-1622	270	27	tablets	tablet	NOUN
admet-1622	270	28	by	by	ADP
admet-1622	270	29	interaction	interaction	NOUN
admet-1622	270	30	with	with	ADP
admet-1622	270	31	weak	weak	ADJ
admet-1622	270	32	bases	basis	NOUN
admet-1622	270	33	.	.	PUNCT
admet-1622	271	1	figure	figure	VERB
admet-1622	271	2	4	4	NUM
admet-1622	271	3	.	.	PUNCT
admet-1622	271	4	graphical	graphical	ADJ
admet-1622	271	5	illustration	illustration	NOUN
admet-1622	271	6	of	of	ADP
admet-1622	271	7	acid	acid	NOUN
admet-1622	271	8	-	-	PUNCT
admet-1622	271	9	base	base	NOUN
admet-1622	271	10	supersolubilization	supersolubilization	NOUN
admet-1622	271	11	(	(	PUNCT
admet-1622	271	12	abs	ab	NOUN
admet-1622	271	13	)	)	PUNCT
admet-1622	271	14	principle	principle	NOUN
admet-1622	271	15	for	for	ADP
admet-1622	271	16	a	a	DET
admet-1622	271	17	basic	basic	ADJ
admet-1622	271	18	drug	drug	NOUN
admet-1622	271	19	,	,	PUNCT
admet-1622	271	20	where	where	SCONJ
admet-1622	271	21	graph	graph	NOUN
admet-1622	271	22	i	i	PRON
admet-1622	271	23	(	(	PUNCT
admet-1622	271	24	top	top	ADJ
admet-1622	271	25	)	)	PUNCT
admet-1622	271	26	represents	represent	VERB
admet-1622	271	27	a	a	DET
admet-1622	271	28	typical	typical	ADJ
admet-1622	271	29	ph	ph	NOUN
admet-1622	271	30	versus	versus	ADP
admet-1622	271	31	solubility	solubility	NOUN
admet-1622	271	32	profile	profile	NOUN
admet-1622	271	33	resulting	result	VERB
admet-1622	271	34	in	in	ADP
admet-1622	271	35	salt	salt	NOUN
admet-1622	271	36	formation	formation	NOUN
admet-1622	271	37	at	at	ADP
admet-1622	271	38	low	low	ADJ
admet-1622	271	39	ph	ph	VERB
admet-1622	271	40	,	,	PUNCT
admet-1622	271	41	and	and	CCONJ
admet-1622	271	42	graph	graph	NOUN
admet-1622	271	43	2	2	NUM
admet-1622	271	44	(	(	PUNCT
admet-1622	271	45	bottom	bottom	ADJ
admet-1622	271	46	)	)	PUNCT
admet-1622	271	47	shows	show	VERB
admet-1622	271	48	a	a	DET
admet-1622	271	49	high	high	ADJ
admet-1622	271	50	increase	increase	NOUN
admet-1622	271	51	in	in	ADP
admet-1622	271	52	solubility	solubility	NOUN
admet-1622	271	53	(	(	PUNCT
admet-1622	271	54	supersolubilization	supersolubilization	NOUN
admet-1622	271	55	)	)	PUNCT
admet-1622	271	56	with	with	ADP
admet-1622	271	57	lowering	lower	VERB
admet-1622	271	58	of	of	ADP
admet-1622	271	59	ph	ph	NOUN
admet-1622	271	60	when	when	SCONJ
admet-1622	271	61	no	no	DET
admet-1622	271	62	salt	salt	NOUN
admet-1622	271	63	is	be	AUX
admet-1622	271	64	formed	form	VERB
admet-1622	271	65	by	by	ADP
admet-1622	271	66	the	the	DET
admet-1622	271	67	addition	addition	NOUN
admet-1622	271	68	of	of	ADP
admet-1622	271	69	a	a	DET
admet-1622	271	70	weak	weak	ADJ
admet-1622	271	71	acid	acid	NOUN
admet-1622	271	72	.	.	PUNCT
admet-1622	272	1	recent	recent	ADJ
admet-1622	272	2	progress	progress	NOUN
admet-1622	272	3	in	in	ADP
admet-1622	272	4	development	development	NOUN
admet-1622	272	5	of	of	ADP
admet-1622	272	6	fdm	fdm	NOUN
admet-1622	272	7	3d	3d	ADV
admet-1622	272	8	-	-	PUNCT
admet-1622	272	9	printed	print	VERB
admet-1622	272	10	tablets	tablet	NOUN
admet-1622	272	11	–	–	PUNCT
admet-1622	272	12	case	case	NOUN
admet-1622	272	13	studies	study	NOUN
admet-1622	272	14	as	as	ADP
admet-1622	272	15	evident	evident	ADJ
admet-1622	272	16	from	from	ADP
admet-1622	272	17	the	the	DET
admet-1622	272	18	above	above	ADJ
admet-1622	272	19	review	review	NOUN
admet-1622	272	20	of	of	ADP
admet-1622	272	21	literature	literature	NOUN
admet-1622	272	22	,	,	PUNCT
admet-1622	272	23	ensuring	ensure	VERB
admet-1622	272	24	rapid	rapid	ADJ
admet-1622	272	25	drug	drug	NOUN
admet-1622	272	26	release	release	NOUN
admet-1622	272	27	is	be	AUX
admet-1622	272	28	a	a	DET
admet-1622	272	29	major	major	ADJ
admet-1622	272	30	challenge	challenge	NOUN
admet-1622	272	31	in	in	ADP
admet-1622	272	32	the	the	DET
admet-1622	272	33	development	development	NOUN
admet-1622	272	34	of	of	ADP
admet-1622	272	35	successful	successful	ADJ
admet-1622	272	36	fdm	fdm	NOUN
admet-1622	272	37	3d	3d	ADV
admet-1622	272	38	-	-	PUNCT
admet-1622	272	39	printed	print	VERB
admet-1622	272	40	tablets	tablet	NOUN
admet-1622	272	41	.	.	PUNCT
admet-1622	273	1	most	most	ADJ
admet-1622	273	2	studies	study	NOUN
admet-1622	273	3	to	to	PART
admet-1622	273	4	increase	increase	VERB
admet-1622	273	5	drug	drug	NOUN
admet-1622	273	6	release	release	NOUN
admet-1622	273	7	rates	rate	NOUN
admet-1622	273	8	from	from	ADP
admet-1622	273	9	such	such	ADJ
admet-1622	273	10	tablets	tablet	NOUN
admet-1622	273	11	reported	report	VERB
admet-1622	273	12	in	in	ADP
admet-1622	273	13	the	the	DET
admet-1622	273	14	literature	literature	NOUN
admet-1622	273	15	have	have	AUX
admet-1622	273	16	been	be	AUX
admet-1622	273	17	preliminary	preliminary	ADJ
admet-1622	273	18	and	and	CCONJ
admet-1622	273	19	exploratory	exploratory	ADJ
admet-1622	273	20	in	in	ADP
admet-1622	273	21	nature	nature	NOUN
admet-1622	273	22	.	.	PUNCT
admet-1622	274	1	however	however	ADV
admet-1622	274	2	,	,	PUNCT
admet-1622	274	3	intense	intense	ADJ
admet-1622	274	4	efforts	effort	NOUN
admet-1622	274	5	towards	towards	ADP
admet-1622	274	6	the	the	DET
admet-1622	274	7	development	development	NOUN
admet-1622	274	8	of	of	ADP
admet-1622	274	9	new	new	ADJ
admet-1622	274	10	strategies	strategy	NOUN
admet-1622	274	11	for	for	ADP
admet-1622	274	12	the	the	DET
admet-1622	274	13	formulation	formulation	NOUN
admet-1622	274	14	of	of	ADP
admet-1622	274	15	rapidly	rapidly	ADV
admet-1622	274	16	dissolving	dissolve	VERB
admet-1622	274	17	fdm	fdm	NOUN
admet-1622	274	18	3d	3d	ADV
admet-1622	274	19	-	-	PUNCT
admet-1622	274	20	printed	print	VERB
admet-1622	274	21	tablets	tablet	NOUN
admet-1622	274	22	are	be	AUX
admet-1622	274	23	continuing	continue	VERB
admet-1622	274	24	.	.	PUNCT
admet-1622	275	1	two	two	NUM
admet-1622	275	2	emerging	emerge	VERB
admet-1622	275	3	strategies	strategy	NOUN
admet-1622	275	4	that	that	PRON
admet-1622	275	5	may	may	AUX
admet-1622	275	6	have	have	VERB
admet-1622	275	7	major	major	ADJ
admet-1622	275	8	impacts	impact	NOUN
admet-1622	275	9	in	in	ADP
admet-1622	275	10	the	the	DET
admet-1622	275	11	development	development	NOUN
admet-1622	275	12	of	of	ADP
admet-1622	275	13	rapidly	rapidly	ADV
admet-1622	275	14	dissolving	dissolve	VERB
admet-1622	275	15	fdm	fdm	NOUN
admet-1622	275	16	3d	3d	ADV
admet-1622	275	17	-	-	PUNCT
admet-1622	275	18	printed	print	VERB
admet-1622	275	19	tablets	tablet	NOUN
admet-1622	275	20	in	in	ADP
admet-1622	275	21	the	the	DET
admet-1622	275	22	future	future	NOUN
admet-1622	275	23	are	be	AUX
admet-1622	275	24	described	describe	VERB
admet-1622	275	25	below	below	ADP
admet-1622	275	26	by	by	ADP
admet-1622	275	27	using	use	VERB
admet-1622	275	28	case	case	NOUN
admet-1622	275	29	studies	study	NOUN
admet-1622	275	30	.	.	PUNCT
admet-1622	276	1	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	PROPN
admet-1622	276	2	abu	abu	PROPN
admet-1622	276	3	t.m	t.m	PROPN
admet-1622	276	4	.	.	PUNCT
admet-1622	276	5	serajuddin	serajuddin	VERB
admet-1622	276	6	admet	admet	PROPN
admet-1622	276	7	&	&	CCONJ
admet-1622	276	8	dmpk	dmpk	PROPN
admet-1622	276	9	11(1	11(1	NUM
admet-1622	276	10	)	)	PUNCT
admet-1622	276	11	(	(	PUNCT
admet-1622	276	12	2023	2023	NUM
admet-1622	276	13	)	)	PUNCT
admet-1622	276	14	33	33	NUM
admet-1622	276	15	-	-	SYM
admet-1622	276	16	55	55	NUM
admet-1622	276	17	46	46	NUM
admet-1622	276	18	case	case	NOUN
admet-1622	276	19	study	study	NOUN
admet-1622	276	20	1	1	NUM
admet-1622	276	21	:	:	PUNCT
admet-1622	276	22	development	development	NOUN
admet-1622	276	23	of	of	ADP
admet-1622	276	24	fdm	fdm	NOUN
admet-1622	276	25	3d	3d	ADV
admet-1622	276	26	-	-	PUNCT
admet-1622	276	27	printed	print	VERB
admet-1622	276	28	tablets	tablet	NOUN
admet-1622	276	29	by	by	ADP
admet-1622	276	30	systematic	systematic	ADJ
admet-1622	276	31	screening	screening	NOUN
admet-1622	276	32	of	of	ADP
admet-1622	276	33	polymers	polymer	NOUN
admet-1622	276	34	for	for	ADP
admet-1622	276	35	rapid	rapid	ADJ
admet-1622	276	36	drug	drug	NOUN
admet-1622	276	37	release	release	NOUN
admet-1622	276	38	as	as	SCONJ
admet-1622	276	39	mentioned	mention	VERB
admet-1622	276	40	earlier	early	ADV
admet-1622	276	41	,	,	PUNCT
admet-1622	276	42	only	only	ADV
admet-1622	276	43	a	a	DET
admet-1622	276	44	very	very	ADV
admet-1622	276	45	limited	limited	ADJ
admet-1622	276	46	number	number	NOUN
admet-1622	276	47	of	of	ADP
admet-1622	276	48	pharmaceutically	pharmaceutically	ADV
admet-1622	276	49	acceptable	acceptable	ADJ
admet-1622	276	50	polymers	polymer	NOUN
admet-1622	276	51	are	be	AUX
admet-1622	276	52	available	available	ADJ
admet-1622	276	53	for	for	ADP
admet-1622	276	54	fdm	fdm	NOUN
admet-1622	276	55	3d	3d	NUM
admet-1622	276	56	printing	printing	NOUN
admet-1622	276	57	.	.	PUNCT
admet-1622	277	1	most	most	ADJ
admet-1622	277	2	polymers	polymer	NOUN
admet-1622	277	3	used	use	VERB
admet-1622	277	4	in	in	ADP
admet-1622	277	5	pharmaceutical	pharmaceutical	ADJ
admet-1622	277	6	dosage	dosage	NOUN
admet-1622	277	7	forms	form	NOUN
admet-1622	277	8	may	may	AUX
admet-1622	277	9	not	not	PART
admet-1622	277	10	be	be	AUX
admet-1622	277	11	extrudable	extrudable	ADJ
admet-1622	277	12	into	into	ADP
admet-1622	277	13	filaments	filament	NOUN
admet-1622	277	14	and	and	CCONJ
admet-1622	277	15	even	even	ADV
admet-1622	277	16	those	those	PRON
admet-1622	277	17	that	that	PRON
admet-1622	277	18	could	could	AUX
admet-1622	277	19	be	be	AUX
admet-1622	277	20	extruded	extrude	VERB
admet-1622	277	21	may	may	AUX
admet-1622	277	22	not	not	PART
admet-1622	277	23	be	be	AUX
admet-1622	277	24	printed	print	VERB
admet-1622	277	25	since	since	SCONJ
admet-1622	277	26	the	the	DET
admet-1622	277	27	filaments	filament	NOUN
admet-1622	277	28	produced	produce	VERB
admet-1622	277	29	may	may	AUX
admet-1622	277	30	be	be	AUX
admet-1622	277	31	either	either	CCONJ
admet-1622	277	32	too	too	ADV
admet-1622	277	33	brittle	brittle	ADJ
admet-1622	277	34	or	or	CCONJ
admet-1622	277	35	too	too	ADV
admet-1622	277	36	soft	soft	ADJ
admet-1622	277	37	.	.	PUNCT
admet-1622	278	1	even	even	ADV
admet-1622	278	2	when	when	SCONJ
admet-1622	278	3	a	a	DET
admet-1622	278	4	polymer	polymer	NOUN
admet-1622	278	5	is	be	AUX
admet-1622	278	6	both	both	CCONJ
admet-1622	278	7	extrudable	extrudable	ADJ
admet-1622	278	8	and	and	CCONJ
admet-1622	278	9	printable	printable	ADJ
admet-1622	278	10	,	,	PUNCT
admet-1622	278	11	it	it	PRON
admet-1622	278	12	may	may	AUX
admet-1622	278	13	have	have	VERB
admet-1622	278	14	other	other	ADJ
admet-1622	278	15	disadvantages	disadvantage	NOUN
admet-1622	278	16	like	like	ADP
admet-1622	278	17	lack	lack	NOUN
admet-1622	278	18	of	of	ADP
admet-1622	278	19	drug	drug	NOUN
admet-1622	278	20	-	-	PUNCT
admet-1622	278	21	polymer	polymer	NOUN
admet-1622	278	22	miscibility	miscibility	NOUN
admet-1622	278	23	,	,	PUNCT
admet-1622	278	24	slow	slow	ADJ
admet-1622	278	25	drug	drug	NOUN
admet-1622	278	26	release	release	NOUN
admet-1622	278	27	rate	rate	NOUN
admet-1622	278	28	,	,	PUNCT
admet-1622	278	29	and	and	CCONJ
admet-1622	278	30	the	the	DET
admet-1622	278	31	need	need	NOUN
admet-1622	278	32	for	for	ADP
admet-1622	278	33	high	high	ADJ
admet-1622	278	34	extrusion	extrusion	NOUN
admet-1622	278	35	and	and	CCONJ
admet-1622	278	36	printing	printing	NOUN
admet-1622	278	37	temperatures	temperature	NOUN
admet-1622	278	38	where	where	SCONJ
admet-1622	278	39	drug	drug	NOUN
admet-1622	278	40	,	,	PUNCT
admet-1622	278	41	polymer	polymer	NOUN
admet-1622	278	42	or	or	CCONJ
admet-1622	278	43	both	both	PRON
admet-1622	278	44	may	may	AUX
admet-1622	278	45	degrade	degrade	VERB
admet-1622	278	46	.	.	PUNCT
admet-1622	279	1	therefore	therefore	ADV
admet-1622	279	2	,	,	PUNCT
admet-1622	279	3	it	it	PRON
admet-1622	279	4	is	be	AUX
admet-1622	279	5	essential	essential	ADJ
admet-1622	279	6	that	that	SCONJ
admet-1622	279	7	polymers	polymer	NOUN
admet-1622	279	8	and	and	CCONJ
admet-1622	279	9	other	other	ADJ
admet-1622	279	10	additives	additive	NOUN
admet-1622	279	11	are	be	AUX
admet-1622	279	12	carefully	carefully	ADV
admet-1622	279	13	selected	select	VERB
admet-1622	279	14	for	for	ADP
admet-1622	279	15	the	the	DET
admet-1622	279	16	successful	successful	ADJ
admet-1622	279	17	development	development	NOUN
admet-1622	279	18	of	of	ADP
admet-1622	279	19	fdm	fdm	NOUN
admet-1622	279	20	3d	3d	ADV
admet-1622	279	21	-	-	PUNCT
admet-1622	279	22	printed	print	VERB
admet-1622	279	23	tablets	tablet	NOUN
admet-1622	279	24	.	.	PUNCT
admet-1622	280	1	however	however	ADV
admet-1622	280	2	,	,	PUNCT
admet-1622	280	3	in	in	ADP
admet-1622	280	4	most	most	ADJ
admet-1622	280	5	of	of	ADP
admet-1622	280	6	the	the	DET
admet-1622	280	7	reported	report	VERB
admet-1622	280	8	studies	study	NOUN
admet-1622	280	9	,	,	PUNCT
admet-1622	280	10	the	the	DET
admet-1622	280	11	selection	selection	NOUN
admet-1622	280	12	of	of	ADP
admet-1622	280	13	polymers	polymer	NOUN
admet-1622	280	14	and	and	CCONJ
admet-1622	280	15	other	other	ADJ
admet-1622	280	16	excipients	excipient	NOUN
admet-1622	280	17	appears	appear	VERB
admet-1622	280	18	to	to	PART
admet-1622	280	19	be	be	AUX
admet-1622	280	20	either	either	CCONJ
admet-1622	280	21	arbitrary	arbitrary	ADJ
admet-1622	280	22	or	or	CCONJ
admet-1622	280	23	by	by	ADP
admet-1622	280	24	trial	trial	NOUN
admet-1622	280	25	and	and	CCONJ
admet-1622	280	26	error	error	NOUN
admet-1622	280	27	.	.	PUNCT
admet-1622	281	1	to	to	PART
admet-1622	281	2	address	address	VERB
admet-1622	281	3	these	these	DET
admet-1622	281	4	issues	issue	NOUN
admet-1622	281	5	,	,	PUNCT
admet-1622	281	6	solanki	solanki	PROPN
admet-1622	281	7	et	et	PROPN
admet-1622	281	8	al	al	PROPN
admet-1622	281	9	.	.	PUNCT
admet-1622	282	1	[	[	X
admet-1622	282	2	19	19	NUM
admet-1622	282	3	]	]	PUNCT
admet-1622	282	4	developed	develop	VERB
admet-1622	282	5	a	a	DET
admet-1622	282	6	systematic	systematic	ADJ
admet-1622	282	7	approach	approach	NOUN
admet-1622	282	8	for	for	ADP
admet-1622	282	9	identifying	identify	VERB
admet-1622	282	10	polymers	polymer	NOUN
admet-1622	282	11	or	or	CCONJ
admet-1622	282	12	polymeric	polymeric	ADJ
admet-1622	282	13	blends	blend	NOUN
admet-1622	282	14	for	for	ADP
admet-1622	282	15	the	the	DET
admet-1622	282	16	development	development	NOUN
admet-1622	282	17	of	of	ADP
admet-1622	282	18	rapidly	rapidly	ADV
admet-1622	282	19	dissolving	dissolve	VERB
admet-1622	282	20	fdm	fdm	NOUN
admet-1622	282	21	3d	3d	ADV
admet-1622	282	22	-	-	PUNCT
admet-1622	282	23	printed	print	VERB
admet-1622	282	24	tablets	tablet	NOUN
admet-1622	282	25	.	.	PUNCT
admet-1622	283	1	later	later	ADV
admet-1622	283	2	,	,	PUNCT
admet-1622	283	3	aho	aho	PROPN
admet-1622	283	4	et	et	PROPN
admet-1622	283	5	al	al	PROPN
admet-1622	283	6	.	.	PUNCT
admet-1622	284	1	[	[	X
admet-1622	284	2	75	75	NUM
admet-1622	284	3	]	]	PUNCT
admet-1622	284	4	also	also	ADV
admet-1622	284	5	developed	develop	VERB
admet-1622	284	6	a	a	DET
admet-1622	284	7	roadmap	roadmap	NOUN
admet-1622	284	8	for	for	ADP
admet-1622	284	9	the	the	DET
admet-1622	284	10	development	development	NOUN
admet-1622	284	11	of	of	ADP
admet-1622	284	12	fdm	fdm	NOUN
admet-1622	284	13	3d	3d	ADV
admet-1622	284	14	-	-	PUNCT
admet-1622	284	15	printed	print	VERB
admet-1622	284	16	tablets	tablet	NOUN
admet-1622	284	17	based	base	VERB
admet-1622	284	18	on	on	ADP
admet-1622	284	19	material	material	NOUN
admet-1622	284	20	properties	property	NOUN
admet-1622	284	21	and	and	CCONJ
admet-1622	284	22	the	the	DET
admet-1622	284	23	processing	processing	NOUN
admet-1622	284	24	behavior	behavior	NOUN
admet-1622	284	25	of	of	ADP
admet-1622	284	26	drug	drug	NOUN
admet-1622	284	27	-	-	PUNCT
admet-1622	284	28	excipient	excipient	NOUN
admet-1622	284	29	combinations	combination	NOUN
admet-1622	284	30	,	,	PUNCT
admet-1622	284	31	but	but	CCONJ
admet-1622	284	32	their	their	PRON
admet-1622	284	33	focus	focus	NOUN
admet-1622	284	34	was	be	AUX
admet-1622	284	35	on	on	ADP
admet-1622	284	36	the	the	DET
admet-1622	284	37	printing	printing	NOUN
admet-1622	284	38	of	of	ADP
admet-1622	284	39	tablets	tablet	NOUN
admet-1622	284	40	rather	rather	ADV
admet-1622	284	41	than	than	ADP
admet-1622	284	42	drug	drug	NOUN
admet-1622	284	43	release	release	NOUN
admet-1622	284	44	rate	rate	NOUN
admet-1622	284	45	.	.	PUNCT
admet-1622	285	1	the	the	DET
admet-1622	285	2	strategy	strategy	NOUN
admet-1622	285	3	developed	develop	VERB
admet-1622	285	4	by	by	ADP
admet-1622	285	5	solanki	solanki	PROPN
admet-1622	285	6	et	et	PROPN
admet-1622	285	7	al	al	PROPN
admet-1622	285	8	.	.	PUNCT
admet-1622	285	9	{	{	PUNCT
admet-1622	285	10	19	19	NUM
admet-1622	285	11	]	]	PUNCT
admet-1622	285	12	for	for	ADP
admet-1622	285	13	the	the	DET
admet-1622	285	14	identification	identification	NOUN
admet-1622	285	15	of	of	ADP
admet-1622	285	16	polymers	polymer	NOUN
admet-1622	285	17	for	for	ADP
admet-1622	285	18	rapid	rapid	ADJ
admet-1622	285	19	drug	drug	NOUN
admet-1622	285	20	release	release	NOUN
admet-1622	285	21	,	,	PUNCT
admet-1622	285	22	as	as	SCONJ
admet-1622	285	23	shown	show	VERB
admet-1622	285	24	schematically	schematically	NOUN
admet-1622	285	25	in	in	ADP
admet-1622	285	26	figure	figure	NOUN
admet-1622	285	27	5	5	NUM
admet-1622	285	28	,	,	PUNCT
admet-1622	285	29	involved	involve	VERB
admet-1622	285	30	the	the	DET
admet-1622	285	31	following	follow	VERB
admet-1622	285	32	steps	step	NOUN
admet-1622	285	33	:	:	PUNCT
admet-1622	285	34	1	1	X
admet-1622	285	35	.	.	X
admet-1622	285	36	hot	hot	ADJ
admet-1622	285	37	melt	melt	NOUN
admet-1622	285	38	extrusion	extrusion	NOUN
admet-1622	285	39	of	of	ADP
admet-1622	285	40	haloperidol	haloperidol	NOUN
admet-1622	285	41	with	with	ADP
admet-1622	285	42	different	different	ADJ
admet-1622	285	43	pharmaceutical	pharmaceutical	ADJ
admet-1622	285	44	grade	grade	NOUN
admet-1622	285	45	polymers	polymer	NOUN
admet-1622	285	46	to	to	PART
admet-1622	285	47	determine	determine	VERB
admet-1622	285	48	whether	whether	SCONJ
admet-1622	285	49	filaments	filament	NOUN
admet-1622	285	50	would	would	AUX
admet-1622	285	51	be	be	AUX
admet-1622	285	52	formed	form	VERB
admet-1622	285	53	and	and	CCONJ
admet-1622	285	54	whether	whether	SCONJ
admet-1622	285	55	the	the	DET
admet-1622	285	56	drug	drug	NOUN
admet-1622	285	57	is	be	AUX
admet-1622	285	58	molecularly	molecularly	ADV
admet-1622	285	59	or	or	CCONJ
admet-1622	285	60	amorphously	amorphously	ADV
admet-1622	285	61	dispersed	disperse	VERB
admet-1622	285	62	in	in	ADP
admet-1622	285	63	the	the	DET
admet-1622	285	64	polymers	polymer	NOUN
admet-1622	285	65	to	to	PART
admet-1622	285	66	form	form	VERB
admet-1622	285	67	amorphous	amorphous	ADJ
admet-1622	285	68	solid	solid	ADJ
admet-1622	285	69	dispersion	dispersion	NOUN
admet-1622	285	70	(	(	PUNCT
admet-1622	285	71	asd	asd	NOUN
admet-1622	285	72	)	)	PUNCT
admet-1622	285	73	,	,	PUNCT
admet-1622	285	74	2	2	X
admet-1622	285	75	.	.	X
admet-1622	285	76	evaluate	evaluate	VERB
admet-1622	285	77	drug	drug	NOUN
admet-1622	285	78	release	release	NOUN
admet-1622	285	79	from	from	ADP
admet-1622	285	80	crushed	crushed	ADJ
admet-1622	285	81	extrudates	extrudate	NOUN
admet-1622	285	82	for	for	ADP
admet-1622	285	83	a	a	DET
admet-1622	285	84	preliminary	preliminary	ADJ
admet-1622	285	85	assessment	assessment	NOUN
admet-1622	285	86	of	of	ADP
admet-1622	285	87	whether	whether	SCONJ
admet-1622	285	88	the	the	DET
admet-1622	285	89	polymer	polymer	NOUN
admet-1622	285	90	would	would	AUX
admet-1622	285	91	provide	provide	VERB
admet-1622	285	92	immediate	immediate	ADJ
admet-1622	285	93	drug	drug	NOUN
admet-1622	285	94	release	release	NOUN
admet-1622	285	95	and	and	CCONJ
admet-1622	285	96	,	,	PUNCT
admet-1622	285	97	if	if	SCONJ
admet-1622	285	98	the	the	DET
admet-1622	285	99	drug	drug	NOUN
admet-1622	285	100	dissolves	dissolve	VERB
admet-1622	285	101	rapidly	rapidly	ADV
admet-1622	285	102	from	from	ADP
admet-1622	285	103	the	the	DET
admet-1622	285	104	extrudates	extrudate	NOUN
admet-1622	285	105	,	,	PUNCT
admet-1622	285	106	whether	whether	SCONJ
admet-1622	285	107	the	the	DET
admet-1622	285	108	filaments	filament	NOUN
admet-1622	285	109	would	would	AUX
admet-1622	285	110	be	be	AUX
admet-1622	285	111	printable	printable	ADJ
admet-1622	285	112	,	,	PUNCT
admet-1622	285	113	3	3	X
admet-1622	285	114	.	.	X
admet-1622	285	115	determine	determine	VERB
admet-1622	285	116	the	the	DET
admet-1622	285	117	miscibility	miscibility	NOUN
admet-1622	285	118	of	of	ADP
admet-1622	285	119	the	the	DET
admet-1622	285	120	drug	drug	NOUN
admet-1622	285	121	with	with	ADP
admet-1622	285	122	polymer	polymer	NOUN
admet-1622	285	123	or	or	CCONJ
admet-1622	285	124	mixtures	mixture	NOUN
admet-1622	285	125	of	of	ADP
admet-1622	285	126	polymers	polymer	NOUN
admet-1622	285	127	to	to	PART
admet-1622	285	128	identify	identify	VERB
admet-1622	285	129	the	the	DET
admet-1622	285	130	maximum	maximum	ADJ
admet-1622	285	131	drug	drug	NOUN
admet-1622	285	132	load	load	NOUN
admet-1622	285	133	that	that	PRON
admet-1622	285	134	may	may	AUX
admet-1622	285	135	be	be	AUX
admet-1622	285	136	used	use	VERB
admet-1622	285	137	in	in	ADP
admet-1622	285	138	the	the	DET
admet-1622	285	139	filaments	filament	NOUN
admet-1622	285	140	identified	identify	VERB
admet-1622	285	141	in	in	ADP
admet-1622	285	142	step	step	NOUN
admet-1622	285	143	2	2	NUM
admet-1622	285	144	above	above	ADP
admet-1622	285	145	,	,	PUNCT
admet-1622	285	146	4	4	NUM
admet-1622	285	147	.	.	PUNCT
admet-1622	285	148	print	print	NOUN
admet-1622	285	149	tablets	tablet	NOUN
admet-1622	285	150	by	by	ADP
admet-1622	285	151	fdm	fdm	NOUN
admet-1622	285	152	using	use	VERB
admet-1622	285	153	drug	drug	NOUN
admet-1622	285	154	-	-	PUNCT
admet-1622	285	155	loaded	load	VERB
admet-1622	285	156	filaments	filament	NOUN
admet-1622	285	157	with	with	ADP
admet-1622	285	158	selected	select	VERB
admet-1622	285	159	polymers	polymer	NOUN
admet-1622	285	160	or	or	CCONJ
admet-1622	285	161	polymer	polymer	NOUN
admet-1622	285	162	blends	blend	NOUN
admet-1622	285	163	using	use	VERB
admet-1622	285	164	optimum	optimum	ADJ
admet-1622	285	165	drug	drug	NOUN
admet-1622	285	166	loads	load	NOUN
admet-1622	285	167	determined	determine	VERB
admet-1622	285	168	by	by	ADP
admet-1622	285	169	drug	drug	NOUN
admet-1622	285	170	-	-	PUNCT
admet-1622	285	171	polymer	polymer	NOUN
admet-1622	285	172	miscibility	miscibility	NOUN
admet-1622	285	173	testing	testing	NOUN
admet-1622	285	174	in	in	ADP
admet-1622	285	175	step	step	NOUN
admet-1622	285	176	3	3	NUM
admet-1622	285	177	above	above	ADV
admet-1622	285	178	.	.	PUNCT
admet-1622	286	1	5	5	X
admet-1622	286	2	.	.	X
admet-1622	286	3	evaluate	evaluate	VERB
admet-1622	286	4	drug	drug	NOUN
admet-1622	286	5	release	release	NOUN
admet-1622	286	6	from	from	ADP
admet-1622	286	7	fdm	fdm	NOUN
admet-1622	286	8	3d	3d	ADV
admet-1622	286	9	-	-	PUNCT
admet-1622	286	10	printed	print	VERB
admet-1622	286	11	tablets	tablet	NOUN
admet-1622	286	12	to	to	PART
admet-1622	286	13	determine	determine	VERB
admet-1622	286	14	whether	whether	SCONJ
admet-1622	286	15	they	they	PRON
admet-1622	286	16	meet	meet	VERB
admet-1622	286	17	the	the	DET
admet-1622	286	18	target	target	NOUN
admet-1622	286	19	drug	drug	NOUN
admet-1622	286	20	release	release	NOUN
admet-1622	286	21	.	.	PUNCT
admet-1622	287	1	figure	figure	NOUN
admet-1622	287	2	5	5	NUM
admet-1622	287	3	.	.	PUNCT
admet-1622	287	4	systematic	systematic	ADJ
admet-1622	287	5	approach	approach	NOUN
admet-1622	287	6	for	for	ADP
admet-1622	287	7	the	the	DET
admet-1622	287	8	identification	identification	NOUN
admet-1622	287	9	of	of	ADP
admet-1622	287	10	polymers	polymer	NOUN
admet-1622	287	11	for	for	ADP
admet-1622	287	12	the	the	DET
admet-1622	287	13	development	development	NOUN
admet-1622	287	14	of	of	ADP
admet-1622	287	15	rapidly	rapidly	ADV
admet-1622	287	16	dissolving	dissolve	VERB
admet-1622	287	17	fdm	fdm	NOUN
admet-1622	287	18	3d	3d	ADV
admet-1622	287	19	-	-	PUNCT
admet-1622	287	20	printed	print	VERB
admet-1622	287	21	tablets	tablet	NOUN
admet-1622	287	22	.	.	PUNCT
admet-1622	288	1	admet	admet	PROPN
admet-1622	288	2	&	&	CCONJ
admet-1622	288	3	dmpk	dmpk	PROPN
admet-1622	288	4	11(1	11(1	NUM
admet-1622	288	5	)	)	PUNCT
admet-1622	288	6	(	(	PUNCT
admet-1622	288	7	2023	2023	NUM
admet-1622	288	8	)	)	PUNCT
admet-1622	288	9	33	33	NUM
admet-1622	288	10	-	-	SYM
admet-1622	288	11	55	55	NUM
admet-1622	288	12	development	development	NOUN
admet-1622	288	13	of	of	ADP
admet-1622	288	14	rapidly	rapidly	ADV
admet-1622	288	15	dissolving	dissolve	VERB
admet-1622	288	16	fdm	fdm	NOUN
admet-1622	288	17	3d	3d	ADV
admet-1622	288	18	-	-	PUNCT
admet-1622	288	19	printed	print	VERB
admet-1622	288	20	tablets	tablet	NOUN
admet-1622	288	21	doi	doi	NOUN
admet-1622	288	22	:	:	PUNCT
admet-1622	288	23	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	288	24	47	47	NUM
admet-1622	288	25	solanki	solanki	PROPN
admet-1622	288	26	et	et	PROPN
admet-1622	288	27	al	al	PROPN
admet-1622	288	28	.	.	PUNCT
admet-1622	289	1	[	[	X
admet-1622	289	2	19	19	NUM
admet-1622	289	3	]	]	PUNCT
admet-1622	289	4	screened	screen	VERB
admet-1622	289	5	four	four	NUM
admet-1622	289	6	commonly	commonly	ADV
admet-1622	289	7	used	use	VERB
admet-1622	289	8	polymers	polymer	NOUN
admet-1622	289	9	,	,	PUNCT
admet-1622	289	10	namely	namely	ADV
admet-1622	289	11	,	,	PUNCT
admet-1622	289	12	kollidon	kollidon	PROPN
admet-1622	289	13	va64	va64	PROPN
admet-1622	289	14	(	(	PUNCT
admet-1622	289	15	vinylpyrrolidone	vinylpyrrolidone	NOUN
admet-1622	289	16	-	-	PUNCT
admet-1622	289	17	vinyl	vinyl	NOUN
admet-1622	289	18	acetate	acetate	NOUN
admet-1622	289	19	copolymer	copolymer	NOUN
admet-1622	289	20	)	)	PUNCT
admet-1622	289	21	,	,	PUNCT
admet-1622	289	22	kollicoat	kollicoat	VERB
admet-1622	289	23	®	®	NOUN
admet-1622	289	24	ir	ir	PROPN
admet-1622	289	25	(	(	PUNCT
admet-1622	289	26	polyvinyl	polyvinyl	NOUN
admet-1622	289	27	alcohol	alcohol	NOUN
admet-1622	289	28	-	-	PUNCT
admet-1622	289	29	polyvinyl	polyvinyl	NOUN
admet-1622	289	30	glycol	glycol	NOUN
admet-1622	289	31	graft	graft	NOUN
admet-1622	289	32	copolymer	copolymer	NOUN
admet-1622	289	33	)	)	PUNCT
admet-1622	289	34	,	,	PUNCT
admet-1622	289	35	affinisol	affinisol	PROPN
admet-1622	289	36	hpmc	hpmc	PROPN
admet-1622	289	37	hme	hme	PROPN
admet-1622	289	38	15cp	15cp	PROPN
admet-1622	289	39	(	(	PUNCT
admet-1622	289	40	hydoxypropyl	hydoxypropyl	INTJ
admet-1622	289	41	methylcellulose	methylcellulose	PROPN
admet-1622	289	42	hme	hme	PROPN
admet-1622	289	43	)	)	PUNCT
admet-1622	289	44	,	,	PUNCT
admet-1622	289	45	and	and	CCONJ
admet-1622	289	46	aquoat	aquoat	NOUN
admet-1622	289	47	as	as	ADP
admet-1622	289	48	-	-	PUNCT
admet-1622	289	49	mg	mg	PROPN
admet-1622	289	50	(	(	PUNCT
admet-1622	289	51	hydroxypropyl	hydroxypropyl	PROPN
admet-1622	289	52	methylcellulose	methylcellulose	NOUN
admet-1622	289	53	acetate	acetate	NOUN
admet-1622	289	54	succinate	succinate	PROPN
admet-1622	289	55	)	)	PUNCT
admet-1622	289	56	for	for	ADP
admet-1622	289	57	their	their	PRON
admet-1622	289	58	suitability	suitability	NOUN
admet-1622	289	59	in	in	ADP
admet-1622	289	60	the	the	DET
admet-1622	289	61	development	development	NOUN
admet-1622	289	62	of	of	ADP
admet-1622	289	63	rapidly	rapidly	ADV
admet-1622	289	64	dissolving	dissolve	VERB
admet-1622	289	65	fdm	fdm	NOUN
admet-1622	289	66	3d	3d	ADV
admet-1622	289	67	-	-	PUNCT
admet-1622	289	68	printed	print	VERB
admet-1622	289	69	tablets	tablet	NOUN
admet-1622	289	70	by	by	ADP
admet-1622	289	71	using	use	VERB
admet-1622	289	72	a	a	DET
admet-1622	289	73	model	model	ADJ
admet-1622	289	74	basic	basic	ADJ
admet-1622	289	75	drug	drug	NOUN
admet-1622	289	76	,	,	PUNCT
admet-1622	289	77	haloperidol	haloperidol	PROPN
admet-1622	289	78	(	(	PUNCT
admet-1622	289	79	pka~8	pka~8	PROPN
admet-1622	289	80	)	)	PUNCT
admet-1622	289	81	,	,	PUNCT
admet-1622	289	82	with	with	ADP
admet-1622	289	83	ph	ph	ADJ
admet-1622	289	84	-	-	ADJ
admet-1622	289	85	dependent	dependent	ADJ
admet-1622	289	86	solubility	solubility	NOUN
admet-1622	289	87	(	(	PUNCT
admet-1622	289	88	1	1	NUM
admet-1622	289	89	-	-	SYM
admet-1622	289	90	4	4	NUM
admet-1622	289	91	mg	mg	NUM
admet-1622	289	92	/	/	SYM
admet-1622	289	93	ml	ml	NOUN
admet-1622	289	94	at	at	ADP
admet-1622	289	95	ph	ph	PROPN
admet-1622	289	96	1	1	NUM
admet-1622	289	97	-	-	SYM
admet-1622	289	98	3	3	NUM
admet-1622	289	99	;	;	PUNCT
admet-1622	289	100	2	2	NUM
admet-1622	289	101	-	-	SYM
admet-1622	289	102	3	3	NUM
admet-1622	289	103	µg	µg	NOUN
admet-1622	289	104	/	/	SYM
admet-1622	289	105	ml	ml	NOUN
admet-1622	289	106	at	at	ADP
admet-1622	289	107	ph~7	ph~7	NOUN
admet-1622	289	108	)	)	PUNCT
admet-1622	289	109	.	.	PUNCT
admet-1622	290	1	in	in	ADP
admet-1622	290	2	step	step	NOUN
admet-1622	290	3	1	1	NUM
admet-1622	290	4	of	of	ADP
admet-1622	290	5	the	the	DET
admet-1622	290	6	process	process	NOUN
admet-1622	290	7	,	,	PUNCT
admet-1622	290	8	they	they	PRON
admet-1622	290	9	observed	observe	VERB
admet-1622	290	10	that	that	SCONJ
admet-1622	290	11	drug	drug	NOUN
admet-1622	290	12	formulations	formulation	NOUN
admet-1622	290	13	with	with	ADP
admet-1622	290	14	all	all	DET
admet-1622	290	15	four	four	NUM
admet-1622	290	16	polymers	polymer	NOUN
admet-1622	290	17	were	be	AUX
admet-1622	290	18	extrudable	extrudable	ADJ
admet-1622	290	19	when	when	SCONJ
admet-1622	290	20	they	they	PRON
admet-1622	290	21	were	be	AUX
admet-1622	290	22	extruded	extrude	VERB
admet-1622	290	23	at	at	ADP
admet-1622	290	24	a	a	DET
admet-1622	290	25	common	common	ADJ
admet-1622	290	26	temperature	temperature	NOUN
admet-1622	290	27	of	of	ADP
admet-1622	290	28	150	150	NUM
admet-1622	290	29	°	°	NOUN
admet-1622	290	30	c	c	NOUN
admet-1622	290	31	.	.	PUNCT
admet-1622	291	1	in	in	ADP
admet-1622	291	2	step	step	NOUN
admet-1622	291	3	2	2	NUM
admet-1622	291	4	,	,	PUNCT
admet-1622	291	5	the	the	DET
admet-1622	291	6	dissolution	dissolution	NOUN
admet-1622	291	7	testing	testing	NOUN
admet-1622	291	8	of	of	ADP
admet-1622	291	9	crushed	crushed	ADJ
admet-1622	291	10	filaments	filament	NOUN
admet-1622	291	11	was	be	AUX
admet-1622	291	12	conducted	conduct	VERB
admet-1622	291	13	at	at	ADP
admet-1622	291	14	ph	ph	PROPN
admet-1622	291	15	2	2	NUM
admet-1622	291	16	and	and	CCONJ
admet-1622	291	17	6.8	6.8	NUM
admet-1622	291	18	,	,	PUNCT
admet-1622	291	19	and	and	CCONJ
admet-1622	291	20	the	the	DET
admet-1622	291	21	printability	printability	NOUN
admet-1622	291	22	of	of	ADP
admet-1622	291	23	whole	whole	ADJ
admet-1622	291	24	(	(	PUNCT
admet-1622	291	25	uncrushed	uncrushed	ADJ
admet-1622	291	26	)	)	PUNCT
admet-1622	291	27	filaments	filament	NOUN
admet-1622	291	28	was	be	AUX
admet-1622	291	29	studied	study	VERB
admet-1622	291	30	by	by	ADP
admet-1622	291	31	printing	print	VERB
admet-1622	291	32	actual	actual	ADJ
admet-1622	291	33	tablets	tablet	NOUN
admet-1622	291	34	.	.	PUNCT
admet-1622	292	1	it	it	PRON
admet-1622	292	2	was	be	AUX
admet-1622	292	3	observed	observe	VERB
admet-1622	292	4	that	that	SCONJ
admet-1622	292	5	the	the	DET
admet-1622	292	6	crushed	crushed	ADJ
admet-1622	292	7	filaments	filament	NOUN
admet-1622	292	8	containing	contain	VERB
admet-1622	292	9	kollidon	kollidon	PROPN
admet-1622	292	10	va64	va64	PROPN
admet-1622	292	11	only	only	ADV
admet-1622	292	12	provided	provide	VERB
admet-1622	292	13	the	the	DET
admet-1622	292	14	most	most	ADV
admet-1622	292	15	rapid	rapid	ADJ
admet-1622	292	16	drug	drug	NOUN
admet-1622	292	17	release	release	NOUN
admet-1622	292	18	rate	rate	NOUN
admet-1622	292	19	,	,	PUNCT
admet-1622	292	20	but	but	CCONJ
admet-1622	292	21	the	the	DET
admet-1622	292	22	filaments	filament	NOUN
admet-1622	292	23	were	be	AUX
admet-1622	292	24	not	not	PART
admet-1622	292	25	printable	printable	ADJ
admet-1622	292	26	.	.	PUNCT
admet-1622	293	1	for	for	ADP
admet-1622	293	2	this	this	DET
admet-1622	293	3	reason	reason	NOUN
admet-1622	293	4	,	,	PUNCT
admet-1622	293	5	1:1	1:1	NUM
admet-1622	293	6	-	-	PUNCT
admet-1622	293	7	mixtures	mixture	NOUN
admet-1622	293	8	of	of	ADP
admet-1622	293	9	kollidon	kollidon	ADJ
admet-1622	293	10	®	®	NOUN
admet-1622	293	11	va64	va64	PROPN
admet-1622	293	12	with	with	ADP
admet-1622	293	13	affinisol	affinisol	NOUN
admet-1622	293	14	as	as	ADV
admet-1622	293	15	well	well	ADV
admet-1622	293	16	as	as	ADP
admet-1622	293	17	hpmcas	hpmca	NOUN
admet-1622	293	18	mg	mg	PROPN
admet-1622	293	19	were	be	AUX
admet-1622	293	20	also	also	ADV
admet-1622	293	21	tested	test	VERB
admet-1622	293	22	for	for	ADP
admet-1622	293	23	dissolution	dissolution	NOUN
admet-1622	293	24	and	and	CCONJ
admet-1622	293	25	printability	printability	NOUN
admet-1622	293	26	,	,	PUNCT
admet-1622	293	27	and	and	CCONJ
admet-1622	293	28	the	the	DET
admet-1622	293	29	results	result	NOUN
admet-1622	293	30	are	be	AUX
admet-1622	293	31	presented	present	VERB
admet-1622	293	32	in	in	ADP
admet-1622	293	33	table	table	NOUN
admet-1622	293	34	2	2	NUM
admet-1622	293	35	.	.	PUNCT
admet-1622	294	1	although	although	SCONJ
admet-1622	294	2	slower	slow	ADJ
admet-1622	294	3	than	than	ADP
admet-1622	294	4	that	that	PRON
admet-1622	294	5	with	with	ADP
admet-1622	294	6	kollidon	kollidon	ADJ
admet-1622	294	7	®	®	NOUN
admet-1622	294	8	va64	va64	PROPN
admet-1622	294	9	alone	alone	ADV
admet-1622	294	10	,	,	PUNCT
admet-1622	294	11	the	the	DET
admet-1622	294	12	drug	drug	NOUN
admet-1622	294	13	-	-	PUNCT
admet-1622	294	14	loaded	load	VERB
admet-1622	294	15	filaments	filament	NOUN
admet-1622	294	16	containing	contain	VERB
admet-1622	294	17	the	the	DET
admet-1622	294	18	1:1	1:1	NUM
admet-1622	294	19	-	-	PUNCT
admet-1622	294	20	mixtures	mixture	NOUN
admet-1622	294	21	of	of	ADP
admet-1622	294	22	kollidon	kollidon	ADJ
admet-1622	294	23	®	®	NOUN
admet-1622	294	24	va64	va64	PROPN
admet-1622	294	25	with	with	ADP
admet-1622	294	26	affinisol	affinisol	NOUN
admet-1622	294	27	was	be	AUX
admet-1622	294	28	still	still	ADV
admet-1622	294	29	quite	quite	ADV
admet-1622	294	30	rapid	rapid	ADJ
admet-1622	294	31	.	.	PUNCT
admet-1622	295	1	filaments	filament	NOUN
admet-1622	295	2	containing	contain	VERB
admet-1622	295	3	kollicoat	kollicoat	PROPN
admet-1622	295	4	®	®	NOUN
admet-1622	295	5	ir	ir	PROPN
admet-1622	295	6	or	or	CCONJ
admet-1622	295	7	1:1	1:1	NUM
admet-1622	295	8	-	-	PUNCT
admet-1622	295	9	mixtures	mixture	NOUN
admet-1622	295	10	of	of	ADP
admet-1622	295	11	kollidon	kollidon	ADJ
admet-1622	295	12	®	®	NOUN
admet-1622	295	13	va64	va64	PROPN
admet-1622	295	14	with	with	ADP
admet-1622	295	15	hpmcas	hpmca	NOUN
admet-1622	295	16	mg	mg	PROPN
admet-1622	295	17	exhibited	exhibit	VERB
admet-1622	295	18	delayed	delay	VERB
admet-1622	295	19	drug	drug	NOUN
admet-1622	295	20	release	release	NOUN
admet-1622	295	21	rate	rate	NOUN
admet-1622	295	22	.	.	PUNCT
admet-1622	296	1	based	base	VERB
admet-1622	296	2	on	on	ADP
admet-1622	296	3	the	the	DET
admet-1622	296	4	results	result	NOUN
admet-1622	296	5	presented	present	VERB
admet-1622	296	6	in	in	ADP
admet-1622	296	7	table	table	NOUN
admet-1622	296	8	2	2	NUM
admet-1622	296	9	,	,	PUNCT
admet-1622	296	10	filaments	filament	NOUN
admet-1622	296	11	containing	contain	VERB
admet-1622	296	12	1:1	1:1	NUM
admet-1622	296	13	kollidon	kollidon	PROPN
admet-1622	296	14	va64	va64	PROPN
admet-1622	296	15	and	and	CCONJ
admet-1622	296	16	affinisol	affinisol	PROPN
admet-1622	296	17	were	be	AUX
admet-1622	296	18	selected	select	VERB
admet-1622	296	19	for	for	ADP
admet-1622	296	20	further	further	ADJ
admet-1622	296	21	development	development	NOUN
admet-1622	296	22	.	.	PUNCT
admet-1622	297	1	the	the	DET
admet-1622	297	2	miscibility	miscibility	NOUN
admet-1622	297	3	of	of	ADP
admet-1622	297	4	haloperidol	haloperidol	NOUN
admet-1622	297	5	with	with	ADP
admet-1622	297	6	kollidon	kollidon	PROPN
admet-1622	297	7	va64	va64	PROPN
admet-1622	297	8	,	,	PUNCT
admet-1622	297	9	affinisol	affinisol	NOUN
admet-1622	297	10	and	and	CCONJ
admet-1622	297	11	their	their	PRON
admet-1622	297	12	mixtures	mixture	NOUN
admet-1622	297	13	was	be	AUX
admet-1622	297	14	then	then	ADV
admet-1622	297	15	studied	study	VERB
admet-1622	297	16	in	in	ADP
admet-1622	297	17	step	step	NOUN
admet-1622	297	18	3	3	NUM
admet-1622	297	19	using	use	VERB
admet-1622	297	20	the	the	DET
admet-1622	297	21	film	film	NOUN
admet-1622	297	22	casting	casting	NOUN
admet-1622	297	23	technique	technique	NOUN
admet-1622	297	24	previously	previously	ADV
admet-1622	297	25	developed	develop	VERB
admet-1622	297	26	by	by	ADP
admet-1622	297	27	parikh	parikh	PROPN
admet-1622	297	28	et	et	PROPN
admet-1622	297	29	al	al	PROPN
admet-1622	297	30	.	.	PUNCT
admet-1622	298	1	[	[	X
admet-1622	298	2	32	32	NUM
admet-1622	298	3	]	]	PUNCT
admet-1622	298	4	.	.	PUNCT
admet-1622	299	1	the	the	DET
admet-1622	299	2	miscibility	miscibility	NOUN
admet-1622	299	3	of	of	ADP
admet-1622	299	4	the	the	DET
admet-1622	299	5	drug	drug	NOUN
admet-1622	299	6	was	be	AUX
admet-1622	299	7	20	20	NUM
admet-1622	299	8	%	%	NOUN
admet-1622	299	9	in	in	ADP
admet-1622	299	10	kollidon	kollidon	PROPN
admet-1622	299	11	va64	va64	PROPN
admet-1622	299	12	,	,	PUNCT
admet-1622	299	13	10	10	NUM
admet-1622	299	14	%	%	NOUN
admet-1622	299	15	in	in	ADP
admet-1622	299	16	affinisol	affinisol	NOUN
admet-1622	299	17	and	and	CCONJ
admet-1622	299	18	15	15	NUM
admet-1622	299	19	%	%	NOUN
admet-1622	299	20	in	in	ADP
admet-1622	299	21	the	the	DET
admet-1622	299	22	kollidon	kollidon	ADJ
admet-1622	299	23	va64affinisol	va64affinisol	PROPN
admet-1622	299	24	mixture	mixture	NOUN
admet-1622	299	25	.	.	PUNCT
admet-1622	300	1	based	base	VERB
admet-1622	300	2	on	on	ADP
admet-1622	300	3	these	these	DET
admet-1622	300	4	results	result	NOUN
admet-1622	300	5	,	,	PUNCT
admet-1622	300	6	the	the	DET
admet-1622	300	7	formulation	formulation	NOUN
admet-1622	300	8	composition	composition	NOUN
admet-1622	300	9	selected	select	VERB
admet-1622	300	10	for	for	ADP
admet-1622	300	11	3d	3d	NUM
admet-1622	300	12	printing	printing	NOUN
admet-1622	300	13	was	be	AUX
admet-1622	300	14	10	10	NUM
admet-1622	300	15	%	%	NOUN
admet-1622	300	16	haloperidol	haloperidol	NOUN
admet-1622	300	17	,	,	PUNCT
admet-1622	300	18	45	45	NUM
admet-1622	300	19	%	%	NOUN
admet-1622	300	20	kollidon	kollidon	PROPN
admet-1622	301	1	va64	va64	PROPN
admet-1622	301	2	and	and	CCONJ
admet-1622	301	3	45	45	NUM
admet-1622	301	4	%	%	NOUN
admet-1622	301	5	affinisol	affinisol	NOUN
admet-1622	301	6	.	.	PUNCT
admet-1622	302	1	table	table	NOUN
admet-1622	302	2	1	1	NUM
admet-1622	302	3	.	.	PUNCT
admet-1622	303	1	the	the	DET
admet-1622	303	2	results	result	NOUN
admet-1622	303	3	of	of	ADP
admet-1622	303	4	the	the	DET
admet-1622	303	5	screening	screening	NOUN
admet-1622	303	6	of	of	ADP
admet-1622	303	7	different	different	ADJ
admet-1622	303	8	polymers	polymer	NOUN
admet-1622	303	9	and	and	CCONJ
admet-1622	303	10	polymer	polymer	NOUN
admet-1622	303	11	-	-	PUNCT
admet-1622	303	12	polymer	polymer	NOUN
admet-1622	303	13	mixtures	mixture	NOUN
admet-1622	303	14	with	with	ADP
admet-1622	303	15	10	10	NUM
admet-1622	303	16	%	%	NOUN
admet-1622	303	17	w	w	PROPN
admet-1622	303	18	/	/	SYM
admet-1622	303	19	w	w	NOUN
admet-1622	303	20	drug	drug	NOUN
admet-1622	303	21	loads	load	NOUN
admet-1622	303	22	for	for	ADP
admet-1622	303	23	drug	drug	NOUN
admet-1622	303	24	release	release	NOUN
admet-1622	303	25	from	from	ADP
admet-1622	303	26	crushed	crushed	ADJ
admet-1622	303	27	filaments	filament	NOUN
admet-1622	303	28	at	at	ADP
admet-1622	303	29	ph	ph	PROPN
admet-1622	303	30	2	2	NUM
admet-1622	303	31	and	and	CCONJ
admet-1622	303	32	6.8	6.8	NUM
admet-1622	303	33	and	and	CCONJ
admet-1622	303	34	printability	printability	NOUN
admet-1622	303	35	of	of	ADP
admet-1622	303	36	whole	whole	ADJ
admet-1622	303	37	filaments	filament	NOUN
admet-1622	303	38	.	.	PUNCT
admet-1622	304	1	polymer	polymer	NOUN
admet-1622	304	2	printability	printability	NOUN
admet-1622	304	3	drug	drug	NOUN
admet-1622	304	4	release	release	NOUN
admet-1622	304	5	from	from	ADP
admet-1622	304	6	milled	mill	VERB
admet-1622	304	7	filaments	filament	NOUN
admet-1622	304	8	10	10	NUM
admet-1622	304	9	%	%	NOUN
admet-1622	304	10	haloperidol	haloperidol	NOUN
admet-1622	304	11	+	+	CCONJ
admet-1622	304	12	90	90	NUM
admet-1622	304	13	%	%	NOUN
admet-1622	304	14	kollidon	kollidon	PROPN
admet-1622	304	15	va	va	PROPN
admet-1622	304	16	64	64	NUM
admet-1622	304	17	breaks	break	NOUN
admet-1622	304	18	into	into	ADP
admet-1622	304	19	the	the	DET
admet-1622	304	20	drive	drive	ADJ
admet-1622	304	21	gear	gear	NOUN
admet-1622	304	22	;	;	PUNCT
admet-1622	304	23	not	not	PART
admet-1622	304	24	printable	printable	VERB
admet-1622	304	25	immediate	immediate	ADJ
admet-1622	304	26	10	10	NUM
admet-1622	304	27	%	%	NOUN
admet-1622	304	28	haloperidol	haloperidol	NOUN
admet-1622	304	29	+	+	CCONJ
admet-1622	304	30	90	90	NUM
admet-1622	304	31	%	%	NOUN
admet-1622	304	32	kollicoat	kollicoat	NOUN
admet-1622	304	33	ir	ir	PROPN
admet-1622	304	34	printable	printable	PROPN
admet-1622	304	35	retarded	retarded	ADJ
admet-1622	304	36	10	10	NUM
admet-1622	304	37	%	%	NOUN
admet-1622	304	38	haloperidol	haloperidol	NOUN
admet-1622	304	39	+	+	CCONJ
admet-1622	304	40	90	90	NUM
admet-1622	304	41	%	%	NOUN
admet-1622	304	42	affinisol	affinisol	NOUN
admet-1622	304	43	15	15	NUM
admet-1622	304	44	cp	cp	PROPN
admet-1622	304	45	printable	printable	NOUN
admet-1622	304	46	retarded	retard	VERB
admet-1622	304	47	10	10	NUM
admet-1622	304	48	%	%	NOUN
admet-1622	304	49	haloperidol	haloperidol	NOUN
admet-1622	304	50	+	+	CCONJ
admet-1622	304	51	45	45	NUM
admet-1622	304	52	%	%	NOUN
admet-1622	304	53	hpmcas	hpmca	NOUN
admet-1622	304	54	mg	mg	PROPN
admet-1622	305	1	+	+	CCONJ
admet-1622	305	2	45	45	NUM
admet-1622	305	3	%	%	NOUN
admet-1622	305	4	kollidon	kollidon	PROPN
admet-1622	305	5	va	va	PROPN
admet-1622	305	6	64	64	NUM
admet-1622	305	7	printable	printable	NOUN
admet-1622	305	8	retarded	retarded	ADJ
admet-1622	305	9	10	10	NUM
admet-1622	305	10	%	%	NOUN
admet-1622	305	11	haloperidol	haloperidol	NOUN
admet-1622	305	12	+	+	CCONJ
admet-1622	305	13	45	45	NUM
admet-1622	305	14	%	%	NOUN
admet-1622	305	15	kollidon	kollidon	PROPN
admet-1622	305	16	va	va	PROPN
admet-1622	305	17	64	64	NUM
admet-1622	305	18	+	+	NUM
admet-1622	305	19	45	45	NUM
admet-1622	305	20	%	%	NOUN
admet-1622	305	21	affinisol	affinisol	NOUN
admet-1622	305	22	15	15	NUM
admet-1622	305	23	cp	cp	NOUN
admet-1622	305	24	printable	printable	NOUN
admet-1622	305	25	immediate	immediate	ADJ
admet-1622	305	26	the	the	DET
admet-1622	305	27	selected	select	VERB
admet-1622	305	28	formulation	formulation	NOUN
admet-1622	305	29	was	be	AUX
admet-1622	305	30	then	then	ADV
admet-1622	305	31	printed	print	VERB
admet-1622	305	32	into	into	ADP
admet-1622	305	33	tablets	tablet	NOUN
admet-1622	305	34	at	at	ADP
admet-1622	305	35	210⁰c	210⁰c	NUM
admet-1622	305	36	in	in	ADP
admet-1622	305	37	step	step	NOUN
admet-1622	305	38	4	4	NUM
admet-1622	305	39	of	of	ADP
admet-1622	305	40	the	the	DET
admet-1622	305	41	process	process	NOUN
admet-1622	305	42	.	.	PUNCT
admet-1622	306	1	two	two	NUM
admet-1622	306	2	infill	infill	NOUN
admet-1622	306	3	densities	density	NOUN
admet-1622	306	4	,	,	PUNCT
admet-1622	306	5	100	100	NUM
admet-1622	306	6	%	%	NOUN
admet-1622	306	7	and	and	CCONJ
admet-1622	306	8	60	60	NUM
admet-1622	306	9	%	%	NOUN
admet-1622	306	10	,	,	PUNCT
admet-1622	306	11	were	be	AUX
admet-1622	306	12	used	use	VERB
admet-1622	306	13	to	to	PART
admet-1622	306	14	determine	determine	VERB
admet-1622	306	15	whether	whether	SCONJ
admet-1622	306	16	there	there	PRON
admet-1622	306	17	would	would	AUX
admet-1622	306	18	be	be	AUX
admet-1622	306	19	any	any	DET
admet-1622	306	20	effect	effect	NOUN
admet-1622	306	21	of	of	ADP
admet-1622	306	22	infill	infill	NOUN
admet-1622	306	23	density	density	NOUN
admet-1622	306	24	on	on	ADP
admet-1622	306	25	drug	drug	NOUN
admet-1622	306	26	release	release	NOUN
admet-1622	306	27	.	.	PUNCT
admet-1622	307	1	as	as	SCONJ
admet-1622	307	2	shown	show	VERB
admet-1622	307	3	in	in	ADP
admet-1622	307	4	figure	figure	NOUN
admet-1622	307	5	6	6	NUM
admet-1622	307	6	,	,	PUNCT
admet-1622	307	7	the	the	DET
admet-1622	307	8	dissolution	dissolution	NOUN
admet-1622	307	9	testing	testing	NOUN
admet-1622	307	10	of	of	ADP
admet-1622	307	11	the	the	DET
admet-1622	307	12	fdm	fdm	NOUN
admet-1622	307	13	3d	3d	ADV
admet-1622	307	14	-	-	PUNCT
admet-1622	307	15	printed	print	VERB
admet-1622	307	16	tablets	tablet	NOUN
admet-1622	307	17	in	in	ADP
admet-1622	307	18	step	step	NOUN
admet-1622	307	19	5	5	NUM
admet-1622	307	20	gave	give	VERB
admet-1622	307	21	~80	~80	NOUN
admet-1622	307	22	%	%	NOUN
admet-1622	307	23	of	of	ADP
admet-1622	307	24	drug	drug	NOUN
admet-1622	307	25	release	release	NOUN
admet-1622	307	26	from	from	ADP
admet-1622	307	27	tablets	tablet	NOUN
admet-1622	307	28	with	with	ADP
admet-1622	307	29	60	60	NUM
admet-1622	307	30	%	%	NOUN
admet-1622	307	31	infill	infill	NOUN
admet-1622	307	32	in	in	ADP
admet-1622	307	33	45	45	NUM
admet-1622	307	34	and	and	CCONJ
admet-1622	307	35	120	120	NUM
admet-1622	307	36	min	min	NOUN
admet-1622	307	37	at	at	ADP
admet-1622	307	38	ph	ph	PROPN
admet-1622	307	39	1.2	1.2	NUM
admet-1622	307	40	and	and	CCONJ
admet-1622	307	41	6.8	6.8	NUM
admet-1622	307	42	,	,	PUNCT
admet-1622	307	43	respectively	respectively	ADV
admet-1622	307	44	.	.	PUNCT
admet-1622	308	1	from	from	ADP
admet-1622	308	2	tablets	tablet	NOUN
admet-1622	308	3	with	with	ADP
admet-1622	308	4	100	100	NUM
admet-1622	308	5	%	%	NOUN
admet-1622	308	6	infill	infill	NOUN
admet-1622	308	7	,	,	PUNCT
admet-1622	308	8	over	over	ADP
admet-1622	308	9	80	80	NUM
admet-1622	308	10	%	%	NOUN
admet-1622	308	11	of	of	ADP
admet-1622	308	12	the	the	DET
admet-1622	308	13	drug	drug	NOUN
admet-1622	308	14	was	be	AUX
admet-1622	308	15	released	release	VERB
admet-1622	308	16	at	at	ADP
admet-1622	308	17	ph	ph	PROPN
admet-1622	308	18	1.2	1.2	NUM
admet-1622	308	19	and	and	CCONJ
admet-1622	308	20	6.8	6.8	NUM
admet-1622	308	21	in	in	ADP
admet-1622	308	22	2	2	NUM
admet-1622	308	23	and	and	CCONJ
admet-1622	308	24	3	3	NUM
admet-1622	308	25	h	h	NOUN
admet-1622	308	26	,	,	PUNCT
admet-1622	308	27	respectively	respectively	ADV
admet-1622	308	28	.	.	PUNCT
admet-1622	309	1	although	although	SCONJ
admet-1622	309	2	the	the	DET
admet-1622	309	3	dissolution	dissolution	ADJ
admet-1622	309	4	rate	rate	NOUN
admet-1622	309	5	of	of	ADP
admet-1622	309	6	haloperidol	haloperidol	PROPN
admet-1622	309	7	obtained	obtain	VERB
admet-1622	309	8	by	by	ADP
admet-1622	309	9	solanki	solanki	PROPN
admet-1622	309	10	et	et	PROPN
admet-1622	309	11	al	al	PROPN
admet-1622	309	12	.	.	PUNCT
admet-1622	310	1	[	[	X
admet-1622	310	2	19	19	NUM
admet-1622	310	3	]	]	PUNCT
admet-1622	310	4	did	do	AUX
admet-1622	310	5	not	not	PART
admet-1622	310	6	meet	meet	VERB
admet-1622	310	7	the	the	DET
admet-1622	310	8	fda	fda	PROPN
admet-1622	310	9	guideline	guideline	NOUN
admet-1622	310	10	of	of	ADP
admet-1622	310	11	85	85	NUM
admet-1622	310	12	%	%	NOUN
admet-1622	310	13	and	and	CCONJ
admet-1622	310	14	higher	high	ADJ
admet-1622	310	15	drug	drug	NOUN
admet-1622	310	16	release	release	NOUN
admet-1622	310	17	in	in	ADP
admet-1622	310	18	60	60	NUM
admet-1622	310	19	min	min	NOUN
admet-1622	310	20	for	for	ADP
admet-1622	310	21	immediate	immediate	ADJ
admet-1622	310	22	drug	drug	NOUN
admet-1622	310	23	release	release	NOUN
admet-1622	310	24	[	[	X
admet-1622	310	25	76	76	NUM
admet-1622	310	26	]	]	X
admet-1622	310	27	,	,	PUNCT
admet-1622	310	28	the	the	DET
admet-1622	310	29	rate	rate	NOUN
admet-1622	310	30	was	be	AUX
admet-1622	310	31	still	still	ADV
admet-1622	310	32	rapid	rapid	ADJ
admet-1622	310	33	enough	enough	ADV
admet-1622	310	34	for	for	ADP
admet-1622	310	35	complete	complete	ADJ
admet-1622	310	36	drug	drug	NOUN
admet-1622	310	37	release	release	NOUN
admet-1622	310	38	in	in	ADP
admet-1622	310	39	2	2	NUM
admet-1622	310	40	-	-	SYM
admet-1622	310	41	3	3	NUM
admet-1622	310	42	h	h	NOUN
admet-1622	310	43	,	,	PUNCT
admet-1622	310	44	indicating	indicate	VERB
admet-1622	310	45	the	the	DET
admet-1622	310	46	potential	potential	NOUN
admet-1622	310	47	for	for	ADP
admet-1622	310	48	relatively	relatively	ADV
admet-1622	310	49	rapid	rapid	ADJ
admet-1622	310	50	and	and	CCONJ
admet-1622	310	51	complete	complete	ADJ
admet-1622	310	52	drug	drug	NOUN
admet-1622	310	53	release	release	NOUN
admet-1622	310	54	during	during	ADP
admet-1622	310	55	the	the	DET
admet-1622	310	56	gastrointestinal	gastrointestinal	ADJ
admet-1622	310	57	residence	residence	NOUN
admet-1622	310	58	time	time	NOUN
admet-1622	310	59	[	[	X
admet-1622	310	60	77	77	NUM
admet-1622	310	61	]	]	PUNCT
admet-1622	310	62	.	.	PUNCT
admet-1622	311	1	thus	thus	ADV
admet-1622	311	2	,	,	PUNCT
admet-1622	311	3	such	such	DET
admet-1622	311	4	a	a	DET
admet-1622	311	5	systematic	systematic	ADJ
admet-1622	311	6	approach	approach	NOUN
admet-1622	311	7	demonstrates	demonstrate	VERB
admet-1622	311	8	how	how	SCONJ
admet-1622	311	9	3d	3d	NOUN
admet-1622	311	10	-	-	PUNCT
admet-1622	311	11	printed	print	VERB
admet-1622	311	12	tablets	tablet	NOUN
admet-1622	311	13	with	with	ADP
admet-1622	311	14	relatively	relatively	ADV
admet-1622	311	15	rapid	rapid	ADJ
admet-1622	311	16	drug	drug	NOUN
admet-1622	311	17	release	release	NOUN
admet-1622	311	18	may	may	AUX
admet-1622	311	19	be	be	AUX
admet-1622	311	20	identified	identify	VERB
admet-1622	311	21	.	.	PUNCT
admet-1622	312	1	if	if	SCONJ
admet-1622	312	2	the	the	DET
admet-1622	312	3	drug	drug	NOUN
admet-1622	312	4	release	release	NOUN
admet-1622	312	5	rate	rate	NOUN
admet-1622	312	6	of	of	ADP
admet-1622	312	7	the	the	DET
admet-1622	312	8	fdm	fdm	NOUN
admet-1622	312	9	3d	3d	ADV
admet-1622	312	10	-	-	PUNCT
admet-1622	312	11	printed	print	VERB
admet-1622	312	12	tablet	tablet	NOUN
admet-1622	312	13	thus	thus	ADV
admet-1622	312	14	obtained	obtain	VERB
admet-1622	312	15	does	do	AUX
admet-1622	312	16	not	not	PART
admet-1622	312	17	meet	meet	VERB
admet-1622	312	18	the	the	DET
admet-1622	312	19	target	target	NOUN
admet-1622	312	20	profile	profile	NOUN
admet-1622	312	21	,	,	PUNCT
admet-1622	312	22	modifications	modification	NOUN
admet-1622	312	23	of	of	ADP
admet-1622	312	24	the	the	DET
admet-1622	312	25	formulation	formulation	NOUN
admet-1622	312	26	may	may	AUX
admet-1622	312	27	be	be	AUX
admet-1622	312	28	made	make	VERB
admet-1622	312	29	to	to	ADP
admet-1622	312	30	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	PROPN
admet-1622	312	31	abu	abu	PROPN
admet-1622	312	32	t.m	t.m	PROPN
admet-1622	312	33	.	.	PUNCT
admet-1622	313	1	serajuddin	serajuddin	VERB
admet-1622	313	2	admet	admet	PROPN
admet-1622	313	3	&	&	CCONJ
admet-1622	313	4	dmpk	dmpk	PROPN
admet-1622	313	5	11(1	11(1	NUM
admet-1622	313	6	)	)	PUNCT
admet-1622	313	7	(	(	PUNCT
admet-1622	313	8	2023	2023	NUM
admet-1622	313	9	)	)	PUNCT
admet-1622	313	10	33	33	NUM
admet-1622	313	11	-	-	SYM
admet-1622	313	12	55	55	NUM
admet-1622	313	13	48	48	NUM
admet-1622	313	14	further	far	ADV
admet-1622	313	15	increase	increase	VERB
admet-1622	313	16	the	the	DET
admet-1622	313	17	drug	drug	NOUN
admet-1622	313	18	release	release	NOUN
admet-1622	313	19	rate	rate	NOUN
admet-1622	313	20	.	.	PUNCT
admet-1622	314	1	later	later	ADJ
admet-1622	314	2	studies	study	NOUN
admet-1622	314	3	in	in	ADP
admet-1622	314	4	our	our	PRON
admet-1622	314	5	laboratory	laboratory	NOUN
admet-1622	314	6	showed	show	VERB
admet-1622	314	7	that	that	SCONJ
admet-1622	314	8	the	the	DET
admet-1622	314	9	formulation	formulation	NOUN
admet-1622	314	10	was	be	AUX
admet-1622	314	11	still	still	ADV
admet-1622	314	12	extrudable	extrudable	ADJ
admet-1622	314	13	into	into	ADP
admet-1622	314	14	filaments	filament	NOUN
admet-1622	314	15	if	if	SCONJ
admet-1622	314	16	the	the	DET
admet-1622	314	17	amount	amount	NOUN
admet-1622	314	18	of	of	ADP
admet-1622	314	19	cellulose	cellulose	NOUN
admet-1622	314	20	was	be	AUX
admet-1622	314	21	reduced	reduce	VERB
admet-1622	314	22	from	from	ADP
admet-1622	314	23	1:1	1:1	NUM
admet-1622	314	24	w	w	PROPN
admet-1622	314	25	/	/	SYM
admet-1622	314	26	w	w	PROPN
admet-1622	314	27	kollidon	kollidon	PROPN
admet-1622	314	28	®	®	NOUN
admet-1622	314	29	va64	va64	PROPN
admet-1622	314	30	to	to	PART
admet-1622	314	31	affinisol	affinisol	VERB
admet-1622	314	32	®	®	NOUN
admet-1622	314	33	15cp	15cp	PROPN
admet-1622	314	34	ratio	ratio	NOUN
admet-1622	314	35	to	to	ADP
admet-1622	314	36	3:1	3:1	NUM
admet-1622	314	37	ratio	ratio	NOUN
admet-1622	314	38	of	of	ADP
admet-1622	314	39	the	the	DET
admet-1622	314	40	same	same	ADJ
admet-1622	314	41	,	,	PUNCT
admet-1622	314	42	and	and	CCONJ
admet-1622	314	43	decreasing	decrease	VERB
admet-1622	314	44	the	the	DET
admet-1622	314	45	amount	amount	NOUN
admet-1622	314	46	of	of	ADP
admet-1622	314	47	cellulose	cellulose	NOUN
admet-1622	314	48	in	in	ADP
admet-1622	314	49	the	the	DET
admet-1622	314	50	formulation	formulation	NOUN
admet-1622	314	51	resulted	result	VERB
admet-1622	314	52	in	in	ADP
admet-1622	314	53	a	a	DET
admet-1622	314	54	higher	high	ADJ
admet-1622	314	55	drug	drug	NOUN
admet-1622	314	56	release	release	NOUN
admet-1622	314	57	rate	rate	NOUN
admet-1622	314	58	from	from	ADP
admet-1622	314	59	the	the	DET
admet-1622	314	60	tablets	tablet	NOUN
admet-1622	314	61	produced	produce	VERB
admet-1622	314	62	.	.	PUNCT
admet-1622	315	1	figure	figure	NOUN
admet-1622	315	2	6	6	NUM
admet-1622	315	3	.	.	PUNCT
admet-1622	316	1	dissolution	dissolution	NOUN
admet-1622	316	2	of	of	ADP
admet-1622	316	3	haloperidol	haloperidol	NOUN
admet-1622	316	4	from	from	ADP
admet-1622	316	5	fdm	fdm	NOUN
admet-1622	316	6	3d	3d	ADV
admet-1622	316	7	-	-	PUNCT
admet-1622	316	8	printed	print	VERB
admet-1622	316	9	tablets	tablet	NOUN
admet-1622	316	10	containing	contain	VERB
admet-1622	316	11	10	10	NUM
admet-1622	316	12	%	%	NOUN
admet-1622	316	13	drug	drug	NOUN
admet-1622	316	14	load	load	NOUN
admet-1622	316	15	in	in	ADP
admet-1622	316	16	1:1	1:1	NUM
admet-1622	316	17	kollidon	kollidon	PROPN
admet-1622	316	18	®	®	NOUN
admet-1622	316	19	va64	va64	PROPN
admet-1622	316	20	-	-	PUNCT
admet-1622	316	21	affinisol	affinisol	NOUN
admet-1622	316	22	®	®	NOUN
admet-1622	316	23	15	15	NUM
admet-1622	316	24	cp	cp	NOUN
admet-1622	316	25	mixtures	mixture	NOUN
admet-1622	316	26	and	and	CCONJ
admet-1622	316	27	having	have	VERB
admet-1622	316	28	100	100	NUM
admet-1622	316	29	%	%	NOUN
admet-1622	316	30	and	and	CCONJ
admet-1622	316	31	60	60	NUM
admet-1622	316	32	%	%	NOUN
admet-1622	316	33	infill	infill	NOUN
admet-1622	316	34	densities	density	NOUN
admet-1622	316	35	at	at	ADP
admet-1622	316	36	ph	ph	PROPN
admet-1622	316	37	2	2	NUM
admet-1622	316	38	and	and	CCONJ
admet-1622	316	39	6.8	6.8	NUM
admet-1622	316	40	.	.	PUNCT
admet-1622	317	1	figure	figure	NOUN
admet-1622	317	2	5	5	NUM
admet-1622	317	3	also	also	ADV
admet-1622	317	4	identifies	identify	VERB
admet-1622	317	5	several	several	ADJ
admet-1622	317	6	issues	issue	NOUN
admet-1622	317	7	that	that	PRON
admet-1622	317	8	are	be	AUX
admet-1622	317	9	common	common	ADJ
admet-1622	317	10	in	in	ADP
admet-1622	317	11	the	the	DET
admet-1622	317	12	3d	3d	NUM
admet-1622	317	13	printing	printing	NOUN
admet-1622	317	14	process	process	NOUN
admet-1622	317	15	.	.	PUNCT
admet-1622	318	1	the	the	DET
admet-1622	318	2	relatively	relatively	ADV
admet-1622	318	3	high	high	ADJ
admet-1622	318	4	temperature	temperature	NOUN
admet-1622	318	5	(	(	PUNCT
admet-1622	318	6	150	150	NUM
admet-1622	318	7	°	°	NOUN
admet-1622	318	8	c	c	NOUN
admet-1622	318	9	)	)	PUNCT
admet-1622	318	10	used	use	VERB
admet-1622	318	11	for	for	ADP
admet-1622	318	12	melt	melt	VERB
admet-1622	318	13	extrusion	extrusion	NOUN
admet-1622	318	14	of	of	ADP
admet-1622	318	15	filaments	filament	NOUN
admet-1622	318	16	and	and	CCONJ
admet-1622	318	17	even	even	ADV
admet-1622	318	18	higher	high	ADJ
admet-1622	318	19	temperature	temperature	NOUN
admet-1622	318	20	(	(	PUNCT
admet-1622	318	21	210	210	NUM
admet-1622	318	22	°	°	NOUN
admet-1622	318	23	c	c	NOUN
admet-1622	318	24	)	)	PUNCT
admet-1622	318	25	necessary	necessary	ADJ
admet-1622	318	26	for	for	ADP
admet-1622	318	27	3d	3d	NUM
admet-1622	318	28	printing	printing	NOUN
admet-1622	318	29	of	of	ADP
admet-1622	318	30	filaments	filament	NOUN
admet-1622	318	31	into	into	ADP
admet-1622	318	32	tablets	tablet	NOUN
admet-1622	318	33	could	could	AUX
admet-1622	318	34	pose	pose	VERB
admet-1622	318	35	issues	issue	NOUN
admet-1622	318	36	if	if	SCONJ
admet-1622	318	37	the	the	DET
admet-1622	318	38	drug	drug	NOUN
admet-1622	318	39	is	be	AUX
admet-1622	318	40	thermolabile	thermolabile	NOUN
admet-1622	318	41	.	.	PUNCT
admet-1622	319	1	there	there	PRON
admet-1622	319	2	could	could	AUX
admet-1622	319	3	also	also	ADV
admet-1622	319	4	be	be	AUX
admet-1622	319	5	issues	issue	NOUN
admet-1622	319	6	with	with	ADP
admet-1622	319	7	drug	drug	NOUN
admet-1622	319	8	loading	loading	NOUN
admet-1622	319	9	in	in	ADP
admet-1622	319	10	tablets	tablet	NOUN
admet-1622	319	11	depending	depend	VERB
admet-1622	319	12	on	on	ADP
admet-1622	319	13	the	the	DET
admet-1622	319	14	drug	drug	NOUN
admet-1622	319	15	-	-	PUNCT
admet-1622	319	16	polymer	polymer	NOUN
admet-1622	319	17	miscibility	miscibility	NOUN
admet-1622	319	18	.	.	PUNCT
admet-1622	320	1	although	although	SCONJ
admet-1622	320	2	the	the	DET
admet-1622	320	3	miscibility	miscibility	NOUN
admet-1622	320	4	may	may	AUX
admet-1622	320	5	differ	differ	VERB
admet-1622	320	6	from	from	ADP
admet-1622	320	7	drug	drug	NOUN
admet-1622	320	8	to	to	ADP
admet-1622	320	9	drug	drug	NOUN
admet-1622	320	10	and	and	CCONJ
admet-1622	320	11	polymer	polymer	NOUN
admet-1622	320	12	to	to	PART
admet-1622	320	13	polymer	polymer	NOUN
admet-1622	320	14	,	,	PUNCT
admet-1622	320	15	it	it	PRON
admet-1622	320	16	is	be	AUX
admet-1622	320	17	essential	essential	ADJ
admet-1622	320	18	that	that	SCONJ
admet-1622	320	19	drug	drug	NOUN
admet-1622	320	20	loading	loading	NOUN
admet-1622	320	21	in	in	ADP
admet-1622	320	22	tablets	tablet	NOUN
admet-1622	320	23	should	should	AUX
admet-1622	320	24	be	be	AUX
admet-1622	320	25	based	base	VERB
admet-1622	320	26	on	on	ADP
admet-1622	320	27	a	a	DET
admet-1622	320	28	thorough	thorough	ADJ
admet-1622	320	29	evaluation	evaluation	NOUN
admet-1622	320	30	of	of	ADP
admet-1622	320	31	the	the	DET
admet-1622	320	32	drug	drug	NOUN
admet-1622	320	33	-	-	PUNCT
admet-1622	320	34	polymer	polymer	NOUN
admet-1622	320	35	miscibility	miscibility	NOUN
admet-1622	320	36	.	.	PUNCT
admet-1622	321	1	thus	thus	ADV
admet-1622	321	2	,	,	PUNCT
admet-1622	321	3	the	the	DET
admet-1622	321	4	systematic	systematic	ADJ
admet-1622	321	5	identification	identification	NOUN
admet-1622	321	6	of	of	ADP
admet-1622	321	7	such	such	ADJ
admet-1622	321	8	issues	issue	NOUN
admet-1622	321	9	during	during	ADP
admet-1622	321	10	the	the	DET
admet-1622	321	11	development	development	NOUN
admet-1622	321	12	program	program	NOUN
admet-1622	321	13	guides	guide	VERB
admet-1622	321	14	the	the	DET
admet-1622	321	15	formulators	formulator	NOUN
admet-1622	321	16	towards	towards	ADP
admet-1622	321	17	evaluating	evaluate	VERB
admet-1622	321	18	and	and	CCONJ
admet-1622	321	19	possibly	possibly	ADV
admet-1622	321	20	resolving	resolve	VERB
admet-1622	321	21	them	they	PRON
admet-1622	321	22	.	.	PUNCT
admet-1622	322	1	case	case	NOUN
admet-1622	322	2	study	study	NOUN
admet-1622	322	3	2	2	NUM
admet-1622	322	4	:	:	PUNCT
admet-1622	322	5	development	development	NOUN
admet-1622	322	6	of	of	ADP
admet-1622	322	7	fdm	fdm	NOUN
admet-1622	322	8	3d	3d	ADV
admet-1622	322	9	-	-	PUNCT
admet-1622	322	10	printed	print	VERB
admet-1622	322	11	tablets	tablet	NOUN
admet-1622	322	12	with	with	ADP
admet-1622	322	13	rapid	rapid	ADJ
admet-1622	322	14	drug	drug	NOUN
admet-1622	322	15	release	release	NOUN
admet-1622	322	16	by	by	ADP
admet-1622	322	17	acid	acid	ADJ
admet-1622	322	18	-	-	PUNCT
admet-1622	322	19	base	base	NOUN
admet-1622	322	20	interactions	interaction	NOUN
admet-1622	322	21	this	this	DET
admet-1622	322	22	case	case	NOUN
admet-1622	322	23	study	study	NOUN
admet-1622	322	24	represents	represent	VERB
admet-1622	322	25	a	a	DET
admet-1622	322	26	recent	recent	ADJ
admet-1622	322	27	advance	advance	NOUN
admet-1622	322	28	in	in	ADP
admet-1622	322	29	fdm	fdm	NOUN
admet-1622	322	30	3d	3d	ADV
admet-1622	322	31	-	-	PUNCT
admet-1622	322	32	printed	print	VERB
admet-1622	322	33	technology	technology	NOUN
admet-1622	322	34	that	that	PRON
admet-1622	322	35	not	not	PART
admet-1622	322	36	only	only	ADV
admet-1622	322	37	provides	provide	VERB
admet-1622	322	38	rapid	rapid	ADJ
admet-1622	322	39	drug	drug	NOUN
admet-1622	322	40	release	release	NOUN
admet-1622	322	41	from	from	ADP
admet-1622	322	42	the	the	DET
admet-1622	322	43	tablets	tablet	NOUN
admet-1622	322	44	,	,	PUNCT
admet-1622	322	45	but	but	CCONJ
admet-1622	322	46	,	,	PUNCT
admet-1622	322	47	at	at	ADP
admet-1622	322	48	the	the	DET
admet-1622	322	49	same	same	ADJ
admet-1622	322	50	time	time	NOUN
admet-1622	322	51	,	,	PUNCT
admet-1622	322	52	also	also	ADV
admet-1622	322	53	resolves	resolve	VERB
admet-1622	322	54	two	two	NUM
admet-1622	322	55	other	other	ADJ
admet-1622	322	56	major	major	ADJ
admet-1622	322	57	issues	issue	NOUN
admet-1622	322	58	faced	face	VERB
admet-1622	322	59	in	in	ADP
admet-1622	322	60	the	the	DET
admet-1622	322	61	development	development	NOUN
admet-1622	322	62	of	of	ADP
admet-1622	322	63	fdm	fdm	NOUN
admet-1622	322	64	3d	3d	ADV
admet-1622	322	65	-	-	PUNCT
admet-1622	322	66	printed	print	VERB
admet-1622	322	67	tablets	tablet	NOUN
admet-1622	322	68	,	,	PUNCT
admet-1622	322	69	namely	namely	ADV
admet-1622	322	70	,	,	PUNCT
admet-1622	322	71	low	low	ADJ
admet-1622	322	72	drug	drug	NOUN
admet-1622	322	73	-	-	PUNCT
admet-1622	322	74	polymer	polymer	NOUN
admet-1622	322	75	miscibility	miscibility	NOUN
admet-1622	322	76	and	and	CCONJ
admet-1622	322	77	the	the	DET
admet-1622	322	78	need	need	NOUN
admet-1622	322	79	for	for	ADP
admet-1622	322	80	high	high	ADJ
admet-1622	322	81	processing	processing	NOUN
admet-1622	322	82	temperature	temperature	NOUN
admet-1622	322	83	.	.	PUNCT
admet-1622	323	1	this	this	DET
admet-1622	323	2	case	case	NOUN
admet-1622	323	3	study	study	NOUN
admet-1622	323	4	is	be	AUX
admet-1622	323	5	based	base	VERB
admet-1622	323	6	on	on	ADP
admet-1622	323	7	the	the	DET
admet-1622	323	8	acid	acid	NOUN
admet-1622	323	9	-	-	PUNCT
admet-1622	323	10	base	base	NOUN
admet-1622	323	11	supersolubilization	supersolubilization	NOUN
admet-1622	323	12	(	(	PUNCT
admet-1622	323	13	abs	ab	NOUN
admet-1622	323	14	)	)	PUNCT
admet-1622	323	15	principle	principle	NOUN
admet-1622	323	16	described	describe	VERB
admet-1622	323	17	earlier	early	ADV
admet-1622	323	18	.	.	PUNCT
admet-1622	324	1	the	the	DET
admet-1622	324	2	application	application	NOUN
admet-1622	324	3	of	of	ADP
admet-1622	324	4	the	the	DET
admet-1622	324	5	abs	ab	NOUN
admet-1622	324	6	principle	principle	NOUN
admet-1622	324	7	in	in	ADP
admet-1622	324	8	increasing	increase	VERB
admet-1622	324	9	release	release	NOUN
admet-1622	324	10	rates	rate	NOUN
admet-1622	324	11	of	of	ADP
admet-1622	324	12	drugs	drug	NOUN
admet-1622	324	13	from	from	ADP
admet-1622	324	14	fdm	fdm	NOUN
admet-1622	324	15	3d	3d	ADV
admet-1622	324	16	-	-	PUNCT
admet-1622	324	17	printed	print	VERB
admet-1622	324	18	tablets	tablet	NOUN
admet-1622	324	19	is	be	AUX
admet-1622	324	20	shown	show	VERB
admet-1622	324	21	schematically	schematically	NOUN
admet-1622	324	22	in	in	ADP
admet-1622	324	23	figure	figure	NOUN
admet-1622	324	24	7	7	NUM
admet-1622	324	25	based	base	VERB
admet-1622	324	26	on	on	ADP
admet-1622	324	27	the	the	DET
admet-1622	324	28	work	work	NOUN
admet-1622	324	29	of	of	ADP
admet-1622	324	30	patel	patel	NOUN
admet-1622	324	31	and	and	CCONJ
admet-1622	324	32	serajuddin	serajuddin	VERB
admet-1622	324	33	[	[	PUNCT
admet-1622	324	34	20	20	NUM
admet-1622	324	35	]	]	PUNCT
admet-1622	324	36	,	,	PUNCT
admet-1622	324	37	where	where	SCONJ
admet-1622	324	38	the	the	DET
admet-1622	324	39	formulation	formulation	NOUN
admet-1622	324	40	contained	contain	VERB
admet-1622	324	41	haloperidol	haloperidol	NOUN
admet-1622	324	42	as	as	ADP
admet-1622	324	43	the	the	DET
admet-1622	324	44	model	model	NOUN
admet-1622	324	45	basic	basic	ADJ
admet-1622	324	46	drug	drug	NOUN
admet-1622	324	47	,	,	PUNCT
admet-1622	324	48	glutaric	glutaric	ADJ
admet-1622	324	49	acid	acid	NOUN
admet-1622	324	50	as	as	ADP
admet-1622	324	51	the	the	DET
admet-1622	324	52	super	super	ADV
admet-1622	324	53	-	-	ADJ
admet-1622	324	54	solubilizing	solubilize	VERB
admet-1622	324	55	agent	agent	NOUN
admet-1622	324	56	,	,	PUNCT
admet-1622	324	57	and	and	CCONJ
admet-1622	325	1	kollidon	kollidon	ADJ
admet-1622	325	2	®	®	NOUN
admet-1622	325	3	va64	va64	PROPN
admet-1622	325	4	as	as	ADP
admet-1622	325	5	the	the	DET
admet-1622	325	6	polymer	polymer	NOUN
admet-1622	325	7	.	.	PUNCT
admet-1622	326	1	in	in	ADP
admet-1622	326	2	the	the	DET
admet-1622	326	3	presence	presence	NOUN
admet-1622	326	4	of	of	ADP
admet-1622	326	5	glutaric	glutaric	ADJ
admet-1622	326	6	acid	acid	NOUN
admet-1622	326	7	,	,	PUNCT
admet-1622	326	8	the	the	DET
admet-1622	326	9	aqueous	aqueous	ADJ
admet-1622	326	10	solubility	solubility	NOUN
admet-1622	326	11	of	of	ADP
admet-1622	326	12	haloperidol	haloperidol	PROPN
admet-1622	326	13	increased	increase	VERB
admet-1622	326	14	to	to	ADP
admet-1622	326	15	>	>	X
admet-1622	326	16	300	300	NUM
admet-1622	326	17	mg	mg	NUM
admet-1622	326	18	/	/	SYM
admet-1622	326	19	ml	ml	NOUN
admet-1622	326	20	,	,	PUNCT
admet-1622	326	21	which	which	PRON
admet-1622	326	22	indicated	indicate	VERB
admet-1622	326	23	that	that	SCONJ
admet-1622	326	24	an	an	DET
admet-1622	326	25	interaction	interaction	NOUN
admet-1622	326	26	between	between	ADP
admet-1622	326	27	haloperidol	haloperidol	PROPN
admet-1622	326	28	and	and	CCONJ
admet-1622	326	29	glutaric	glutaric	PROPN
admet-1622	326	30	acid	acid	NOUN
admet-1622	326	31	occurred	occur	VERB
admet-1622	326	32	,	,	PUNCT
admet-1622	326	33	leading	lead	VERB
admet-1622	326	34	to	to	ADP
admet-1622	326	35	the	the	DET
admet-1622	326	36	supersolubilization	supersolubilization	NOUN
admet-1622	326	37	of	of	ADP
admet-1622	326	38	the	the	DET
admet-1622	326	39	drug	drug	NOUN
admet-1622	326	40	.	.	PUNCT
admet-1622	327	1	such	such	DET
admet-1622	327	2	an	an	DET
admet-1622	327	3	interaction	interaction	NOUN
admet-1622	327	4	between	between	ADP
admet-1622	327	5	haloperidol	haloperidol	PROPN
admet-1622	327	6	and	and	CCONJ
admet-1622	327	7	glutaric	glutaric	ADJ
admet-1622	327	8	acid	acid	NOUN
admet-1622	327	9	was	be	AUX
admet-1622	327	10	also	also	ADV
admet-1622	327	11	observed	observe	VERB
admet-1622	327	12	in	in	ADP
admet-1622	327	13	the	the	DET
admet-1622	327	14	solid	solid	ADJ
admet-1622	327	15	state	state	NOUN
admet-1622	327	16	,	,	PUNCT
admet-1622	327	17	which	which	PRON
admet-1622	327	18	reduced	reduce	VERB
admet-1622	327	19	the	the	DET
admet-1622	327	20	melt	melt	NOUN
admet-1622	327	21	extrusion	extrusion	NOUN
admet-1622	327	22	temperature	temperature	NOUN
admet-1622	327	23	of	of	ADP
admet-1622	327	24	the	the	DET
admet-1622	327	25	formulation	formulation	NOUN
admet-1622	327	26	from	from	ADP
admet-1622	327	27	150	150	NUM
admet-1622	327	28	°	°	NOUN
admet-1622	327	29	c	c	NOUN
admet-1622	327	30	to	to	ADP
admet-1622	327	31	115	115	NUM
admet-1622	327	32	°	°	NOUN
admet-1622	327	33	c	c	NOUN
admet-1622	327	34	since	since	SCONJ
admet-1622	327	35	the	the	DET
admet-1622	327	36	haloperidol	haloperidol	NOUN
admet-1622	327	37	-	-	PUNCT
admet-1622	327	38	glutaric	glutaric	ADJ
admet-1622	327	39	mixture	mixture	NOUN
admet-1622	327	40	converted	convert	VERB
admet-1622	327	41	to	to	ADP
admet-1622	327	42	a	a	DET
admet-1622	327	43	semisolid	semisolid	NOUN
admet-1622	327	44	mass	mass	NOUN
admet-1622	327	45	during	during	ADP
admet-1622	327	46	melt	melt	NOUN
admet-1622	327	47	extrusion	extrusion	NOUN
admet-1622	327	48	that	that	PRON
admet-1622	327	49	plasticized	plasticize	VERB
admet-1622	327	50	the	the	DET
admet-1622	327	51	polymer	polymer	NOUN
admet-1622	327	52	.	.	PUNCT
admet-1622	328	1	while	while	SCONJ
admet-1622	328	2	the	the	DET
admet-1622	328	3	haloperidol	haloperidol	PROPN
admet-1622	328	4	-	-	PUNCT
admet-1622	328	5	kollidon	kollidon	NOUN
admet-1622	328	6	®	®	NOUN
admet-1622	328	7	va64	va64	PROPN
admet-1622	328	8	mixture	mixture	NOUN
admet-1622	328	9	was	be	AUX
admet-1622	328	10	not	not	PART
admet-1622	328	11	printable	printable	ADJ
admet-1622	328	12	,	,	PUNCT
admet-1622	328	13	the	the	DET
admet-1622	328	14	plasticizing	plasticizing	NOUN
admet-1622	328	15	effect	effect	NOUN
admet-1622	328	16	of	of	ADP
admet-1622	328	17	the	the	DET
admet-1622	328	18	acid	acid	NOUN
admet-1622	328	19	-	-	PUNCT
admet-1622	328	20	base	base	NOUN
admet-1622	328	21	mixture	mixture	NOUN
admet-1622	328	22	when	when	SCONJ
admet-1622	328	23	glutaric	glutaric	ADJ
admet-1622	328	24	acid	acid	NOUN
admet-1622	328	25	was	be	AUX
admet-1622	328	26	added	add	VERB
admet-1622	328	27	to	to	ADP
admet-1622	328	28	the	the	DET
admet-1622	328	29	formulation	formulation	NOUN
admet-1622	328	30	also	also	ADV
admet-1622	328	31	made	make	VERB
admet-1622	328	32	the	the	DET
admet-1622	328	33	filaments	filament	NOUN
admet-1622	328	34	printable	printable	ADJ
admet-1622	328	35	and	and	CCONJ
admet-1622	328	36	lowered	lower	VERB
admet-1622	328	37	the	the	DET
admet-1622	328	38	printing	printing	NOUN
admet-1622	328	39	temperature	temperature	NOUN
admet-1622	328	40	to	to	ADP
admet-1622	328	41	as	as	ADV
admet-1622	328	42	low	low	ADJ
admet-1622	328	43	as	as	ADP
admet-1622	328	44	120	120	NUM
admet-1622	328	45	°	°	NOUN
admet-1622	328	46	c	c	NOUN
admet-1622	328	47	as	as	SCONJ
admet-1622	328	48	compared	compare	VERB
admet-1622	328	49	to	to	ADP
admet-1622	328	50	~200	~200	PRON
admet-1622	329	1	°	°	ADP
admet-1622	329	2	c	c	NOUN
admet-1622	329	3	required	require	VERB
admet-1622	329	4	in	in	ADP
admet-1622	329	5	the	the	DET
admet-1622	329	6	absence	absence	NOUN
admet-1622	329	7	of	of	ADP
admet-1622	329	8	glutaric	glutaric	ADJ
admet-1622	329	9	acid	acid	NOUN
admet-1622	329	10	.	.	PUNCT
admet-1622	330	1	the	the	DET
admet-1622	330	2	drug	drug	NOUN
admet-1622	330	3	was	be	AUX
admet-1622	330	4	also	also	ADV
admet-1622	330	5	highly	highly	ADV
admet-1622	330	6	miscible	miscible	ADJ
admet-1622	330	7	with	with	ADP
admet-1622	330	8	the	the	DET
admet-1622	330	9	formulation	formulation	NOUN
admet-1622	330	10	to	to	ADP
admet-1622	330	11	as	as	ADV
admet-1622	330	12	high	high	ADJ
admet-1622	330	13	as	as	ADP
admet-1622	330	14	50	50	NUM
admet-1622	330	15	%	%	NOUN
admet-1622	330	16	w	w	PROPN
admet-1622	330	17	/	/	SYM
admet-1622	330	18	w.	w.	PROPN
admet-1622	330	19	admet	admet	PROPN
admet-1622	330	20	&	&	CCONJ
admet-1622	330	21	dmpk	dmpk	PROPN
admet-1622	330	22	11(1	11(1	NUM
admet-1622	330	23	)	)	PUNCT
admet-1622	330	24	(	(	PUNCT
admet-1622	330	25	2023	2023	NUM
admet-1622	330	26	)	)	PUNCT
admet-1622	330	27	33	33	NUM
admet-1622	330	28	-	-	SYM
admet-1622	330	29	55	55	NUM
admet-1622	330	30	development	development	NOUN
admet-1622	330	31	of	of	ADP
admet-1622	330	32	rapidly	rapidly	ADV
admet-1622	330	33	dissolving	dissolve	VERB
admet-1622	330	34	fdm	fdm	NOUN
admet-1622	330	35	3d	3d	ADV
admet-1622	330	36	-	-	PUNCT
admet-1622	330	37	printed	print	VERB
admet-1622	330	38	tablets	tablet	NOUN
admet-1622	330	39	doi	doi	NOUN
admet-1622	330	40	:	:	PUNCT
admet-1622	330	41	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	330	42	49	49	NUM
admet-1622	330	43	figure	figure	NOUN
admet-1622	330	44	7	7	NUM
admet-1622	330	45	.	.	PUNCT
admet-1622	330	46	effects	effect	NOUN
admet-1622	330	47	acid	acid	NOUN
admet-1622	330	48	-	-	PUNCT
admet-1622	330	49	base	base	NOUN
admet-1622	330	50	interaction	interaction	NOUN
admet-1622	330	51	between	between	ADP
admet-1622	330	52	glutaric	glutaric	ADJ
admet-1622	330	53	acid	acid	NOUN
admet-1622	330	54	and	and	CCONJ
admet-1622	330	55	haloperidol	haloperidol	VERB
admet-1622	330	56	on	on	ADP
admet-1622	330	57	melt	melt	NOUN
admet-1622	330	58	extrusion	extrusion	NOUN
admet-1622	330	59	and	and	CCONJ
admet-1622	330	60	printing	printing	NOUN
admet-1622	330	61	temperatures	temperature	NOUN
admet-1622	330	62	,	,	PUNCT
admet-1622	330	63	printability	printability	NOUN
admet-1622	330	64	,	,	PUNCT
admet-1622	330	65	and	and	CCONJ
admet-1622	330	66	drug	drug	NOUN
admet-1622	330	67	-	-	PUNCT
admet-1622	330	68	polymer	polymer	NOUN
admet-1622	330	69	miscibility	miscibility	NOUN
admet-1622	330	70	of	of	ADP
admet-1622	330	71	fdm	fdm	NOUN
admet-1622	330	72	3d	3d	NUM
admet-1622	330	73	printed	print	VERB
admet-1622	330	74	tablets	tablet	NOUN
admet-1622	330	75	.	.	PUNCT
admet-1622	331	1	the	the	DET
admet-1622	331	2	drug	drug	NOUN
admet-1622	331	3	release	release	NOUN
admet-1622	331	4	rates	rate	NOUN
admet-1622	331	5	from	from	ADP
admet-1622	331	6	tablets	tablet	NOUN
admet-1622	331	7	containing	contain	VERB
admet-1622	331	8	glutaric	glutaric	ADJ
admet-1622	331	9	acid	acid	NOUN
admet-1622	331	10	were	be	AUX
admet-1622	331	11	rapid	rapid	ADJ
admet-1622	331	12	.	.	PUNCT
admet-1622	332	1	as	as	SCONJ
admet-1622	332	2	shown	show	VERB
admet-1622	332	3	in	in	ADP
admet-1622	332	4	fig	fig	NOUN
admet-1622	332	5	.	.	PUNCT
admet-1622	333	1	8	8	NUM
admet-1622	333	2	,	,	PUNCT
admet-1622	333	3	almost	almost	ADV
admet-1622	333	4	all	all	DET
admet-1622	333	5	the	the	DET
admet-1622	333	6	drug	drug	NOUN
admet-1622	333	7	dissolved	dissolve	VERB
admet-1622	333	8	at	at	ADP
admet-1622	333	9	both	both	DET
admet-1622	333	10	ph	ph	ADJ
admet-1622	333	11	2	2	NUM
admet-1622	333	12	and	and	CCONJ
admet-1622	333	13	6.8	6.8	NUM
admet-1622	333	14	in	in	ADP
admet-1622	333	15	30	30	NUM
admet-1622	333	16	min	min	NOUN
admet-1622	333	17	,	,	PUNCT
admet-1622	333	18	and	and	CCONJ
admet-1622	333	19	because	because	SCONJ
admet-1622	333	20	of	of	ADP
admet-1622	333	21	the	the	DET
admet-1622	333	22	high	high	ADJ
admet-1622	333	23	dissolution	dissolution	NOUN
admet-1622	333	24	rate	rate	NOUN
admet-1622	333	25	of	of	ADP
admet-1622	333	26	the	the	DET
admet-1622	333	27	drug	drug	NOUN
admet-1622	333	28	from	from	ADP
admet-1622	333	29	such	such	DET
admet-1622	333	30	a	a	DET
admet-1622	333	31	formulation	formulation	NOUN
admet-1622	333	32	,	,	PUNCT
admet-1622	333	33	there	there	PRON
admet-1622	333	34	was	be	VERB
admet-1622	333	35	also	also	ADV
admet-1622	333	36	no	no	DET
admet-1622	333	37	significant	significant	ADJ
admet-1622	333	38	effect	effect	NOUN
admet-1622	333	39	of	of	ADP
admet-1622	333	40	the	the	DET
admet-1622	333	41	infill	infill	NOUN
admet-1622	333	42	density	density	NOUN
admet-1622	333	43	.	.	PUNCT
admet-1622	334	1	figure	figure	NOUN
admet-1622	334	2	8	8	NUM
admet-1622	334	3	.	.	PUNCT
admet-1622	335	1	dissolution	dissolution	NOUN
admet-1622	335	2	of	of	ADP
admet-1622	335	3	haloperidol	haloperidol	NOUN
admet-1622	335	4	from	from	ADP
admet-1622	335	5	fdm	fdm	NOUN
admet-1622	335	6	3d	3d	ADV
admet-1622	335	7	-	-	PUNCT
admet-1622	335	8	printed	print	VERB
admet-1622	335	9	tablets	tablet	NOUN
admet-1622	335	10	containing	contain	VERB
admet-1622	335	11	15	15	NUM
admet-1622	335	12	%	%	NOUN
admet-1622	335	13	drug	drug	NOUN
admet-1622	335	14	load	load	NOUN
admet-1622	335	15	from	from	ADP
admet-1622	335	16	a	a	DET
admet-1622	335	17	formulation	formulation	NOUN
admet-1622	335	18	containing	contain	VERB
admet-1622	335	19	1:2	1:2	NUM
admet-1622	335	20	molar	molar	ADJ
admet-1622	335	21	ratio	ratio	NOUN
admet-1622	335	22	of	of	ADP
admet-1622	335	23	drug	drug	NOUN
admet-1622	335	24	to	to	ADP
admet-1622	335	25	glutaric	glutaric	ADJ
admet-1622	335	26	acid	acid	NOUN
admet-1622	335	27	and	and	CCONJ
admet-1622	335	28	having	have	VERB
admet-1622	335	29	100	100	NUM
admet-1622	335	30	%	%	NOUN
admet-1622	335	31	and	and	CCONJ
admet-1622	335	32	60	60	NUM
admet-1622	335	33	%	%	NOUN
admet-1622	335	34	infill	infill	NOUN
admet-1622	335	35	densities	density	NOUN
admet-1622	335	36	at	at	ADP
admet-1622	335	37	ph	ph	PROPN
admet-1622	335	38	2	2	NUM
admet-1622	335	39	and	and	CCONJ
admet-1622	335	40	6.8	6.8	NUM
admet-1622	335	41	.	.	PUNCT
admet-1622	336	1	kol	kol	PROPN
admet-1622	336	2	,	,	PUNCT
admet-1622	336	3	hal	hal	PROPN
admet-1622	336	4	and	and	CCONJ
admet-1622	336	5	ga	ga	PROPN
admet-1622	336	6	represent	represent	VERB
admet-1622	336	7	kollidon	kollidon	PROPN
admet-1622	336	8	®	®	PROPN
admet-1622	336	9	va64	va64	PROPN
admet-1622	336	10	,	,	PUNCT
admet-1622	336	11	haloperidol	haloperidol	NOUN
admet-1622	336	12	,	,	PUNCT
admet-1622	336	13	and	and	CCONJ
admet-1622	336	14	glutaric	glutaric	ADJ
admet-1622	336	15	acid	acid	NOUN
admet-1622	336	16	.	.	PUNCT
admet-1622	337	1	similar	similar	ADJ
admet-1622	337	2	results	result	NOUN
admet-1622	337	3	were	be	AUX
admet-1622	337	4	also	also	ADV
admet-1622	337	5	obtained	obtain	VERB
admet-1622	337	6	for	for	ADP
admet-1622	337	7	fdm	fdm	NOUN
admet-1622	337	8	3d	3d	ADV
admet-1622	337	9	-	-	PUNCT
admet-1622	337	10	printed	print	VERB
admet-1622	337	11	tablets	tablet	NOUN
admet-1622	337	12	containing	contain	VERB
admet-1622	337	13	haloperidol	haloperidol	NOUN
admet-1622	337	14	-	-	PUNCT
admet-1622	337	15	malic	malic	ADJ
admet-1622	337	16	acid	acid	NOUN
admet-1622	337	17	mixtures	mixture	NOUN
admet-1622	337	18	[	[	X
admet-1622	337	19	21	21	NUM
admet-1622	337	20	]	]	PUNCT
admet-1622	337	21	,	,	PUNCT
admet-1622	337	22	where	where	SCONJ
admet-1622	337	23	the	the	DET
admet-1622	337	24	kollidon	kollidon	PROPN
admet-1622	337	25	®	®	NOUN
admet-1622	337	26	va64	va64	NOUN
admet-1622	337	27	-	-	PUNCT
admet-1622	337	28	haloperidol	haloperidol	ADJ
admet-1622	337	29	-	-	PUNCT
admet-1622	337	30	malic	malic	ADJ
admet-1622	337	31	acid	acid	NOUN
admet-1622	337	32	ternary	ternary	ADJ
admet-1622	337	33	mixtures	mixture	NOUN
admet-1622	337	34	could	could	AUX
admet-1622	337	35	be	be	AUX
admet-1622	337	36	extruded	extrude	VERB
admet-1622	337	37	into	into	ADP
admet-1622	337	38	filaments	filament	NOUN
admet-1622	337	39	at	at	ADP
admet-1622	337	40	120	120	NUM
admet-1622	337	41	°	°	NOUN
admet-1622	337	42	c	c	NOUN
admet-1622	337	43	and	and	CCONJ
admet-1622	337	44	printed	print	VERB
admet-1622	337	45	into	into	ADP
admet-1622	337	46	tablets	tablet	NOUN
admet-1622	337	47	at	at	ADP
admet-1622	337	48	125	125	NUM
admet-1622	337	49	and	and	CCONJ
admet-1622	337	50	100	100	NUM
admet-1622	337	51	°	°	NOUN
admet-1622	337	52	c	c	NOUN
admet-1622	337	53	,	,	PUNCT
admet-1622	337	54	respectively	respectively	ADV
admet-1622	337	55	,	,	PUNCT
admet-1622	337	56	at	at	ADP
admet-1622	337	57	15	15	NUM
admet-1622	337	58	%	%	NOUN
admet-1622	337	59	and	and	CCONJ
admet-1622	337	60	30	30	NUM
admet-1622	337	61	%	%	NOUN
admet-1622	337	62	drug	drug	NOUN
admet-1622	337	63	loads	load	NOUN
admet-1622	337	64	.	.	PUNCT
admet-1622	338	1	as	as	ADV
admet-1622	338	2	high	high	ADJ
admet-1622	338	3	as	as	ADP
admet-1622	338	4	50	50	NUM
admet-1622	338	5	%	%	NOUN
admet-1622	338	6	w	w	PROPN
admet-1622	338	7	/	/	SYM
admet-1622	338	8	w	w	NOUN
admet-1622	338	9	drug	drug	NOUN
admet-1622	338	10	load	load	NOUN
admet-1622	338	11	could	could	AUX
admet-1622	338	12	be	be	AUX
admet-1622	338	13	achieved	achieve	VERB
admet-1622	338	14	due	due	ADP
admet-1622	338	15	to	to	ADP
admet-1622	338	16	the	the	DET
admet-1622	338	17	high	high	ADJ
admet-1622	338	18	miscibility	miscibility	NOUN
admet-1622	338	19	of	of	ADP
admet-1622	338	20	the	the	DET
admet-1622	338	21	drug	drug	NOUN
admet-1622	338	22	with	with	ADP
admet-1622	338	23	the	the	DET
admet-1622	338	24	formulation	formulation	NOUN
admet-1622	338	25	;	;	PUNCT
admet-1622	338	26	however	however	ADV
admet-1622	338	27	,	,	PUNCT
admet-1622	338	28	the	the	DET
admet-1622	338	29	filaments	filament	NOUN
admet-1622	338	30	were	be	AUX
admet-1622	338	31	too	too	ADV
admet-1622	338	32	soft	soft	ADJ
admet-1622	338	33	with	with	ADP
admet-1622	338	34	40	40	NUM
admet-1622	338	35	and	and	CCONJ
admet-1622	338	36	50	50	NUM
admet-1622	338	37	%	%	NOUN
admet-1622	338	38	w	w	PROPN
admet-1622	338	39	/	/	SYM
admet-1622	338	40	w	w	NOUN
admet-1622	338	41	drug	drug	NOUN
admet-1622	338	42	loads	load	NOUN
admet-1622	338	43	,	,	PUNCT
admet-1622	338	44	and	and	CCONJ
admet-1622	338	45	,	,	PUNCT
admet-1622	338	46	therefore	therefore	ADV
admet-1622	338	47	,	,	PUNCT
admet-1622	338	48	formulations	formulation	NOUN
admet-1622	338	49	with	with	ADP
admet-1622	338	50	only	only	ADV
admet-1622	338	51	15	15	NUM
admet-1622	338	52	and	and	CCONJ
admet-1622	338	53	30	30	NUM
admet-1622	338	54	%	%	NOUN
admet-1622	338	55	w	w	PROPN
admet-1622	338	56	/	/	SYM
admet-1622	338	57	w	w	NOUN
admet-1622	338	58	drug	drug	NOUN
admet-1622	338	59	loads	load	NOUN
admet-1622	338	60	were	be	AUX
admet-1622	338	61	printed	print	VERB
admet-1622	338	62	.	.	PUNCT
admet-1622	339	1	over	over	ADP
admet-1622	339	2	80	80	NUM
admet-1622	339	3	%	%	NOUN
admet-1622	339	4	drug	drug	NOUN
admet-1622	339	5	release	release	NOUN
admet-1622	339	6	could	could	AUX
admet-1622	339	7	be	be	AUX
admet-1622	339	8	achieved	achieve	VERB
admet-1622	339	9	from	from	ADP
admet-1622	339	10	100	100	NUM
admet-1622	339	11	%	%	NOUN
admet-1622	339	12	infill	infill	NOUN
admet-1622	339	13	tablets	tablet	NOUN
admet-1622	339	14	in	in	ADP
admet-1622	339	15	<	<	PROPN
admet-1622	339	16	30	30	NUM
admet-1622	339	17	min	min	NOUN
admet-1622	339	18	at	at	ADP
admet-1622	339	19	ph	ph	PROPN
admet-1622	339	20	1.2	1.2	NUM
admet-1622	339	21	and	and	CCONJ
admet-1622	339	22	6.8	6.8	NUM
admet-1622	339	23	.	.	NUM
admet-1622	340	1	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	PROPN
admet-1622	340	2	abu	abu	PROPN
admet-1622	340	3	t.m	t.m	PROPN
admet-1622	340	4	.	.	PUNCT
admet-1622	340	5	serajuddin	serajuddin	VERB
admet-1622	340	6	admet	admet	PROPN
admet-1622	340	7	&	&	CCONJ
admet-1622	340	8	dmpk	dmpk	PROPN
admet-1622	340	9	11(1	11(1	NUM
admet-1622	340	10	)	)	PUNCT
admet-1622	340	11	(	(	PUNCT
admet-1622	340	12	2023	2023	NUM
admet-1622	340	13	)	)	PUNCT
admet-1622	340	14	33	33	NUM
admet-1622	340	15	-	-	SYM
admet-1622	340	16	55	55	NUM
admet-1622	340	17	50	50	NUM
admet-1622	340	18	summary	summary	NOUN
admet-1622	340	19	and	and	CCONJ
admet-1622	340	20	conclusions	conclusion	NOUN
admet-1622	340	21	although	although	SCONJ
admet-1622	340	22	there	there	PRON
admet-1622	340	23	has	have	AUX
admet-1622	340	24	been	be	AUX
admet-1622	340	25	a	a	DET
admet-1622	340	26	great	great	ADJ
admet-1622	340	27	interest	interest	NOUN
admet-1622	340	28	and	and	CCONJ
admet-1622	340	29	much	much	ADJ
admet-1622	340	30	research	research	NOUN
admet-1622	340	31	in	in	ADP
admet-1622	340	32	recent	recent	ADJ
admet-1622	340	33	years	year	NOUN
admet-1622	340	34	in	in	ADP
admet-1622	340	35	the	the	DET
admet-1622	340	36	fdm	fdm	NOUN
admet-1622	340	37	3d	3d	ADV
admet-1622	340	38	-	-	PUNCT
admet-1622	340	39	printing	print	VERB
admet-1622	340	40	technology	technology	NOUN
admet-1622	340	41	for	for	ADP
admet-1622	340	42	the	the	DET
admet-1622	340	43	development	development	NOUN
admet-1622	340	44	of	of	ADP
admet-1622	340	45	tablets	tablet	NOUN
admet-1622	340	46	for	for	ADP
admet-1622	340	47	personalized	personalized	ADJ
admet-1622	340	48	medicines	medicine	NOUN
admet-1622	340	49	,	,	PUNCT
admet-1622	340	50	it	it	PRON
admet-1622	340	51	faces	face	VERB
admet-1622	340	52	many	many	ADJ
admet-1622	340	53	challenges	challenge	NOUN
admet-1622	340	54	,	,	PUNCT
admet-1622	340	55	such	such	ADJ
admet-1622	340	56	as	as	ADP
admet-1622	340	57	limited	limited	ADJ
admet-1622	340	58	availability	availability	NOUN
admet-1622	340	59	of	of	ADP
admet-1622	340	60	suitable	suitable	ADJ
admet-1622	340	61	polymers	polymer	NOUN
admet-1622	340	62	,	,	PUNCT
admet-1622	340	63	low	low	ADJ
admet-1622	340	64	drug	drug	NOUN
admet-1622	340	65	-	-	PUNCT
admet-1622	340	66	polymer	polymer	NOUN
admet-1622	340	67	miscibility	miscibility	NOUN
admet-1622	340	68	,	,	PUNCT
admet-1622	340	69	the	the	DET
admet-1622	340	70	need	need	NOUN
admet-1622	340	71	for	for	ADP
admet-1622	340	72	high	high	ADJ
admet-1622	340	73	processing	processing	NOUN
admet-1622	340	74	temperatures	temperature	NOUN
admet-1622	340	75	,	,	PUNCT
admet-1622	340	76	and	and	CCONJ
admet-1622	340	77	the	the	DET
admet-1622	340	78	slow	slow	ADJ
admet-1622	340	79	drug	drug	NOUN
admet-1622	340	80	release	release	NOUN
admet-1622	340	81	rate	rate	NOUN
admet-1622	340	82	that	that	PRON
admet-1622	340	83	impede	impede	VERB
admet-1622	340	84	the	the	DET
admet-1622	340	85	development	development	NOUN
admet-1622	340	86	of	of	ADP
admet-1622	340	87	clinically	clinically	ADV
admet-1622	340	88	efficacious	efficacious	ADJ
admet-1622	340	89	and	and	CCONJ
admet-1622	340	90	commercially	commercially	ADV
admet-1622	340	91	viable	viable	ADJ
admet-1622	340	92	fdm	fdm	NOUN
admet-1622	340	93	3d	3d	NUM
admet-1622	340	94	printed	print	VERB
admet-1622	340	95	tablets	tablet	NOUN
admet-1622	340	96	.	.	PUNCT
admet-1622	341	1	these	these	DET
admet-1622	341	2	challenges	challenge	NOUN
admet-1622	341	3	are	be	AUX
admet-1622	341	4	discussed	discuss	VERB
admet-1622	341	5	in	in	ADP
admet-1622	341	6	this	this	DET
admet-1622	341	7	article	article	NOUN
admet-1622	341	8	with	with	ADP
admet-1622	341	9	a	a	DET
admet-1622	341	10	special	special	ADJ
admet-1622	341	11	focus	focus	NOUN
admet-1622	341	12	on	on	ADP
admet-1622	341	13	the	the	DET
admet-1622	341	14	drug	drug	NOUN
admet-1622	341	15	release	release	NOUN
admet-1622	341	16	rate	rate	NOUN
admet-1622	341	17	.	.	PUNCT
admet-1622	342	1	the	the	DET
admet-1622	342	2	fdm	fdm	NOUN
admet-1622	342	3	3d	3d	NOUN
admet-1622	342	4	printing	printing	NOUN
admet-1622	342	5	produces	produce	VERB
admet-1622	342	6	compact	compact	ADJ
admet-1622	342	7	tablets	tablet	NOUN
admet-1622	342	8	that	that	PRON
admet-1622	342	9	dissolve	dissolve	VERB
admet-1622	342	10	slowly	slowly	ADV
admet-1622	342	11	by	by	ADP
admet-1622	342	12	erosion	erosion	NOUN
admet-1622	342	13	,	,	PUNCT
admet-1622	342	14	while	while	SCONJ
admet-1622	342	15	rapid	rapid	ADJ
admet-1622	342	16	drug	drug	NOUN
admet-1622	342	17	release	release	NOUN
admet-1622	342	18	is	be	AUX
admet-1622	342	19	important	important	ADJ
admet-1622	342	20	for	for	ADP
admet-1622	342	21	the	the	DET
admet-1622	342	22	clinical	clinical	ADJ
admet-1622	342	23	efficacy	efficacy	NOUN
admet-1622	342	24	of	of	ADP
admet-1622	342	25	most	most	ADJ
admet-1622	342	26	drug	drug	NOUN
admet-1622	342	27	candidates	candidate	NOUN
admet-1622	342	28	.	.	PUNCT
admet-1622	343	1	such	such	ADJ
admet-1622	343	2	strategies	strategy	NOUN
admet-1622	343	3	as	as	ADP
admet-1622	343	4	using	use	VERB
admet-1622	343	5	rapidly	rapidly	ADV
admet-1622	343	6	dissolving	dissolve	VERB
admet-1622	343	7	polymers	polymer	NOUN
admet-1622	343	8	or	or	CCONJ
admet-1622	343	9	polymer	polymer	NOUN
admet-1622	343	10	-	-	PUNCT
admet-1622	343	11	polymer	polymer	NOUN
admet-1622	343	12	mixtures	mixture	NOUN
admet-1622	343	13	,	,	PUNCT
admet-1622	343	14	incorporation	incorporation	NOUN
admet-1622	343	15	of	of	ADP
admet-1622	343	16	additives	additive	NOUN
admet-1622	343	17	,	,	PUNCT
admet-1622	343	18	modification	modification	NOUN
admet-1622	343	19	of	of	ADP
admet-1622	343	20	tablet	tablet	NOUN
admet-1622	343	21	pattern	pattern	NOUN
admet-1622	343	22	and	and	CCONJ
admet-1622	343	23	geometry	geometry	NOUN
admet-1622	343	24	,	,	PUNCT
admet-1622	343	25	and	and	CCONJ
admet-1622	343	26	supersolubilization	supersolubilization	NOUN
admet-1622	343	27	by	by	ADP
admet-1622	343	28	acid	acid	NOUN
admet-1622	343	29	-	-	PUNCT
admet-1622	343	30	base	base	NOUN
admet-1622	343	31	interaction	interaction	NOUN
admet-1622	343	32	to	to	PART
admet-1622	343	33	increase	increase	VERB
admet-1622	343	34	drug	drug	NOUN
admet-1622	343	35	dissolution	dissolution	NOUN
admet-1622	343	36	rates	rate	NOUN
admet-1622	343	37	are	be	AUX
admet-1622	343	38	reviewed	review	VERB
admet-1622	343	39	and	and	CCONJ
admet-1622	343	40	the	the	DET
admet-1622	343	41	pros	pro	NOUN
admet-1622	343	42	and	and	CCONJ
admet-1622	343	43	cons	con	NOUN
admet-1622	343	44	of	of	ADP
admet-1622	343	45	these	these	DET
admet-1622	343	46	strategies	strategy	NOUN
admet-1622	343	47	are	be	AUX
admet-1622	343	48	discussed	discuss	VERB
admet-1622	343	49	.	.	PUNCT
admet-1622	344	1	many	many	ADJ
admet-1622	344	2	polymers	polymer	NOUN
admet-1622	344	3	,	,	PUNCT
admet-1622	344	4	such	such	ADJ
admet-1622	344	5	as	as	ADP
admet-1622	344	6	pvps	pvps	NOUN
admet-1622	344	7	,	,	PUNCT
admet-1622	344	8	kollidon	kollidon	PROPN
admet-1622	344	9	®	®	NOUN
admet-1622	344	10	va64	va64	PROPN
admet-1622	344	11	,	,	PUNCT
admet-1622	344	12	etc	etc	X
admet-1622	344	13	.	.	X
admet-1622	344	14	,	,	PUNCT
admet-1622	344	15	are	be	AUX
admet-1622	344	16	highly	highly	ADV
admet-1622	344	17	water	water	NOUN
admet-1622	344	18	-	-	PUNCT
admet-1622	344	19	soluble	soluble	ADJ
admet-1622	344	20	and	and	CCONJ
admet-1622	344	21	could	could	AUX
admet-1622	344	22	potentially	potentially	ADV
admet-1622	344	23	increase	increase	VERB
admet-1622	344	24	dissolution	dissolution	ADJ
admet-1622	344	25	rates	rate	NOUN
admet-1622	344	26	of	of	ADP
admet-1622	344	27	drugs	drug	NOUN
admet-1622	344	28	from	from	ADP
admet-1622	344	29	the	the	DET
admet-1622	344	30	fdm	fdm	NOUN
admet-1622	344	31	3d	3d	ADV
admet-1622	344	32	-	-	PUNCT
admet-1622	344	33	printed	print	VERB
admet-1622	344	34	tablets	tablet	NOUN
admet-1622	344	35	,	,	PUNCT
admet-1622	344	36	but	but	CCONJ
admet-1622	344	37	their	their	PRON
admet-1622	344	38	filaments	filament	NOUN
admet-1622	344	39	are	be	AUX
admet-1622	344	40	too	too	ADV
admet-1622	344	41	brittle	brittle	ADJ
admet-1622	344	42	and	and	CCONJ
admet-1622	344	43	can	can	AUX
admet-1622	344	44	not	not	PART
admet-1622	344	45	be	be	AUX
admet-1622	344	46	printed	print	VERB
admet-1622	344	47	.	.	PUNCT
admet-1622	345	1	on	on	ADP
admet-1622	345	2	the	the	DET
admet-1622	345	3	other	other	ADJ
admet-1622	345	4	hand	hand	NOUN
admet-1622	345	5	,	,	PUNCT
admet-1622	345	6	cellulosic	cellulosic	NOUN
admet-1622	345	7	filaments	filament	NOUN
admet-1622	345	8	are	be	AUX
admet-1622	345	9	printable	printable	ADJ
admet-1622	345	10	,	,	PUNCT
admet-1622	345	11	but	but	CCONJ
admet-1622	345	12	the	the	DET
admet-1622	345	13	tablets	tablet	NOUN
admet-1622	345	14	produced	produce	VERB
admet-1622	345	15	are	be	AUX
admet-1622	345	16	slowly	slowly	ADV
admet-1622	345	17	dissolving	dissolve	VERB
admet-1622	345	18	.	.	PUNCT
admet-1622	346	1	mixing	mix	VERB
admet-1622	346	2	cellulose	cellulose	NOUN
admet-1622	346	3	with	with	ADP
admet-1622	346	4	kollidon	kollidon	ADJ
admet-1622	346	5	®	®	NOUN
admet-1622	346	6	va64	va64	PROPN
admet-1622	346	7	is	be	AUX
admet-1622	346	8	a	a	DET
admet-1622	346	9	promising	promising	ADJ
admet-1622	346	10	way	way	NOUN
admet-1622	346	11	of	of	ADP
admet-1622	346	12	increasing	increase	VERB
admet-1622	346	13	dissolution	dissolution	ADJ
admet-1622	346	14	rates	rate	NOUN
admet-1622	346	15	of	of	ADP
admet-1622	346	16	the	the	DET
admet-1622	346	17	formulations	formulation	NOUN
admet-1622	346	18	as	as	SCONJ
admet-1622	346	19	the	the	DET
admet-1622	346	20	mixtures	mixture	NOUN
admet-1622	346	21	are	be	AUX
admet-1622	346	22	printable	printable	ADJ
admet-1622	346	23	and	and	CCONJ
admet-1622	346	24	,	,	PUNCT
admet-1622	346	25	at	at	ADP
admet-1622	346	26	the	the	DET
admet-1622	346	27	same	same	ADJ
admet-1622	346	28	time	time	NOUN
admet-1622	346	29	,	,	PUNCT
admet-1622	346	30	they	they	PRON
admet-1622	346	31	can	can	AUX
admet-1622	346	32	improve	improve	VERB
admet-1622	346	33	dissolution	dissolution	NOUN
admet-1622	346	34	rates	rate	NOUN
admet-1622	346	35	over	over	ADP
admet-1622	346	36	that	that	PRON
admet-1622	346	37	with	with	ADP
admet-1622	346	38	celluloses	cellulose	NOUN
admet-1622	346	39	alone	alone	ADV
admet-1622	346	40	.	.	PUNCT
admet-1622	347	1	a	a	DET
admet-1622	347	2	polymer	polymer	NOUN
admet-1622	347	3	like	like	ADP
admet-1622	347	4	eudragit	eudragit	NOUN
admet-1622	347	5	®	®	NOUN
admet-1622	347	6	epo	epo	NOUN
admet-1622	347	7	can	can	AUX
admet-1622	347	8	also	also	ADV
admet-1622	347	9	produce	produce	VERB
admet-1622	347	10	rapidly	rapidly	ADV
admet-1622	347	11	dissolving	dissolve	VERB
admet-1622	347	12	tablets	tablet	NOUN
admet-1622	347	13	;	;	PUNCT
admet-1622	347	14	however	however	ADV
admet-1622	347	15	,	,	PUNCT
admet-1622	347	16	since	since	SCONJ
admet-1622	347	17	it	it	PRON
admet-1622	347	18	dissolves	dissolve	VERB
admet-1622	347	19	only	only	ADV
admet-1622	347	20	at	at	ADP
admet-1622	347	21	ph<5	ph<5	PROPN
admet-1622	347	22	,	,	PUNCT
admet-1622	347	23	the	the	DET
admet-1622	347	24	dissolution	dissolution	NOUN
admet-1622	347	25	of	of	ADP
admet-1622	347	26	tablets	tablet	NOUN
admet-1622	347	27	under	under	ADP
admet-1622	347	28	intestinal	intestinal	ADJ
admet-1622	347	29	ph	ph	ADJ
admet-1622	347	30	conditions	condition	NOUN
admet-1622	347	31	at	at	ADP
admet-1622	347	32	ph>5	ph>5	PROPN
admet-1622	347	33	could	could	AUX
admet-1622	347	34	be	be	AUX
admet-1622	347	35	slow	slow	ADJ
admet-1622	347	36	and	and	CCONJ
admet-1622	347	37	incomplete	incomplete	ADJ
admet-1622	347	38	.	.	PUNCT
admet-1622	348	1	the	the	DET
admet-1622	348	2	printability	printability	NOUN
admet-1622	348	3	of	of	ADP
admet-1622	348	4	eudragit	eudragit	PROPN
admet-1622	348	5	®	®	NOUN
admet-1622	348	6	epo	epo	NOUN
admet-1622	348	7	could	could	AUX
admet-1622	348	8	also	also	ADV
admet-1622	348	9	be	be	AUX
admet-1622	348	10	a	a	DET
admet-1622	348	11	concern	concern	NOUN
admet-1622	348	12	since	since	SCONJ
admet-1622	348	13	it	it	PRON
admet-1622	348	14	has	have	VERB
admet-1622	348	15	a	a	DET
admet-1622	348	16	relatively	relatively	ADV
admet-1622	348	17	low	low	ADJ
admet-1622	348	18	glass	glass	NOUN
admet-1622	348	19	transition	transition	NOUN
admet-1622	348	20	temperature	temperature	NOUN
admet-1622	348	21	(	(	PUNCT
admet-1622	348	22	~50	~50	PROPN
admet-1622	348	23	°	°	NOUN
admet-1622	348	24	c	c	NOUN
admet-1622	348	25	)	)	PUNCT
admet-1622	348	26	and	and	CCONJ
admet-1622	348	27	its	its	PRON
admet-1622	348	28	filaments	filament	NOUN
admet-1622	348	29	may	may	AUX
admet-1622	348	30	require	require	VERB
admet-1622	348	31	solid	solid	ADJ
admet-1622	348	32	additives	additive	NOUN
admet-1622	348	33	to	to	PART
admet-1622	348	34	make	make	VERB
admet-1622	348	35	them	they	PRON
admet-1622	348	36	harder	hard	ADJ
admet-1622	348	37	for	for	ADP
admet-1622	348	38	printing	print	VERB
admet-1622	348	39	.	.	PUNCT
admet-1622	349	1	the	the	DET
admet-1622	349	2	incorporation	incorporation	NOUN
admet-1622	349	3	of	of	ADP
admet-1622	349	4	additives	additive	NOUN
admet-1622	349	5	can	can	AUX
admet-1622	349	6	also	also	ADV
admet-1622	349	7	increase	increase	VERB
admet-1622	349	8	the	the	DET
admet-1622	349	9	dissolution	dissolution	NOUN
admet-1622	349	10	rates	rate	NOUN
admet-1622	349	11	of	of	ADP
admet-1622	349	12	drugs	drug	NOUN
admet-1622	349	13	and	and	CCONJ
admet-1622	349	14	improve	improve	VERB
admet-1622	349	15	the	the	DET
admet-1622	349	16	printability	printability	NOUN
admet-1622	349	17	of	of	ADP
admet-1622	349	18	tablets	tablet	NOUN
admet-1622	349	19	.	.	PUNCT
admet-1622	350	1	however	however	ADV
admet-1622	350	2	,	,	PUNCT
admet-1622	350	3	the	the	DET
admet-1622	350	4	rationale	rationale	NOUN
admet-1622	350	5	for	for	ADP
admet-1622	350	6	the	the	DET
admet-1622	350	7	use	use	NOUN
admet-1622	350	8	of	of	ADP
admet-1622	350	9	different	different	ADJ
admet-1622	350	10	additives	additive	NOUN
admet-1622	350	11	has	have	AUX
admet-1622	350	12	not	not	PART
admet-1622	350	13	been	be	AUX
admet-1622	350	14	fully	fully	ADV
admet-1622	350	15	elucidated	elucidated	ADJ
admet-1622	350	16	in	in	ADP
admet-1622	350	17	the	the	DET
admet-1622	350	18	literature	literature	NOUN
admet-1622	350	19	,	,	PUNCT
admet-1622	350	20	and	and	CCONJ
admet-1622	350	21	the	the	DET
admet-1622	350	22	selection	selection	NOUN
admet-1622	350	23	of	of	ADP
admet-1622	350	24	appropriate	appropriate	ADJ
admet-1622	350	25	additives	additive	NOUN
admet-1622	350	26	will	will	AUX
admet-1622	350	27	require	require	VERB
admet-1622	350	28	careful	careful	ADJ
admet-1622	350	29	consideration	consideration	NOUN
admet-1622	350	30	and	and	CCONJ
admet-1622	350	31	further	further	ADJ
admet-1622	350	32	research	research	NOUN
admet-1622	350	33	.	.	PUNCT
admet-1622	351	1	additionally	additionally	ADV
admet-1622	351	2	,	,	PUNCT
admet-1622	351	3	there	there	PRON
admet-1622	351	4	could	could	AUX
admet-1622	351	5	be	be	AUX
admet-1622	351	6	phase	phase	NOUN
admet-1622	351	7	separation	separation	NOUN
admet-1622	351	8	and	and	CCONJ
admet-1622	351	9	potential	potential	ADJ
admet-1622	351	10	physical	physical	ADJ
admet-1622	351	11	instability	instability	NOUN
admet-1622	351	12	of	of	ADP
admet-1622	351	13	filaments	filament	NOUN
admet-1622	351	14	and	and	CCONJ
admet-1622	351	15	tablets	tablet	NOUN
admet-1622	351	16	if	if	SCONJ
admet-1622	351	17	the	the	DET
admet-1622	351	18	additives	additive	NOUN
admet-1622	351	19	are	be	AUX
admet-1622	351	20	not	not	PART
admet-1622	351	21	miscible	miscible	ADJ
admet-1622	351	22	with	with	ADP
admet-1622	351	23	polymers	polymer	NOUN
admet-1622	351	24	.	.	PUNCT
admet-1622	352	1	among	among	ADP
admet-1622	352	2	different	different	ADJ
admet-1622	352	3	methods	method	NOUN
admet-1622	352	4	of	of	ADP
admet-1622	352	5	modifying	modify	VERB
admet-1622	352	6	tablet	tablet	NOUN
admet-1622	352	7	patterns	pattern	NOUN
admet-1622	352	8	and	and	CCONJ
admet-1622	352	9	geometry	geometry	NOUN
admet-1622	352	10	,	,	PUNCT
admet-1622	352	11	changing	change	VERB
admet-1622	352	12	infill	infill	NOUN
admet-1622	352	13	density	density	NOUN
admet-1622	352	14	is	be	AUX
admet-1622	352	15	the	the	DET
admet-1622	352	16	most	most	ADV
admet-1622	352	17	used	use	VERB
admet-1622	352	18	,	,	PUNCT
admet-1622	352	19	and	and	CCONJ
admet-1622	352	20	further	further	ADJ
admet-1622	352	21	research	research	NOUN
admet-1622	352	22	and	and	CCONJ
admet-1622	352	23	technological	technological	ADJ
admet-1622	352	24	progress	progress	NOUN
admet-1622	352	25	are	be	AUX
admet-1622	352	26	necessary	necessary	ADJ
admet-1622	352	27	for	for	ADP
admet-1622	352	28	the	the	DET
admet-1622	352	29	implementation	implementation	NOUN
admet-1622	352	30	of	of	ADP
admet-1622	352	31	other	other	ADJ
admet-1622	352	32	methods	method	NOUN
admet-1622	352	33	.	.	PUNCT
admet-1622	353	1	there	there	PRON
admet-1622	353	2	are	be	VERB
admet-1622	353	3	,	,	PUNCT
admet-1622	353	4	however	however	ADV
admet-1622	353	5	,	,	PUNCT
admet-1622	353	6	limitations	limitation	NOUN
admet-1622	353	7	to	to	ADP
admet-1622	353	8	what	what	DET
admet-1622	353	9	extent	extent	NOUN
admet-1622	353	10	the	the	DET
admet-1622	353	11	dissolution	dissolution	NOUN
admet-1622	353	12	rate	rate	NOUN
admet-1622	353	13	may	may	AUX
admet-1622	353	14	be	be	AUX
admet-1622	353	15	improved	improve	VERB
admet-1622	353	16	by	by	ADP
admet-1622	353	17	this	this	DET
admet-1622	353	18	method	method	NOUN
admet-1622	353	19	.	.	PUNCT
admet-1622	354	1	two	two	NUM
admet-1622	354	2	emerging	emerge	VERB
admet-1622	354	3	strategies	strategy	NOUN
admet-1622	354	4	for	for	ADP
admet-1622	354	5	the	the	DET
admet-1622	354	6	development	development	NOUN
admet-1622	354	7	of	of	ADP
admet-1622	354	8	rapidly	rapidly	ADV
admet-1622	354	9	dissolving	dissolve	VERB
admet-1622	354	10	fdm	fdm	NOUN
admet-1622	354	11	3d	3d	NOUN
admet-1622	354	12	-	-	PUNCT
admet-1622	354	13	printed	print	VERB
admet-1622	354	14	are	be	AUX
admet-1622	354	15	elaborated	elaborate	VERB
admet-1622	354	16	by	by	ADP
admet-1622	354	17	using	use	VERB
admet-1622	354	18	case	case	NOUN
admet-1622	354	19	studies	study	NOUN
admet-1622	354	20	,	,	PUNCT
admet-1622	354	21	where	where	SCONJ
admet-1622	354	22	one	one	PRON
admet-1622	354	23	provides	provide	VERB
admet-1622	354	24	a	a	DET
admet-1622	354	25	systematic	systematic	ADJ
admet-1622	354	26	approach	approach	NOUN
admet-1622	354	27	for	for	ADP
admet-1622	354	28	screening	screen	VERB
admet-1622	354	29	polymers	polymer	NOUN
admet-1622	354	30	for	for	ADP
admet-1622	354	31	rapidly	rapidly	ADV
admet-1622	354	32	dissolving	dissolve	VERB
admet-1622	354	33	tablets	tablet	NOUN
admet-1622	354	34	,	,	PUNCT
admet-1622	354	35	and	and	CCONJ
admet-1622	354	36	the	the	DET
admet-1622	354	37	other	other	ADJ
admet-1622	354	38	involves	involve	VERB
admet-1622	354	39	the	the	DET
admet-1622	354	40	acid	acid	NOUN
admet-1622	354	41	-	-	PUNCT
admet-1622	354	42	base	base	NOUN
admet-1622	354	43	supersolubilization	supersolubilization	NOUN
admet-1622	354	44	(	(	PUNCT
admet-1622	354	45	abs	ab	NOUN
admet-1622	354	46	)	)	PUNCT
admet-1622	354	47	principle	principle	NOUN
admet-1622	354	48	that	that	SCONJ
admet-1622	354	49	not	not	PART
admet-1622	354	50	only	only	ADV
admet-1622	354	51	increases	increase	VERB
admet-1622	354	52	solubility	solubility	NOUN
admet-1622	354	53	and	and	CCONJ
admet-1622	354	54	dissolution	dissolution	NOUN
admet-1622	354	55	rates	rate	NOUN
admet-1622	354	56	of	of	ADP
admet-1622	354	57	drugs	drug	NOUN
admet-1622	354	58	but	but	CCONJ
admet-1622	354	59	also	also	ADV
admet-1622	354	60	increases	increase	VERB
admet-1622	354	61	drug	drug	NOUN
admet-1622	354	62	-	-	PUNCT
admet-1622	354	63	polymer	polymer	NOUN
admet-1622	354	64	miscibility	miscibility	NOUN
admet-1622	354	65	and	and	CCONJ
admet-1622	354	66	decreases	decrease	VERB
admet-1622	354	67	processing	processing	NOUN
admet-1622	354	68	temperatures	temperature	NOUN
admet-1622	354	69	for	for	ADP
admet-1622	354	70	tablets	tablet	NOUN
admet-1622	354	71	.	.	PUNCT
admet-1622	355	1	although	although	SCONJ
admet-1622	355	2	very	very	ADV
admet-1622	355	3	promising	promising	ADJ
admet-1622	355	4	,	,	PUNCT
admet-1622	355	5	most	most	ADJ
admet-1622	355	6	of	of	ADP
admet-1622	355	7	the	the	DET
admet-1622	355	8	strategies	strategy	NOUN
admet-1622	355	9	applied	apply	VERB
admet-1622	355	10	to	to	ADP
admet-1622	355	11	the	the	DET
admet-1622	355	12	development	development	NOUN
admet-1622	355	13	of	of	ADP
admet-1622	355	14	fdm	fdm	NOUN
admet-1622	355	15	3d	3d	ADV
admet-1622	355	16	-	-	PUNCT
admet-1622	355	17	printed	print	VERB
admet-1622	355	18	tablets	tablet	NOUN
admet-1622	355	19	are	be	AUX
admet-1622	355	20	rather	rather	ADV
admet-1622	355	21	at	at	ADP
admet-1622	355	22	their	their	PRON
admet-1622	355	23	early	early	ADJ
admet-1622	355	24	stages	stage	NOUN
admet-1622	355	25	of	of	ADP
admet-1622	355	26	development	development	NOUN
admet-1622	355	27	,	,	PUNCT
admet-1622	355	28	and	and	CCONJ
admet-1622	355	29	further	further	ADJ
admet-1622	355	30	research	research	NOUN
admet-1622	355	31	is	be	AUX
admet-1622	355	32	needed	need	VERB
admet-1622	355	33	for	for	ADP
admet-1622	355	34	the	the	DET
admet-1622	355	35	implementation	implementation	NOUN
admet-1622	355	36	of	of	ADP
admet-1622	355	37	these	these	DET
admet-1622	355	38	strategies	strategy	NOUN
admet-1622	355	39	into	into	ADP
admet-1622	355	40	the	the	DET
admet-1622	355	41	development	development	NOUN
admet-1622	355	42	of	of	ADP
admet-1622	355	43	marketed	market	VERB
admet-1622	355	44	drug	drug	NOUN
admet-1622	355	45	products	product	NOUN
admet-1622	355	46	.	.	PUNCT
admet-1622	356	1	many	many	ADJ
admet-1622	356	2	of	of	ADP
admet-1622	356	3	the	the	DET
admet-1622	356	4	gaps	gap	NOUN
admet-1622	356	5	in	in	ADP
admet-1622	356	6	the	the	DET
admet-1622	356	7	current	current	ADJ
admet-1622	356	8	state	state	NOUN
admet-1622	356	9	of	of	ADP
admet-1622	356	10	the	the	DET
admet-1622	356	11	fdm	fdm	NOUN
admet-1622	356	12	3d	3d	ADV
admet-1622	356	13	-	-	PUNCT
admet-1622	356	14	printing	print	VERB
admet-1622	356	15	technology	technology	NOUN
admet-1622	356	16	have	have	AUX
admet-1622	356	17	been	be	AUX
admet-1622	356	18	presented	present	VERB
admet-1622	356	19	in	in	ADP
admet-1622	356	20	this	this	DET
admet-1622	356	21	article	article	NOUN
admet-1622	356	22	,	,	PUNCT
admet-1622	356	23	and	and	CCONJ
admet-1622	356	24	a	a	DET
admet-1622	356	25	few	few	ADJ
admet-1622	356	26	strategies	strategy	NOUN
admet-1622	356	27	to	to	PART
admet-1622	356	28	fill	fill	VERB
admet-1622	356	29	those	those	DET
admet-1622	356	30	gaps	gap	NOUN
admet-1622	356	31	have	have	AUX
admet-1622	356	32	been	be	AUX
admet-1622	356	33	highlighted	highlight	VERB
admet-1622	356	34	.	.	PUNCT
admet-1622	357	1	hopefully	hopefully	ADV
admet-1622	357	2	,	,	PUNCT
admet-1622	357	3	they	they	PRON
admet-1622	357	4	will	will	AUX
admet-1622	357	5	provide	provide	VERB
admet-1622	357	6	guidance	guidance	NOUN
admet-1622	357	7	for	for	ADP
admet-1622	357	8	the	the	DET
admet-1622	357	9	future	future	ADJ
admet-1622	357	10	development	development	NOUN
admet-1622	357	11	of	of	ADP
admet-1622	357	12	the	the	DET
admet-1622	357	13	technology	technology	NOUN
admet-1622	357	14	.	.	PUNCT
admet-1622	358	1	conflict	conflict	NOUN
admet-1622	358	2	of	of	ADP
admet-1622	358	3	interest	interest	NOUN
admet-1622	358	4	:	:	PUNCT
admet-1622	358	5	the	the	DET
admet-1622	358	6	author	author	NOUN
admet-1622	358	7	declares	declare	VERB
admet-1622	358	8	no	no	DET
admet-1622	358	9	conflict	conflict	NOUN
admet-1622	358	10	of	of	ADP
admet-1622	358	11	interest	interest	NOUN
admet-1622	358	12	.	.	PUNCT
admet-1622	359	1	references	reference	NOUN
admet-1622	359	2	[	[	X
admet-1622	359	3	1	1	NUM
admet-1622	359	4	]	]	PUNCT
admet-1622	359	5	a.	a.	NOUN
admet-1622	359	6	awad	awad	PROPN
admet-1622	359	7	,	,	PUNCT
admet-1622	359	8	a.	a.	NOUN
admet-1622	359	9	goyanes	goyane	NOUN
admet-1622	359	10	,	,	PUNCT
admet-1622	359	11	a.	a.	PROPN
admet-1622	359	12	basit	basit	PROPN
admet-1622	359	13	,	,	PUNCT
admet-1622	359	14	a.	a.	PROPN
admet-1622	359	15	zidan	zidan	PROPN
admet-1622	359	16	,	,	PUNCT
admet-1622	359	17	c.	c.	PROPN
admet-1622	359	18	xu	xu	PROPN
admet-1622	359	19	,	,	PUNCT
admet-1622	359	20	d.	d.	PROPN
admet-1622	359	21	li	li	PROPN
admet-1622	359	22	,	,	PUNCT
admet-1622	359	23	r.	r.	PROPN
admet-1622	359	24	narayan	narayan	PROPN
admet-1622	359	25	,	,	PUNCT
admet-1622	359	26	r.k	r.k	PROPN
admet-1622	359	27	.	.	PROPN
admet-1622	359	28	chen	chen	PROPN
admet-1622	359	29	.	.	PUNCT
admet-1622	360	1	a	a	DET
admet-1622	360	2	review	review	NOUN
admet-1622	360	3	of	of	ADP
admet-1622	360	4	state	state	NOUN
admet-1622	360	5	-	-	PUNCT
admet-1622	360	6	of	of	ADP
admet-1622	360	7	-	-	PUNCT
admet-1622	360	8	theart	theart	NOUN
admet-1622	360	9	on	on	ADP
admet-1622	360	10	enabling	enable	VERB
admet-1622	360	11	additive	additive	ADJ
admet-1622	360	12	manufacturing	manufacturing	NOUN
admet-1622	360	13	processes	process	NOUN
admet-1622	360	14	for	for	ADP
admet-1622	360	15	precision	precision	NOUN
admet-1622	360	16	medicine	medicine	NOUN
admet-1622	360	17	.	.	PUNCT
admet-1622	361	1	journal	journal	NOUN
admet-1622	361	2	of	of	ADP
admet-1622	361	3	manufacturing	manufacturing	NOUN
admet-1622	361	4	science	science	NOUN
admet-1622	361	5	and	and	CCONJ
admet-1622	361	6	engineering	engineering	NOUN
admet-1622	361	7	145	145	NUM
admet-1622	361	8	(	(	PUNCT
admet-1622	361	9	2023	2023	NUM
admet-1622	361	10	)	)	PUNCT
admet-1622	361	11	010802	010802	NUM
admet-1622	361	12	.	.	PUNCT
admet-1622	362	1	https://doi.org/10.1115/1.4056199	https://doi.org/10.1115/1.4056199	VERB
admet-1622	363	1	[	[	X
admet-1622	363	2	2	2	NUM
admet-1622	363	3	]	]	X
admet-1622	363	4	k.v	k.v	PROPN
admet-1622	363	5	.	.	PROPN
admet-1622	363	6	wong	wong	PROPN
admet-1622	363	7	,	,	PUNCT
admet-1622	363	8	a.	a.	PROPN
admet-1622	363	9	hernandez	hernandez	PROPN
admet-1622	363	10	.	.	PUNCT
admet-1622	364	1	a	a	DET
admet-1622	364	2	review	review	NOUN
admet-1622	364	3	of	of	ADP
admet-1622	364	4	additive	additive	ADJ
admet-1622	364	5	manufacturing	manufacturing	NOUN
admet-1622	364	6	.	.	PUNCT
admet-1622	365	1	international	international	ADJ
admet-1622	365	2	scholarly	scholarly	ADJ
admet-1622	365	3	research	research	NOUN
admet-1622	365	4	notices	notice	VERB
admet-1622	365	5	2012	2012	NUM
admet-1622	365	6	(	(	PUNCT
admet-1622	365	7	2012	2012	NUM
admet-1622	365	8	)	)	PUNCT
admet-1622	365	9	208760	208760	NUM
admet-1622	365	10	.	.	PUNCT
admet-1622	366	1	https://doi.org/10.5402/2012/208760	https://doi.org/10.5402/2012/208760	ADV
admet-1622	366	2	https://doi.org/10.1115/1.4056199	https://doi.org/10.1115/1.4056199	VERB
admet-1622	367	1	https://doi.org/10.5402/2012/208760	https://doi.org/10.5402/2012/208760	PROPN
admet-1622	367	2	admet	admet	PROPN
admet-1622	367	3	&	&	CCONJ
admet-1622	367	4	dmpk	dmpk	PROPN
admet-1622	367	5	11(1	11(1	NUM
admet-1622	367	6	)	)	PUNCT
admet-1622	367	7	(	(	PUNCT
admet-1622	367	8	2023	2023	NUM
admet-1622	367	9	)	)	PUNCT
admet-1622	367	10	33	33	NUM
admet-1622	367	11	-	-	SYM
admet-1622	367	12	55	55	NUM
admet-1622	367	13	development	development	NOUN
admet-1622	367	14	of	of	ADP
admet-1622	367	15	rapidly	rapidly	ADV
admet-1622	367	16	dissolving	dissolve	VERB
admet-1622	367	17	fdm	fdm	NOUN
admet-1622	367	18	3d	3d	ADV
admet-1622	367	19	-	-	PUNCT
admet-1622	367	20	printed	print	VERB
admet-1622	367	21	tablets	tablet	NOUN
admet-1622	367	22	doi	doi	NOUN
admet-1622	367	23	:	:	PUNCT
admet-1622	367	24	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	367	25	51	51	NUM
admet-1622	367	26	[	[	X
admet-1622	367	27	3	3	NUM
admet-1622	367	28	]	]	PUNCT
admet-1622	367	29	spritam	spritam	NOUN
admet-1622	367	30	fda	fda	PROPN
admet-1622	367	31	approval	approval	NOUN
admet-1622	367	32	history	history	NOUN
admet-1622	367	33	.	.	PUNCT
admet-1622	368	1	https://www.drugs.com/history/spritam.html	https://www.drugs.com/history/spritam.html	X
admet-1622	368	2	(	(	PUNCT
admet-1622	368	3	last	last	ADV
admet-1622	368	4	accessed	access	VERB
admet-1622	368	5	:	:	PUNCT
admet-1622	368	6	november	november	PROPN
admet-1622	368	7	12	12	NUM
admet-1622	368	8	,	,	PUNCT
admet-1622	368	9	2022	2022	NUM
admet-1622	368	10	)	)	PUNCT
admet-1622	369	1	[	[	X
admet-1622	369	2	4	4	NUM
admet-1622	369	3	]	]	PUNCT
admet-1622	369	4	a.	a.	NOUN
admet-1622	369	5	melocchi	melocchi	PROPN
admet-1622	369	6	,	,	PUNCT
admet-1622	369	7	m.	m.	NOUN
admet-1622	369	8	uboldi	uboldi	NOUN
admet-1622	369	9	,	,	PUNCT
admet-1622	369	10	m.	m.	NOUN
admet-1622	369	11	cerea	cerea	PROPN
admet-1622	369	12	,	,	PUNCT
admet-1622	369	13	a.	a.	NOUN
admet-1622	369	14	foppoli	foppoli	NOUN
admet-1622	369	15	,	,	PUNCT
admet-1622	369	16	a.	a.	PROPN
admet-1622	369	17	maroni	maroni	PROPN
admet-1622	369	18	,	,	PUNCT
admet-1622	369	19	s.	s.	PROPN
admet-1622	369	20	moutaharrik	moutaharrik	PROPN
admet-1622	369	21	,	,	PUNCT
admet-1622	369	22	l.	l.	PROPN
admet-1622	369	23	palugan	palugan	PROPN
admet-1622	369	24	,	,	PUNCT
admet-1622	369	25	l.	l.	PROPN
admet-1622	369	26	zema	zema	PROPN
admet-1622	369	27	,	,	PUNCT
admet-1622	369	28	a.	a.	PROPN
admet-1622	369	29	gazzaniga	gazzaniga	NOUN
admet-1622	369	30	.	.	PUNCT
admet-1622	370	1	a	a	DET
admet-1622	370	2	graphical	graphical	ADJ
admet-1622	370	3	review	review	NOUN
admet-1622	370	4	on	on	ADP
admet-1622	370	5	the	the	DET
admet-1622	370	6	escalation	escalation	NOUN
admet-1622	370	7	of	of	ADP
admet-1622	370	8	fused	fuse	VERB
admet-1622	370	9	deposition	deposition	NOUN
admet-1622	370	10	modeling	modeling	NOUN
admet-1622	370	11	(	(	PUNCT
admet-1622	370	12	fdm	fdm	NOUN
admet-1622	370	13	)	)	PUNCT
admet-1622	370	14	3d	3d	NOUN
admet-1622	370	15	printing	printing	NOUN
admet-1622	370	16	in	in	ADP
admet-1622	370	17	the	the	DET
admet-1622	370	18	pharmaceutical	pharmaceutical	ADJ
admet-1622	370	19	field	field	NOUN
admet-1622	370	20	.	.	PUNCT
admet-1622	371	1	journal	journal	NOUN
admet-1622	371	2	of	of	ADP
admet-1622	371	3	pharmaceutical	pharmaceutical	ADJ
admet-1622	371	4	sciences	science	NOUN
admet-1622	371	5	109(10	109(10	NUM
admet-1622	371	6	)	)	PUNCT
admet-1622	371	7	(	(	PUNCT
admet-1622	371	8	2020	2020	NUM
admet-1622	371	9	)	)	PUNCT
admet-1622	371	10	2943	2943	NUM
admet-1622	371	11	-	-	SYM
admet-1622	371	12	2957	2957	NUM
admet-1622	371	13	.	.	PUNCT
admet-1622	372	1	https://doi.org/10.1016/j.xphs.2020.07.011	https://doi.org/10.1016/j.xphs.2020.07.011	NUM
admet-1622	372	2	[	[	SYM
admet-1622	372	3	5	5	X
admet-1622	372	4	]	]	PUNCT
admet-1622	372	5	j.	j.	PROPN
admet-1622	372	6	wang	wang	PROPN
admet-1622	372	7	,	,	PUNCT
admet-1622	372	8	y.	y.	PROPN
admet-1622	372	9	zhang	zhang	PROPN
admet-1622	372	10	,	,	PUNCT
admet-1622	372	11	n.h	n.h	PROPN
admet-1622	372	12	.	.	PROPN
admet-1622	372	13	aghda	aghda	PROPN
admet-1622	372	14	,	,	PUNCT
admet-1622	372	15	a.r	a.r	PROPN
admet-1622	372	16	.	.	PROPN
admet-1622	372	17	pillai	pillai	PROPN
admet-1622	372	18	,	,	PUNCT
admet-1622	372	19	r.	r.	PROPN
admet-1622	372	20	thakkar	thakkar	PROPN
admet-1622	372	21	,	,	PUNCT
admet-1622	372	22	a.	a.	NOUN
admet-1622	372	23	nokhodchi	nokhodchi	PROPN
admet-1622	372	24	,	,	PUNCT
admet-1622	372	25	m.	m.	NOUN
admet-1622	372	26	maniruzzaman	maniruzzaman	NOUN
admet-1622	372	27	.	.	PUNCT
admet-1622	373	1	emerging	emerge	VERB
admet-1622	373	2	3d	3d	NUM
admet-1622	373	3	printing	printing	NOUN
admet-1622	373	4	technologies	technology	NOUN
admet-1622	373	5	for	for	ADP
admet-1622	373	6	drug	drug	NOUN
admet-1622	373	7	delivery	delivery	NOUN
admet-1622	373	8	devices	device	NOUN
admet-1622	373	9	:	:	PUNCT
admet-1622	373	10	current	current	ADJ
admet-1622	373	11	status	status	NOUN
admet-1622	373	12	and	and	CCONJ
admet-1622	373	13	future	future	ADJ
admet-1622	373	14	perspective	perspective	NOUN
admet-1622	373	15	.	.	PUNCT
admet-1622	374	1	advanced	advanced	ADJ
admet-1622	374	2	drug	drug	NOUN
admet-1622	374	3	delivery	delivery	NOUN
admet-1622	374	4	reviews	review	VERB
admet-1622	374	5	174	174	NUM
admet-1622	374	6	(	(	PUNCT
admet-1622	374	7	2021	2021	NUM
admet-1622	374	8	)	)	PUNCT
admet-1622	374	9	294	294	NUM
admet-1622	374	10	-	-	SYM
admet-1622	374	11	316	316	NUM
admet-1622	374	12	.	.	PUNCT
admet-1622	375	1	https://doi.org/10.1016/j.addr.2021.04.019	https://doi.org/10.1016/j.addr.2021.04.019	NUM
admet-1622	376	1	[	[	X
admet-1622	376	2	6	6	NUM
admet-1622	376	3	]	]	PUNCT
admet-1622	376	4	w.	w.	PROPN
admet-1622	376	5	jamróz	jamróz	PROPN
admet-1622	376	6	,	,	PUNCT
admet-1622	376	7	j.	j.	PROPN
admet-1622	376	8	szafraniec	szafraniec	PROPN
admet-1622	376	9	,	,	PUNCT
admet-1622	376	10	m.	m.	NOUN
admet-1622	376	11	kurek	kurek	PROPN
admet-1622	376	12	,	,	PUNCT
admet-1622	376	13	r.	r.	PROPN
admet-1622	376	14	jachowicz	jachowicz	PROPN
admet-1622	376	15	.	.	PUNCT
admet-1622	377	1	3d	3d	NUM
admet-1622	377	2	printing	printing	NOUN
admet-1622	377	3	in	in	ADP
admet-1622	377	4	pharmaceutical	pharmaceutical	NOUN
admet-1622	377	5	and	and	CCONJ
admet-1622	377	6	medical	medical	ADJ
admet-1622	377	7	applications	application	NOUN
admet-1622	377	8	–	–	PUNCT
admet-1622	377	9	recent	recent	ADJ
admet-1622	377	10	achievements	achievement	NOUN
admet-1622	377	11	and	and	CCONJ
admet-1622	377	12	challenges	challenge	NOUN
admet-1622	377	13	.	.	PUNCT
admet-1622	378	1	pharmaceutical	pharmaceutical	NOUN
admet-1622	378	2	research	research	PROPN
admet-1622	378	3	35(9	35(9	NUM
admet-1622	378	4	)	)	PUNCT
admet-1622	378	5	,	,	PUNCT
admet-1622	378	6	(	(	PUNCT
admet-1622	378	7	2018	2018	NUM
admet-1622	378	8	)	)	PUNCT
admet-1622	378	9	1	1	NUM
admet-1622	378	10	-	-	SYM
admet-1622	378	11	22	22	NUM
admet-1622	378	12	.	.	PUNCT
admet-1622	379	1	https://doi.org/10.1007/s11095-018-2454-x	https://doi.org/10.1007/s11095-018-2454-x	PROPN
admet-1622	380	1	[	[	X
admet-1622	380	2	7	7	NUM
admet-1622	380	3	]	]	X
admet-1622	380	4	c.	c.	PROPN
admet-1622	380	5	parulski	parulski	PROPN
admet-1622	380	6	,	,	PUNCT
admet-1622	380	7	o.	o.	PROPN
admet-1622	380	8	jennotte	jennotte	PROPN
admet-1622	380	9	,	,	PUNCT
admet-1622	380	10	a.	a.	PROPN
admet-1622	380	11	lechanteur	lechanteur	PROPN
admet-1622	380	12	,	,	PUNCT
admet-1622	380	13	b.	b.	PROPN
admet-1622	380	14	evrard	evrard	PROPN
admet-1622	380	15	.	.	PUNCT
admet-1622	381	1	challenges	challenge	NOUN
admet-1622	381	2	of	of	ADP
admet-1622	381	3	fused	fuse	VERB
admet-1622	381	4	deposition	deposition	NOUN
admet-1622	381	5	modeling	modeling	NOUN
admet-1622	381	6	3d	3d	NUM
admet-1622	381	7	printing	printing	NOUN
admet-1622	381	8	in	in	ADP
admet-1622	381	9	pharmaceutical	pharmaceutical	ADJ
admet-1622	381	10	applications	application	NOUN
admet-1622	381	11	:	:	PUNCT
admet-1622	381	12	where	where	SCONJ
admet-1622	381	13	are	be	AUX
admet-1622	381	14	we	we	PRON
admet-1622	381	15	now	now	ADV
admet-1622	381	16	?	?	PUNCT
admet-1622	381	17	.	.	PUNCT
admet-1622	382	1	advanced	advanced	ADJ
admet-1622	382	2	drug	drug	NOUN
admet-1622	382	3	delivery	delivery	NOUN
admet-1622	382	4	reviews	review	NOUN
admet-1622	382	5	.	.	PUNCT
admet-1622	383	1	175	175	NUM
admet-1622	383	2	(	(	PUNCT
admet-1622	383	3	2021	2021	NUM
admet-1622	383	4	)	)	PUNCT
admet-1622	383	5	113810	113810	NUM
admet-1622	383	6	.	.	PUNCT
admet-1622	384	1	https://doi.org/10.1016/j.addr.2021.05.020	https://doi.org/10.1016/j.addr.2021.05.020	NOUN
admet-1622	384	2	[	[	X
admet-1622	384	3	8	8	NUM
admet-1622	384	4	]	]	X
admet-1622	384	5	h.	h.	NOUN
admet-1622	384	6	ragelle	ragelle	PROPN
admet-1622	384	7	,	,	PUNCT
admet-1622	384	8	s.	s.	PROPN
admet-1622	384	9	rahimian	rahimian	PROPN
admet-1622	384	10	,	,	PUNCT
admet-1622	384	11	e.a	e.a	PROPN
admet-1622	384	12	.	.	PROPN
admet-1622	384	13	guzzi	guzzi	PROPN
admet-1622	384	14	,	,	PUNCT
admet-1622	384	15	p.d	p.d	PROPN
admet-1622	384	16	.	.	PROPN
admet-1622	384	17	westenskow	westenskow	PROPN
admet-1622	384	18	,	,	PUNCT
admet-1622	384	19	m.w	m.w	PROPN
admet-1622	384	20	.	.	PROPN
admet-1622	384	21	tibbitt	tibbitt	PROPN
admet-1622	384	22	,	,	PUNCT
admet-1622	384	23	g.	g.	PROPN
admet-1622	384	24	schwach	schwach	PROPN
admet-1622	384	25	,	,	PUNCT
admet-1622	384	26	r.	r.	PROPN
admet-1622	384	27	langer	langer	PROPN
admet-1622	384	28	.	.	PUNCT
admet-1622	385	1	additive	additive	ADJ
admet-1622	385	2	manufacturing	manufacturing	NOUN
admet-1622	385	3	in	in	ADP
admet-1622	385	4	drug	drug	NOUN
admet-1622	385	5	delivery	delivery	NOUN
admet-1622	385	6	:	:	PUNCT
admet-1622	385	7	innovative	innovative	ADJ
admet-1622	385	8	drug	drug	NOUN
admet-1622	385	9	product	product	NOUN
admet-1622	385	10	design	design	NOUN
admet-1622	385	11	and	and	CCONJ
admet-1622	385	12	opportunities	opportunity	NOUN
admet-1622	385	13	for	for	ADP
admet-1622	385	14	industrial	industrial	ADJ
admet-1622	385	15	application	application	NOUN
admet-1622	385	16	.	.	PUNCT
admet-1622	386	1	advanced	advanced	ADJ
admet-1622	386	2	drug	drug	NOUN
admet-1622	386	3	delivery	delivery	NOUN
admet-1622	386	4	reviews	review	VERB
admet-1622	386	5	178	178	NUM
admet-1622	386	6	(	(	PUNCT
admet-1622	386	7	2021	2021	NUM
admet-1622	386	8	)	)	PUNCT
admet-1622	386	9	113990	113990	NUM
admet-1622	386	10	.	.	PUNCT
admet-1622	387	1	https://doi.org/10.1016/j.addr.2021.113990	https://doi.org/10.1016/j.addr.2021.113990	PROPN
admet-1622	387	2	[	[	X
admet-1622	388	1	9	9	NUM
admet-1622	388	2	]	]	SYM
admet-1622	388	3	r.d.p	r.d.p	NOUN
admet-1622	388	4	.	.	PUNCT
admet-1622	388	5	reddy	reddy	PROPN
admet-1622	388	6	,	,	PUNCT
admet-1622	388	7	v.	v.	PROPN
admet-1622	388	8	sharma	sharma	PROPN
admet-1622	388	9	.	.	PUNCT
admet-1622	389	1	additive	additive	ADJ
admet-1622	389	2	manufacturing	manufacturing	NOUN
admet-1622	389	3	in	in	ADP
admet-1622	389	4	drug	drug	NOUN
admet-1622	389	5	delivery	delivery	NOUN
admet-1622	389	6	applications	application	NOUN
admet-1622	389	7	:	:	PUNCT
admet-1622	389	8	a	a	DET
admet-1622	389	9	review	review	NOUN
admet-1622	389	10	.	.	PUNCT
admet-1622	390	1	international	international	ADJ
admet-1622	390	2	journal	journal	PROPN
admet-1622	390	3	of	of	ADP
admet-1622	390	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	390	5	589	589	NUM
admet-1622	390	6	(	(	PUNCT
admet-1622	390	7	2020	2020	NUM
admet-1622	390	8	)	)	PUNCT
admet-1622	390	9	119820	119820	NUM
admet-1622	390	10	.	.	PUNCT
admet-1622	391	1	https://doi.org/10.1016/j.ijpharm.2020.119820	https://doi.org/10.1016/j.ijpharm.2020.119820	NOUN
admet-1622	391	2	[	[	X
admet-1622	391	3	10	10	NUM
admet-1622	391	4	]	]	X
admet-1622	391	5	i.	i.	PROPN
admet-1622	391	6	seoane	seoane	PROPN
admet-1622	391	7	-	-	PUNCT
admet-1622	391	8	viaño	viaño	ADJ
admet-1622	391	9	,	,	PUNCT
admet-1622	391	10	s.j	s.j	PROPN
admet-1622	391	11	.	.	PROPN
admet-1622	391	12	trenfield	trenfield	PROPN
admet-1622	391	13	,	,	PUNCT
admet-1622	391	14	a.w	a.w	PROPN
admet-1622	391	15	.	.	PROPN
admet-1622	391	16	basit	basit	PROPN
admet-1622	391	17	,	,	PUNCT
admet-1622	391	18	a.	a.	NOUN
admet-1622	391	19	goyanes	goyane	NOUN
admet-1622	391	20	.	.	PUNCT
admet-1622	392	1	translating	translate	VERB
admet-1622	392	2	3d	3d	NUM
admet-1622	392	3	printed	print	VERB
admet-1622	392	4	pharmaceuticals	pharmaceutical	NOUN
admet-1622	392	5	:	:	PUNCT
admet-1622	392	6	from	from	ADP
admet-1622	392	7	hype	hype	NOUN
admet-1622	392	8	to	to	ADP
admet-1622	392	9	real	real	ADJ
admet-1622	392	10	-	-	PUNCT
admet-1622	392	11	world	world	NOUN
admet-1622	392	12	clinical	clinical	ADJ
admet-1622	392	13	applications	application	NOUN
admet-1622	392	14	.	.	PUNCT
admet-1622	393	1	advanced	advanced	ADJ
admet-1622	393	2	drug	drug	NOUN
admet-1622	393	3	delivery	delivery	NOUN
admet-1622	393	4	reviews	review	VERB
admet-1622	393	5	174	174	NUM
admet-1622	393	6	(	(	PUNCT
admet-1622	393	7	2021	2021	NUM
admet-1622	393	8	)	)	PUNCT
admet-1622	393	9	553	553	NUM
admet-1622	393	10	-	-	SYM
admet-1622	393	11	575	575	NUM
admet-1622	393	12	.	.	PUNCT
admet-1622	394	1	https://doi.org/10.1016/j.addr.2021.05.003	https://doi.org/10.1016/j.addr.2021.05.003	NOUN
admet-1622	394	2	[	[	X
admet-1622	394	3	11	11	NUM
admet-1622	394	4	]	]	X
admet-1622	394	5	s.j	s.j	PROPN
admet-1622	394	6	.	.	PROPN
admet-1622	394	7	trenfield	trenfield	PROPN
admet-1622	394	8	,	,	PUNCT
admet-1622	394	9	a.	a.	NOUN
admet-1622	394	10	awad	awad	PROPN
admet-1622	394	11	,	,	PUNCT
admet-1622	394	12	a.	a.	NOUN
admet-1622	394	13	goyanes	goyanes	PROPN
admet-1622	394	14	,	,	PUNCT
admet-1622	394	15	s.	s.	PROPN
admet-1622	394	16	gaisford	gaisford	PROPN
admet-1622	394	17	,	,	PUNCT
admet-1622	394	18	a.w	a.w	PROPN
admet-1622	394	19	.	.	PROPN
admet-1622	394	20	basit	basit	PROPN
admet-1622	394	21	.	.	PUNCT
admet-1622	395	1	3d	3d	NUM
admet-1622	395	2	printing	printing	NOUN
admet-1622	395	3	pharmaceuticals	pharmaceutical	NOUN
admet-1622	395	4	:	:	PUNCT
admet-1622	395	5	drug	drug	NOUN
admet-1622	395	6	development	development	NOUN
admet-1622	395	7	to	to	PART
admet-1622	395	8	frontline	frontline	NOUN
admet-1622	395	9	care	care	NOUN
admet-1622	395	10	.	.	PUNCT
admet-1622	396	1	trends	trend	NOUN
admet-1622	396	2	in	in	ADP
admet-1622	396	3	pharmacological	pharmacological	ADJ
admet-1622	396	4	sciences	science	NOUN
admet-1622	396	5	39(5	39(5	NUM
admet-1622	396	6	)	)	PUNCT
admet-1622	396	7	(	(	PUNCT
admet-1622	396	8	2018	2018	NUM
admet-1622	396	9	)	)	PUNCT
admet-1622	396	10	440	440	NUM
admet-1622	396	11	-	-	SYM
admet-1622	396	12	451	451	NUM
admet-1622	396	13	.	.	PUNCT
admet-1622	397	1	https://doi.org/10.1016/j.tips.2018.02.006	https://doi.org/10.1016/j.tips.2018.02.006	PRON
admet-1622	397	2	[	[	X
admet-1622	397	3	12	12	NUM
admet-1622	397	4	]	]	PUNCT
admet-1622	397	5	l.	l.	PROPN
admet-1622	397	6	zema	zema	PROPN
admet-1622	397	7	,	,	PUNCT
admet-1622	397	8	a.	a.	NOUN
admet-1622	397	9	melocchi	melocchi	PROPN
admet-1622	397	10	,	,	PUNCT
admet-1622	397	11	a.	a.	PROPN
admet-1622	397	12	maroni	maroni	PROPN
admet-1622	397	13	,	,	PUNCT
admet-1622	397	14	a.	a.	PROPN
admet-1622	397	15	gazzaniga	gazzaniga	NOUN
admet-1622	397	16	.	.	PUNCT
admet-1622	398	1	three	three	NUM
admet-1622	398	2	-	-	PUNCT
admet-1622	398	3	dimensional	dimensional	ADJ
admet-1622	398	4	printing	printing	NOUN
admet-1622	398	5	of	of	ADP
admet-1622	398	6	medicinal	medicinal	ADJ
admet-1622	398	7	products	product	NOUN
admet-1622	398	8	and	and	CCONJ
admet-1622	398	9	the	the	DET
admet-1622	398	10	challenge	challenge	NOUN
admet-1622	398	11	of	of	ADP
admet-1622	398	12	personalized	personalized	ADJ
admet-1622	398	13	therapy	therapy	NOUN
admet-1622	398	14	.	.	PUNCT
admet-1622	399	1	journal	journal	PROPN
admet-1622	399	2	of	of	ADP
admet-1622	399	3	pharmaceutical	pharmaceutical	PROPN
admet-1622	399	4	sciences	science	NOUN
admet-1622	399	5	106(7	106(7	NUM
admet-1622	399	6	)	)	PUNCT
admet-1622	399	7	(	(	PUNCT
admet-1622	399	8	2017	2017	NUM
admet-1622	399	9	)	)	PUNCT
admet-1622	399	10	1697	1697	NUM
admet-1622	399	11	-	-	SYM
admet-1622	399	12	1705	1705	NUM
admet-1622	399	13	.	.	PUNCT
admet-1622	400	1	https://doi.org/10.1016/j.xphs.2017.03.021	https://doi.org/10.1016/j.xphs.2017.03.021	NOUN
admet-1622	400	2	[	[	X
admet-1622	400	3	13	13	NUM
admet-1622	400	4	]	]	PUNCT
admet-1622	400	5	s.	s.	PROPN
admet-1622	400	6	bandari	bandari	PROPN
admet-1622	400	7	,	,	PUNCT
admet-1622	400	8	d.	d.	PROPN
admet-1622	400	9	nyavanandi	nyavanandi	PROPN
admet-1622	400	10	,	,	PUNCT
admet-1622	400	11	n.	n.	PROPN
admet-1622	400	12	dumpa	dumpa	PROPN
admet-1622	400	13	,	,	PUNCT
admet-1622	400	14	m.a	m.a	PROPN
admet-1622	400	15	.	.	PROPN
admet-1622	400	16	repka	repka	PROPN
admet-1622	400	17	.	.	PUNCT
admet-1622	401	1	coupling	couple	VERB
admet-1622	401	2	hot	hot	ADJ
admet-1622	401	3	melt	melt	NOUN
admet-1622	401	4	extrusion	extrusion	NOUN
admet-1622	401	5	and	and	CCONJ
admet-1622	401	6	fused	fuse	VERB
admet-1622	401	7	deposition	deposition	NOUN
admet-1622	401	8	modeling	modeling	NOUN
admet-1622	401	9	:	:	PUNCT
admet-1622	401	10	critical	critical	ADJ
admet-1622	401	11	properties	property	NOUN
admet-1622	401	12	for	for	ADP
admet-1622	401	13	successful	successful	ADJ
admet-1622	401	14	performance	performance	NOUN
admet-1622	401	15	.	.	PUNCT
admet-1622	402	1	advanced	advanced	ADJ
admet-1622	402	2	drug	drug	NOUN
admet-1622	402	3	delivery	delivery	NOUN
admet-1622	402	4	reviews	review	VERB
admet-1622	402	5	172	172	NUM
admet-1622	402	6	(	(	PUNCT
admet-1622	402	7	2021	2021	NUM
admet-1622	402	8	)	)	PUNCT
admet-1622	402	9	52	52	NUM
admet-1622	402	10	-	-	SYM
admet-1622	402	11	63	63	NUM
admet-1622	402	12	.	.	PUNCT
admet-1622	403	1	https://doi.org/10.1016/j.addr.2021.02.006	https://doi.org/10.1016/j.addr.2021.02.006	NOUN
admet-1622	403	2	[	[	X
admet-1622	403	3	14	14	NUM
admet-1622	403	4	]	]	X
admet-1622	403	5	d.k	d.k	PROPN
admet-1622	403	6	.	.	PROPN
admet-1622	403	7	tan	tan	PROPN
admet-1622	403	8	,	,	PUNCT
admet-1622	403	9	m.	m.	NOUN
admet-1622	403	10	maniruzzaman	maniruzzaman	NOUN
admet-1622	403	11	,	,	PUNCT
admet-1622	403	12	a.	a.	NOUN
admet-1622	403	13	nokhodchi	nokhodchi	PROPN
admet-1622	403	14	.	.	PUNCT
admet-1622	404	1	advanced	advanced	ADJ
admet-1622	404	2	pharmaceutical	pharmaceutical	ADJ
admet-1622	404	3	applications	application	NOUN
admet-1622	404	4	of	of	ADP
admet-1622	404	5	hot	hot	ADJ
admet-1622	404	6	-	-	PUNCT
admet-1622	404	7	melt	melt	NOUN
admet-1622	404	8	extrusion	extrusion	NOUN
admet-1622	404	9	coupled	couple	VERB
admet-1622	404	10	with	with	ADP
admet-1622	404	11	fused	fuse	VERB
admet-1622	404	12	deposition	deposition	NOUN
admet-1622	404	13	modelling	modelling	NOUN
admet-1622	404	14	(	(	PUNCT
admet-1622	404	15	fdm	fdm	NOUN
admet-1622	404	16	)	)	PUNCT
admet-1622	404	17	3d	3d	NOUN
admet-1622	404	18	printing	printing	NOUN
admet-1622	404	19	for	for	ADP
admet-1622	404	20	personalised	personalised	ADJ
admet-1622	404	21	drug	drug	NOUN
admet-1622	404	22	delivery	delivery	NOUN
admet-1622	404	23	.	.	PUNCT
admet-1622	405	1	pharmaceutics	pharmaceutic	NOUN
admet-1622	405	2	10(4	10(4	NUM
admet-1622	405	3	)	)	PUNCT
admet-1622	405	4	(	(	PUNCT
admet-1622	405	5	2018	2018	NUM
admet-1622	405	6	)	)	PUNCT
admet-1622	405	7	203	203	NUM
admet-1622	405	8	.	.	PUNCT
admet-1622	405	9	https://doi.org/10.3390/pharmaceutics10040203	https://doi.org/10.3390/pharmaceutics10040203	PROPN
admet-1622	406	1	[	[	X
admet-1622	406	2	15	15	NUM
admet-1622	406	3	]	]	X
admet-1622	406	4	s.a	s.a	PROPN
admet-1622	406	5	.	.	PROPN
admet-1622	406	6	khaled	khaled	PROPN
admet-1622	406	7	,	,	PUNCT
admet-1622	406	8	j.c	j.c	PROPN
admet-1622	406	9	.	.	PROPN
admet-1622	406	10	burley	burley	PROPN
admet-1622	406	11	,	,	PUNCT
admet-1622	406	12	m.r	m.r	PROPN
admet-1622	406	13	.	.	PROPN
admet-1622	406	14	alexander	alexander	PROPN
admet-1622	406	15	,	,	PUNCT
admet-1622	406	16	j.	j.	PROPN
admet-1622	406	17	yang	yang	PROPN
admet-1622	406	18	,	,	PUNCT
admet-1622	406	19	c.j	c.j	PROPN
admet-1622	406	20	.	.	PROPN
admet-1622	406	21	roberts	roberts	PROPN
admet-1622	406	22	.	.	PUNCT
admet-1622	407	1	3d	3d	NUM
admet-1622	407	2	printing	printing	NOUN
admet-1622	407	3	of	of	ADP
admet-1622	407	4	five	five	NUM
admet-1622	407	5	-	-	PUNCT
admet-1622	407	6	in	in	ADP
admet-1622	407	7	-	-	PUNCT
admet-1622	407	8	one	one	NUM
admet-1622	407	9	dose	dose	NOUN
admet-1622	407	10	combination	combination	NOUN
admet-1622	407	11	polypill	polypill	NOUN
admet-1622	407	12	with	with	ADP
admet-1622	407	13	defined	define	VERB
admet-1622	407	14	immediate	immediate	ADJ
admet-1622	407	15	and	and	CCONJ
admet-1622	407	16	sustained	sustained	ADJ
admet-1622	407	17	release	release	NOUN
admet-1622	407	18	profiles	profile	NOUN
admet-1622	407	19	.	.	PUNCT
admet-1622	408	1	journal	journal	NOUN
admet-1622	408	2	of	of	ADP
admet-1622	408	3	controlled	control	VERB
admet-1622	408	4	release	release	NOUN
admet-1622	408	5	217	217	NUM
admet-1622	408	6	(	(	PUNCT
admet-1622	408	7	2015	2015	NUM
admet-1622	408	8	)	)	PUNCT
admet-1622	408	9	308	308	NUM
admet-1622	408	10	-	-	SYM
admet-1622	408	11	314	314	NUM
admet-1622	408	12	.	.	PUNCT
admet-1622	409	1	https://doi.org/10.1016/j.jconrel.2015.09.028	https://doi.org/10.1016/j.jconrel.2015.09.028	ADJ
admet-1622	409	2	[	[	X
admet-1622	409	3	16	16	NUM
admet-1622	409	4	]	]	X
admet-1622	409	5	s.a	s.a	PROPN
admet-1622	409	6	.	.	PROPN
admet-1622	409	7	khaled	khaled	PROPN
admet-1622	409	8	,	,	PUNCT
admet-1622	409	9	j.c	j.c	PROPN
admet-1622	409	10	.	.	PROPN
admet-1622	409	11	burley	burley	PROPN
admet-1622	409	12	,	,	PUNCT
admet-1622	409	13	m.r	m.r	PROPN
admet-1622	409	14	.	.	PROPN
admet-1622	409	15	alexander	alexander	PROPN
admet-1622	409	16	,	,	PUNCT
admet-1622	409	17	j.	j.	PROPN
admet-1622	409	18	yang	yang	PROPN
admet-1622	409	19	,	,	PUNCT
admet-1622	409	20	c.j	c.j	PROPN
admet-1622	409	21	.	.	PROPN
admet-1622	409	22	roberts	roberts	PROPN
admet-1622	409	23	.	.	PUNCT
admet-1622	410	1	3d	3d	NUM
admet-1622	410	2	printing	printing	NOUN
admet-1622	410	3	of	of	ADP
admet-1622	410	4	tablets	tablet	NOUN
admet-1622	410	5	containing	contain	VERB
admet-1622	410	6	multiple	multiple	ADJ
admet-1622	410	7	drugs	drug	NOUN
admet-1622	410	8	with	with	ADP
admet-1622	410	9	defined	define	VERB
admet-1622	410	10	release	release	NOUN
admet-1622	410	11	profiles	profile	NOUN
admet-1622	410	12	.	.	PUNCT
admet-1622	411	1	international	international	ADJ
admet-1622	411	2	journal	journal	PROPN
admet-1622	411	3	of	of	ADP
admet-1622	411	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	411	5	494(2	494(2	NUM
admet-1622	411	6	)	)	PUNCT
admet-1622	411	7	(	(	PUNCT
admet-1622	411	8	2015	2015	NUM
admet-1622	411	9	)	)	PUNCT
admet-1622	411	10	643	643	NUM
admet-1622	411	11	-	-	SYM
admet-1622	411	12	650	650	NUM
admet-1622	411	13	.	.	PUNCT
admet-1622	412	1	https://doi.org/10.1016/j.ijpharm.2015.07.067	https://doi.org/10.1016/j.ijpharm.2015.07.067	NOUN
admet-1622	412	2	[	[	X
admet-1622	412	3	17	17	NUM
admet-1622	412	4	]	]	X
admet-1622	412	5	p.a	p.a	PROPN
admet-1622	412	6	.	.	PROPN
admet-1622	412	7	dickinson	dickinson	PROPN
admet-1622	412	8	,	,	PUNCT
admet-1622	412	9	f.	f.	PROPN
admet-1622	412	10	kesisoglou	kesisoglou	PROPN
admet-1622	412	11	,	,	PUNCT
admet-1622	412	12	t.	t.	PROPN
admet-1622	412	13	flanagan	flanagan	PROPN
admet-1622	412	14	,	,	PUNCT
admet-1622	412	15	m.n	m.n	PROPN
admet-1622	412	16	.	.	PROPN
admet-1622	412	17	martinez	martinez	PROPN
admet-1622	412	18	,	,	PUNCT
admet-1622	412	19	h.b	h.b	PROPN
admet-1622	412	20	.	.	PROPN
admet-1622	412	21	mistry	mistry	PROPN
admet-1622	412	22	,	,	PUNCT
admet-1622	412	23	j.r	j.r	PROPN
admet-1622	412	24	.	.	PROPN
admet-1622	412	25	crison	crison	PROPN
admet-1622	412	26	,	,	PUNCT
admet-1622	412	27	j.e	j.e	PROPN
admet-1622	412	28	.	.	PROPN
admet-1622	412	29	polli	polli	PROPN
admet-1622	412	30	,	,	PUNCT
admet-1622	412	31	m.t	m.t	PROPN
admet-1622	412	32	.	.	PROPN
admet-1622	412	33	cruañes	cruañes	PROPN
admet-1622	412	34	,	,	PUNCT
admet-1622	412	35	a.t	a.t	PROPN
admet-1622	412	36	.	.	PUNCT
admet-1622	412	37	serajuddin	serajuddin	PROPN
admet-1622	412	38	,	,	PUNCT
admet-1622	412	39	a.	a.	NOUN
admet-1622	412	40	müllertz	müllertz	NOUN
admet-1622	412	41	.	.	PUNCT
admet-1622	413	1	optimizing	optimize	VERB
admet-1622	413	2	clinical	clinical	ADJ
admet-1622	413	3	drug	drug	NOUN
admet-1622	413	4	product	product	NOUN
admet-1622	413	5	performance	performance	NOUN
admet-1622	413	6	:	:	PUNCT
admet-1622	413	7	applying	apply	VERB
admet-1622	413	8	biopharmaceutics	biopharmaceutics	NOUN
admet-1622	413	9	risk	risk	NOUN
admet-1622	413	10	assessment	assessment	NOUN
admet-1622	413	11	roadmap	roadmap	NOUN
admet-1622	413	12	(	(	PUNCT
admet-1622	413	13	bioram	bioram	PROPN
admet-1622	413	14	)	)	PUNCT
admet-1622	413	15	and	and	CCONJ
admet-1622	413	16	the	the	DET
admet-1622	413	17	bioram	bioram	NOUN
admet-1622	413	18	scoring	score	VERB
admet-1622	413	19	grid	grid	NOUN
admet-1622	413	20	.	.	PUNCT
admet-1622	414	1	journal	journal	NOUN
admet-1622	414	2	of	of	ADP
admet-1622	414	3	pharmaceutical	pharmaceutical	PROPN
admet-1622	414	4	sciences	science	NOUN
admet-1622	414	5	105	105	NUM
admet-1622	414	6	(	(	PUNCT
admet-1622	414	7	2016	2016	NUM
admet-1622	414	8	)	)	PUNCT
admet-1622	414	9	3243	3243	NUM
admet-1622	414	10	-	-	SYM
admet-1622	414	11	3255	3255	NUM
admet-1622	414	12	.	.	PUNCT
admet-1622	415	1	https://doi.org/10.1016/j.xphs.2016.07.024	https://doi.org/10.1016/j.xphs.2016.07.024	PROPN
admet-1622	415	2	[	[	X
admet-1622	415	3	18	18	NUM
admet-1622	415	4	]	]	PUNCT
admet-1622	415	5	a.	a.	NOUN
admet-1622	415	6	selen	selen	PROPN
admet-1622	415	7	,	,	PUNCT
admet-1622	415	8	p.a	p.a	PROPN
admet-1622	415	9	.	.	PROPN
admet-1622	415	10	dickinson	dickinson	PROPN
admet-1622	415	11	,	,	PUNCT
admet-1622	415	12	a.	a.	NOUN
admet-1622	415	13	müllertz	müllertz	PROPN
admet-1622	415	14	,	,	PUNCT
admet-1622	415	15	j.r	j.r	PROPN
admet-1622	415	16	.	.	PROPN
admet-1622	415	17	crison	crison	PROPN
admet-1622	415	18	,	,	PUNCT
admet-1622	415	19	h.b	h.b	PROPN
admet-1622	415	20	.	.	PROPN
admet-1622	415	21	mistry	mistry	PROPN
admet-1622	415	22	,	,	PUNCT
admet-1622	415	23	m.t	m.t	PROPN
admet-1622	415	24	.	.	PROPN
admet-1622	415	25	cruañes	cruañes	PROPN
admet-1622	415	26	,	,	PUNCT
admet-1622	415	27	m.n	m.n	PROPN
admet-1622	415	28	.	.	PROPN
admet-1622	415	29	martinez	martinez	PROPN
admet-1622	415	30	,	,	PUNCT
admet-1622	415	31	h.	h.	PROPN
admet-1622	415	32	lennernäs	lennernäs	PROPN
admet-1622	415	33	,	,	PUNCT
admet-1622	415	34	t.l	t.l	PROPN
admet-1622	415	35	.	.	PROPN
admet-1622	415	36	wigal	wigal	PROPN
admet-1622	415	37	,	,	PUNCT
admet-1622	415	38	d.c	d.c	PROPN
admet-1622	415	39	.	.	PROPN
admet-1622	415	40	swinney	swinney	PROPN
admet-1622	415	41	.	.	PUNCT
admet-1622	416	1	the	the	DET
admet-1622	416	2	biopharmaceutics	biopharmaceutics	NOUN
admet-1622	416	3	risk	risk	NOUN
admet-1622	416	4	assessment	assessment	NOUN
admet-1622	416	5	roadmap	roadmap	NOUN
admet-1622	416	6	for	for	ADP
admet-1622	416	7	optimizing	optimize	VERB
admet-1622	416	8	clinical	clinical	ADJ
admet-1622	416	9	drug	drug	NOUN
admet-1622	416	10	product	product	NOUN
admet-1622	416	11	performance	performance	NOUN
admet-1622	416	12	.	.	PUNCT
admet-1622	417	1	journal	journal	NOUN
admet-1622	417	2	of	of	ADP
admet-1622	417	3	pharmaceutical	pharmaceutical	PROPN
admet-1622	417	4	sciences	science	NOUN
admet-1622	417	5	103	103	NUM
admet-1622	417	6	(	(	PUNCT
admet-1622	417	7	2014	2014	NUM
admet-1622	417	8	)	)	PUNCT
admet-1622	417	9	3377	3377	NUM
admet-1622	417	10	-	-	SYM
admet-1622	417	11	3397	3397	NUM
admet-1622	417	12	.	.	PUNCT
admet-1622	418	1	https://doi.org/10.1002/jps.24162	https://doi.org/10.1002/jps.24162	PROPN
admet-1622	418	2	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	VERB
admet-1622	418	3	https://www.drugs.com/history/spritam.html	https://www.drugs.com/history/spritam.html	PRON
admet-1622	418	4	https://doi.org/10.1016/j.xphs.2020.07.011	https://doi.org/10.1016/j.xphs.2020.07.011	NOUN
admet-1622	418	5	https://doi.org/10.1016/j.addr.2021.04.019	https://doi.org/10.1016/j.addr.2021.04.019	NUM
admet-1622	418	6	https://doi.org/10.1007/s11095-018-2454-x	https://doi.org/10.1007/s11095-018-2454-x	PROPN
admet-1622	418	7	https://doi.org/10.1016/j.addr.2021.05.020	https://doi.org/10.1016/j.addr.2021.05.020	PROPN
admet-1622	418	8	https://doi.org/10.1016/j.addr.2021.113990	https://doi.org/10.1016/j.addr.2021.113990	PROPN
admet-1622	418	9	https://doi.org/10.1016/j.addr.2021.113990	https://doi.org/10.1016/j.addr.2021.113990	PROPN
admet-1622	418	10	https://doi.org/10.1016/j.ijpharm.2020.119820	https://doi.org/10.1016/j.ijpharm.2020.119820	NOUN
admet-1622	418	11	https://doi.org/10.1016/j.addr.2021.05.003	https://doi.org/10.1016/j.addr.2021.05.003	PROPN
admet-1622	418	12	https://doi.org/10.1016/j.tips.2018.02.006	https://doi.org/10.1016/j.tips.2018.02.006	PROPN
admet-1622	418	13	https://doi.org/10.1016/j.xphs.2017.03.021	https://doi.org/10.1016/j.xphs.2017.03.021	PROPN
admet-1622	418	14	https://doi.org/10.1016/j.addr.2021.02.006	https://doi.org/10.1016/j.addr.2021.02.006	NOUN
admet-1622	418	15	https://doi.org/10.3390/pharmaceutics10040203	https://doi.org/10.3390/pharmaceutics10040203	NOUN
admet-1622	418	16	https://doi.org/10.1016/j.jconrel.2015.09.028	https://doi.org/10.1016/j.jconrel.2015.09.028	PROPN
admet-1622	418	17	https://doi.org/10.1016/j.ijpharm.2015.07.067	https://doi.org/10.1016/j.ijpharm.2015.07.067	NOUN
admet-1622	418	18	https://doi.org/10.1016/j.xphs.2016.07.024	https://doi.org/10.1016/j.xphs.2016.07.024	PROPN
admet-1622	418	19	https://doi.org/10.1002/jps.24162	https://doi.org/10.1002/jps.24162	PROPN
admet-1622	418	20	abu	abu	PROPN
admet-1622	418	21	t.m	t.m	PROPN
admet-1622	418	22	.	.	PUNCT
admet-1622	419	1	serajuddin	serajuddin	VERB
admet-1622	419	2	admet	admet	PROPN
admet-1622	419	3	&	&	CCONJ
admet-1622	419	4	dmpk	dmpk	PROPN
admet-1622	419	5	11(1	11(1	NUM
admet-1622	419	6	)	)	PUNCT
admet-1622	419	7	(	(	PUNCT
admet-1622	419	8	2023	2023	NUM
admet-1622	419	9	)	)	PUNCT
admet-1622	419	10	33	33	NUM
admet-1622	419	11	-	-	SYM
admet-1622	419	12	55	55	NUM
admet-1622	419	13	52	52	NUM
admet-1622	419	14	[	[	X
admet-1622	419	15	19	19	NUM
admet-1622	419	16	]	]	X
admet-1622	419	17	n.g	n.g	PROPN
admet-1622	419	18	.	.	PROPN
admet-1622	419	19	solanki	solanki	PROPN
admet-1622	419	20	,	,	PUNCT
admet-1622	419	21	m.	m.	NOUN
admet-1622	419	22	tahsin	tahsin	PROPN
admet-1622	419	23	,	,	PUNCT
admet-1622	419	24	a.v	a.v	PROPN
admet-1622	419	25	.	.	PROPN
admet-1622	419	26	shah	shah	PROPN
admet-1622	419	27	,	,	PUNCT
admet-1622	419	28	a.t	a.t	PROPN
admet-1622	419	29	.	.	PUNCT
admet-1622	419	30	serajuddin	serajuddin	PROPN
admet-1622	419	31	.	.	PUNCT
admet-1622	420	1	formulation	formulation	NOUN
admet-1622	420	2	of	of	ADP
admet-1622	420	3	3d	3d	NUM
admet-1622	420	4	printed	print	VERB
admet-1622	420	5	tablet	tablet	NOUN
admet-1622	420	6	for	for	ADP
admet-1622	420	7	rapid	rapid	ADJ
admet-1622	420	8	drug	drug	NOUN
admet-1622	420	9	release	release	NOUN
admet-1622	420	10	by	by	ADP
admet-1622	420	11	fused	fuse	VERB
admet-1622	420	12	deposition	deposition	NOUN
admet-1622	420	13	modeling	modeling	NOUN
admet-1622	420	14	:	:	PUNCT
admet-1622	420	15	screening	screen	VERB
admet-1622	420	16	polymers	polymer	NOUN
admet-1622	420	17	for	for	ADP
admet-1622	420	18	drug	drug	NOUN
admet-1622	420	19	release	release	NOUN
admet-1622	420	20	,	,	PUNCT
admet-1622	420	21	drug	drug	NOUN
admet-1622	420	22	-	-	PUNCT
admet-1622	420	23	polymer	polymer	NOUN
admet-1622	420	24	miscibility	miscibility	NOUN
admet-1622	420	25	and	and	CCONJ
admet-1622	420	26	printability	printability	NOUN
admet-1622	420	27	.	.	PUNCT
admet-1622	421	1	journal	journal	PROPN
admet-1622	421	2	of	of	ADP
admet-1622	421	3	pharmaceutical	pharmaceutical	PROPN
admet-1622	421	4	sciences	science	NOUN
admet-1622	421	5	107	107	NUM
admet-1622	421	6	(	(	PUNCT
admet-1622	421	7	2018	2018	NUM
admet-1622	421	8	)	)	PUNCT
admet-1622	421	9	390	390	NUM
admet-1622	421	10	-	-	SYM
admet-1622	421	11	401	401	NUM
admet-1622	421	12	.	.	PUNCT
admet-1622	422	1	https://doi.org/10.1016/j.xphs.2017.10.021	https://doi.org/10.1016/j.xphs.2017.10.021	PROPN
admet-1622	422	2	[	[	X
admet-1622	422	3	20	20	NUM
admet-1622	422	4	]	]	X
admet-1622	422	5	n.g	n.g	PROPN
admet-1622	422	6	.	.	PROPN
admet-1622	422	7	patel	patel	PROPN
admet-1622	422	8	,	,	PUNCT
admet-1622	422	9	a.t	a.t	PROPN
admet-1622	422	10	.	.	PUNCT
admet-1622	422	11	serajuddin	serajuddin	PROPN
admet-1622	422	12	.	.	PUNCT
admet-1622	423	1	development	development	NOUN
admet-1622	423	2	of	of	ADP
admet-1622	423	3	fdm	fdm	NOUN
admet-1622	423	4	3d	3d	ADV
admet-1622	423	5	-	-	PUNCT
admet-1622	423	6	printed	print	VERB
admet-1622	423	7	tablets	tablet	NOUN
admet-1622	423	8	with	with	ADP
admet-1622	423	9	rapid	rapid	ADJ
admet-1622	423	10	drug	drug	NOUN
admet-1622	423	11	release	release	NOUN
admet-1622	423	12	,	,	PUNCT
admet-1622	423	13	high	high	ADJ
admet-1622	423	14	drugpolymer	drugpolymer	ADJ
admet-1622	423	15	miscibility	miscibility	NOUN
admet-1622	423	16	and	and	CCONJ
admet-1622	423	17	reduced	reduce	VERB
admet-1622	423	18	printing	printing	NOUN
admet-1622	423	19	temperature	temperature	NOUN
admet-1622	423	20	by	by	ADP
admet-1622	423	21	applying	apply	VERB
admet-1622	423	22	the	the	DET
admet-1622	423	23	acid	acid	NOUN
admet-1622	423	24	-	-	PUNCT
admet-1622	423	25	base	base	NOUN
admet-1622	423	26	supersolubilization	supersolubilization	NOUN
admet-1622	423	27	(	(	PUNCT
admet-1622	423	28	abs	ab	NOUN
admet-1622	423	29	)	)	PUNCT
admet-1622	423	30	principle	principle	NOUN
admet-1622	423	31	.	.	PUNCT
admet-1622	424	1	international	international	ADJ
admet-1622	424	2	journal	journal	PROPN
admet-1622	424	3	of	of	ADP
admet-1622	424	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	424	5	600	600	NUM
admet-1622	424	6	(	(	PUNCT
admet-1622	424	7	2021	2021	NUM
admet-1622	424	8	)	)	PUNCT
admet-1622	424	9	120524	120524	NUM
admet-1622	424	10	.	.	PUNCT
admet-1622	425	1	https://doi.org/10.1016/j.ijpharm.2021.120524	https://doi.org/10.1016/j.ijpharm.2021.120524	PROPN
admet-1622	425	2	[	[	X
admet-1622	425	3	21	21	NUM
admet-1622	425	4	]	]	X
admet-1622	425	5	n.g	n.g	PROPN
admet-1622	425	6	.	.	PROPN
admet-1622	425	7	patel	patel	PROPN
admet-1622	425	8	,	,	PUNCT
admet-1622	425	9	a.t	a.t	PROPN
admet-1622	425	10	.	.	PUNCT
admet-1622	425	11	serajuddin	serajuddin	VERB
admet-1622	425	12	.	.	PUNCT
admet-1622	426	1	improving	improve	VERB
admet-1622	426	2	drug	drug	NOUN
admet-1622	426	3	release	release	NOUN
admet-1622	426	4	rate	rate	NOUN
admet-1622	426	5	,	,	PUNCT
admet-1622	426	6	drug	drug	NOUN
admet-1622	426	7	-	-	PUNCT
admet-1622	426	8	polymer	polymer	NOUN
admet-1622	426	9	miscibility	miscibility	NOUN
admet-1622	426	10	,	,	PUNCT
admet-1622	426	11	printability	printability	NOUN
admet-1622	426	12	,	,	PUNCT
admet-1622	426	13	and	and	CCONJ
admet-1622	426	14	processability	processability	NOUN
admet-1622	426	15	of	of	ADP
admet-1622	426	16	fdm	fdm	NOUN
admet-1622	426	17	3d	3d	ADV
admet-1622	426	18	-	-	PUNCT
admet-1622	426	19	printed	print	VERB
admet-1622	426	20	tablets	tablet	NOUN
admet-1622	426	21	by	by	ADP
admet-1622	426	22	weak	weak	ADJ
admet-1622	426	23	acid	acid	NOUN
admet-1622	426	24	-	-	PUNCT
admet-1622	426	25	base	base	NOUN
admet-1622	426	26	interaction	interaction	NOUN
admet-1622	426	27	.	.	PUNCT
admet-1622	427	1	international	international	ADJ
admet-1622	427	2	journal	journal	PROPN
admet-1622	427	3	of	of	ADP
admet-1622	427	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	427	5	(	(	PUNCT
admet-1622	427	6	2023	2023	NUM
admet-1622	427	7	)	)	PUNCT
admet-1622	427	8	,	,	PUNCT
admet-1622	427	9	in	in	ADP
admet-1622	427	10	press	press	NOUN
admet-1622	428	1	[	[	X
admet-1622	428	2	22	22	NUM
admet-1622	428	3	]	]	PUNCT
admet-1622	428	4	k.	k.	PROPN
admet-1622	428	5	ilyés	ilyés	PROPN
admet-1622	428	6	,	,	PUNCT
admet-1622	428	7	n.k	n.k	PROPN
admet-1622	428	8	.	.	PROPN
admet-1622	428	9	kovács	kovács	PROPN
admet-1622	428	10	,	,	PUNCT
admet-1622	428	11	a.	a.	PROPN
admet-1622	428	12	balogh	balogh	PROPN
admet-1622	428	13	,	,	PUNCT
admet-1622	428	14	e.	e.	PROPN
admet-1622	428	15	borbás	borbás	PROPN
admet-1622	428	16	,	,	PUNCT
admet-1622	428	17	b.	b.	PROPN
admet-1622	428	18	farkas	farkas	PROPN
admet-1622	428	19	,	,	PUNCT
admet-1622	428	20	t.	t.	PROPN
admet-1622	428	21	casian	casian	PROPN
admet-1622	428	22	,	,	PUNCT
admet-1622	428	23	g.	g.	PROPN
admet-1622	428	24	marosi	marosi	PROPN
admet-1622	428	25	,	,	PUNCT
admet-1622	428	26	i.	i.	NOUN
admet-1622	428	27	tomuță	tomuță	NOUN
admet-1622	428	28	,	,	PUNCT
admet-1622	428	29	z.k	z.k	PROPN
admet-1622	428	30	.	.	PROPN
admet-1622	428	31	nagy	nagy	PROPN
admet-1622	428	32	.	.	PUNCT
admet-1622	429	1	the	the	DET
admet-1622	429	2	applicability	applicability	NOUN
admet-1622	429	3	of	of	ADP
admet-1622	429	4	pharmaceutical	pharmaceutical	ADJ
admet-1622	429	5	polymeric	polymeric	ADJ
admet-1622	429	6	blends	blend	NOUN
admet-1622	429	7	for	for	ADP
admet-1622	429	8	the	the	DET
admet-1622	429	9	fused	fuse	VERB
admet-1622	429	10	deposition	deposition	NOUN
admet-1622	429	11	modelling	modelling	NOUN
admet-1622	429	12	(	(	PUNCT
admet-1622	429	13	fdm	fdm	NOUN
admet-1622	429	14	)	)	PUNCT
admet-1622	429	15	3d	3d	NOUN
admet-1622	429	16	technique	technique	NOUN
admet-1622	429	17	:	:	PUNCT
admet-1622	429	18	material	material	NOUN
admet-1622	429	19	considerations	consideration	NOUN
admet-1622	429	20	–	–	PUNCT
admet-1622	429	21	printability	printability	NOUN
admet-1622	429	22	–	–	PUNCT
admet-1622	429	23	process	process	NOUN
admet-1622	429	24	modulation	modulation	NOUN
admet-1622	429	25	,	,	PUNCT
admet-1622	429	26	with	with	ADP
admet-1622	429	27	consecutive	consecutive	ADJ
admet-1622	429	28	effects	effect	NOUN
admet-1622	429	29	on	on	ADP
admet-1622	429	30	in	in	ADP
admet-1622	429	31	vitro	vitro	X
admet-1622	429	32	release	release	NOUN
admet-1622	429	33	,	,	PUNCT
admet-1622	429	34	stability	stability	NOUN
admet-1622	429	35	and	and	CCONJ
admet-1622	429	36	degradation	degradation	NOUN
admet-1622	429	37	.	.	PUNCT
admet-1622	430	1	european	european	ADJ
admet-1622	430	2	journal	journal	PROPN
admet-1622	430	3	of	of	ADP
admet-1622	430	4	pharmaceutical	pharmaceutical	PROPN
admet-1622	430	5	sciences	science	NOUN
admet-1622	430	6	129	129	NUM
admet-1622	430	7	(	(	PUNCT
admet-1622	430	8	2019	2019	NUM
admet-1622	430	9	)	)	PUNCT
admet-1622	430	10	110123	110123	NUM
admet-1622	430	11	.	.	PUNCT
admet-1622	431	1	https://doi.org/10.1016/j.ejps.2018.12.019	https://doi.org/10.1016/j.ejps.2018.12.019	NUM
admet-1622	432	1	[	[	X
admet-1622	432	2	23	23	NUM
admet-1622	432	3	]	]	X
admet-1622	432	4	r.	r.	PROPN
admet-1622	432	5	govender	govender	PROPN
admet-1622	432	6	,	,	PUNCT
admet-1622	432	7	e.o	e.o	PROPN
admet-1622	432	8	.	.	PROPN
admet-1622	432	9	kissi	kissi	PROPN
admet-1622	432	10	,	,	PUNCT
admet-1622	432	11	a.	a.	PROPN
admet-1622	432	12	larsson	larsson	PROPN
admet-1622	432	13	,	,	PUNCT
admet-1622	432	14	i.	i.	PROPN
admet-1622	432	15	tho	tho	PROPN
admet-1622	432	16	.	.	PUNCT
admet-1622	432	17	polymers	polymer	NOUN
admet-1622	432	18	in	in	ADP
admet-1622	432	19	pharmaceutical	pharmaceutical	ADJ
admet-1622	432	20	additive	additive	ADJ
admet-1622	432	21	manufacturing	manufacturing	NOUN
admet-1622	432	22	:	:	PUNCT
admet-1622	432	23	a	a	DET
admet-1622	432	24	balancing	balance	VERB
admet-1622	432	25	act	act	NOUN
admet-1622	432	26	between	between	ADP
admet-1622	432	27	printability	printability	NOUN
admet-1622	432	28	and	and	CCONJ
admet-1622	432	29	product	product	NOUN
admet-1622	432	30	performance	performance	NOUN
admet-1622	432	31	.	.	PUNCT
admet-1622	433	1	advanced	advanced	ADJ
admet-1622	433	2	drug	drug	NOUN
admet-1622	433	3	delivery	delivery	NOUN
admet-1622	433	4	reviews	review	VERB
admet-1622	433	5	177	177	NUM
admet-1622	433	6	(	(	PUNCT
admet-1622	433	7	2021	2021	NUM
admet-1622	433	8	)	)	PUNCT
admet-1622	433	9	113923	113923	NUM
admet-1622	433	10	.	.	PUNCT
admet-1622	434	1	https://doi.org/10.1016/j.addr.2021.113923	https://doi.org/10.1016/j.addr.2021.113923	PROPN
admet-1622	434	2	[	[	X
admet-1622	434	3	24	24	NUM
admet-1622	434	4	]	]	X
admet-1622	434	5	j.m	j.m	PROPN
admet-1622	434	6	.	.	PROPN
admet-1622	434	7	nasereddin	nasereddin	PROPN
admet-1622	434	8	,	,	PUNCT
admet-1622	434	9	n.	n.	PROPN
admet-1622	434	10	wellner	wellner	PROPN
admet-1622	434	11	,	,	PUNCT
admet-1622	434	12	m.	m.	NOUN
admet-1622	434	13	alhijjaj	alhijjaj	PROPN
admet-1622	434	14	,	,	PUNCT
admet-1622	434	15	p.	p.	PROPN
admet-1622	434	16	belton	belton	PROPN
admet-1622	434	17	,	,	PUNCT
admet-1622	434	18	s.	s.	PROPN
admet-1622	434	19	qi	qi	PROPN
admet-1622	434	20	.	.	PUNCT
admet-1622	434	21	development	development	NOUN
admet-1622	434	22	of	of	ADP
admet-1622	434	23	a	a	DET
admet-1622	434	24	simple	simple	ADJ
admet-1622	434	25	mechanical	mechanical	ADJ
admet-1622	434	26	screening	screening	NOUN
admet-1622	434	27	method	method	NOUN
admet-1622	434	28	for	for	ADP
admet-1622	434	29	predicting	predict	VERB
admet-1622	434	30	the	the	DET
admet-1622	434	31	feedability	feedability	NOUN
admet-1622	434	32	of	of	ADP
admet-1622	434	33	a	a	DET
admet-1622	434	34	pharmaceutical	pharmaceutical	ADJ
admet-1622	434	35	fdm	fdm	NOUN
admet-1622	434	36	3d	3d	NOUN
admet-1622	434	37	printing	printing	NOUN
admet-1622	434	38	filament	filament	NOUN
admet-1622	434	39	.	.	PUNCT
admet-1622	435	1	pharmaceutical	pharmaceutical	PROPN
admet-1622	435	2	research	research	NOUN
admet-1622	435	3	35	35	NUM
admet-1622	435	4	(	(	PUNCT
admet-1622	435	5	2018	2018	NUM
admet-1622	435	6	)	)	PUNCT
admet-1622	435	7	1	1	NUM
admet-1622	435	8	-	-	SYM
admet-1622	435	9	13	13	NUM
admet-1622	435	10	.	.	PUNCT
admet-1622	436	1	https://doi.org/10.1007/s11095-018-2432-3	https://doi.org/10.1007/s11095-018-2432-3	NUM
admet-1622	437	1	[	[	X
admet-1622	437	2	25	25	NUM
admet-1622	437	3	]	]	PUNCT
admet-1622	437	4	s.	s.	PROPN
admet-1622	437	5	borandeh	borandeh	PROPN
admet-1622	437	6	,	,	PUNCT
admet-1622	437	7	b.	b.	PROPN
admet-1622	437	8	van	van	PROPN
admet-1622	437	9	bochove	bochove	PROPN
admet-1622	437	10	,	,	PUNCT
admet-1622	437	11	a.	a.	NOUN
admet-1622	437	12	teotia	teotia	PROPN
admet-1622	437	13	,	,	PUNCT
admet-1622	437	14	j.	j.	PROPN
admet-1622	437	15	seppälä	seppälä	PROPN
admet-1622	437	16	.	.	PUNCT
admet-1622	438	1	polymeric	polymeric	ADJ
admet-1622	438	2	drug	drug	NOUN
admet-1622	438	3	delivery	delivery	NOUN
admet-1622	438	4	systems	system	NOUN
admet-1622	438	5	by	by	ADP
admet-1622	438	6	additive	additive	ADJ
admet-1622	438	7	manufacturing	manufacturing	NOUN
admet-1622	438	8	.	.	PUNCT
admet-1622	439	1	advanced	advanced	ADJ
admet-1622	439	2	drug	drug	NOUN
admet-1622	439	3	delivery	delivery	NOUN
admet-1622	439	4	reviews	review	VERB
admet-1622	439	5	173	173	NUM
admet-1622	439	6	(	(	PUNCT
admet-1622	439	7	2021	2021	NUM
admet-1622	439	8	)	)	PUNCT
admet-1622	439	9	349	349	NUM
admet-1622	439	10	-	-	SYM
admet-1622	439	11	373	373	NUM
admet-1622	439	12	.	.	PUNCT
admet-1622	440	1	https://doi.org/10.1016/j.addr.2021.03.022	https://doi.org/10.1016/j.addr.2021.03.022	NOUN
admet-1622	441	1	[	[	X
admet-1622	441	2	26	26	NUM
admet-1622	441	3	]	]	X
admet-1622	441	4	s.	s.	PROPN
admet-1622	441	5	cailleaux	cailleaux	PROPN
admet-1622	441	6	,	,	PUNCT
admet-1622	441	7	n.m	n.m	PROPN
admet-1622	441	8	.	.	PROPN
admet-1622	441	9	sanchez	sanchez	PROPN
admet-1622	441	10	-	-	PUNCT
admet-1622	441	11	ballester	ballester	PROPN
admet-1622	441	12	,	,	PUNCT
admet-1622	441	13	y.a	y.a	PROPN
admet-1622	441	14	.	.	PROPN
admet-1622	441	15	gueche	gueche	PROPN
admet-1622	441	16	,	,	PUNCT
admet-1622	441	17	b.	b.	PROPN
admet-1622	441	18	bataille	bataille	PROPN
admet-1622	441	19	,	,	PUNCT
admet-1622	441	20	i.	i.	PROPN
admet-1622	441	21	soulairol	soulairol	PROPN
admet-1622	441	22	.	.	PUNCT
admet-1622	442	1	fused	fuse	VERB
admet-1622	442	2	deposition	deposition	NOUN
admet-1622	442	3	modeling	modeling	NOUN
admet-1622	442	4	(	(	PUNCT
admet-1622	442	5	fdm	fdm	NOUN
admet-1622	442	6	)	)	PUNCT
admet-1622	442	7	,	,	PUNCT
admet-1622	442	8	the	the	DET
admet-1622	442	9	new	new	ADJ
admet-1622	442	10	asset	asset	NOUN
admet-1622	442	11	for	for	ADP
admet-1622	442	12	the	the	DET
admet-1622	442	13	production	production	NOUN
admet-1622	442	14	of	of	ADP
admet-1622	442	15	tailored	tailor	VERB
admet-1622	442	16	medicines	medicine	NOUN
admet-1622	442	17	.	.	PUNCT
admet-1622	443	1	journal	journal	PROPN
admet-1622	443	2	of	of	ADP
admet-1622	443	3	controlled	control	VERB
admet-1622	443	4	release	release	NOUN
admet-1622	443	5	330	330	NUM
admet-1622	443	6	(	(	PUNCT
admet-1622	443	7	2021	2021	NUM
admet-1622	443	8	)	)	PUNCT
admet-1622	443	9	821	821	NUM
admet-1622	443	10	-	-	SYM
admet-1622	443	11	841	841	NUM
admet-1622	443	12	.	.	PUNCT
admet-1622	444	1	https://doi.org/10.1016/j.jconrel.2020.10.056	https://doi.org/10.1016/j.jconrel.2020.10.056	PROPN
admet-1622	445	1	[	[	X
admet-1622	445	2	27	27	NUM
admet-1622	445	3	]	]	PUNCT
admet-1622	445	4	s.	s.	PROPN
admet-1622	445	5	henry	henry	PROPN
admet-1622	445	6	,	,	PUNCT
admet-1622	445	7	a.	a.	NOUN
admet-1622	445	8	samaro	samaro	PROPN
admet-1622	445	9	,	,	PUNCT
admet-1622	445	10	f.h	f.h	PROPN
admet-1622	445	11	.	.	PROPN
admet-1622	445	12	marchesini	marchesini	PROPN
admet-1622	445	13	,	,	PUNCT
admet-1622	445	14	b.	b.	PROPN
admet-1622	445	15	shaqour	shaqour	PROPN
admet-1622	445	16	,	,	PUNCT
admet-1622	445	17	j.	j.	PROPN
admet-1622	445	18	macedo	macedo	PROPN
admet-1622	445	19	,	,	PUNCT
admet-1622	445	20	v.	v.	ADP
admet-1622	445	21	vanhoorne	vanhoorne	NOUN
admet-1622	445	22	,	,	PUNCT
admet-1622	445	23	c.	c.	PROPN
admet-1622	445	24	vervaet	vervaet	PROPN
admet-1622	445	25	.	.	PUNCT
admet-1622	446	1	extrusion	extrusion	NOUN
admet-1622	446	2	-	-	PUNCT
admet-1622	446	3	based	base	VERB
admet-1622	446	4	3d	3d	PROPN
admet-1622	446	5	printing	printing	NOUN
admet-1622	446	6	of	of	ADP
admet-1622	446	7	oral	oral	ADJ
admet-1622	446	8	solid	solid	ADJ
admet-1622	446	9	dosage	dosage	NOUN
admet-1622	446	10	forms	form	NOUN
admet-1622	446	11	:	:	PUNCT
admet-1622	446	12	material	material	NOUN
admet-1622	446	13	requirements	requirement	NOUN
admet-1622	446	14	and	and	CCONJ
admet-1622	446	15	equipment	equipment	NOUN
admet-1622	446	16	dependencies	dependency	NOUN
admet-1622	446	17	.	.	PUNCT
admet-1622	447	1	international	international	ADJ
admet-1622	447	2	journal	journal	PROPN
admet-1622	447	3	of	of	ADP
admet-1622	447	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	447	5	598	598	NUM
admet-1622	447	6	(	(	PUNCT
admet-1622	447	7	2021	2021	NUM
admet-1622	447	8	)	)	PUNCT
admet-1622	447	9	120361	120361	NUM
admet-1622	447	10	.	.	PUNCT
admet-1622	448	1	https://doi.org/10.1016/j.ijpharm.2021.120361	https://doi.org/10.1016/j.ijpharm.2021.120361	NOUN
admet-1622	448	2	[	[	X
admet-1622	448	3	28	28	NUM
admet-1622	448	4	]	]	X
admet-1622	448	5	r.	r.	PROPN
admet-1622	448	6	liu	liu	PROPN
admet-1622	448	7	,	,	PUNCT
admet-1622	448	8	water	water	NOUN
admet-1622	448	9	-	-	PUNCT
admet-1622	448	10	insoluble	insoluble	ADJ
admet-1622	448	11	drug	drug	NOUN
admet-1622	448	12	formulation	formulation	NOUN
admet-1622	448	13	,	,	PUNCT
admet-1622	448	14	3rd	3rd	ADJ
admet-1622	448	15	edition	edition	NOUN
admet-1622	448	16	ed	ed	NOUN
admet-1622	448	17	.	.	PROPN
admet-1622	448	18	,	,	PUNCT
admet-1622	448	19	boca	boca	PROPN
admet-1622	448	20	raton	raton	PROPN
admet-1622	448	21	,	,	PUNCT
admet-1622	448	22	2018	2018	NUM
admet-1622	448	23	.	.	PUNCT
admet-1622	449	1	https:/doi.org/10.1201/9781315120492	https:/doi.org/10.1201/9781315120492	PROPN
admet-1622	449	2	.	.	PUNCT
admet-1622	450	1	[	[	X
admet-1622	450	2	29	29	NUM
admet-1622	450	3	]	]	X
admet-1622	450	4	g.g	g.g	PROPN
admet-1622	450	5	.	.	PROPN
admet-1622	450	6	pereira	pereira	PROPN
admet-1622	450	7	,	,	PUNCT
admet-1622	450	8	s.	s.	PROPN
admet-1622	450	9	figueiredo	figueiredo	PROPN
admet-1622	450	10	,	,	PUNCT
admet-1622	450	11	a.i	a.i	PROPN
admet-1622	450	12	.	.	PROPN
admet-1622	450	13	fernandes	fernandes	PROPN
admet-1622	450	14	,	,	PUNCT
admet-1622	450	15	j.f	j.f	PROPN
admet-1622	450	16	.	.	PROPN
admet-1622	450	17	pinto	pinto	NOUN
admet-1622	450	18	.	.	PUNCT
admet-1622	450	19	polymer	polymer	NOUN
admet-1622	450	20	selection	selection	NOUN
admet-1622	450	21	for	for	ADP
admet-1622	450	22	hot	hot	ADJ
admet-1622	450	23	-	-	PUNCT
admet-1622	450	24	melt	melt	NOUN
admet-1622	450	25	extrusion	extrusion	NOUN
admet-1622	450	26	coupled	couple	VERB
admet-1622	450	27	to	to	ADP
admet-1622	450	28	fused	fuse	VERB
admet-1622	450	29	deposition	deposition	NOUN
admet-1622	450	30	modelling	modelling	NOUN
admet-1622	450	31	in	in	ADP
admet-1622	450	32	pharmaceutics	pharmaceutic	NOUN
admet-1622	450	33	.	.	PUNCT
admet-1622	451	1	pharmaceutics	pharmaceutic	NOUN
admet-1622	451	2	12	12	NUM
admet-1622	451	3	(	(	PUNCT
admet-1622	451	4	2020	2020	NUM
admet-1622	451	5	)	)	PUNCT
admet-1622	451	6	795	795	NUM
admet-1622	451	7	.	.	PUNCT
admet-1622	452	1	https://doi.org/10.3390/pharmaceutics12090795	https://doi.org/10.3390/pharmaceutics12090795	PROPN
admet-1622	452	2	[	[	X
admet-1622	453	1	30	30	NUM
admet-1622	453	2	]	]	X
admet-1622	453	3	g.m	g.m	PROPN
admet-1622	453	4	.	.	PUNCT
admet-1622	453	5	khalid	khalid	PROPN
admet-1622	453	6	,	,	PUNCT
admet-1622	453	7	n.	n.	PROPN
admet-1622	453	8	billa	billa	PROPN
admet-1622	453	9	.	.	PUNCT
admet-1622	454	1	solid	solid	ADJ
admet-1622	454	2	dispersion	dispersion	NOUN
admet-1622	454	3	formulations	formulation	NOUN
admet-1622	454	4	by	by	ADP
admet-1622	454	5	fdm	fdm	NOUN
admet-1622	454	6	3d	3d	NUM
admet-1622	454	7	printing	printing	NOUN
admet-1622	454	8	—	—	PUNCT
admet-1622	454	9	a	a	DET
admet-1622	454	10	review	review	NOUN
admet-1622	454	11	.	.	PUNCT
admet-1622	455	1	pharmaceutics	pharmaceutic	NOUN
admet-1622	455	2	14	14	NUM
admet-1622	455	3	(	(	PUNCT
admet-1622	455	4	2022	2022	NUM
admet-1622	455	5	)	)	PUNCT
admet-1622	455	6	690	690	NUM
admet-1622	455	7	.	.	PUNCT
admet-1622	456	1	https://doi.org/10.3390/pharmaceutics14040690	https://doi.org/10.3390/pharmaceutics14040690	PROPN
admet-1622	456	2	[	[	X
admet-1622	456	3	31	31	NUM
admet-1622	456	4	]	]	X
admet-1622	456	5	l.a	l.a	PROPN
admet-1622	456	6	.	.	PROPN
admet-1622	456	7	pinho	pinho	PROPN
admet-1622	456	8	,	,	PUNCT
admet-1622	456	9	a.l	a.l	PROPN
admet-1622	456	10	.	.	PROPN
admet-1622	456	11	lima	lima	PROPN
admet-1622	456	12	,	,	PUNCT
admet-1622	456	13	l.l	l.l	PROPN
admet-1622	456	14	.	.	PROPN
admet-1622	456	15	sa	sa	PROPN
admet-1622	456	16	-	-	PUNCT
admet-1622	456	17	barreto	barreto	PROPN
admet-1622	456	18	,	,	PUNCT
admet-1622	456	19	t.	t.	PROPN
admet-1622	456	20	gratieri	gratieri	PROPN
admet-1622	456	21	,	,	PUNCT
admet-1622	456	22	g.m	g.m	PROPN
admet-1622	456	23	.	.	PROPN
admet-1622	457	1	gelfuso	gelfuso	PROPN
admet-1622	457	2	,	,	PUNCT
admet-1622	457	3	r.n	r.n	PROPN
admet-1622	457	4	.	.	PROPN
admet-1622	457	5	marreto	marreto	NOUN
admet-1622	457	6	,	,	PUNCT
admet-1622	457	7	m.	m.	NOUN
admet-1622	457	8	cunha	cunha	NOUN
admet-1622	457	9	-	-	NOUN
admet-1622	457	10	filho	filho	NOUN
admet-1622	457	11	.	.	PUNCT
admet-1622	458	1	preformulation	preformulation	NOUN
admet-1622	458	2	studies	study	NOUN
admet-1622	458	3	to	to	PART
admet-1622	458	4	guide	guide	VERB
admet-1622	458	5	the	the	DET
admet-1622	458	6	production	production	NOUN
admet-1622	458	7	of	of	ADP
admet-1622	458	8	medicines	medicine	NOUN
admet-1622	458	9	by	by	ADP
admet-1622	458	10	fused	fuse	VERB
admet-1622	458	11	deposition	deposition	NOUN
admet-1622	458	12	modeling	modeling	NOUN
admet-1622	458	13	3d	3d	NUM
admet-1622	458	14	printing	printing	NOUN
admet-1622	458	15	.	.	PUNCT
admet-1622	459	1	aaps	aap	NOUN
admet-1622	459	2	pharmscitech	pharmscitech	VERB
admet-1622	459	3	22	22	NUM
admet-1622	459	4	(	(	PUNCT
admet-1622	459	5	2021	2021	NUM
admet-1622	459	6	)	)	PUNCT
admet-1622	459	7	1	1	NUM
admet-1622	459	8	-	-	SYM
admet-1622	459	9	12	12	NUM
admet-1622	459	10	.	.	PUNCT
admet-1622	460	1	https://doi.org/10.1016/j.jpha.2021.09.010	https://doi.org/10.1016/j.jpha.2021.09.010	NOUN
admet-1622	460	2	[	[	X
admet-1622	460	3	32	32	NUM
admet-1622	460	4	]	]	PUNCT
admet-1622	460	5	t.	t.	PROPN
admet-1622	460	6	parikh	parikh	PROPN
admet-1622	460	7	,	,	PUNCT
admet-1622	460	8	s.s	s.s	PROPN
admet-1622	460	9	.	.	PROPN
admet-1622	460	10	gupta	gupta	PROPN
admet-1622	460	11	,	,	PUNCT
admet-1622	460	12	a.k	a.k	PROPN
admet-1622	460	13	.	.	PROPN
admet-1622	460	14	meena	meena	PROPN
admet-1622	460	15	,	,	PUNCT
admet-1622	460	16	i.	i.	PROPN
admet-1622	460	17	vitez	vitez	PROPN
admet-1622	460	18	,	,	PUNCT
admet-1622	460	19	n.	n.	PROPN
admet-1622	460	20	mahajan	mahajan	PROPN
admet-1622	460	21	,	,	PUNCT
admet-1622	460	22	a.t	a.t	PROPN
admet-1622	460	23	.	.	PUNCT
admet-1622	460	24	serajuddin	serajuddin	PROPN
admet-1622	460	25	.	.	PUNCT
admet-1622	461	1	application	application	NOUN
admet-1622	461	2	of	of	ADP
admet-1622	461	3	film	film	NOUN
admet-1622	461	4	-	-	PUNCT
admet-1622	461	5	casting	cast	VERB
admet-1622	461	6	technique	technique	NOUN
admet-1622	461	7	to	to	PART
admet-1622	461	8	investigate	investigate	VERB
admet-1622	461	9	drug	drug	NOUN
admet-1622	461	10	–	–	PUNCT
admet-1622	461	11	polymer	polymer	NOUN
admet-1622	461	12	miscibility	miscibility	NOUN
admet-1622	461	13	in	in	ADP
admet-1622	461	14	solid	solid	ADJ
admet-1622	461	15	dispersion	dispersion	NOUN
admet-1622	461	16	and	and	CCONJ
admet-1622	461	17	hot	hot	ADJ
admet-1622	461	18	-	-	PUNCT
admet-1622	461	19	melt	melt	NOUN
admet-1622	461	20	extrudate	extrudate	NOUN
admet-1622	461	21	.	.	PUNCT
admet-1622	462	1	journal	journal	NOUN
admet-1622	462	2	of	of	ADP
admet-1622	462	3	pharmaceutical	pharmaceutical	PROPN
admet-1622	462	4	sciences	science	NOUN
admet-1622	462	5	104	104	NUM
admet-1622	462	6	(	(	PUNCT
admet-1622	462	7	2015	2015	NUM
admet-1622	462	8	)	)	PUNCT
admet-1622	462	9	2142	2142	NUM
admet-1622	462	10	-	-	SYM
admet-1622	462	11	2152	2152	NUM
admet-1622	462	12	.	.	PUNCT
admet-1622	463	1	https://doi.org/10.1002/jps.24446	https://doi.org/10.1002/jps.24446	NOUN
admet-1622	463	2	[	[	X
admet-1622	463	3	33	33	NUM
admet-1622	463	4	]	]	X
admet-1622	463	5	c.	c.	PROPN
admet-1622	463	6	wei	wei	PROPN
admet-1622	463	7	,	,	PUNCT
admet-1622	463	8	n.g	n.g	PROPN
admet-1622	463	9	.	.	PROPN
admet-1622	463	10	solanki	solanki	PROPN
admet-1622	463	11	,	,	PUNCT
admet-1622	463	12	j.m	j.m	PROPN
admet-1622	463	13	.	.	PROPN
admet-1622	463	14	vasoya	vasoya	PROPN
admet-1622	463	15	,	,	PUNCT
admet-1622	463	16	a.v	a.v	PROPN
admet-1622	463	17	.	.	PROPN
admet-1622	463	18	shah	shah	PROPN
admet-1622	463	19	,	,	PUNCT
admet-1622	463	20	a.t	a.t	PROPN
admet-1622	463	21	.	.	PUNCT
admet-1622	463	22	serajuddin	serajuddin	PROPN
admet-1622	463	23	.	.	PUNCT
admet-1622	464	1	development	development	NOUN
admet-1622	464	2	of	of	ADP
admet-1622	464	3	3d	3d	NUM
admet-1622	464	4	printed	print	VERB
admet-1622	464	5	tablets	tablet	NOUN
admet-1622	464	6	by	by	ADP
admet-1622	464	7	fused	fuse	VERB
admet-1622	464	8	deposition	deposition	NOUN
admet-1622	464	9	modeling	modeling	NOUN
admet-1622	464	10	using	use	VERB
admet-1622	464	11	polyvinyl	polyvinyl	NOUN
admet-1622	464	12	alcohol	alcohol	NOUN
admet-1622	464	13	as	as	ADP
admet-1622	464	14	polymeric	polymeric	ADJ
admet-1622	464	15	matrix	matrix	NOUN
admet-1622	464	16	for	for	ADP
admet-1622	464	17	rapid	rapid	ADJ
admet-1622	464	18	drug	drug	NOUN
admet-1622	464	19	release	release	NOUN
admet-1622	464	20	.	.	PUNCT
admet-1622	465	1	journal	journal	NOUN
admet-1622	465	2	of	of	ADP
admet-1622	465	3	pharmaceutical	pharmaceutical	PROPN
admet-1622	465	4	sciences	science	NOUN
admet-1622	465	5	109	109	NUM
admet-1622	465	6	(	(	PUNCT
admet-1622	465	7	2020	2020	NUM
admet-1622	465	8	)	)	PUNCT
admet-1622	465	9	1558	1558	NUM
admet-1622	465	10	-	-	SYM
admet-1622	465	11	1572	1572	NUM
admet-1622	465	12	.	.	PUNCT
admet-1622	466	1	https://doi.org/10.1016/j.xphs.2020.01.015	https://doi.org/10.1016/j.xphs.2020.01.015	PRON
admet-1622	466	2	[	[	X
admet-1622	466	3	34	34	NUM
admet-1622	466	4	]	]	X
admet-1622	466	5	n.	n.	PROPN
admet-1622	466	6	solanki	solanki	PROPN
admet-1622	466	7	,	,	PUNCT
admet-1622	466	8	s.s	s.s	PROPN
admet-1622	466	9	.	.	PROPN
admet-1622	466	10	gupta	gupta	PROPN
admet-1622	466	11	,	,	PUNCT
admet-1622	466	12	a.t	a.t	PROPN
admet-1622	466	13	.	.	PUNCT
admet-1622	466	14	serajuddin	serajuddin	PROPN
admet-1622	466	15	.	.	PUNCT
admet-1622	467	1	rheological	rheological	ADJ
admet-1622	467	2	analysis	analysis	NOUN
admet-1622	467	3	of	of	ADP
admet-1622	467	4	itraconazole	itraconazole	ADJ
admet-1622	467	5	-	-	PUNCT
admet-1622	467	6	polymer	polymer	NOUN
admet-1622	467	7	mixtures	mixture	NOUN
admet-1622	467	8	to	to	PART
admet-1622	467	9	determine	determine	VERB
admet-1622	467	10	optimal	optimal	ADJ
admet-1622	467	11	melt	melt	NOUN
admet-1622	467	12	extrusion	extrusion	NOUN
admet-1622	467	13	temperature	temperature	NOUN
admet-1622	467	14	for	for	ADP
admet-1622	467	15	development	development	NOUN
admet-1622	467	16	of	of	ADP
admet-1622	467	17	amorphous	amorphous	ADJ
admet-1622	467	18	solid	solid	ADJ
admet-1622	467	19	dispersion	dispersion	NOUN
admet-1622	467	20	.	.	PUNCT
admet-1622	468	1	https://doi.org/10.1016/j.xphs.2017.10.021	https://doi.org/10.1016/j.xphs.2017.10.021	PROPN
admet-1622	468	2	https://doi.org/10.1016/j.xphs.2017.10.021	https://doi.org/10.1016/j.xphs.2017.10.021	PROPN
admet-1622	468	3	https://doi.org/10.1016/j.ijpharm.2021.120524	https://doi.org/10.1016/j.ijpharm.2021.120524	PROPN
admet-1622	468	4	https://doi.org/10.1016/j.ijpharm.2021.120524	https://doi.org/10.1016/j.ijpharm.2021.120524	PROPN
admet-1622	468	5	https://doi.org/10.1016/j.ejps.2018.12.019	https://doi.org/10.1016/j.ejps.2018.12.019	NUM
admet-1622	468	6	https://doi.org/10.1016/j.addr.2021.113923	https://doi.org/10.1016/j.addr.2021.113923	PROPN
admet-1622	468	7	https://doi.org/10.1007/s11095-018-2432-3	https://doi.org/10.1007/s11095-018-2432-3	NUM
admet-1622	468	8	https://doi.org/10.1016/j.addr.2021.03.022	https://doi.org/10.1016/j.addr.2021.03.022	NOUN
admet-1622	468	9	https://doi.org/10.1016/j.addr.2021.03.022	https://doi.org/10.1016/j.addr.2021.03.022	NOUN
admet-1622	468	10	https://doi.org/10.1016/j.jconrel.2020.10.056	https://doi.org/10.1016/j.jconrel.2020.10.056	PROPN
admet-1622	468	11	https://doi.org/10.1016/j.ijpharm.2021.120361	https://doi.org/10.1016/j.ijpharm.2021.120361	PROPN
admet-1622	468	12	https://doi.org/10.1016/j.ijpharm.2021.120361	https://doi.org/10.1016/j.ijpharm.2021.120361	PROPN
admet-1622	468	13	https://doi.org/10.1201/9781315120492	https://doi.org/10.1201/9781315120492	VERB
admet-1622	468	14	https://doi.org/10.1201/9781315120492	https://doi.org/10.1201/9781315120492	NOUN
admet-1622	469	1	https://doi.org/10.3390/pharmaceutics12090795	https://doi.org/10.3390/pharmaceutics12090795	PROPN
admet-1622	469	2	https://doi.org/10.3390/pharmaceutics12090795	https://doi.org/10.3390/pharmaceutics12090795	PROPN
admet-1622	469	3	https://doi.org/10.3390/pharmaceutics14040690	https://doi.org/10.3390/pharmaceutics14040690	VERB
admet-1622	469	4	https://doi.org/10.1016/j.jpha.2021.09.010	https://doi.org/10.1016/j.jpha.2021.09.010	PROPN
admet-1622	469	5	https://doi.org/10.1002/jps.24446	https://doi.org/10.1002/jps.24446	PROPN
admet-1622	469	6	https://doi.org/10.1016/j.xphs.2020.01.015	https://doi.org/10.1016/j.xphs.2020.01.015	PROPN
admet-1622	469	7	admet	admet	PROPN
admet-1622	469	8	&	&	CCONJ
admet-1622	469	9	dmpk	dmpk	PROPN
admet-1622	469	10	11(1	11(1	NUM
admet-1622	469	11	)	)	PUNCT
admet-1622	469	12	(	(	PUNCT
admet-1622	469	13	2023	2023	NUM
admet-1622	469	14	)	)	PUNCT
admet-1622	469	15	33	33	NUM
admet-1622	469	16	-	-	SYM
admet-1622	469	17	55	55	NUM
admet-1622	469	18	development	development	NOUN
admet-1622	469	19	of	of	ADP
admet-1622	469	20	rapidly	rapidly	ADV
admet-1622	469	21	dissolving	dissolve	VERB
admet-1622	469	22	fdm	fdm	NOUN
admet-1622	469	23	3d	3d	ADV
admet-1622	469	24	-	-	PUNCT
admet-1622	469	25	printed	print	VERB
admet-1622	469	26	tablets	tablet	NOUN
admet-1622	469	27	doi	doi	NOUN
admet-1622	469	28	:	:	PUNCT
admet-1622	469	29	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	469	30	53	53	NUM
admet-1622	469	31	european	european	ADJ
admet-1622	469	32	journal	journal	NOUN
admet-1622	469	33	of	of	ADP
admet-1622	469	34	pharmaceutical	pharmaceutical	PROPN
admet-1622	469	35	sciences	science	NOUN
admet-1622	469	36	111	111	NUM
admet-1622	469	37	(	(	PUNCT
admet-1622	469	38	2018	2018	NUM
admet-1622	469	39	)	)	PUNCT
admet-1622	469	40	482	482	NUM
admet-1622	469	41	-	-	SYM
admet-1622	469	42	491	491	NUM
admet-1622	469	43	.	.	PUNCT
admet-1622	470	1	https://doi.org/10.1016/j.ejps.2017.10.034	https://doi.org/10.1016/j.ejps.2017.10.034	NOUN
admet-1622	470	2	[	[	X
admet-1622	470	3	35	35	NUM
admet-1622	470	4	]	]	X
admet-1622	470	5	s.s	s.s	PROPN
admet-1622	470	6	.	.	PROPN
admet-1622	470	7	gupta	gupta	PROPN
admet-1622	470	8	,	,	PUNCT
admet-1622	470	9	t.	t.	PROPN
admet-1622	470	10	parikh	parikh	PROPN
admet-1622	470	11	,	,	PUNCT
admet-1622	470	12	a.k	a.k	PROPN
admet-1622	470	13	.	.	PROPN
admet-1622	470	14	meena	meena	PROPN
admet-1622	470	15	,	,	PUNCT
admet-1622	470	16	n.	n.	PROPN
admet-1622	470	17	mahajan	mahajan	PROPN
admet-1622	470	18	,	,	PUNCT
admet-1622	470	19	i.	i.	PROPN
admet-1622	470	20	vitez	vitez	PROPN
admet-1622	470	21	,	,	PUNCT
admet-1622	470	22	a.t	a.t	PROPN
admet-1622	470	23	.	.	PUNCT
admet-1622	470	24	serajuddin	serajuddin	PROPN
admet-1622	470	25	.	.	PUNCT
admet-1622	471	1	effect	effect	NOUN
admet-1622	471	2	of	of	ADP
admet-1622	471	3	carbamazepine	carbamazepine	NOUN
admet-1622	471	4	on	on	ADP
admet-1622	471	5	viscoelastic	viscoelastic	ADJ
admet-1622	471	6	properties	property	NOUN
admet-1622	471	7	and	and	CCONJ
admet-1622	471	8	hot	hot	ADJ
admet-1622	471	9	melt	melt	NOUN
admet-1622	471	10	extrudability	extrudability	NOUN
admet-1622	471	11	of	of	ADP
admet-1622	471	12	soluplus	soluplus	ADJ
admet-1622	471	13	®	®	NOUN
admet-1622	471	14	.	.	PUNCT
admet-1622	472	1	international	international	ADJ
admet-1622	472	2	journal	journal	PROPN
admet-1622	472	3	of	of	ADP
admet-1622	472	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	472	5	478	478	NUM
admet-1622	472	6	(	(	PUNCT
admet-1622	472	7	2015	2015	NUM
admet-1622	472	8	)	)	PUNCT
admet-1622	472	9	232	232	NUM
admet-1622	472	10	-	-	SYM
admet-1622	472	11	239	239	NUM
admet-1622	472	12	.	.	PUNCT
admet-1622	473	1	https://doi.org/10.1016/j.ijpharm.2014.11.025	https://doi.org/10.1016/j.ijpharm.2014.11.025	PROPN
admet-1622	473	2	[	[	X
admet-1622	473	3	36	36	NUM
admet-1622	473	4	]	]	X
admet-1622	473	5	n.l	n.l	PROPN
admet-1622	473	6	.	.	PROPN
admet-1622	473	7	funk	funk	PROPN
admet-1622	473	8	,	,	PUNCT
admet-1622	473	9	s.	s.	PROPN
admet-1622	473	10	fantaus	fantaus	PROPN
admet-1622	473	11	,	,	PUNCT
admet-1622	473	12	r.c.r	r.c.r	PROPN
admet-1622	473	13	.	.	PROPN
admet-1622	473	14	beck	beck	PROPN
admet-1622	473	15	.	.	PUNCT
admet-1622	474	1	immediate	immediate	ADJ
admet-1622	474	2	release	release	NOUN
admet-1622	474	3	3d	3d	NUM
admet-1622	474	4	printed	print	VERB
admet-1622	474	5	oral	oral	ADJ
admet-1622	474	6	dosage	dosage	NOUN
admet-1622	474	7	forms	form	NOUN
admet-1622	474	8	:	:	PUNCT
admet-1622	474	9	how	how	SCONJ
admet-1622	474	10	different	different	ADJ
admet-1622	474	11	polymers	polymer	NOUN
admet-1622	474	12	have	have	AUX
admet-1622	474	13	been	be	AUX
admet-1622	474	14	explored	explore	VERB
admet-1622	474	15	to	to	PART
admet-1622	474	16	reach	reach	VERB
admet-1622	474	17	suitable	suitable	ADJ
admet-1622	474	18	drug	drug	NOUN
admet-1622	474	19	release	release	NOUN
admet-1622	474	20	behaviour	behaviour	NOUN
admet-1622	474	21	.	.	PUNCT
admet-1622	475	1	international	international	ADJ
admet-1622	475	2	journal	journal	PROPN
admet-1622	475	3	of	of	ADP
admet-1622	475	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	475	5	(	(	PUNCT
admet-1622	475	6	2022	2022	NUM
admet-1622	475	7	)	)	PUNCT
admet-1622	475	8	122066	122066	NUM
admet-1622	475	9	.	.	PUNCT
admet-1622	476	1	https://doi.org/10.1016/j.ijpharm.2022.122066	https://doi.org/10.1016/j.ijpharm.2022.122066	PROPN
admet-1622	477	1	[	[	X
admet-1622	477	2	37	37	NUM
admet-1622	477	3	]	]	PUNCT
admet-1622	477	4	s.	s.	PROPN
admet-1622	477	5	thakral	thakral	PROPN
admet-1622	477	6	,	,	PUNCT
admet-1622	477	7	n.k	n.k	PROPN
admet-1622	477	8	.	.	NOUN
admet-1622	477	9	thakral	thakral	ADJ
admet-1622	477	10	,	,	PUNCT
admet-1622	477	11	d.k	d.k	PROPN
admet-1622	477	12	.	.	PROPN
admet-1622	477	13	majumdar	majumdar	PROPN
admet-1622	477	14	.	.	PUNCT
admet-1622	478	1	eudragit	eudragit	PROPN
admet-1622	478	2	:	:	PUNCT
admet-1622	478	3	a	a	DET
admet-1622	478	4	technology	technology	NOUN
admet-1622	478	5	evaluation	evaluation	NOUN
admet-1622	478	6	.	.	PUNCT
admet-1622	479	1	expert	expert	NOUN
admet-1622	479	2	opin	opin	NOUN
admet-1622	479	3	drug	drug	NOUN
admet-1622	479	4	deliv	deliv	VERB
admet-1622	479	5	10	10	NUM
admet-1622	479	6	(	(	PUNCT
admet-1622	479	7	2013	2013	NUM
admet-1622	479	8	)	)	PUNCT
admet-1622	479	9	131	131	NUM
admet-1622	479	10	-	-	SYM
admet-1622	479	11	149	149	NUM
admet-1622	479	12	.	.	PUNCT
admet-1622	480	1	https://doi.org/10.1517/17425247.2013.736962	https://doi.org/10.1517/17425247.2013.736962	PROPN
admet-1622	480	2	.	.	PUNCT
admet-1622	481	1	[	[	X
admet-1622	481	2	38	38	NUM
admet-1622	481	3	]	]	X
admet-1622	481	4	h.e	h.e	PROPN
admet-1622	481	5	.	.	PROPN
admet-1622	481	6	gültekin	gültekin	PROPN
admet-1622	481	7	,	,	PUNCT
admet-1622	481	8	s.	s.	PROPN
admet-1622	481	9	tort	tort	PROPN
admet-1622	481	10	,	,	PUNCT
admet-1622	481	11	f.	f.	PROPN
admet-1622	481	12	acartürk	acartürk	PROPN
admet-1622	481	13	.	.	PUNCT
admet-1622	482	1	an	an	DET
admet-1622	482	2	effective	effective	ADJ
admet-1622	482	3	technology	technology	NOUN
admet-1622	482	4	for	for	ADP
admet-1622	482	5	the	the	DET
admet-1622	482	6	development	development	NOUN
admet-1622	482	7	of	of	ADP
admet-1622	482	8	immediate	immediate	ADJ
admet-1622	482	9	release	release	NOUN
admet-1622	482	10	solid	solid	ADJ
admet-1622	482	11	dosage	dosage	NOUN
admet-1622	482	12	forms	form	NOUN
admet-1622	482	13	containing	contain	VERB
admet-1622	482	14	low	low	ADJ
admet-1622	482	15	-	-	PUNCT
admet-1622	482	16	dose	dose	NOUN
admet-1622	482	17	drug	drug	NOUN
admet-1622	482	18	:	:	PUNCT
admet-1622	482	19	fused	fuse	VERB
admet-1622	482	20	deposition	deposition	NOUN
admet-1622	482	21	modeling	model	VERB
admet-1622	482	22	3d	3d	NUM
admet-1622	482	23	printing	printing	NOUN
admet-1622	482	24	.	.	PUNCT
admet-1622	483	1	pharmaceutical	pharmaceutical	PROPN
admet-1622	483	2	research	research	NOUN
admet-1622	483	3	36	36	NUM
admet-1622	483	4	(	(	PUNCT
admet-1622	483	5	2019	2019	NUM
admet-1622	483	6	)	)	PUNCT
admet-1622	483	7	1	1	NUM
admet-1622	483	8	-	-	SYM
admet-1622	483	9	13	13	NUM
admet-1622	483	10	.	.	PUNCT
admet-1622	484	1	https://doi.org/10.1007/s11095-019-2655-y	https://doi.org/10.1007/s11095-019-2655-y	X
admet-1622	485	1	[	[	X
admet-1622	485	2	39	39	NUM
admet-1622	485	3	]	]	PUNCT
admet-1622	485	4	k.	k.	PROPN
admet-1622	485	5	pietrzak	pietrzak	PROPN
admet-1622	485	6	,	,	PUNCT
admet-1622	485	7	a.	a.	PROPN
admet-1622	485	8	isreb	isreb	PROPN
admet-1622	485	9	,	,	PUNCT
admet-1622	485	10	m.a	m.a	PROPN
admet-1622	485	11	.	.	PROPN
admet-1622	485	12	alhnan	alhnan	PROPN
admet-1622	485	13	.	.	PUNCT
admet-1622	486	1	a	a	DET
admet-1622	486	2	flexible	flexible	ADJ
admet-1622	486	3	-	-	PUNCT
admet-1622	486	4	dose	dose	NOUN
admet-1622	486	5	dispenser	dispenser	NOUN
admet-1622	486	6	for	for	ADP
admet-1622	486	7	immediate	immediate	ADJ
admet-1622	486	8	and	and	CCONJ
admet-1622	486	9	extended	extended	ADJ
admet-1622	486	10	release	release	NOUN
admet-1622	486	11	3d	3d	NUM
admet-1622	486	12	printed	print	VERB
admet-1622	486	13	tablets	tablet	NOUN
admet-1622	486	14	.	.	PUNCT
admet-1622	487	1	european	european	PROPN
admet-1622	487	2	journal	journal	PROPN
admet-1622	487	3	of	of	ADP
admet-1622	487	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	487	5	biopharmaceutics	biopharmaceutics	NOUN
admet-1622	487	6	96	96	NUM
admet-1622	487	7	(	(	PUNCT
admet-1622	487	8	2015	2015	NUM
admet-1622	487	9	)	)	PUNCT
admet-1622	487	10	380	380	NUM
admet-1622	487	11	-	-	SYM
admet-1622	487	12	387	387	NUM
admet-1622	487	13	.	.	PUNCT
admet-1622	488	1	https://doi.org/10.1016/j.ejpb.2015.07.027	https://doi.org/10.1016/j.ejpb.2015.07.027	PROPN
admet-1622	489	1	[	[	X
admet-1622	489	2	40	40	NUM
admet-1622	489	3	]	]	X
admet-1622	489	4	y.m	y.m	PROPN
admet-1622	489	5	.	.	PROPN
admet-1622	489	6	than	than	ADP
admet-1622	489	7	,	,	PUNCT
admet-1622	489	8	v.	v.	PROPN
admet-1622	489	9	titapiwatanakun	titapiwatanakun	NOUN
admet-1622	489	10	.	.	PUNCT
admet-1622	490	1	tailoring	tailor	VERB
admet-1622	490	2	immediate	immediate	ADJ
admet-1622	490	3	release	release	NOUN
admet-1622	490	4	fdm	fdm	NOUN
admet-1622	490	5	3d	3d	NUM
admet-1622	490	6	printed	print	VERB
admet-1622	490	7	tablets	tablet	NOUN
admet-1622	490	8	using	use	VERB
admet-1622	490	9	a	a	DET
admet-1622	490	10	quality	quality	NOUN
admet-1622	490	11	by	by	ADP
admet-1622	490	12	design	design	NOUN
admet-1622	490	13	(	(	PUNCT
admet-1622	490	14	qbd	qbd	NOUN
admet-1622	490	15	)	)	PUNCT
admet-1622	490	16	approach	approach	NOUN
admet-1622	490	17	.	.	PUNCT
admet-1622	491	1	international	international	ADJ
admet-1622	491	2	journal	journal	PROPN
admet-1622	491	3	of	of	ADP
admet-1622	491	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	491	5	599	599	NUM
admet-1622	491	6	(	(	PUNCT
admet-1622	491	7	2021	2021	NUM
admet-1622	491	8	)	)	PUNCT
admet-1622	491	9	120402	120402	NUM
admet-1622	491	10	.	.	PUNCT
admet-1622	492	1	https://doi.org/10.1016/j.ijpharm.2021.120402	https://doi.org/10.1016/j.ijpharm.2021.120402	PROPN
admet-1622	493	1	[	[	X
admet-1622	493	2	41	41	NUM
admet-1622	493	3	]	]	PUNCT
admet-1622	493	4	x.	x.	NOUN
admet-1622	493	5	lin	lin	PROPN
admet-1622	493	6	,	,	PUNCT
admet-1622	493	7	l.	l.	PROPN
admet-1622	493	8	su	su	PROPN
admet-1622	493	9	,	,	PUNCT
admet-1622	493	10	n.	n.	PROPN
admet-1622	493	11	li	li	PROPN
admet-1622	493	12	,	,	PUNCT
admet-1622	493	13	y.	y.	PROPN
admet-1622	493	14	hu	hu	PROPN
admet-1622	493	15	,	,	PUNCT
admet-1622	493	16	g.	g.	PROPN
admet-1622	493	17	tang	tang	PROPN
admet-1622	493	18	,	,	PUNCT
admet-1622	493	19	l.	l.	PROPN
admet-1622	493	20	liu	liu	PROPN
admet-1622	493	21	,	,	PUNCT
admet-1622	493	22	h.	h.	PROPN
admet-1622	493	23	li	li	PROPN
admet-1622	493	24	,	,	PUNCT
admet-1622	493	25	z.	z.	PROPN
admet-1622	493	26	yang	yang	PROPN
admet-1622	493	27	.	.	PUNCT
admet-1622	494	1	understanding	understand	VERB
admet-1622	494	2	the	the	DET
admet-1622	494	3	mechanism	mechanism	NOUN
admet-1622	494	4	of	of	ADP
admet-1622	494	5	dissolution	dissolution	NOUN
admet-1622	494	6	enhancement	enhancement	NOUN
admet-1622	494	7	for	for	ADP
admet-1622	494	8	poorly	poorly	ADV
admet-1622	494	9	water	water	NOUN
admet-1622	494	10	-	-	PUNCT
admet-1622	494	11	soluble	soluble	ADJ
admet-1622	494	12	drugs	drug	NOUN
admet-1622	494	13	by	by	ADP
admet-1622	494	14	solid	solid	ADJ
admet-1622	494	15	dispersions	dispersion	NOUN
admet-1622	494	16	containing	contain	VERB
admet-1622	494	17	eudragit	eudragit	NOUN
admet-1622	494	18	®	®	PROPN
admet-1622	494	19	e	e	X
admet-1622	494	20	po	po	PROPN
admet-1622	494	21	.	.	PROPN
admet-1622	494	22	journal	journal	PROPN
admet-1622	494	23	of	of	ADP
admet-1622	494	24	drug	drug	NOUN
admet-1622	494	25	delivery	delivery	NOUN
admet-1622	494	26	science	science	NOUN
admet-1622	494	27	technology	technology	NOUN
admet-1622	494	28	48	48	NUM
admet-1622	494	29	(	(	PUNCT
admet-1622	494	30	2018	2018	NUM
admet-1622	494	31	)	)	PUNCT
admet-1622	494	32	328	328	NUM
admet-1622	494	33	-	-	SYM
admet-1622	494	34	337	337	NUM
admet-1622	494	35	.	.	PUNCT
admet-1622	495	1	https://doi.org/10.1016/j.jddst.2018.10.008	https://doi.org/10.1016/j.jddst.2018.10.008	NOUN
admet-1622	496	1	[	[	X
admet-1622	496	2	42	42	NUM
admet-1622	496	3	]	]	PUNCT
admet-1622	496	4	h.	h.	PROPN
admet-1622	496	5	liu	liu	PROPN
admet-1622	496	6	,	,	PUNCT
admet-1622	496	7	p.	p.	PROPN
admet-1622	496	8	wang	wang	PROPN
admet-1622	496	9	,	,	PUNCT
admet-1622	496	10	x.	x.	PROPN
admet-1622	496	11	zhang	zhang	PROPN
admet-1622	496	12	,	,	PUNCT
admet-1622	496	13	f.	f.	PROPN
admet-1622	496	14	shen	shen	PROPN
admet-1622	496	15	,	,	PUNCT
admet-1622	496	16	c.g	c.g	PROPN
admet-1622	496	17	.	.	PROPN
admet-1622	496	18	gogos	gogos	PROPN
admet-1622	496	19	.	.	PUNCT
admet-1622	497	1	effects	effect	NOUN
admet-1622	497	2	of	of	ADP
admet-1622	497	3	extrusion	extrusion	NOUN
admet-1622	497	4	process	process	NOUN
admet-1622	497	5	parameters	parameter	NOUN
admet-1622	497	6	on	on	ADP
admet-1622	497	7	the	the	DET
admet-1622	497	8	dissolution	dissolution	ADJ
admet-1622	497	9	behavior	behavior	NOUN
admet-1622	497	10	of	of	ADP
admet-1622	497	11	indomethacin	indomethacin	NOUN
admet-1622	497	12	in	in	ADP
admet-1622	497	13	eudragit	eudragit	ADJ
admet-1622	497	14	®	®	NOUN
admet-1622	497	15	e	e	X
admet-1622	497	16	po	po	X
admet-1622	497	17	solid	solid	ADJ
admet-1622	497	18	dispersions	dispersion	NOUN
admet-1622	497	19	.	.	PUNCT
admet-1622	498	1	international	international	ADJ
admet-1622	498	2	journal	journal	PROPN
admet-1622	498	3	of	of	ADP
admet-1622	498	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	498	5	383	383	NUM
admet-1622	498	6	(	(	PUNCT
admet-1622	498	7	2010	2010	NUM
admet-1622	498	8	)	)	PUNCT
admet-1622	498	9	161	161	NUM
admet-1622	498	10	-	-	SYM
admet-1622	498	11	169	169	NUM
admet-1622	498	12	.	.	PUNCT
admet-1622	499	1	https://doi.org/10.1016/j.ijpharm.2009.09.003	https://doi.org/10.1016/j.ijpharm.2009.09.003	NOUN
admet-1622	499	2	[	[	X
admet-1622	499	3	43	43	NUM
admet-1622	499	4	]	]	X
admet-1622	499	5	m.	m.	NOUN
admet-1622	499	6	alhijjaj	alhijjaj	PROPN
admet-1622	499	7	,	,	PUNCT
admet-1622	499	8	p.	p.	PROPN
admet-1622	499	9	belton	belton	PROPN
admet-1622	499	10	,	,	PUNCT
admet-1622	499	11	s.	s.	PROPN
admet-1622	499	12	qi	qi	PROPN
admet-1622	499	13	.	.	PUNCT
admet-1622	500	1	an	an	DET
admet-1622	500	2	investigation	investigation	NOUN
admet-1622	500	3	into	into	ADP
admet-1622	500	4	the	the	DET
admet-1622	500	5	use	use	NOUN
admet-1622	500	6	of	of	ADP
admet-1622	500	7	polymer	polymer	NOUN
admet-1622	500	8	blends	blend	NOUN
admet-1622	500	9	to	to	PART
admet-1622	500	10	improve	improve	VERB
admet-1622	500	11	the	the	DET
admet-1622	500	12	printability	printability	NOUN
admet-1622	500	13	of	of	ADP
admet-1622	500	14	and	and	CCONJ
admet-1622	500	15	regulate	regulate	VERB
admet-1622	500	16	drug	drug	NOUN
admet-1622	500	17	release	release	NOUN
admet-1622	500	18	from	from	ADP
admet-1622	500	19	pharmaceutical	pharmaceutical	ADJ
admet-1622	500	20	solid	solid	ADJ
admet-1622	500	21	dispersions	dispersion	NOUN
admet-1622	500	22	prepared	prepare	VERB
admet-1622	500	23	via	via	ADP
admet-1622	500	24	fused	fuse	VERB
admet-1622	500	25	deposition	deposition	NOUN
admet-1622	500	26	modeling	modeling	NOUN
admet-1622	500	27	(	(	PUNCT
admet-1622	500	28	fdm	fdm	NOUN
admet-1622	500	29	)	)	PUNCT
admet-1622	500	30	3d	3d	NUM
admet-1622	500	31	printing	printing	NOUN
admet-1622	500	32	.	.	PUNCT
admet-1622	501	1	european	european	PROPN
admet-1622	501	2	journal	journal	PROPN
admet-1622	501	3	of	of	ADP
admet-1622	501	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	501	5	biopharmaceutics	biopharmaceutics	NOUN
admet-1622	501	6	108	108	NUM
admet-1622	501	7	(	(	PUNCT
admet-1622	501	8	2016	2016	NUM
admet-1622	501	9	)	)	PUNCT
admet-1622	501	10	111125	111125	NUM
admet-1622	501	11	.	.	PUNCT
admet-1622	502	1	https://doi.org/10.1016/j.ejpb.2016.08.016	https://doi.org/10.1016/j.ejpb.2016.08.016	PROPN
admet-1622	502	2	[	[	X
admet-1622	502	3	44	44	NUM
admet-1622	502	4	]	]	PUNCT
admet-1622	502	5	x.	x.	NOUN
admet-1622	502	6	wang	wang	PROPN
admet-1622	502	7	,	,	PUNCT
admet-1622	502	8	y.	y.	PROPN
admet-1622	502	9	zhu	zhu	PROPN
admet-1622	502	10	,	,	PUNCT
admet-1622	502	11	x.	x.	PROPN
admet-1622	502	12	zhao	zhao	PROPN
admet-1622	502	13	,	,	PUNCT
admet-1622	502	14	s.	s.	PROPN
admet-1622	502	15	zhang	zhang	PROPN
admet-1622	502	16	,	,	PUNCT
admet-1622	502	17	m.	m.	PROPN
admet-1622	502	18	cao	cao	PROPN
admet-1622	502	19	,	,	PUNCT
admet-1622	502	20	x.	x.	PROPN
admet-1622	502	21	wang	wang	PROPN
admet-1622	502	22	,	,	PUNCT
admet-1622	502	23	w.	w.	PROPN
admet-1622	502	24	li	li	PROPN
admet-1622	502	25	.	.	PROPN
admet-1622	502	26	development	development	NOUN
admet-1622	502	27	and	and	CCONJ
admet-1622	502	28	characterization	characterization	NOUN
admet-1622	502	29	of	of	ADP
admet-1622	502	30	an	an	DET
admet-1622	502	31	amorphous	amorphous	ADJ
admet-1622	502	32	curcumin	curcumin	NOUN
admet-1622	502	33	-	-	PUNCT
admet-1622	502	34	eudragit	eudragit	NOUN
admet-1622	502	35	®	®	NOUN
admet-1622	502	36	e100	e100	PROPN
admet-1622	502	37	solid	solid	ADJ
admet-1622	502	38	dispersions	dispersion	NOUN
admet-1622	502	39	with	with	ADP
admet-1622	502	40	improved	improved	ADJ
admet-1622	502	41	solubility	solubility	NOUN
admet-1622	502	42	,	,	PUNCT
admet-1622	502	43	stability	stability	NOUN
admet-1622	502	44	,	,	PUNCT
admet-1622	502	45	and	and	CCONJ
admet-1622	502	46	pharmacokinetic	pharmacokinetic	ADJ
admet-1622	502	47	properties	property	NOUN
admet-1622	502	48	.	.	PUNCT
admet-1622	503	1	pharmaceutical	pharmaceutical	NOUN
admet-1622	503	2	development	development	NOUN
admet-1622	503	3	technology	technology	NOUN
admet-1622	503	4	(	(	PUNCT
admet-1622	503	5	2022	2022	NUM
admet-1622	503	6	)	)	PUNCT
admet-1622	503	7	1	1	NUM
admet-1622	503	8	-	-	SYM
admet-1622	503	9	16	16	NUM
admet-1622	503	10	.	.	PUNCT
admet-1622	503	11	https://doi.org/10.1080/10837450.2022.2141778	https://doi.org/10.1080/10837450.2022.2141778	PUNCT
admet-1622	504	1	[	[	X
admet-1622	504	2	45	45	NUM
admet-1622	504	3	]	]	X
admet-1622	504	4	n.	n.	PROPN
admet-1622	504	5	washington	washington	PROPN
admet-1622	504	6	,	,	PUNCT
admet-1622	504	7	c.	c.	PROPN
admet-1622	504	8	washington	washington	PROPN
admet-1622	504	9	,	,	PUNCT
admet-1622	504	10	c.	c.	PROPN
admet-1622	504	11	wilson	wilson	PROPN
admet-1622	504	12	,	,	PUNCT
admet-1622	504	13	physiological	physiological	ADJ
admet-1622	504	14	pharmaceutics	pharmaceutic	NOUN
admet-1622	504	15	:	:	PUNCT
admet-1622	504	16	barriers	barrier	NOUN
admet-1622	504	17	to	to	ADP
admet-1622	504	18	drug	drug	NOUN
admet-1622	504	19	absorption	absorption	NOUN
admet-1622	504	20	,	,	PUNCT
admet-1622	504	21	crc	crc	NOUN
admet-1622	504	22	press	press	NOUN
admet-1622	504	23	,	,	PUNCT
admet-1622	504	24	2000	2000	NUM
admet-1622	504	25	,	,	PUNCT
admet-1622	504	26	0429204590	0429204590	NUM
admet-1622	504	27	.	.	PUNCT
admet-1622	505	1	[	[	X
admet-1622	505	2	46	46	NUM
admet-1622	505	3	]	]	X
admet-1622	505	4	y.	y.	PROPN
admet-1622	505	5	yang	yang	PROPN
admet-1622	505	6	,	,	PUNCT
admet-1622	505	7	h.	h.	PROPN
admet-1622	505	8	wang	wang	PROPN
admet-1622	505	9	,	,	PUNCT
admet-1622	505	10	x.	x.	PROPN
admet-1622	505	11	xu	xu	PROPN
admet-1622	505	12	,	,	PUNCT
admet-1622	505	13	g.	g.	PROPN
admet-1622	505	14	yang	yang	PROPN
admet-1622	505	15	.	.	PUNCT
admet-1622	506	1	strategies	strategy	NOUN
admet-1622	506	2	and	and	CCONJ
admet-1622	506	3	mechanisms	mechanism	NOUN
admet-1622	506	4	to	to	PART
admet-1622	506	5	improve	improve	VERB
admet-1622	506	6	the	the	DET
admet-1622	506	7	printability	printability	NOUN
admet-1622	506	8	of	of	ADP
admet-1622	506	9	pharmaceutical	pharmaceutical	ADJ
admet-1622	506	10	polymers	polymer	NOUN
admet-1622	506	11	eudragit	eudragit	VERB
admet-1622	506	12	®	®	NOUN
admet-1622	506	13	epo	epo	NOUN
admet-1622	506	14	and	and	CCONJ
admet-1622	506	15	soluplus	soluplus	ADJ
admet-1622	506	16	®	®	NOUN
admet-1622	506	17	.	.	PUNCT
admet-1622	507	1	international	international	ADJ
admet-1622	507	2	journal	journal	PROPN
admet-1622	507	3	of	of	ADP
admet-1622	507	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	507	5	599	599	NUM
admet-1622	507	6	(	(	PUNCT
admet-1622	507	7	2021	2021	NUM
admet-1622	507	8	)	)	PUNCT
admet-1622	507	9	120410	120410	NUM
admet-1622	507	10	.	.	PUNCT
admet-1622	508	1	https://doi.org/10.1016/j.ijpharm.2021.120410	https://doi.org/10.1016/j.ijpharm.2021.120410	PROPN
admet-1622	508	2	[	[	X
admet-1622	508	3	47	47	NUM
admet-1622	508	4	]	]	PUNCT
admet-1622	508	5	m.	m.	NOUN
admet-1622	508	6	saydam	saydam	NOUN
admet-1622	508	7	,	,	PUNCT
admet-1622	508	8	s.	s.	PROPN
admet-1622	508	9	takka	takka	PROPN
admet-1622	508	10	.	.	PUNCT
admet-1622	509	1	improving	improve	VERB
admet-1622	509	2	the	the	DET
admet-1622	509	3	dissolution	dissolution	NOUN
admet-1622	509	4	of	of	ADP
admet-1622	509	5	a	a	DET
admet-1622	509	6	water	water	NOUN
admet-1622	509	7	-	-	PUNCT
admet-1622	509	8	insoluble	insoluble	ADJ
admet-1622	509	9	orphan	orphan	NOUN
admet-1622	509	10	drug	drug	NOUN
admet-1622	509	11	through	through	ADP
admet-1622	509	12	a	a	DET
admet-1622	509	13	fused	fuse	VERB
admet-1622	509	14	deposition	deposition	NOUN
admet-1622	509	15	modelling	model	VERB
admet-1622	509	16	3	3	NUM
admet-1622	509	17	-	-	PUNCT
admet-1622	509	18	dimensional	dimensional	ADJ
admet-1622	509	19	printing	printing	NOUN
admet-1622	509	20	technology	technology	NOUN
admet-1622	509	21	approach	approach	NOUN
admet-1622	509	22	.	.	PUNCT
admet-1622	510	1	european	european	PROPN
admet-1622	510	2	journal	journal	PROPN
admet-1622	510	3	of	of	ADP
admet-1622	510	4	pharmaceutical	pharmaceutical	PROPN
admet-1622	510	5	sciences	science	NOUN
admet-1622	510	6	152	152	NUM
admet-1622	510	7	(	(	PUNCT
admet-1622	510	8	2020	2020	NUM
admet-1622	510	9	)	)	PUNCT
admet-1622	510	10	105426	105426	NUM
admet-1622	510	11	.	.	PUNCT
admet-1622	511	1	https://doi.org/10.1016/j.ejps.2020.105426	https://doi.org/10.1016/j.ejps.2020.105426	PROPN
admet-1622	512	1	[	[	X
admet-1622	512	2	48	48	NUM
admet-1622	512	3	]	]	X
admet-1622	512	4	t.c	t.c	PROPN
admet-1622	512	5	.	.	PROPN
admet-1622	512	6	okwuosa	okwuosa	PROPN
admet-1622	512	7	,	,	PUNCT
admet-1622	512	8	d.	d.	PROPN
admet-1622	512	9	stefaniak	stefaniak	PROPN
admet-1622	512	10	,	,	PUNCT
admet-1622	512	11	b.	b.	PROPN
admet-1622	512	12	arafat	arafat	PROPN
admet-1622	512	13	,	,	PUNCT
admet-1622	512	14	a.	a.	PROPN
admet-1622	512	15	isreb	isreb	PROPN
admet-1622	512	16	,	,	PUNCT
admet-1622	512	17	k.-w	k.-w	PROPN
admet-1622	512	18	.	.	PUNCT
admet-1622	513	1	wan	wan	PROPN
admet-1622	513	2	,	,	PUNCT
admet-1622	513	3	m.a	m.a	PROPN
admet-1622	513	4	.	.	PROPN
admet-1622	513	5	alhnan	alhnan	PROPN
admet-1622	513	6	.	.	PUNCT
admet-1622	514	1	a	a	DET
admet-1622	514	2	lower	low	ADJ
admet-1622	514	3	temperature	temperature	NOUN
admet-1622	514	4	fdm	fdm	NOUN
admet-1622	514	5	3d	3d	NOUN
admet-1622	514	6	printing	printing	NOUN
admet-1622	514	7	for	for	ADP
admet-1622	514	8	the	the	DET
admet-1622	514	9	manufacture	manufacture	NOUN
admet-1622	514	10	of	of	ADP
admet-1622	514	11	patient	patient	NOUN
admet-1622	514	12	-	-	PUNCT
admet-1622	514	13	specific	specific	ADJ
admet-1622	514	14	immediate	immediate	ADJ
admet-1622	514	15	release	release	NOUN
admet-1622	514	16	tablets	tablet	NOUN
admet-1622	514	17	.	.	PUNCT
admet-1622	515	1	pharmaceutical	pharmaceutical	PROPN
admet-1622	515	2	research	research	NOUN
admet-1622	515	3	33	33	NUM
admet-1622	515	4	(	(	PUNCT
admet-1622	515	5	2016	2016	NUM
admet-1622	515	6	)	)	PUNCT
admet-1622	515	7	2704	2704	NUM
admet-1622	515	8	-	-	SYM
admet-1622	515	9	2712	2712	NUM
admet-1622	515	10	.	.	PUNCT
admet-1622	516	1	https://doi.org/10.1007/s11095-016-1995-0	https://doi.org/10.1007/s11095-016-1995-0	NUM
admet-1622	517	1	[	[	X
admet-1622	517	2	49	49	NUM
admet-1622	517	3	]	]	PUNCT
admet-1622	517	4	m.	m.	PROPN
admet-1622	517	5	sadia	sadia	PROPN
admet-1622	517	6	,	,	PUNCT
admet-1622	517	7	a.	a.	PROPN
admet-1622	517	8	sośnicka	sośnicka	PROPN
admet-1622	517	9	,	,	PUNCT
admet-1622	517	10	b.	b.	PROPN
admet-1622	517	11	arafat	arafat	PROPN
admet-1622	517	12	,	,	PUNCT
admet-1622	517	13	a.	a.	PROPN
admet-1622	517	14	isreb	isreb	PROPN
admet-1622	517	15	,	,	PUNCT
admet-1622	517	16	w.	w.	PROPN
admet-1622	517	17	ahmed	ahmed	PROPN
admet-1622	517	18	,	,	PUNCT
admet-1622	517	19	a.	a.	PROPN
admet-1622	517	20	kelarakis	kelarakis	PROPN
admet-1622	517	21	,	,	PUNCT
admet-1622	517	22	m.a	m.a	PROPN
admet-1622	517	23	.	.	PROPN
admet-1622	517	24	alhnan	alhnan	PROPN
admet-1622	517	25	.	.	PUNCT
admet-1622	518	1	adaptation	adaptation	NOUN
admet-1622	518	2	of	of	ADP
admet-1622	518	3	pharmaceutical	pharmaceutical	ADJ
admet-1622	518	4	excipients	excipient	NOUN
admet-1622	518	5	to	to	PART
admet-1622	518	6	fdm	fdm	VERB
admet-1622	518	7	3d	3d	NOUN
admet-1622	518	8	printing	printing	NOUN
admet-1622	518	9	for	for	ADP
admet-1622	518	10	the	the	DET
admet-1622	518	11	fabrication	fabrication	NOUN
admet-1622	518	12	of	of	ADP
admet-1622	518	13	patient	patient	NOUN
admet-1622	518	14	-	-	PUNCT
admet-1622	518	15	tailored	tailor	VERB
admet-1622	518	16	immediate	immediate	ADJ
admet-1622	518	17	release	release	NOUN
admet-1622	518	18	tablets	tablet	NOUN
admet-1622	518	19	.	.	PUNCT
admet-1622	519	1	international	international	ADJ
admet-1622	519	2	journal	journal	PROPN
admet-1622	519	3	of	of	ADP
admet-1622	519	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	519	5	513	513	NUM
admet-1622	519	6	(	(	PUNCT
admet-1622	519	7	2016	2016	NUM
admet-1622	519	8	)	)	PUNCT
admet-1622	519	9	659	659	NUM
admet-1622	519	10	-	-	SYM
admet-1622	519	11	668	668	NUM
admet-1622	519	12	.	.	PUNCT
admet-1622	520	1	https://doi.org/10.1016/j.ijpharm.2016.09.050	https://doi.org/10.1016/j.ijpharm.2016.09.050	PRON
admet-1622	521	1	[	[	X
admet-1622	521	2	50	50	NUM
admet-1622	521	3	]	]	PUNCT
admet-1622	521	4	m.	m.	NOUN
admet-1622	521	5	fanous	fanous	ADJ
admet-1622	521	6	,	,	PUNCT
admet-1622	521	7	m.	m.	NOUN
admet-1622	521	8	bitar	bitar	PROPN
admet-1622	521	9	,	,	PUNCT
admet-1622	521	10	s.	s.	PROPN
admet-1622	521	11	gold	gold	PROPN
admet-1622	521	12	,	,	PUNCT
admet-1622	521	13	a.	a.	PROPN
admet-1622	521	14	sobczuk	sobczuk	PROPN
admet-1622	521	15	,	,	PUNCT
admet-1622	521	16	s.	s.	PROPN
admet-1622	521	17	hirsch	hirsch	PROPN
admet-1622	521	18	,	,	PUNCT
admet-1622	521	19	j.	j.	PROPN
admet-1622	521	20	ogorka	ogorka	PROPN
admet-1622	521	21	,	,	PUNCT
admet-1622	521	22	g.	g.	PROPN
admet-1622	521	23	imanidis	imanidis	PROPN
admet-1622	521	24	.	.	PUNCT
admet-1622	522	1	development	development	NOUN
admet-1622	522	2	of	of	ADP
admet-1622	522	3	immediate	immediate	ADJ
admet-1622	522	4	release	release	NOUN
admet-1622	522	5	3d	3d	NOUN
admet-1622	522	6	-	-	PUNCT
admet-1622	522	7	printed	print	VERB
admet-1622	522	8	dosage	dosage	NOUN
admet-1622	522	9	forms	form	NOUN
admet-1622	522	10	for	for	ADP
admet-1622	522	11	a	a	DET
admet-1622	522	12	poorly	poorly	ADV
admet-1622	522	13	water	water	NOUN
admet-1622	522	14	-	-	PUNCT
admet-1622	522	15	soluble	soluble	ADJ
admet-1622	522	16	drug	drug	NOUN
admet-1622	522	17	by	by	ADP
admet-1622	522	18	fused	fuse	VERB
admet-1622	522	19	deposition	deposition	NOUN
admet-1622	522	20	modeling	modeling	NOUN
admet-1622	522	21	:	:	PUNCT
admet-1622	522	22	study	study	NOUN
admet-1622	522	23	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	522	24	https://doi.org/10.1016/j.ejps.2017.10.034	https://doi.org/10.1016/j.ejps.2017.10.034	NUM
admet-1622	522	25	https://doi.org/10.1016/j.ejps.2017.10.034	https://doi.org/10.1016/j.ejps.2017.10.034	NUM
admet-1622	522	26	https://doi.org/10.1016/j.ijpharm.2014.11.025	https://doi.org/10.1016/j.ijpharm.2014.11.025	PROPN
admet-1622	522	27	https://doi.org/10.1016/j.ijpharm.2022.122066	https://doi.org/10.1016/j.ijpharm.2022.122066	NOUN
admet-1622	522	28	https://doi.org/10.1517/17425247.2013.736962	https://doi.org/10.1517/17425247.2013.736962	PROPN
admet-1622	522	29	https://doi.org/10.1007/s11095-019-2655-y	https://doi.org/10.1007/s11095-019-2655-y	PROPN
admet-1622	522	30	https://doi.org/10.1016/j.ejpb.2015.07.027	https://doi.org/10.1016/j.ejpb.2015.07.027	PROPN
admet-1622	522	31	https://doi.org/10.1016/j.ijpharm.2021.120402	https://doi.org/10.1016/j.ijpharm.2021.120402	PROPN
admet-1622	522	32	https://doi.org/10.1016/j.jddst.2018.10.008	https://doi.org/10.1016/j.jddst.2018.10.008	VERB
admet-1622	522	33	https://doi.org/10.1016/j.ijpharm.2009.09.003	https://doi.org/10.1016/j.ijpharm.2009.09.003	NOUN
admet-1622	522	34	https://doi.org/10.1016/j.ejpb.2016.08.016	https://doi.org/10.1016/j.ejpb.2016.08.016	PROPN
admet-1622	522	35	https://doi.org/10.1080/10837450.2022.2141778	https://doi.org/10.1080/10837450.2022.2141778	PROPN
admet-1622	522	36	https://doi.org/10.1080/10837450.2022.2141778	https://doi.org/10.1080/10837450.2022.2141778	PROPN
admet-1622	523	1	https://doi.org/10.1016/j.ijpharm.2021.120410	https://doi.org/10.1016/j.ijpharm.2021.120410	PROPN
admet-1622	523	2	https://doi.org/10.1016/j.ejps.2020.105426	https://doi.org/10.1016/j.ejps.2020.105426	PROPN
admet-1622	523	3	https://doi.org/10.1007/s11095-016-1995-0	https://doi.org/10.1007/s11095-016-1995-0	NUM
admet-1622	524	1	https://doi.org/10.1016/j.ijpharm.2016.09.050	https://doi.org/10.1016/j.ijpharm.2016.09.050	PRON
admet-1622	524	2	https://doi.org/10.1016/j.ijpharm.2016.09.050	https://doi.org/10.1016/j.ijpharm.2016.09.050	PROPN
admet-1622	524	3	abu	abu	PROPN
admet-1622	524	4	t.m	t.m	PROPN
admet-1622	524	5	.	.	PUNCT
admet-1622	525	1	serajuddin	serajuddin	VERB
admet-1622	525	2	admet	admet	PROPN
admet-1622	525	3	&	&	CCONJ
admet-1622	525	4	dmpk	dmpk	PROPN
admet-1622	525	5	11(1	11(1	NUM
admet-1622	525	6	)	)	PUNCT
admet-1622	525	7	(	(	PUNCT
admet-1622	525	8	2023	2023	NUM
admet-1622	525	9	)	)	PUNCT
admet-1622	525	10	33	33	NUM
admet-1622	525	11	-	-	SYM
admet-1622	525	12	55	55	NUM
admet-1622	525	13	54	54	NUM
admet-1622	525	14	of	of	ADP
admet-1622	525	15	morphology	morphology	NOUN
admet-1622	525	16	,	,	PUNCT
admet-1622	525	17	solid	solid	ADJ
admet-1622	525	18	state	state	NOUN
admet-1622	525	19	and	and	CCONJ
admet-1622	525	20	dissolution	dissolution	NOUN
admet-1622	525	21	.	.	PUNCT
admet-1622	526	1	international	international	ADJ
admet-1622	526	2	journal	journal	PROPN
admet-1622	526	3	of	of	ADP
admet-1622	526	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	526	5	599	599	NUM
admet-1622	526	6	(	(	PUNCT
admet-1622	526	7	2021	2021	NUM
admet-1622	526	8	)	)	PUNCT
admet-1622	526	9	120417	120417	NUM
admet-1622	526	10	.	.	PUNCT
admet-1622	527	1	https://doi.org/10.1016/j.ijpharm.2021.120417	https://doi.org/10.1016/j.ijpharm.2021.120417	ADV
admet-1622	527	2	[	[	X
admet-1622	527	3	51	51	NUM
admet-1622	527	4	]	]	X
admet-1622	527	5	h.e	h.e	PROPN
admet-1622	527	6	.	.	PROPN
admet-1622	527	7	gültekin	gültekin	PROPN
admet-1622	527	8	,	,	PUNCT
admet-1622	527	9	s.	s.	PROPN
admet-1622	527	10	tort	tort	PROPN
admet-1622	527	11	,	,	PUNCT
admet-1622	527	12	f.	f.	PROPN
admet-1622	527	13	acartürk	acartürk	PROPN
admet-1622	527	14	.	.	PUNCT
admet-1622	528	1	fabrication	fabrication	NOUN
admet-1622	528	2	of	of	ADP
admet-1622	528	3	three	three	NUM
admet-1622	528	4	dimensional	dimensional	ADJ
admet-1622	528	5	printed	print	VERB
admet-1622	528	6	tablets	tablet	NOUN
admet-1622	528	7	in	in	ADP
admet-1622	528	8	flexible	flexible	ADJ
admet-1622	528	9	doses	dose	NOUN
admet-1622	528	10	:	:	PUNCT
admet-1622	528	11	a	a	DET
admet-1622	528	12	comprehensive	comprehensive	ADJ
admet-1622	528	13	study	study	NOUN
admet-1622	528	14	from	from	ADP
admet-1622	528	15	design	design	NOUN
admet-1622	528	16	to	to	ADP
admet-1622	528	17	evaluation	evaluation	NOUN
admet-1622	528	18	.	.	PUNCT
admet-1622	529	1	journal	journal	NOUN
admet-1622	529	2	of	of	ADP
admet-1622	529	3	drug	drug	NOUN
admet-1622	529	4	delivery	delivery	NOUN
admet-1622	529	5	science	science	NOUN
admet-1622	529	6	technology	technology	NOUN
admet-1622	529	7	74	74	NUM
admet-1622	529	8	(	(	PUNCT
admet-1622	529	9	2022	2022	NUM
admet-1622	529	10	)	)	PUNCT
admet-1622	529	11	103538	103538	NUM
admet-1622	529	12	.	.	PUNCT
admet-1622	530	1	https://doi.org/10.1016/j.jddst.2022.103538	https://doi.org/10.1016/j.jddst.2022.103538	VERB
admet-1622	530	2	[	[	X
admet-1622	530	3	52	52	NUM
admet-1622	530	4	]	]	X
admet-1622	530	5	h.	h.	PROPN
admet-1622	530	6	öblom	öblom	PROPN
admet-1622	530	7	,	,	PUNCT
admet-1622	530	8	j.	j.	PROPN
admet-1622	530	9	zhang	zhang	PROPN
admet-1622	530	10	,	,	PUNCT
admet-1622	530	11	m.	m.	NOUN
admet-1622	530	12	pimparade	pimparade	PROPN
admet-1622	530	13	,	,	PUNCT
admet-1622	530	14	i.	i.	NOUN
admet-1622	530	15	speer	speer	PROPN
admet-1622	530	16	,	,	PUNCT
admet-1622	530	17	m.	m.	NOUN
admet-1622	530	18	preis	preis	PROPN
admet-1622	530	19	,	,	PUNCT
admet-1622	530	20	m.	m.	NOUN
admet-1622	530	21	repka	repka	PROPN
admet-1622	530	22	,	,	PUNCT
admet-1622	530	23	n.	n.	PROPN
admet-1622	530	24	sandler	sandler	PROPN
admet-1622	530	25	.	.	PUNCT
admet-1622	531	1	3d	3d	NUM
admet-1622	531	2	-	-	PUNCT
admet-1622	531	3	printed	print	VERB
admet-1622	531	4	isoniazid	isoniazid	NOUN
admet-1622	531	5	tablets	tablet	NOUN
admet-1622	531	6	for	for	ADP
admet-1622	531	7	the	the	DET
admet-1622	531	8	treatment	treatment	NOUN
admet-1622	531	9	and	and	CCONJ
admet-1622	531	10	prevention	prevention	NOUN
admet-1622	531	11	of	of	ADP
admet-1622	531	12	tuberculosis	tuberculosis	NOUN
admet-1622	531	13	—	—	PUNCT
admet-1622	531	14	personalized	personalized	ADJ
admet-1622	531	15	dosing	dosing	NOUN
admet-1622	531	16	and	and	CCONJ
admet-1622	531	17	drug	drug	NOUN
admet-1622	531	18	release	release	NOUN
admet-1622	531	19	.	.	PUNCT
admet-1622	532	1	aaps	aap	NOUN
admet-1622	532	2	pharmscitech	pharmscitech	VERB
admet-1622	532	3	20	20	NUM
admet-1622	532	4	(	(	PUNCT
admet-1622	532	5	2019	2019	NUM
admet-1622	532	6	)	)	PUNCT
admet-1622	532	7	1	1	NUM
admet-1622	532	8	-	-	SYM
admet-1622	532	9	13	13	NUM
admet-1622	532	10	.	.	PUNCT
admet-1622	533	1	https://doi.org/10.1208/s12249-018-1233-7	https://doi.org/10.1208/s12249-018-1233-7	PROPN
admet-1622	534	1	[	[	X
admet-1622	534	2	53	53	NUM
admet-1622	534	3	]	]	X
admet-1622	534	4	g.	g.	PROPN
admet-1622	534	5	kollamaram	kollamaram	PROPN
admet-1622	534	6	,	,	PUNCT
admet-1622	534	7	d.m	d.m	PROPN
admet-1622	534	8	.	.	PROPN
admet-1622	534	9	croker	croker	PROPN
admet-1622	534	10	,	,	PUNCT
admet-1622	534	11	g.m	g.m	PROPN
admet-1622	534	12	.	.	PROPN
admet-1622	534	13	walker	walker	PROPN
admet-1622	534	14	,	,	PUNCT
admet-1622	534	15	a.	a.	PROPN
admet-1622	534	16	goyanes	goyanes	PROPN
admet-1622	534	17	,	,	PUNCT
admet-1622	534	18	a.w	a.w	PROPN
admet-1622	534	19	.	.	PROPN
admet-1622	534	20	basit	basit	PROPN
admet-1622	534	21	,	,	PUNCT
admet-1622	534	22	s.	s.	PROPN
admet-1622	534	23	gaisford	gaisford	PROPN
admet-1622	534	24	.	.	PUNCT
admet-1622	535	1	low	low	ADJ
admet-1622	535	2	temperature	temperature	NOUN
admet-1622	535	3	fused	fuse	VERB
admet-1622	535	4	deposition	deposition	NOUN
admet-1622	535	5	modeling	modeling	NOUN
admet-1622	535	6	(	(	PUNCT
admet-1622	535	7	fdm	fdm	NOUN
admet-1622	535	8	)	)	PUNCT
admet-1622	535	9	3d	3d	NOUN
admet-1622	535	10	printing	printing	NOUN
admet-1622	535	11	of	of	ADP
admet-1622	535	12	thermolabile	thermolabile	NOUN
admet-1622	535	13	drugs	drug	NOUN
admet-1622	535	14	.	.	PUNCT
admet-1622	536	1	international	international	ADJ
admet-1622	536	2	journal	journal	PROPN
admet-1622	536	3	of	of	ADP
admet-1622	536	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	536	5	545	545	NUM
admet-1622	536	6	(	(	PUNCT
admet-1622	536	7	2018	2018	NUM
admet-1622	536	8	)	)	PUNCT
admet-1622	536	9	144	144	NUM
admet-1622	536	10	-	-	SYM
admet-1622	536	11	152	152	NUM
admet-1622	536	12	.	.	PUNCT
admet-1622	537	1	https://doi.org/10.1016/j.ijpharm.2018.04.055	https://doi.org/10.1016/j.ijpharm.2018.04.055	PROPN
admet-1622	538	1	[	[	X
admet-1622	538	2	54	54	NUM
admet-1622	538	3	]	]	X
admet-1622	538	4	n.g	n.g	PROPN
admet-1622	538	5	.	.	PROPN
admet-1622	538	6	patel	patel	PROPN
admet-1622	538	7	,	,	PUNCT
admet-1622	538	8	a.t	a.t	PROPN
admet-1622	538	9	.	.	PUNCT
admet-1622	538	10	serajuddin	serajuddin	PROPN
admet-1622	538	11	.	.	PUNCT
admet-1622	538	12	moisture	moisture	NOUN
admet-1622	538	13	sorption	sorption	NOUN
admet-1622	538	14	by	by	ADP
admet-1622	538	15	polymeric	polymeric	ADJ
admet-1622	538	16	excipients	excipient	NOUN
admet-1622	538	17	commonly	commonly	ADV
admet-1622	538	18	used	use	VERB
admet-1622	538	19	in	in	ADP
admet-1622	538	20	amorphous	amorphous	ADJ
admet-1622	538	21	solid	solid	ADJ
admet-1622	538	22	dispersion	dispersion	NOUN
admet-1622	538	23	and	and	CCONJ
admet-1622	538	24	its	its	PRON
admet-1622	538	25	effect	effect	NOUN
admet-1622	538	26	on	on	ADP
admet-1622	538	27	glass	glass	NOUN
admet-1622	538	28	transition	transition	NOUN
admet-1622	538	29	temperature	temperature	NOUN
admet-1622	538	30	:	:	PUNCT
admet-1622	538	31	i.	i.	PROPN
admet-1622	538	32	polyvinylpyrrolidone	polyvinylpyrrolidone	PROPN
admet-1622	538	33	and	and	CCONJ
admet-1622	538	34	related	related	ADJ
admet-1622	538	35	copolymers	copolymer	NOUN
admet-1622	538	36	.	.	PUNCT
admet-1622	539	1	international	international	ADJ
admet-1622	539	2	journal	journal	PROPN
admet-1622	539	3	of	of	ADP
admet-1622	539	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	539	5	616	616	NUM
admet-1622	539	6	(	(	PUNCT
admet-1622	539	7	2022	2022	NUM
admet-1622	539	8	)	)	PUNCT
admet-1622	539	9	121532	121532	NUM
admet-1622	539	10	.	.	PUNCT
admet-1622	540	1	https://doi.org/10.1016/j.ijpharm.2022.121532	https://doi.org/10.1016/j.ijpharm.2022.121532	NOUN
admet-1622	540	2	[	[	X
admet-1622	540	3	55	55	NUM
admet-1622	540	4	]	]	PUNCT
admet-1622	540	5	m.	m.	NOUN
admet-1622	540	6	đuranović	đuranović	NOUN
admet-1622	540	7	,	,	PUNCT
admet-1622	540	8	m.	m.	NOUN
admet-1622	540	9	madžarević	madžarević	NOUN
admet-1622	540	10	,	,	PUNCT
admet-1622	540	11	b.	b.	PROPN
admet-1622	540	12	ivković	ivković	PROPN
admet-1622	540	13	,	,	PUNCT
admet-1622	540	14	s.	s.	PROPN
admet-1622	540	15	ibrić	ibrić	PROPN
admet-1622	540	16	,	,	PUNCT
admet-1622	540	17	s.	s.	PROPN
admet-1622	540	18	cvijić	cvijić	PROPN
admet-1622	540	19	.	.	PUNCT
admet-1622	541	1	the	the	DET
admet-1622	541	2	evaluation	evaluation	NOUN
admet-1622	541	3	of	of	ADP
admet-1622	541	4	the	the	DET
admet-1622	541	5	effect	effect	NOUN
admet-1622	541	6	of	of	ADP
admet-1622	541	7	different	different	ADJ
admet-1622	541	8	superdisintegrants	superdisintegrant	NOUN
admet-1622	541	9	on	on	ADP
admet-1622	541	10	the	the	DET
admet-1622	541	11	drug	drug	NOUN
admet-1622	541	12	release	release	NOUN
admet-1622	541	13	from	from	ADP
admet-1622	541	14	fdm	fdm	NOUN
admet-1622	541	15	3d	3d	NUM
admet-1622	541	16	printed	print	VERB
admet-1622	541	17	tablets	tablet	NOUN
admet-1622	541	18	through	through	ADP
admet-1622	541	19	different	different	ADJ
admet-1622	541	20	applied	applied	ADJ
admet-1622	541	21	strategies	strategy	NOUN
admet-1622	541	22	:	:	PUNCT
admet-1622	541	23	in	in	ADP
admet-1622	541	24	vitro	vitro	VERB
admet-1622	541	25	-	-	PUNCT
admet-1622	541	26	in	in	ADP
admet-1622	541	27	silico	silico	NOUN
admet-1622	541	28	assessment	assessment	NOUN
admet-1622	541	29	.	.	PUNCT
admet-1622	542	1	international	international	ADJ
admet-1622	542	2	journal	journal	PROPN
admet-1622	542	3	of	of	ADP
admet-1622	542	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	542	5	610	610	NUM
admet-1622	542	6	(	(	PUNCT
admet-1622	542	7	2021	2021	NUM
admet-1622	542	8	)	)	PUNCT
admet-1622	542	9	121194	121194	NUM
admet-1622	542	10	.	.	PUNCT
admet-1622	543	1	https://doi.org/10.1016/j.ijpharm.2021.121194	https://doi.org/10.1016/j.ijpharm.2021.121194	PROPN
admet-1622	544	1	[	[	X
admet-1622	544	2	56	56	NUM
admet-1622	544	3	]	]	PUNCT
admet-1622	544	4	k.	k.	PROPN
admet-1622	544	5	shi	shi	PROPN
admet-1622	544	6	,	,	PUNCT
admet-1622	544	7	j.p	j.p	PROPN
admet-1622	544	8	.	.	PROPN
admet-1622	544	9	salvage	salvage	PROPN
admet-1622	544	10	,	,	PUNCT
admet-1622	544	11	m.	m.	NOUN
admet-1622	544	12	maniruzzaman	maniruzzaman	NOUN
admet-1622	544	13	,	,	PUNCT
admet-1622	544	14	a.	a.	NOUN
admet-1622	544	15	nokhodchi	nokhodchi	PROPN
admet-1622	544	16	.	.	PUNCT
admet-1622	545	1	role	role	NOUN
admet-1622	545	2	of	of	ADP
admet-1622	545	3	release	release	NOUN
admet-1622	545	4	modifiers	modifier	NOUN
admet-1622	545	5	to	to	PART
admet-1622	545	6	modulate	modulate	VERB
admet-1622	545	7	drug	drug	NOUN
admet-1622	545	8	release	release	NOUN
admet-1622	545	9	from	from	ADP
admet-1622	545	10	fused	fuse	VERB
admet-1622	545	11	deposition	deposition	NOUN
admet-1622	545	12	modelling	modelling	NOUN
admet-1622	545	13	(	(	PUNCT
admet-1622	545	14	fdm	fdm	NOUN
admet-1622	545	15	)	)	PUNCT
admet-1622	545	16	3d	3d	NOUN
admet-1622	545	17	printed	print	VERB
admet-1622	545	18	tablets	tablet	NOUN
admet-1622	545	19	.	.	PUNCT
admet-1622	546	1	international	international	ADJ
admet-1622	546	2	journal	journal	PROPN
admet-1622	546	3	of	of	ADP
admet-1622	546	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	546	5	597	597	NUM
admet-1622	546	6	(	(	PUNCT
admet-1622	546	7	2021	2021	NUM
admet-1622	546	8	)	)	PUNCT
admet-1622	546	9	120315	120315	NUM
admet-1622	546	10	.	.	PUNCT
admet-1622	547	1	https://doi.org/10.1016/j.ijpharm.2021.120315	https://doi.org/10.1016/j.ijpharm.2021.120315	PROPN
admet-1622	547	2	[	[	X
admet-1622	547	3	57	57	NUM
admet-1622	547	4	]	]	PUNCT
admet-1622	547	5	l.	l.	PROPN
admet-1622	547	6	krueger	krueger	PROPN
admet-1622	547	7	,	,	PUNCT
admet-1622	547	8	j.a	j.a	PROPN
admet-1622	547	9	.	.	PROPN
admet-1622	547	10	miles	miles	PROPN
admet-1622	547	11	,	,	PUNCT
admet-1622	547	12	a.	a.	NOUN
admet-1622	547	13	popat	popat	PROPN
admet-1622	547	14	.	.	PUNCT
admet-1622	548	1	3d	3d	NUM
admet-1622	548	2	printing	print	VERB
admet-1622	548	3	hybrid	hybrid	NOUN
admet-1622	548	4	materials	material	NOUN
admet-1622	548	5	using	use	VERB
admet-1622	548	6	fused	fuse	VERB
admet-1622	548	7	deposition	deposition	NOUN
admet-1622	548	8	modelling	modelling	NOUN
admet-1622	548	9	for	for	ADP
admet-1622	548	10	solid	solid	ADJ
admet-1622	548	11	oral	oral	ADJ
admet-1622	548	12	dosage	dosage	NOUN
admet-1622	548	13	forms	form	NOUN
admet-1622	548	14	.	.	PUNCT
admet-1622	549	1	journal	journal	NOUN
admet-1622	549	2	of	of	ADP
admet-1622	549	3	controlled	control	VERB
admet-1622	549	4	release	release	NOUN
admet-1622	549	5	351	351	NUM
admet-1622	549	6	(	(	PUNCT
admet-1622	549	7	2022	2022	NUM
admet-1622	549	8	)	)	PUNCT
admet-1622	549	9	444	444	NUM
admet-1622	549	10	-	-	SYM
admet-1622	549	11	455	455	NUM
admet-1622	549	12	.	.	PUNCT
admet-1622	550	1	https://doi.org/10.1016/j.jconrel.2022.09.032	https://doi.org/10.1016/j.jconrel.2022.09.032	NOUN
admet-1622	551	1	[	[	X
admet-1622	551	2	58	58	NUM
admet-1622	551	3	]	]	PUNCT
admet-1622	551	4	r.	r.	PROPN
admet-1622	551	5	thakkar	thakkar	PROPN
admet-1622	551	6	,	,	PUNCT
admet-1622	551	7	a.r	a.r	PROPN
admet-1622	551	8	.	.	PROPN
admet-1622	551	9	pillai	pillai	PROPN
admet-1622	551	10	,	,	PUNCT
admet-1622	551	11	j.	j.	PROPN
admet-1622	551	12	zhang	zhang	PROPN
admet-1622	551	13	,	,	PUNCT
admet-1622	551	14	y.	y.	PROPN
admet-1622	551	15	zhang	zhang	PROPN
admet-1622	551	16	,	,	PUNCT
admet-1622	551	17	v.	v.	PROPN
admet-1622	551	18	kulkarni	kulkarni	PROPN
admet-1622	551	19	,	,	PUNCT
admet-1622	551	20	m.	m.	NOUN
admet-1622	551	21	maniruzzaman	maniruzzaman	PROPN
admet-1622	551	22	.	.	PUNCT
admet-1622	552	1	novel	novel	NOUN
admet-1622	552	2	on	on	ADP
admet-1622	552	3	-	-	PUNCT
admet-1622	552	4	demand	demand	NOUN
admet-1622	552	5	3dimensional	3dimensional	PROPN
admet-1622	552	6	(	(	PUNCT
admet-1622	552	7	3	3	NUM
admet-1622	552	8	-	-	SYM
admet-1622	552	9	d	d	NOUN
admet-1622	552	10	)	)	PUNCT
admet-1622	552	11	printed	print	VERB
admet-1622	552	12	tablets	tablet	NOUN
admet-1622	552	13	using	use	VERB
admet-1622	552	14	fill	fill	NOUN
admet-1622	552	15	density	density	NOUN
admet-1622	552	16	as	as	ADP
admet-1622	552	17	an	an	DET
admet-1622	552	18	effective	effective	ADJ
admet-1622	552	19	release	release	NOUN
admet-1622	552	20	-	-	PUNCT
admet-1622	552	21	controlling	control	VERB
admet-1622	552	22	tool	tool	NOUN
admet-1622	552	23	.	.	PUNCT
admet-1622	553	1	polymers	polymer	NOUN
admet-1622	553	2	12	12	NUM
admet-1622	553	3	(	(	PUNCT
admet-1622	553	4	2020	2020	NUM
admet-1622	553	5	)	)	PUNCT
admet-1622	553	6	1872	1872	NUM
admet-1622	553	7	.	.	PUNCT
admet-1622	554	1	https://doi.org/10.3390/polym12091872	https://doi.org/10.3390/polym12091872	PROPN
admet-1622	555	1	[	[	X
admet-1622	555	2	59	59	NUM
admet-1622	555	3	]	]	PUNCT
admet-1622	555	4	j.	j.	PROPN
admet-1622	555	5	zhang	zhang	PROPN
admet-1622	555	6	,	,	PUNCT
admet-1622	555	7	r.	r.	PROPN
admet-1622	555	8	thakkar	thakkar	PROPN
admet-1622	555	9	,	,	PUNCT
admet-1622	555	10	y.	y.	PROPN
admet-1622	555	11	zhang	zhang	PROPN
admet-1622	555	12	,	,	PUNCT
admet-1622	555	13	m.	m.	NOUN
admet-1622	555	14	maniruzzaman	maniruzzaman	PROPN
admet-1622	555	15	.	.	PUNCT
admet-1622	555	16	structure	structure	NOUN
admet-1622	555	17	-	-	PUNCT
admet-1622	555	18	function	function	NOUN
admet-1622	555	19	correlation	correlation	NOUN
admet-1622	555	20	and	and	CCONJ
admet-1622	555	21	personalized	personalize	VERB
admet-1622	555	22	3d	3d	NUM
admet-1622	555	23	printed	print	VERB
admet-1622	555	24	tablets	tablet	NOUN
admet-1622	555	25	using	use	VERB
admet-1622	555	26	a	a	DET
admet-1622	555	27	quality	quality	NOUN
admet-1622	555	28	by	by	ADP
admet-1622	555	29	design	design	NOUN
admet-1622	555	30	(	(	PUNCT
admet-1622	555	31	qbd	qbd	NOUN
admet-1622	555	32	)	)	PUNCT
admet-1622	555	33	approach	approach	NOUN
admet-1622	555	34	.	.	PUNCT
admet-1622	556	1	international	international	ADJ
admet-1622	556	2	journal	journal	PROPN
admet-1622	556	3	of	of	ADP
admet-1622	556	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	556	5	590	590	NUM
admet-1622	556	6	(	(	PUNCT
admet-1622	556	7	2020	2020	NUM
admet-1622	556	8	)	)	PUNCT
admet-1622	556	9	119945	119945	NUM
admet-1622	556	10	.	.	PUNCT
admet-1622	557	1	https://doi.org/10.1016/j.ijpharm.2020.119945	https://doi.org/10.1016/j.ijpharm.2020.119945	NOUN
admet-1622	557	2	[	[	X
admet-1622	557	3	60	60	NUM
admet-1622	557	4	]	]	PUNCT
admet-1622	557	5	a.	a.	NOUN
admet-1622	557	6	goyanes	goyane	NOUN
admet-1622	557	7	,	,	PUNCT
admet-1622	557	8	a.b	a.b	PROPN
admet-1622	557	9	.	.	PROPN
admet-1622	557	10	buanz	buanz	PROPN
admet-1622	557	11	,	,	PUNCT
admet-1622	557	12	a.w	a.w	PROPN
admet-1622	557	13	.	.	PROPN
admet-1622	557	14	basit	basit	PROPN
admet-1622	557	15	,	,	PUNCT
admet-1622	557	16	s.	s.	PROPN
admet-1622	557	17	gaisford	gaisford	PROPN
admet-1622	557	18	.	.	PUNCT
admet-1622	558	1	fused	fuse	VERB
admet-1622	558	2	-	-	PUNCT
admet-1622	558	3	filament	filament	NOUN
admet-1622	558	4	3d	3d	NOUN
admet-1622	558	5	printing	printing	NOUN
admet-1622	558	6	(	(	PUNCT
admet-1622	558	7	3dp	3dp	ADJ
admet-1622	558	8	)	)	PUNCT
admet-1622	558	9	for	for	ADP
admet-1622	558	10	fabrication	fabrication	NOUN
admet-1622	558	11	of	of	ADP
admet-1622	558	12	tablets	tablet	NOUN
admet-1622	558	13	.	.	PUNCT
admet-1622	559	1	international	international	ADJ
admet-1622	559	2	journal	journal	PROPN
admet-1622	559	3	of	of	ADP
admet-1622	559	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	559	5	476	476	NUM
admet-1622	559	6	(	(	PUNCT
admet-1622	559	7	2014	2014	NUM
admet-1622	559	8	)	)	PUNCT
admet-1622	559	9	88	88	NUM
admet-1622	559	10	-	-	SYM
admet-1622	559	11	92	92	NUM
admet-1622	559	12	.	.	PUNCT
admet-1622	560	1	https://doi.org/10.1016/j.ijpharm.2014.09.044	https://doi.org/10.1016/j.ijpharm.2014.09.044	PROPN
admet-1622	560	2	[	[	X
admet-1622	560	3	61	61	NUM
admet-1622	560	4	]	]	PUNCT
admet-1622	560	5	b.	b.	PROPN
admet-1622	560	6	arafat	arafat	PROPN
admet-1622	560	7	,	,	PUNCT
admet-1622	560	8	m.	m.	NOUN
admet-1622	560	9	wojsz	wojsz	PROPN
admet-1622	560	10	,	,	PUNCT
admet-1622	560	11	a.	a.	PROPN
admet-1622	560	12	isreb	isreb	PROPN
admet-1622	560	13	,	,	PUNCT
admet-1622	560	14	r.t	r.t	PROPN
admet-1622	560	15	.	.	PROPN
admet-1622	560	16	forbes	forbes	PROPN
admet-1622	560	17	,	,	PUNCT
admet-1622	560	18	m.	m.	PROPN
admet-1622	560	19	isreb	isreb	PROPN
admet-1622	560	20	,	,	PUNCT
admet-1622	560	21	w.	w.	PROPN
admet-1622	560	22	ahmed	ahmed	PROPN
admet-1622	560	23	,	,	PUNCT
admet-1622	560	24	t.	t.	PROPN
admet-1622	560	25	arafat	arafat	PROPN
admet-1622	560	26	,	,	PUNCT
admet-1622	560	27	m.a	m.a	PROPN
admet-1622	560	28	.	.	PROPN
admet-1622	560	29	alhnan	alhnan	PROPN
admet-1622	560	30	.	.	PUNCT
admet-1622	561	1	tablet	tablet	NOUN
admet-1622	561	2	fragmentation	fragmentation	NOUN
admet-1622	561	3	without	without	ADP
admet-1622	561	4	a	a	DET
admet-1622	561	5	disintegrant	disintegrant	NOUN
admet-1622	561	6	:	:	PUNCT
admet-1622	561	7	a	a	DET
admet-1622	561	8	novel	novel	ADJ
admet-1622	561	9	design	design	NOUN
admet-1622	561	10	approach	approach	NOUN
admet-1622	561	11	for	for	ADP
admet-1622	561	12	accelerating	accelerate	VERB
admet-1622	561	13	disintegration	disintegration	NOUN
admet-1622	561	14	and	and	CCONJ
admet-1622	561	15	drug	drug	NOUN
admet-1622	561	16	release	release	NOUN
admet-1622	561	17	from	from	ADP
admet-1622	561	18	3d	3d	NUM
admet-1622	561	19	printed	print	VERB
admet-1622	561	20	cellulosic	cellulosic	NOUN
admet-1622	561	21	tablets	tablet	NOUN
admet-1622	561	22	.	.	PUNCT
admet-1622	562	1	european	european	ADJ
admet-1622	562	2	journal	journal	PROPN
admet-1622	562	3	of	of	ADP
admet-1622	562	4	pharmaceutical	pharmaceutical	PROPN
admet-1622	562	5	sciences	science	NOUN
admet-1622	562	6	118	118	NUM
admet-1622	562	7	(	(	PUNCT
admet-1622	562	8	2018	2018	NUM
admet-1622	562	9	)	)	PUNCT
admet-1622	562	10	191	191	NUM
admet-1622	562	11	-	-	SYM
admet-1622	562	12	199	199	NUM
admet-1622	562	13	.	.	PUNCT
admet-1622	563	1	https://doi.org/10.1016/j.ejps.2018.03.019	https://doi.org/10.1016/j.ejps.2018.03.019	NOUN
admet-1622	563	2	[	[	X
admet-1622	563	3	62	62	NUM
admet-1622	563	4	]	]	PUNCT
admet-1622	563	5	m.	m.	PROPN
admet-1622	563	6	sadia	sadia	PROPN
admet-1622	563	7	,	,	PUNCT
admet-1622	563	8	b.	b.	PROPN
admet-1622	563	9	arafat	arafat	PROPN
admet-1622	563	10	,	,	PUNCT
admet-1622	563	11	w.	w.	PROPN
admet-1622	563	12	ahmed	ahmed	PROPN
admet-1622	563	13	,	,	PUNCT
admet-1622	563	14	r.t	r.t	PROPN
admet-1622	563	15	.	.	PROPN
admet-1622	563	16	forbes	forbes	PROPN
admet-1622	563	17	,	,	PUNCT
admet-1622	563	18	m.a	m.a	PROPN
admet-1622	563	19	.	.	PROPN
admet-1622	563	20	alhnan	alhnan	PROPN
admet-1622	563	21	.	.	PUNCT
admet-1622	564	1	channelled	channel	VERB
admet-1622	564	2	tablets	tablet	NOUN
admet-1622	564	3	:	:	PUNCT
admet-1622	564	4	an	an	DET
admet-1622	564	5	innovative	innovative	ADJ
admet-1622	564	6	approach	approach	NOUN
admet-1622	564	7	to	to	ADP
admet-1622	564	8	accelerating	accelerate	VERB
admet-1622	564	9	drug	drug	NOUN
admet-1622	564	10	release	release	NOUN
admet-1622	564	11	from	from	ADP
admet-1622	564	12	3d	3d	NUM
admet-1622	564	13	printed	print	VERB
admet-1622	564	14	tablets	tablet	NOUN
admet-1622	564	15	.	.	PUNCT
admet-1622	565	1	journal	journal	PROPN
admet-1622	565	2	of	of	ADP
admet-1622	565	3	controlled	control	VERB
admet-1622	565	4	release	release	NOUN
admet-1622	565	5	269	269	NUM
admet-1622	565	6	(	(	PUNCT
admet-1622	565	7	2018	2018	NUM
admet-1622	565	8	)	)	PUNCT
admet-1622	565	9	355	355	NUM
admet-1622	565	10	-	-	SYM
admet-1622	565	11	363	363	NUM
admet-1622	565	12	.	.	PUNCT
admet-1622	566	1	https://doi.org/10.1016/j.jconrel.2017.11.022	https://doi.org/10.1016/j.jconrel.2017.11.022	NOUN
admet-1622	567	1	[	[	X
admet-1622	567	2	63	63	NUM
admet-1622	567	3	]	]	PUNCT
admet-1622	567	4	a.	a.	NOUN
admet-1622	567	5	isreb	isreb	PROPN
admet-1622	567	6	,	,	PUNCT
admet-1622	567	7	k.	k.	PROPN
admet-1622	567	8	baj	baj	PROPN
admet-1622	567	9	,	,	PUNCT
admet-1622	567	10	m.	m.	NOUN
admet-1622	567	11	wojsz	wojsz	PROPN
admet-1622	567	12	,	,	PUNCT
admet-1622	567	13	m.	m.	NOUN
admet-1622	567	14	isreb	isreb	PROPN
admet-1622	567	15	,	,	PUNCT
admet-1622	567	16	m.	m.	NOUN
admet-1622	567	17	peak	peak	PROPN
admet-1622	567	18	,	,	PUNCT
admet-1622	567	19	m.a	m.a	PROPN
admet-1622	567	20	.	.	PROPN
admet-1622	567	21	alhnan	alhnan	PROPN
admet-1622	567	22	.	.	PUNCT
admet-1622	568	1	3d	3d	PROPN
admet-1622	568	2	printed	print	VERB
admet-1622	568	3	oral	oral	ADJ
admet-1622	568	4	theophylline	theophylline	NOUN
admet-1622	568	5	doses	dose	NOUN
admet-1622	568	6	with	with	ADP
admet-1622	568	7	innovative	innovative	ADJ
admet-1622	568	8	‘	'	PUNCT
admet-1622	568	9	radiator	radiator	NOUN
admet-1622	568	10	-	-	PUNCT
admet-1622	568	11	like’design	like’design	NOUN
admet-1622	568	12	:	:	PUNCT
admet-1622	568	13	impact	impact	NOUN
admet-1622	568	14	of	of	ADP
admet-1622	568	15	polyethylene	polyethylene	NOUN
admet-1622	568	16	oxide	oxide	NOUN
admet-1622	568	17	(	(	PUNCT
admet-1622	568	18	peo	peo	NOUN
admet-1622	568	19	)	)	PUNCT
admet-1622	568	20	molecular	molecular	ADJ
admet-1622	568	21	weight	weight	NOUN
admet-1622	568	22	.	.	PUNCT
admet-1622	569	1	international	international	ADJ
admet-1622	569	2	journal	journal	PROPN
admet-1622	569	3	of	of	ADP
admet-1622	569	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	569	5	564	564	NUM
admet-1622	569	6	(	(	PUNCT
admet-1622	569	7	2019	2019	NUM
admet-1622	569	8	)	)	PUNCT
admet-1622	569	9	98	98	NUM
admet-1622	569	10	-	-	SYM
admet-1622	569	11	105	105	NUM
admet-1622	569	12	.	.	PUNCT
admet-1622	570	1	https://doi.org/10.1016/j.ijpharm.2019.04.017	https://doi.org/10.1016/j.ijpharm.2019.04.017	X
admet-1622	570	2	[	[	SYM
admet-1622	570	3	64	64	NUM
admet-1622	570	4	]	]	X
admet-1622	570	5	s.a	s.a	PROPN
admet-1622	570	6	.	.	PROPN
admet-1622	570	7	khaled	khaled	PROPN
admet-1622	570	8	,	,	PUNCT
admet-1622	570	9	m.r	m.r	PROPN
admet-1622	570	10	.	.	PROPN
admet-1622	570	11	alexander	alexander	PROPN
admet-1622	570	12	,	,	PUNCT
admet-1622	570	13	d.j	d.j	PROPN
admet-1622	570	14	.	.	PROPN
admet-1622	570	15	irvine	irvine	PROPN
admet-1622	570	16	,	,	PUNCT
admet-1622	570	17	r.d	r.d	PROPN
admet-1622	570	18	.	.	PROPN
admet-1622	570	19	wildman	wildman	PROPN
admet-1622	570	20	,	,	PUNCT
admet-1622	570	21	m.j	m.j	PROPN
admet-1622	570	22	.	.	PROPN
admet-1622	570	23	wallace	wallace	PROPN
admet-1622	570	24	,	,	PUNCT
admet-1622	570	25	s.	s.	PROPN
admet-1622	570	26	sharpe	sharpe	PROPN
admet-1622	570	27	,	,	PUNCT
admet-1622	570	28	j.	j.	PROPN
admet-1622	570	29	yoo	yoo	PROPN
admet-1622	570	30	,	,	PUNCT
admet-1622	570	31	c.j	c.j	PROPN
admet-1622	570	32	.	.	PROPN
admet-1622	570	33	roberts	roberts	PROPN
admet-1622	570	34	.	.	PUNCT
admet-1622	571	1	extrusion	extrusion	NOUN
admet-1622	571	2	3d	3d	NOUN
admet-1622	571	3	printing	printing	NOUN
admet-1622	571	4	of	of	ADP
admet-1622	571	5	paracetamol	paracetamol	NOUN
admet-1622	571	6	tablets	tablet	NOUN
admet-1622	571	7	from	from	ADP
admet-1622	571	8	a	a	DET
admet-1622	571	9	single	single	ADJ
admet-1622	571	10	formulation	formulation	NOUN
admet-1622	571	11	with	with	ADP
admet-1622	571	12	tunable	tunable	ADJ
admet-1622	571	13	release	release	NOUN
admet-1622	571	14	profiles	profile	NOUN
admet-1622	571	15	through	through	ADP
admet-1622	571	16	control	control	NOUN
admet-1622	571	17	of	of	ADP
admet-1622	571	18	tablet	tablet	ADJ
admet-1622	571	19	geometry	geometry	NOUN
admet-1622	571	20	.	.	PUNCT
admet-1622	572	1	aaps	aap	NOUN
admet-1622	572	2	pharmscitech	pharmscitech	VERB
admet-1622	572	3	19	19	NUM
admet-1622	572	4	(	(	PUNCT
admet-1622	572	5	2018	2018	NUM
admet-1622	572	6	)	)	PUNCT
admet-1622	572	7	3403	3403	NUM
admet-1622	572	8	-	-	SYM
admet-1622	572	9	3413	3413	NUM
admet-1622	572	10	.	.	PUNCT
admet-1622	573	1	https://doi.org/10.1208/s12249-018-1107-z	https://doi.org/10.1208/s12249-018-1107-z	PROPN
admet-1622	573	2	https://doi.org/10.1016/j.ijpharm.2021.120417	https://doi.org/10.1016/j.ijpharm.2021.120417	ADV
admet-1622	573	3	https://doi.org/10.1016/j.jddst.2022.103538	https://doi.org/10.1016/j.jddst.2022.103538	VERB
admet-1622	573	4	https://doi.org/10.1208/s12249-018-1233-7	https://doi.org/10.1208/s12249-018-1233-7	PROPN
admet-1622	573	5	https://doi.org/10.1016/j.ijpharm.2018.04.055	https://doi.org/10.1016/j.ijpharm.2018.04.055	PROPN
admet-1622	573	6	https://doi.org/10.1016/j.ijpharm.2022.121532	https://doi.org/10.1016/j.ijpharm.2022.121532	PROPN
admet-1622	573	7	https://doi.org/10.1016/j.ijpharm.2022.121532	https://doi.org/10.1016/j.ijpharm.2022.121532	PROPN
admet-1622	573	8	https://doi.org/10.1016/j.ijpharm.2021.121194	https://doi.org/10.1016/j.ijpharm.2021.121194	NOUN
admet-1622	573	9	https://doi.org/10.1016/j.ijpharm.2021.120315	https://doi.org/10.1016/j.ijpharm.2021.120315	PROPN
admet-1622	573	10	https://doi.org/10.1016/j.jconrel.2022.09.032	https://doi.org/10.1016/j.jconrel.2022.09.032	NUM
admet-1622	573	11	https://doi.org/10.1016/j.jconrel.2022.09.032	https://doi.org/10.1016/j.jconrel.2022.09.032	NUM
admet-1622	573	12	https://doi.org/10.3390/polym12091872	https://doi.org/10.3390/polym12091872	PROPN
admet-1622	573	13	https://doi.org/10.1016/j.ijpharm.2020.119945	https://doi.org/10.1016/j.ijpharm.2020.119945	PROPN
admet-1622	573	14	https://doi.org/10.1016/j.ijpharm.2014.09.044	https://doi.org/10.1016/j.ijpharm.2014.09.044	PROPN
admet-1622	573	15	https://doi.org/10.1016/j.ijpharm.2014.09.044	https://doi.org/10.1016/j.ijpharm.2014.09.044	PROPN
admet-1622	573	16	https://doi.org/10.1016/j.ejps.2018.03.019	https://doi.org/10.1016/j.ejps.2018.03.019	PROPN
admet-1622	573	17	https://doi.org/10.1016/j.jconrel.2017.11.022	https://doi.org/10.1016/j.jconrel.2017.11.022	PROPN
admet-1622	573	18	https://doi.org/10.1016/j.ijpharm.2019.04.017	https://doi.org/10.1016/j.ijpharm.2019.04.017	PRON
admet-1622	573	19	https://doi.org/10.1208/s12249-018-1107-z	https://doi.org/10.1208/s12249-018-1107-z	ADV
admet-1622	573	20	https://doi.org/10.1208/s12249-018-1107-z	https://doi.org/10.1208/s12249-018-1107-z	PROPN
admet-1622	573	21	admet	admet	NOUN
admet-1622	573	22	&	&	CCONJ
admet-1622	573	23	dmpk	dmpk	PROPN
admet-1622	573	24	11(1	11(1	NUM
admet-1622	573	25	)	)	PUNCT
admet-1622	573	26	(	(	PUNCT
admet-1622	573	27	2023	2023	NUM
admet-1622	573	28	)	)	PUNCT
admet-1622	573	29	33	33	NUM
admet-1622	573	30	-	-	SYM
admet-1622	573	31	55	55	NUM
admet-1622	573	32	development	development	NOUN
admet-1622	573	33	of	of	ADP
admet-1622	573	34	rapidly	rapidly	ADV
admet-1622	573	35	dissolving	dissolve	VERB
admet-1622	573	36	fdm	fdm	NOUN
admet-1622	573	37	3d	3d	ADV
admet-1622	573	38	-	-	PUNCT
admet-1622	573	39	printed	print	VERB
admet-1622	573	40	tablets	tablet	NOUN
admet-1622	573	41	doi	doi	NOUN
admet-1622	573	42	:	:	PUNCT
admet-1622	573	43	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	NUM
admet-1622	573	44	55	55	NUM
admet-1622	573	45	[	[	SYM
admet-1622	573	46	65	65	NUM
admet-1622	573	47	]	]	X
admet-1622	573	48	a.	a.	NOUN
admet-1622	573	49	goyanes	goyanes	PROPN
admet-1622	573	50	,	,	PUNCT
admet-1622	573	51	p.r	p.r	PROPN
admet-1622	573	52	.	.	PROPN
admet-1622	573	53	martinez	martinez	PROPN
admet-1622	573	54	,	,	PUNCT
admet-1622	573	55	a.	a.	NOUN
admet-1622	573	56	buanz	buanz	PROPN
admet-1622	573	57	,	,	PUNCT
admet-1622	573	58	a.w	a.w	PROPN
admet-1622	573	59	.	.	PROPN
admet-1622	573	60	basit	basit	PROPN
admet-1622	573	61	,	,	PUNCT
admet-1622	573	62	s.	s.	PROPN
admet-1622	573	63	gaisford	gaisford	PROPN
admet-1622	573	64	.	.	PUNCT
admet-1622	574	1	effect	effect	NOUN
admet-1622	574	2	of	of	ADP
admet-1622	574	3	geometry	geometry	NOUN
admet-1622	574	4	on	on	ADP
admet-1622	574	5	drug	drug	NOUN
admet-1622	574	6	release	release	NOUN
admet-1622	574	7	from	from	ADP
admet-1622	574	8	3d	3d	NUM
admet-1622	574	9	printed	print	VERB
admet-1622	574	10	tablets	tablet	NOUN
admet-1622	574	11	.	.	PUNCT
admet-1622	575	1	international	international	ADJ
admet-1622	575	2	journal	journal	PROPN
admet-1622	575	3	of	of	ADP
admet-1622	575	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	575	5	494	494	NUM
admet-1622	575	6	(	(	PUNCT
admet-1622	575	7	2015	2015	NUM
admet-1622	575	8	)	)	PUNCT
admet-1622	575	9	657	657	NUM
admet-1622	575	10	-	-	SYM
admet-1622	575	11	663	663	NUM
admet-1622	575	12	.	.	PUNCT
admet-1622	576	1	https://doi.org/10.1016/j.ijpharm.2015.04.069	https://doi.org/10.1016/j.ijpharm.2015.04.069	NOUN
admet-1622	576	2	[	[	X
admet-1622	576	3	66	66	NUM
admet-1622	576	4	]	]	PUNCT
admet-1622	576	5	s.	s.	PROPN
admet-1622	576	6	palekar	palekar	PROPN
admet-1622	576	7	,	,	PUNCT
admet-1622	576	8	p.k	p.k	PROPN
admet-1622	576	9	.	.	PROPN
admet-1622	576	10	nukala	nukala	PROPN
admet-1622	576	11	,	,	PUNCT
admet-1622	576	12	s.m	s.m	PROPN
admet-1622	576	13	.	.	PROPN
admet-1622	576	14	mishra	mishra	PROPN
admet-1622	576	15	,	,	PUNCT
admet-1622	576	16	t.	t.	PROPN
admet-1622	576	17	kipping	kipping	PROPN
admet-1622	576	18	,	,	PUNCT
admet-1622	576	19	k.	k.	PROPN
admet-1622	576	20	patel	patel	PROPN
admet-1622	576	21	.	.	PUNCT
admet-1622	577	1	application	application	NOUN
admet-1622	577	2	of	of	ADP
admet-1622	577	3	3d	3d	NUM
admet-1622	577	4	printing	printing	NOUN
admet-1622	577	5	technology	technology	NOUN
admet-1622	577	6	and	and	CCONJ
admet-1622	577	7	quality	quality	NOUN
admet-1622	577	8	by	by	ADP
admet-1622	577	9	design	design	NOUN
admet-1622	577	10	approach	approach	NOUN
admet-1622	577	11	for	for	ADP
admet-1622	577	12	development	development	NOUN
admet-1622	577	13	of	of	ADP
admet-1622	577	14	age	age	NOUN
admet-1622	577	15	-	-	PUNCT
admet-1622	577	16	appropriate	appropriate	ADJ
admet-1622	577	17	pediatric	pediatric	ADJ
admet-1622	577	18	formulation	formulation	NOUN
admet-1622	577	19	of	of	ADP
admet-1622	577	20	baclofen	baclofen	PROPN
admet-1622	577	21	.	.	PUNCT
admet-1622	578	1	international	international	ADJ
admet-1622	578	2	journal	journal	PROPN
admet-1622	578	3	of	of	ADP
admet-1622	578	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	578	5	556	556	NUM
admet-1622	578	6	(	(	PUNCT
admet-1622	578	7	2019	2019	NUM
admet-1622	578	8	)	)	PUNCT
admet-1622	578	9	106	106	NUM
admet-1622	578	10	-	-	SYM
admet-1622	578	11	116	116	NUM
admet-1622	578	12	.	.	PUNCT
admet-1622	579	1	https://doi.org/10.1016/j.ijpharm.2018.11.062	https://doi.org/10.1016/j.ijpharm.2018.11.062	NOUN
admet-1622	579	2	[	[	X
admet-1622	579	3	67	67	X
admet-1622	579	4	]	]	X
admet-1622	579	5	v.	v.	PROPN
admet-1622	579	6	raje	raje	PROPN
admet-1622	579	7	,	,	PUNCT
admet-1622	579	8	s.	s.	PROPN
admet-1622	579	9	palekar	palekar	PROPN
admet-1622	579	10	,	,	PUNCT
admet-1622	579	11	s.	s.	PROPN
admet-1622	579	12	banella	banella	PROPN
admet-1622	579	13	,	,	PUNCT
admet-1622	579	14	k.	k.	PROPN
admet-1622	579	15	patel	patel	PROPN
admet-1622	579	16	.	.	PUNCT
admet-1622	580	1	tunable	tunable	ADJ
admet-1622	580	2	drug	drug	NOUN
admet-1622	580	3	release	release	NOUN
admet-1622	580	4	from	from	ADP
admet-1622	580	5	fused	fuse	VERB
admet-1622	580	6	deposition	deposition	NOUN
admet-1622	580	7	modelling	modelling	NOUN
admet-1622	580	8	(	(	PUNCT
admet-1622	580	9	fdm	fdm	NOUN
admet-1622	580	10	)	)	PUNCT
admet-1622	580	11	3d	3d	NOUN
admet-1622	580	12	-	-	PUNCT
admet-1622	580	13	printed	print	VERB
admet-1622	580	14	tablets	tablet	NOUN
admet-1622	580	15	fabricated	fabricate	VERB
admet-1622	580	16	using	use	VERB
admet-1622	580	17	a	a	DET
admet-1622	580	18	novel	novel	ADJ
admet-1622	580	19	extrudable	extrudable	ADJ
admet-1622	580	20	polymer	polymer	NOUN
admet-1622	580	21	.	.	PUNCT
admet-1622	581	1	pharmaceutics	pharmaceutic	NOUN
admet-1622	581	2	14	14	NUM
admet-1622	581	3	(	(	PUNCT
admet-1622	581	4	2022	2022	NUM
admet-1622	581	5	)	)	PUNCT
admet-1622	581	6	2192	2192	NUM
admet-1622	581	7	.	.	PUNCT
admet-1622	582	1	https://doi.org/10.3390/pharmaceutics14102192	https://doi.org/10.3390/pharmaceutics14102192	NOUN
admet-1622	582	2	[	[	X
admet-1622	582	3	68	68	NUM
admet-1622	582	4	]	]	PUNCT
admet-1622	582	5	a.	a.	NOUN
admet-1622	582	6	melocchi	melocchi	PROPN
admet-1622	582	7	,	,	PUNCT
admet-1622	582	8	f.	f.	PROPN
admet-1622	582	9	briatico	briatico	PROPN
admet-1622	582	10	-	-	PUNCT
admet-1622	582	11	vangosa	vangosa	PROPN
admet-1622	582	12	,	,	PUNCT
admet-1622	582	13	m.	m.	NOUN
admet-1622	582	14	uboldi	uboldi	PROPN
admet-1622	582	15	,	,	PUNCT
admet-1622	582	16	f.	f.	PROPN
admet-1622	582	17	parietti	parietti	PROPN
admet-1622	582	18	,	,	PUNCT
admet-1622	582	19	m.	m.	NOUN
admet-1622	582	20	turchi	turchi	PROPN
admet-1622	582	21	,	,	PUNCT
admet-1622	582	22	d.	d.	PROPN
admet-1622	582	23	von	von	PROPN
admet-1622	582	24	zeppelin	zeppelin	PROPN
admet-1622	582	25	,	,	PUNCT
admet-1622	582	26	a.	a.	PROPN
admet-1622	582	27	maroni	maroni	PROPN
admet-1622	582	28	,	,	PUNCT
admet-1622	582	29	l.	l.	PROPN
admet-1622	582	30	zema	zema	PROPN
admet-1622	582	31	,	,	PUNCT
admet-1622	582	32	a.	a.	NOUN
admet-1622	582	33	gazzaniga	gazzaniga	PROPN
admet-1622	582	34	,	,	PUNCT
admet-1622	582	35	a.	a.	PROPN
admet-1622	582	36	zidan	zidan	PROPN
admet-1622	582	37	.	.	PUNCT
admet-1622	583	1	quality	quality	NOUN
admet-1622	583	2	considerations	consideration	NOUN
admet-1622	583	3	on	on	ADP
admet-1622	583	4	the	the	DET
admet-1622	583	5	pharmaceutical	pharmaceutical	ADJ
admet-1622	583	6	applications	application	NOUN
admet-1622	583	7	of	of	ADP
admet-1622	583	8	fused	fuse	VERB
admet-1622	583	9	deposition	deposition	NOUN
admet-1622	583	10	modeling	model	VERB
admet-1622	583	11	3d	3d	NUM
admet-1622	583	12	printing	printing	NOUN
admet-1622	583	13	.	.	PUNCT
admet-1622	584	1	international	international	ADJ
admet-1622	584	2	journal	journal	PROPN
admet-1622	584	3	of	of	ADP
admet-1622	584	4	pharmaceutics	pharmaceutic	NOUN
admet-1622	584	5	592	592	NUM
admet-1622	584	6	(	(	PUNCT
admet-1622	584	7	2021	2021	NUM
admet-1622	584	8	)	)	PUNCT
admet-1622	584	9	119901	119901	NUM
admet-1622	584	10	.	.	PUNCT
admet-1622	585	1	https://doi.org/10.1016/j.ijpharm.2020.119901	https://doi.org/10.1016/j.ijpharm.2020.119901	PROPN
admet-1622	585	2	[	[	X
admet-1622	585	3	69	69	NUM
admet-1622	585	4	]	]	PUNCT
admet-1622	585	5	t.	t.	PROPN
admet-1622	585	6	parikh	parikh	PROPN
admet-1622	585	7	,	,	PUNCT
admet-1622	585	8	h.k	h.k	PROPN
admet-1622	585	9	.	.	PROPN
admet-1622	585	10	sandhu	sandhu	PROPN
admet-1622	585	11	,	,	PUNCT
admet-1622	585	12	t.t	t.t	PROPN
admet-1622	585	13	.	.	PROPN
admet-1622	585	14	talele	talele	PROPN
admet-1622	585	15	,	,	PUNCT
admet-1622	585	16	a.	a.	PROPN
admet-1622	585	17	serajuddin	serajuddin	PROPN
admet-1622	585	18	.	.	PUNCT
admet-1622	586	1	characterization	characterization	NOUN
admet-1622	586	2	of	of	ADP
admet-1622	586	3	solid	solid	ADJ
admet-1622	586	4	dispersion	dispersion	NOUN
admet-1622	586	5	of	of	ADP
admet-1622	586	6	itraconazole	itraconazole	NOUN
admet-1622	586	7	prepared	prepare	VERB
admet-1622	586	8	by	by	ADP
admet-1622	586	9	solubilization	solubilization	NOUN
admet-1622	586	10	in	in	ADP
admet-1622	586	11	concentrated	concentrated	ADJ
admet-1622	586	12	aqueous	aqueous	ADJ
admet-1622	586	13	solutions	solution	NOUN
admet-1622	586	14	of	of	ADP
admet-1622	586	15	weak	weak	ADJ
admet-1622	586	16	organic	organic	ADJ
admet-1622	586	17	acids	acid	NOUN
admet-1622	586	18	and	and	CCONJ
admet-1622	586	19	drying	dry	VERB
admet-1622	586	20	.	.	PUNCT
admet-1622	587	1	pharmaceutical	pharmaceutical	PROPN
admet-1622	587	2	research	research	NOUN
admet-1622	587	3	33	33	NUM
admet-1622	587	4	(	(	PUNCT
admet-1622	587	5	2016	2016	NUM
admet-1622	587	6	)	)	PUNCT
admet-1622	587	7	1456	1456	NUM
admet-1622	587	8	-	-	SYM
admet-1622	587	9	1471	1471	NUM
admet-1622	587	10	.	.	PUNCT
admet-1622	588	1	https://doi.org/10.1007/s11095-016-1890-8	https://doi.org/10.1007/s11095-016-1890-8	NUM
admet-1622	589	1	[	[	X
admet-1622	589	2	70	70	NUM
admet-1622	589	3	]	]	PUNCT
admet-1622	589	4	a.	a.	NOUN
admet-1622	589	5	shah	shah	PROPN
admet-1622	589	6	,	,	PUNCT
admet-1622	589	7	a.	a.	PROPN
admet-1622	589	8	serajuddin	serajuddin	PROPN
admet-1622	589	9	,	,	PUNCT
admet-1622	589	10	supersolubilization	supersolubilization	NOUN
admet-1622	589	11	by	by	ADP
admet-1622	589	12	using	use	VERB
admet-1622	589	13	nonsalt	nonsalt	NOUN
admet-1622	589	14	-	-	PUNCT
admet-1622	589	15	forming	form	VERB
admet-1622	589	16	acid	acid	NOUN
admet-1622	589	17	-	-	PUNCT
admet-1622	589	18	base	base	NOUN
admet-1622	589	19	interaction	interaction	NOUN
admet-1622	589	20	,	,	PUNCT
admet-1622	589	21	in	in	ADP
admet-1622	589	22	amorphous	amorphous	ADJ
admet-1622	589	23	solid	solid	ADJ
admet-1622	589	24	dispersions	dispersion	NOUN
admet-1622	589	25	,	,	PUNCT
admet-1622	589	26	springer2014	springer2014	PROPN
admet-1622	589	27	,	,	PUNCT
admet-1622	589	28	p.	p.	NOUN
admet-1622	589	29	595	595	NUM
admet-1622	589	30	-	-	SYM
admet-1622	589	31	611	611	NUM
admet-1622	589	32	.	.	PUNCT
admet-1622	590	1	[	[	X
admet-1622	590	2	71	71	NUM
admet-1622	590	3	]	]	X
admet-1622	590	4	s.	s.	PROPN
admet-1622	590	5	singh	singh	PROPN
admet-1622	590	6	,	,	PUNCT
admet-1622	590	7	t.	t.	PROPN
admet-1622	590	8	parikh	parikh	PROPN
admet-1622	590	9	,	,	PUNCT
admet-1622	590	10	h.k	h.k	PROPN
admet-1622	590	11	.	.	PROPN
admet-1622	590	12	sandhu	sandhu	PROPN
admet-1622	590	13	,	,	PUNCT
admet-1622	590	14	n.h	n.h	PROPN
admet-1622	590	15	.	.	PROPN
admet-1622	590	16	shah	shah	PROPN
admet-1622	590	17	,	,	PUNCT
admet-1622	590	18	a.w	a.w	PROPN
admet-1622	590	19	.	.	PROPN
admet-1622	590	20	malick	malick	PROPN
admet-1622	590	21	,	,	PUNCT
admet-1622	590	22	d.	d.	PROPN
admet-1622	590	23	singhal	singhal	PROPN
admet-1622	590	24	,	,	PUNCT
admet-1622	590	25	a.	a.	PROPN
admet-1622	590	26	serajuddin	serajuddin	PROPN
admet-1622	590	27	.	.	PUNCT
admet-1622	591	1	supersolubilization	supersolubilization	NOUN
admet-1622	591	2	and	and	CCONJ
admet-1622	591	3	amorphization	amorphization	NOUN
admet-1622	591	4	of	of	ADP
admet-1622	591	5	a	a	DET
admet-1622	591	6	model	model	ADJ
admet-1622	591	7	basic	basic	ADJ
admet-1622	591	8	drug	drug	NOUN
admet-1622	591	9	,	,	PUNCT
admet-1622	591	10	haloperidol	haloperidol	NOUN
admet-1622	591	11	,	,	PUNCT
admet-1622	591	12	by	by	ADP
admet-1622	591	13	interaction	interaction	NOUN
admet-1622	591	14	with	with	ADP
admet-1622	591	15	weak	weak	ADJ
admet-1622	591	16	acids	acid	NOUN
admet-1622	591	17	.	.	PUNCT
admet-1622	592	1	pharmaceutical	pharmaceutical	ADJ
admet-1622	592	2	research	research	NOUN
admet-1622	592	3	30	30	NUM
admet-1622	592	4	(	(	PUNCT
admet-1622	592	5	2013	2013	NUM
admet-1622	592	6	)	)	PUNCT
admet-1622	592	7	1561	1561	NUM
admet-1622	592	8	-	-	SYM
admet-1622	592	9	1573	1573	NUM
admet-1622	592	10	.	.	PUNCT
admet-1622	593	1	https://doi.org/10.1007/s11095-013-0994-7	https://doi.org/10.1007/s11095-013-0994-7	NUM
admet-1622	594	1	[	[	X
admet-1622	594	2	72	72	NUM
admet-1622	594	3	]	]	X
admet-1622	594	4	a.t	a.t	PROPN
admet-1622	594	5	.	.	PUNCT
admet-1622	594	6	serajuddin	serajuddin	PROPN
admet-1622	594	7	.	.	PUNCT
admet-1622	595	1	salt	salt	NOUN
admet-1622	595	2	formation	formation	NOUN
admet-1622	595	3	to	to	PART
admet-1622	595	4	improve	improve	VERB
admet-1622	595	5	drug	drug	NOUN
admet-1622	595	6	solubility	solubility	NOUN
admet-1622	595	7	.	.	PUNCT
admet-1622	596	1	advanced	advanced	ADJ
admet-1622	596	2	drug	drug	NOUN
admet-1622	596	3	delivery	delivery	NOUN
admet-1622	596	4	reviews	review	VERB
admet-1622	596	5	59	59	NUM
admet-1622	596	6	(	(	PUNCT
admet-1622	596	7	2007	2007	NUM
admet-1622	596	8	)	)	PUNCT
admet-1622	596	9	603	603	NUM
admet-1622	596	10	-	-	SYM
admet-1622	596	11	616	616	NUM
admet-1622	596	12	.	.	PUNCT
admet-1622	597	1	https://doi.org/10.1016/j.addr.2007.05.010	https://doi.org/10.1016/j.addr.2007.05.010	NOUN
admet-1622	597	2	[	[	X
admet-1622	597	3	73	73	NUM
admet-1622	597	4	]	]	SYM
admet-1622	597	5	a.t	a.t	PROPN
admet-1622	597	6	.	.	PUNCT
admet-1622	597	7	serajuddin	serajuddin	PROPN
admet-1622	597	8	,	,	PUNCT
admet-1622	597	9	c.i	c.i	PROPN
admet-1622	597	10	.	.	PROPN
admet-1622	597	11	jarowski	jarowski	PROPN
admet-1622	597	12	.	.	PUNCT
admet-1622	598	1	effect	effect	NOUN
admet-1622	598	2	of	of	ADP
admet-1622	598	3	diffusion	diffusion	NOUN
admet-1622	598	4	layer	layer	NOUN
admet-1622	598	5	ph	ph	NOUN
admet-1622	598	6	and	and	CCONJ
admet-1622	598	7	solubility	solubility	NOUN
admet-1622	598	8	on	on	ADP
admet-1622	598	9	the	the	DET
admet-1622	598	10	dissolution	dissolution	NOUN
admet-1622	598	11	rate	rate	NOUN
admet-1622	598	12	of	of	ADP
admet-1622	598	13	pharmaceutical	pharmaceutical	NOUN
admet-1622	598	14	bases	basis	NOUN
admet-1622	598	15	and	and	CCONJ
admet-1622	598	16	their	their	PRON
admet-1622	598	17	hydrochloride	hydrochloride	NOUN
admet-1622	598	18	salts	salt	NOUN
admet-1622	598	19	i	i	PRON
admet-1622	598	20	:	:	PUNCT
admet-1622	598	21	phenazopyridine	phenazopyridine	PROPN
admet-1622	598	22	.	.	PUNCT
admet-1622	599	1	journal	journal	PROPN
admet-1622	599	2	of	of	ADP
admet-1622	599	3	pharmaceutical	pharmaceutical	NOUN
admet-1622	599	4	sciences	science	NOUN
admet-1622	599	5	74	74	NUM
admet-1622	599	6	(	(	PUNCT
admet-1622	599	7	1985	1985	NUM
admet-1622	599	8	)	)	PUNCT
admet-1622	599	9	142	142	NUM
admet-1622	599	10	-	-	SYM
admet-1622	599	11	147	147	NUM
admet-1622	599	12	.	.	PUNCT
admet-1622	600	1	https://doi.org/10.1002/jps.2600740208	https://doi.org/10.1002/jps.2600740208	PROPN
admet-1622	600	2	[	[	X
admet-1622	600	3	74	74	NUM
admet-1622	600	4	]	]	PUNCT
admet-1622	600	5	t.	t.	PROPN
admet-1622	600	6	parikh	parikh	PROPN
admet-1622	600	7	,	,	PUNCT
admet-1622	600	8	a.	a.	PROPN
admet-1622	600	9	serajuddin	serajuddin	PROPN
admet-1622	600	10	.	.	PUNCT
admet-1622	601	1	development	development	NOUN
admet-1622	601	2	of	of	ADP
admet-1622	601	3	fast	fast	ADV
admet-1622	601	4	-	-	PUNCT
admet-1622	601	5	dissolving	dissolve	VERB
admet-1622	601	6	amorphous	amorphous	ADJ
admet-1622	601	7	solid	solid	ADJ
admet-1622	601	8	dispersion	dispersion	NOUN
admet-1622	601	9	of	of	ADP
admet-1622	601	10	itraconazole	itraconazole	NOUN
admet-1622	601	11	by	by	ADP
admet-1622	601	12	melt	melt	VERB
admet-1622	601	13	extrusion	extrusion	NOUN
admet-1622	601	14	of	of	ADP
admet-1622	601	15	its	its	PRON
admet-1622	601	16	mixture	mixture	NOUN
admet-1622	601	17	with	with	ADP
admet-1622	601	18	weak	weak	ADJ
admet-1622	601	19	organic	organic	ADJ
admet-1622	601	20	carboxylic	carboxylic	ADJ
admet-1622	601	21	acid	acid	NOUN
admet-1622	601	22	and	and	CCONJ
admet-1622	601	23	polymer	polymer	NOUN
admet-1622	601	24	.	.	PUNCT
admet-1622	602	1	pharmaceutical	pharmaceutical	ADJ
admet-1622	602	2	research	research	NOUN
admet-1622	602	3	35	35	NUM
admet-1622	602	4	(	(	PUNCT
admet-1622	602	5	2018	2018	NUM
admet-1622	602	6	)	)	PUNCT
admet-1622	602	7	1	1	NUM
admet-1622	602	8	-	-	SYM
admet-1622	602	9	10	10	NUM
admet-1622	602	10	.	.	PUNCT
admet-1622	603	1	https://doi.org/10.1007/s11095-018-2407-4	https://doi.org/10.1007/s11095-018-2407-4	VERB
admet-1622	604	1	[	[	X
admet-1622	604	2	75	75	NUM
admet-1622	604	3	]	]	PUNCT
admet-1622	604	4	j.	j.	PROPN
admet-1622	604	5	aho	aho	PROPN
admet-1622	604	6	,	,	PUNCT
admet-1622	604	7	j.p	j.p	PROPN
admet-1622	604	8	.	.	PROPN
admet-1622	604	9	bøtker	bøtker	PROPN
admet-1622	604	10	,	,	PUNCT
admet-1622	604	11	n.	n.	PROPN
admet-1622	604	12	genina	genina	PROPN
admet-1622	604	13	,	,	PUNCT
admet-1622	604	14	m.	m.	NOUN
admet-1622	604	15	edinger	edinger	NOUN
admet-1622	604	16	,	,	PUNCT
admet-1622	604	17	l.	l.	PROPN
admet-1622	604	18	arnfast	arnfast	PROPN
admet-1622	604	19	,	,	PUNCT
admet-1622	604	20	j.	j.	PROPN
admet-1622	604	21	rantanen	rantanen	PROPN
admet-1622	604	22	.	.	PUNCT
admet-1622	604	23	roadmap	roadmap	NOUN
admet-1622	604	24	to	to	ADP
admet-1622	604	25	3d	3d	NOUN
admet-1622	604	26	-	-	PUNCT
admet-1622	604	27	printed	print	VERB
admet-1622	604	28	oral	oral	ADJ
admet-1622	604	29	pharmaceutical	pharmaceutical	ADJ
admet-1622	604	30	dosage	dosage	NOUN
admet-1622	604	31	forms	form	NOUN
admet-1622	604	32	:	:	PUNCT
admet-1622	604	33	feedstock	feedstock	NOUN
admet-1622	604	34	filament	filament	NOUN
admet-1622	604	35	properties	property	NOUN
admet-1622	604	36	and	and	CCONJ
admet-1622	604	37	characterization	characterization	NOUN
admet-1622	604	38	for	for	ADP
admet-1622	604	39	fused	fuse	VERB
admet-1622	604	40	deposition	deposition	NOUN
admet-1622	604	41	modeling	modeling	NOUN
admet-1622	604	42	.	.	PUNCT
admet-1622	605	1	journal	journal	NOUN
admet-1622	605	2	of	of	ADP
admet-1622	605	3	pharmaceutical	pharmaceutical	PROPN
admet-1622	605	4	sciences	science	NOUN
admet-1622	605	5	108	108	NUM
admet-1622	605	6	(	(	PUNCT
admet-1622	605	7	2019	2019	NUM
admet-1622	605	8	)	)	PUNCT
admet-1622	605	9	26	26	NUM
admet-1622	605	10	-	-	SYM
admet-1622	605	11	35	35	NUM
admet-1622	605	12	.	.	PUNCT
admet-1622	606	1	https://doi.org/10.1016/j.xphs.2018.11.012	https://doi.org/10.1016/j.xphs.2018.11.012	NOUN
admet-1622	606	2	[	[	X
admet-1622	606	3	76	76	NUM
admet-1622	606	4	]	]	X
admet-1622	606	5	guidance	guidance	NOUN
admet-1622	606	6	for	for	ADP
admet-1622	606	7	industry	industry	NOUN
admet-1622	606	8	dissolution	dissolution	NOUN
admet-1622	606	9	testing	testing	NOUN
admet-1622	606	10	of	of	ADP
admet-1622	606	11	immediate	immediate	ADJ
admet-1622	606	12	release	release	NOUN
admet-1622	606	13	solid	solid	ADJ
admet-1622	606	14	oral	oral	ADJ
admet-1622	606	15	dosage	dosage	NOUN
admet-1622	606	16	forms	form	NOUN
admet-1622	606	17	,	,	PUNCT
admet-1622	606	18	https://www.fda.gov/media/70936/download	https://www.fda.gov/media/70936/download	ADV
admet-1622	606	19	(	(	PUNCT
admet-1622	606	20	november	november	PROPN
admet-1622	606	21	12	12	NUM
admet-1622	606	22	,	,	PUNCT
admet-1622	606	23	2022	2022	NUM
admet-1622	606	24	)	)	PUNCT
admet-1622	606	25	.	.	PUNCT
admet-1622	607	1	[	[	X
admet-1622	607	2	77	77	NUM
admet-1622	607	3	]	]	X
admet-1622	607	4	j.b	j.b	PROPN
admet-1622	607	5	.	.	PUNCT
admet-1622	607	6	dressman	dressman	PROPN
admet-1622	607	7	,	,	PUNCT
admet-1622	607	8	g.l	g.l	PROPN
admet-1622	607	9	.	.	PROPN
admet-1622	607	10	amidon	amidon	PROPN
admet-1622	607	11	,	,	PUNCT
admet-1622	607	12	c.	c.	PROPN
admet-1622	607	13	reppas	reppas	PROPN
admet-1622	607	14	,	,	PUNCT
admet-1622	607	15	v.p	v.p	PROPN
admet-1622	607	16	.	.	PROPN
admet-1622	607	17	shah	shah	PROPN
admet-1622	607	18	.	.	PUNCT
admet-1622	608	1	dissolution	dissolution	PROPN
admet-1622	608	2	testing	testing	NOUN
admet-1622	608	3	as	as	ADP
admet-1622	608	4	a	a	DET
admet-1622	608	5	prognostic	prognostic	ADJ
admet-1622	608	6	tool	tool	NOUN
admet-1622	608	7	for	for	ADP
admet-1622	608	8	oral	oral	ADJ
admet-1622	608	9	drug	drug	NOUN
admet-1622	608	10	absorption	absorption	NOUN
admet-1622	608	11	:	:	PUNCT
admet-1622	608	12	immediate	immediate	ADJ
admet-1622	608	13	release	release	NOUN
admet-1622	608	14	dosage	dosage	NOUN
admet-1622	608	15	forms	form	NOUN
admet-1622	608	16	.	.	PUNCT
admet-1622	609	1	pharmaceutical	pharmaceutical	ADJ
admet-1622	609	2	research	research	NOUN
admet-1622	609	3	15	15	NUM
admet-1622	609	4	(	(	PUNCT
admet-1622	609	5	1998	1998	NUM
admet-1622	609	6	)	)	PUNCT
admet-1622	609	7	11	11	NUM
admet-1622	609	8	-	-	SYM
admet-1622	609	9	22	22	NUM
admet-1622	609	10	.	.	PUNCT
admet-1622	610	1	https://doi.org/10.1023/a:1011984216775	https://doi.org/10.1023/a:1011984216775	VERB
admet-1622	610	2	©	©	NOUN
admet-1622	610	3	2023	2023	NUM
admet-1622	610	4	by	by	ADP
admet-1622	610	5	the	the	DET
admet-1622	610	6	authors	author	NOUN
admet-1622	610	7	;	;	PUNCT
admet-1622	610	8	licensee	licensee	PROPN
admet-1622	610	9	iapc	iapc	PROPN
admet-1622	610	10	,	,	PUNCT
admet-1622	610	11	zagreb	zagreb	PROPN
admet-1622	610	12	,	,	PUNCT
admet-1622	610	13	croatia	croatia	PROPN
admet-1622	610	14	.	.	PUNCT
admet-1622	611	1	this	this	DET
admet-1622	611	2	article	article	NOUN
admet-1622	611	3	is	be	AUX
admet-1622	611	4	an	an	DET
admet-1622	611	5	open	open	ADJ
admet-1622	611	6	-	-	PUNCT
admet-1622	611	7	access	access	NOUN
admet-1622	611	8	article	article	NOUN
admet-1622	611	9	distributed	distribute	VERB
admet-1622	611	10	under	under	ADP
admet-1622	611	11	the	the	DET
admet-1622	611	12	terms	term	NOUN
admet-1622	611	13	and	and	CCONJ
admet-1622	611	14	conditions	condition	NOUN
admet-1622	611	15	of	of	ADP
admet-1622	611	16	the	the	DET
admet-1622	611	17	creative	creative	ADJ
admet-1622	611	18	commons	common	NOUN
admet-1622	611	19	attribution	attribution	NOUN
admet-1622	611	20	license	license	NOUN
admet-1622	611	21	(	(	PUNCT
admet-1622	611	22	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
admet-1622	611	23	)	)	PUNCT
admet-1622	611	24	https://doi.org/10.5599/admet.1622	https://doi.org/10.5599/admet.1622	VERB
admet-1622	611	25	https://doi.org/10.1016/j.ijpharm.2015.04.069	https://doi.org/10.1016/j.ijpharm.2015.04.069	PROPN
admet-1622	611	26	https://doi.org/10.1016/j.ijpharm.2015.04.069	https://doi.org/10.1016/j.ijpharm.2015.04.069	PROPN
admet-1622	611	27	https://doi.org/10.1016/j.ijpharm.2018.11.062	https://doi.org/10.1016/j.ijpharm.2018.11.062	PRON
admet-1622	611	28	https://doi.org/10.1016/j.ijpharm.2018.11.062	https://doi.org/10.1016/j.ijpharm.2018.11.062	PRON
admet-1622	611	29	https://doi.org/10.3390/pharmaceutics14102192	https://doi.org/10.3390/pharmaceutics14102192	PRON
admet-1622	611	30	https://doi.org/10.1016/j.ijpharm.2020.119901	https://doi.org/10.1016/j.ijpharm.2020.119901	PROPN
admet-1622	611	31	https://doi.org/10.1016/j.ijpharm.2020.119901	https://doi.org/10.1016/j.ijpharm.2020.119901	PROPN
admet-1622	611	32	https://doi.org/10.1007/s11095-016-1890-8	https://doi.org/10.1007/s11095-016-1890-8	NUM
admet-1622	611	33	https://doi.org/10.1007/s11095-013-0994-7	https://doi.org/10.1007/s11095-013-0994-7	NUM
admet-1622	611	34	https://doi.org/10.1016/j.addr.2007.05.010	https://doi.org/10.1016/j.addr.2007.05.010	PROPN
admet-1622	611	35	https://doi.org/10.1002/jps.2600740208	https://doi.org/10.1002/jps.2600740208	PROPN
admet-1622	611	36	https://doi.org/10.1007/s11095-018-2407-4	https://doi.org/10.1007/s11095-018-2407-4	NOUN
admet-1622	611	37	https://doi.org/10.1016/j.xphs.2018.11.012	https://doi.org/10.1016/j.xphs.2018.11.012	NOUN
admet-1622	611	38	https://doi.org/10.1016/j.xphs.2018.11.012	https://doi.org/10.1016/j.xphs.2018.11.012	NOUN
admet-1622	611	39	https://www.fda.gov/media/70936/download	https://www.fda.gov/media/70936/download	ADJ
admet-1622	611	40	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN